The under-recognition of trauma in the diagnosis of Borderline Personality Disorder (BPD) by Tallon, Doris
i 
OXFORD BROOKES UNIVERSITY 
The Under-recognition of Trauma in the Diagnosis 
of Borderline Personality Disorder (BPD)
Doris Tallon 
The thesis is submitted to the Department of Life and Social Sciences, 
Oxford Brookes University in partial fulfilment of the requirement of 
the award of Doctor of Philosophy. 
Supervised by: 
Professor Nigel Wellman, Director of Studies, Faculty of Health and Life 
Science 
Lindsey Coombes, Department of Psychology, Social Work and Public 
Health 
Doctor Reza Oskrochi, Senior Lecturer – Statistics, Department of 







BPD is a complex condition presenting with a wide array of features, making it 
difficult to diagnose and treat. Controversially, there is also concern about BPD 
misdiagnosis due to under-recognition of trauma and PTSD/CPTSD (Complex 
PTSD) because of common aetiology. PTSD/CPTSD has a better track record of 
successful treatment; as typically BPD treatment focuses more on symptoms, 
while PTSD/CPTSD treats underlying traumatic causes. Aim: The research 
objective is to assess if early screening for traumatic exposure and PTSD/CPTSD 
symptoms will enhance BPD diagnosis, and lead to improved 
treatment. Methodology: Following clinical and academic reviews, two stages 
were completed. Stage 1: Initially medical records of BPD (N=60) patients in three 
UK Mental Health Hospitals were examined for evidence of BPD, trauma, PTSD and 
CPTSD. Stage 2: Separate BPD outpatients (N=40) were screened for trauma, 
PTSD/CPTSD using a new simple ‘BPD Trauma Exposure and Reactions Screen’ 
(BTERS). Reliability and validity was then assessed using recommended reference 
instruments (CAPS and SIDES). Results: Trauma was recorded in 47% of the stage 
1 medical records, 100% in stage 2, 92.5% trauma in childhood. Sixty percent of 
stage 2 patients suffered distressing non-life-threatening trauma consistent with 
Adjustment Disorder. High trauma percentages in BPD are explained by a 
combination of life-threatening trauma, requiring specialist PTSD/CPTSD 
treatment, and non-life-threatening, which is treatable using similar techniques 
by BPD clinicians without specialist training. Conclusions: Although insufficient 
evidence for BPD misdiagnosis was found, an under-diagnosis of comorbid 
PTSD/CPTSD was confirmed. Without initial screening (BTERS) of BPD patients, 
clinicians are missing PTSD/CPTSD diagnoses, and hence are losing the opportunity 
for early treatment for a significant percentage of BPD patients, which could be 






This small but hopefully important step in the management of BPD is dedicated to 
BPD sufferers everywhere, in the anticipation that one day their underpinning 
traumatic stressors will be relieved by receiving enhanced treatment. In particular, 
the BPD patients of Prospect Park Hospital in Reading and Athena in Upton Park 
Hospital have provided the faith, support, collaboration and commitment to 
achieving the goal we set out here of breaking the seemingly endless cycle of 
readmission. What we have achieved with this project would not be possible 
without them. More than anybody else, the hard working and dedicated BPD 
clinicians have given the level of collaboration and clinical engagement that any 
researcher can only hope for. The conclusions proposed here are their 
conclusions; the recommendations, their recommendations, as no solution to the 
challenges of BPD treatment is possible without such competent professionals. 
Like other long-term trauma therapists, I felt intensely frustrated when I 
encountered BPD patients who seemed stuck with treatment routines that did not 
seem to adequately address the underlying causes of their suffering. Many of my 
former colleagues in the Erleigh Road Trauma Centre and some BPD specialists felt 
similarly, and it was they who provided the push for me to undertake this task. In 
this regard I cannot thank Professor Suzanna Rose and Dr Rashmi Shanker enough, 
who had such faith in my undeserved ability to complete this work. Suzanna is my 
mentor, my inspiration, and a key figure in the Steering Group of this Project. 
Equally important is my ever patient supervisor and guide throughout this long 
journey from Thames Valley University to Oxford Brookes, Professor Nigel 
Wellman. Also from the Steering Group, I must pay a special thank you to Doctor 
Rex Haigh. Rex stands out as a clinical director who has the empathy, expertise, 
dedication and above all, the leadership and courage to deliver real benefits to the 
BPD community. Without Rex’s critical insight and encouragement, this project 
could not succeed. Lastly, I must thank my colleagues who steadfastly supported 
me throughout this project. They are too numerous to name all individually but I 
would like to nonetheless acknowledge the following: Michael Neenan, Nicolette 
Cook, Sheila Woods, Yolanda Williams, Nigel Peterson and Vanessa Jones. A 
  
v 
project such as this builds on the dedicated academic and clinical achievements 
and excellent publications of other professionals. I sincerely hope that I have 
credited not only pioneers like Judith Herman, and recent practitioners such as 
Sven Barnow in Germany, but BPD and trauma experts everywhere. I could not 
have accessed such a gold mine of rich knowledge without serious, serious 
assistance from many library personnel. In this respect, I should mention Karine 
Barker from The Radcliffe Science Library in Oxford and all the Library members of 
Prospect Park Hospital. Finally, I would like to thank my children Guy and Zoe 
whom I adore, and who have been steadfastly supporting and patient with me 
through this very difficult time. Lastly, to my beloved husband David for 
demonstrating confidence in my ability to complete this huge task. He knows that 






 Table of Contents 
Abstract ................................................................................................................... iii 
Acknowledgements ................................................................................................ iv 
Table of Contents ................................................................................................... vii 
Appendices ............................................................................................................ xiii 
List of Tables ........................................................................................................... ix 
List of Figures .......................................................................................................... xi 
1 INTRODUCTION ........................................................................... 1 
1.1 Background to the Problem, and why the Research is Important ............ 1 
1.2 Structure of the Thesis ............................................................................... 3 
1.3 The Dilemma of Diagnosing BPD: should it be CPTSD? ............................. 5 
1.4 Diagnostic Criteria ..................................................................................... 7 
1.5 Brief Description of the Disorders and Traumatic Stressors ..................... 9 
1.5.1 Traumatic Stressors ........................................................................... 9 
1.5.2 Adjustment Disorder ........................................................................ 10 
1.5.3 PTSD ................................................................................................. 11 
1.5.4 CPTSD ............................................................................................... 11 
1.6 Comparisons between the Disorders ...................................................... 13 
1.6.1 Similarities and Differences between PTSD and CPTSD .................. 13 
1.6.2 The Links between BPD and Trauma, CPTSD ................................... 14 
1.7 The Problem with BPD Assessment and Diagnosis ................................. 16 
1.8 Research Concept and Question ............................................................. 18 
1.9 Secondary Research Questions, Objectives and Hypotheses .................. 20 
1.10 Contribution to Academic and Clinical Knowledge ................................. 22 
1.11 Concluding Remarks ................................................................................ 22 
2 LITERATURE REVIEW .................................................................. 23 
2.1 Introduction ............................................................................................. 23 
2.2 Key Empirical Studies of Relationship between Trauma, BPD & CPTSD . 24 
2.2.1 Search Methodology for Empirical Studies ..................................... 26 
2.2.2 Search Results of the Empirical Studies ........................................... 29 
2.2.3 Chronology of Articles ..................................................................... 31 
2.2.4 Location, Timing of Studies and Participant Selection .................... 31 
2.2.5 Assessment Personnel for Traumatic Histories ............................... 32 
2.2.6 Assessment Techniques and Instruments in the Empirical Studies 32 
  
viii 
2.2.7 Findings from Empirical Studies....................................................... 33 
2.3 Theoretical Studies for the Mis/Over-Diagnosing Controversy ............... 35 
2.3.1 Symptoms ........................................................................................ 35 
2.3.1.1 BPD Symptoms ................................................................................. 35 
2.3.1.1.1 CPTSD Symptoms ............................................................................. 36 
2.3.2 Aetiology .......................................................................................... 36 
2.3.2.1 BPD Aetiology .................................................................................. 36 
2.3.2.1.1 Genetic/Epigenetic and Neuro-transmitting Factors ...................... 37 
2.3.2.1.2 Neurobiological Factors ................................................................... 39 
2.3.2.1.3 Social Factors ................................................................................... 40 
2.3.2.1.4 Bio-Psychosocial Factors .................................................................. 42 
2.3.2.2 CPTSD Aetiology ............................................................................... 45 
2.3.3 Diagnosis .......................................................................................... 46 
2.3.3.1 BPD Diagnosis .................................................................................. 47 
2.3.3.1.1 Onset and Prognosis of BPD ............................................................ 47 
2.3.3.1.2 BPD Diagnostic Criteria .................................................................... 48 
2.3.3.1.3 BPD Diagnosis in Practice ................................................................. 49 
2.3.3.2 CPTSD Diagnosis ............................................................................... 49 
2.3.3.2.1 The DESNOS Criteria ........................................................................ 51 
2.3.4 BPD Comorbidity .............................................................................. 52 
2.3.5 Physical & Structural Effects of Trauma pre Treatment .................. 53 
2.3.6 Treatment of the Disorders ............................................................. 53 
2.3.6.1 BPD Treatment ................................................................................. 53 
2.3.6.1.1 Trauma Treatment for BPD Patients ............................................... 55 
2.3.6.1.2 Consequences of not Screening and Treating for Trauma .............. 57 
2.3.6.2 CPTSD Treatment ............................................................................. 58 
2.3.6.2.1 Phase One - Stabilisation and Skills Reinforcement ........................ 59 
2.3.6.2.2 Phase Two - Reappraisal of Trauma Memory/Trauma Processing . 59 
2.3.6.2.3 Phase Three - Greater Engagement in Community Life .................. 59 
2.3.6.3 Impact on the Brain following Treatment ....................................... 60 
2.3.6.4 Treatment Conclusions .................................................................... 60 
2.4 Question 4: Existing Screening and Assessment Instruments ................. 61 
2.4.1 BPD Screening and Assessment Instruments .................................. 61 
2.4.2 Assessment Instruments for PTSD and CPTSD (DESNOS) ................ 62 
2.4.3 Trauma Screening Instruments........................................................ 63 
2.5 Literature Review Conclusions ................................................................ 65 
  
ix 
3 Methodology: Design ................................................................. 69 
3.1 Introduction ............................................................................................. 69 
3.2 Rationale for the Design .......................................................................... 71 
3.2.1 Data Collection Rationale: Quantitative or Qualitative ................... 72 
3.3 Types of Mixed Method Designs ............................................................. 72 
3.3.1 Triangulation Design ........................................................................ 73 
3.3.2 Other Mixed Methods ..................................................................... 74 
3.4 Selected Approach for the Design ........................................................... 74 
3.5 Design Concept ........................................................................................ 77 
3.5.1 Stage 1, Survey ................................................................................. 77 
3.5.2 Clinicians Interviews (Grounded Theory and Const. Comp.) ........... 77 
3.5.2.1 Grounded Theory ............................................................................. 78 
3.5.2.2 Constant Comparison Method ........................................................ 80 
3.5.2.2.1 Step 1:  Comparison within a Single Interview ................................ 82 
3.5.2.2.2 Step 2:  Comparison between Interviews within the First Group ... 82 
3.5.2.2.3 Step 3: Comparison of Interviews from Different Groups ............... 82 
3.5.3 Stage 2: Reliability Study for Screening Instrument ........................ 83 
3.6 Research Ethical Concerns ....................................................................... 83 
3.6.1 Safeguarding of Vulnerable Patients ............................................... 84 
3.6.2 Grounding Techniques for Intense Anxiety ..................................... 85 
3.6.3 Impact on Interviewers (Vicarious Traumatisation) ........................ 86 
3.7 Validity of the Research Design ............................................................... 87 
3.7.1 Application of Validity to Screen Development .............................. 90 
3.7.2 Threats to Internal Validity .............................................................. 92 
3.7.3 Threats to External Validity ............................................................. 93 
3.8 Mitigations for Threats to Validity .......................................................... 94 
3.8.1 Blinding ............................................................................................ 95 
3.8.2 Attrition Mitigations ........................................................................ 96 
3.8.3 Researcher Bias Mitigations ............................................................ 96 
3.8.4 Other Mitigations ............................................................................. 96 
3.9 Target Group and Recruitment ............................................................... 97 
3.10 Data Analysis ........................................................................................... 98 
3.10.1 Qualitative Software vs. Manual Analysis ....................................... 99 
3.11 Quality Control ........................................................................................ 99 
3.11.1 QUADAS ........................................................................................... 99 
  
x 
3.11.2 Steering Group ............................................................................... 100 
3.11.3 STARD ............................................................................................. 100 
3.12 Research Design Conclusions ................................................................ 101 
4 Methodology: Stage 1, Medical Records & Clinician Interviews 103 
4.1 Introduction ........................................................................................... 103 
4.2 Patients’ Medical Records Survey Methodology ................................... 105 
4.2.1 Sample Frame ................................................................................ 108 
4.3 Results of Patients’ Records Survey ....................................................... 109 
4.3.1 Demographics ................................................................................ 109 
4.3.2 Clinician’s Diagnoses ...................................................................... 109 
4.3.3 Recorded Symptoms ...................................................................... 110 
4.3.4 DSM Criteria for BPD ...................................................................... 112 
4.3.5 Instruments used ........................................................................... 114 
4.3.6 Psychotherapy Treatment ............................................................. 114 
4.3.7 Validation of the Stage 1 Survey Results ....................................... 115 
4.3.8 Limitations ..................................................................................... 117 
4.3.9 Validation of Interpretations of Survey ......................................... 118 
4.3.10 Discussion on Quantitative Survey Results .................................... 118 
4.4 Stage 1, second part, Clinician Discussions: Qualitative Review ........... 119 
4.4.1 Interview Methodology ................................................................. 120 
4.4.1.1 Constant Comparison .................................................................... 122 
4.4.1.1.1 Step 1 Aims and Methodology....................................................... 123 
4.4.1.1.2 Step 1 Results ................................................................................. 123 
4.4.1.1.3 Step 2 Aims and Methodology....................................................... 124 
4.4.1.1.4 Step 2 Results ................................................................................. 124 
4.4.1.1.5 Step 3 Aims and Methodology....................................................... 125 
4.4.1.1.6 Step 3 Results ................................................................................. 126 
4.4.2 Additional Results from Clinician Interviews ................................. 127 
4.4.3 Follow-up of Stage 1 Patients ........................................................ 127 
4.5 Stage 1 Conclusions ............................................................................... 127 
5 Methodology: Stage 2, Trauma, PTSD & CPTSD Screening Trial . 129 
5.1 Introduction ........................................................................................... 129 
5.1.1 Stage 2 Objectives .......................................................................... 130 
5.2 Stage 2 Methodology ............................................................................ 130 
5.2.1 Screen Concept Decision (A) .......................................................... 132 
  
xi 
5.2.1.1 Generating the Items for Screen Questions (B) ............................. 133 
5.2.2 Initial Content Validity of the BTERS Screen (C) ............................ 135 
5.3 Stage 2 Ethical Approval ....................................................................... 138 
5.4 Patient Selection and Recruitment ........................................................ 139 
5.5 Pilot Study Objectives ............................................................................ 141 
5.6 Pilot Study Methodology (D) ................................................................. 142 
5.6.1 Impact on Interviewers (Vicarious Traumatisation) ...................... 143 
5.7 Accuracy of Pilot – Construct Validity (E) .............................................. 143 
5.8 Changes following Pilot – Face & Content Validity Enhancement ........ 145 
5.9 Main BTERS Reliability Trial Methodology ............................................ 147 
5.10 Stage 2 Results ...................................................................................... 150 
5.11 Stage 2 Limitations ................................................................................ 153 
5.12 Unanticipated Clinical Finding .............................................................. 155 
5.13 Reliability Study Discussions .................................................................. 156 
5.13.1 Adjustment Disorder ...................................................................... 157 
5.13.1.1 Adjustment Disorder Criteria ......................................................... 158 
5.13.1.2 Aetiology ........................................................................................ 158 
5.13.1.3 Differential Diagnosis ..................................................................... 159 
5.13.1.4 Treatment ...................................................................................... 159 
5.14 Comparison of Stage 2 with Stage 1 Results ......................................... 160 
5.15 Comparison of Stage 1 and 2 with other Empirical Studies .................. 161 
5.16 Stage 2 Conclusions ............................................................................... 163 
6 Discussion ............................................................................... 165 
6.1 Introduction ........................................................................................... 165 
6.2 Discussing the Research Findings .......................................................... 166 
6.3 Conclusions ............................................................................................ 174 
6.4 Advantages and Limitations of the Research ........................................ 175 
6.4.1 Effectiveness of Thesis Structure ................................................... 175 
6.4.2 Evaluation of the Effectiveness of Research Design ...................... 176 
6.5 Overall Limitations ................................................................................ 176 
6.5.1 Advantages and Disadvantages of the Research ........................... 177 
6.5.2 Evaluation of the Effectiveness of Research Design ...................... 177 
6.6 Recommendations ................................................................................. 178 
6.6.1 Clinical Implications and Recommendations ................................. 178 
6.6.2 Research Recommendations ......................................................... 180 
  
xii 
6.6.3 BTERS Screen Recommendations .................................................. 181 
6.7 Original Contribution to Clinical and Academic Knowledge ................. 182 
6.8 The Future Outlook ................................................................................ 183 
Bibliography ......................................................................................................... 185 






APPENDIX 1 BTERS Screen .................................................................................... 1-1 
APPENDIX 2 PTSD Screens .................................................................................... 2-1 
APPENDIX 3 BPD Screens ...................................................................................... 3-1 
APPENDIX 4 Steering Group Terms of Reference ................................................. 4-1 
APPENDIX 5 Protocol, Stage 1............................................................................... 6-1 
APPENDIX 6 Patient Information Sheet, Stage 1 .................................................. 6-1 
APPENDIX 7 Clinician Information Sheet, Stage 1 ................................................ 7-1 
APPENDIX 8 Recruitment Poster, Stage 1 ............................................................. 8-1 
APPENDIX 9 Hospital Discharge Statistics ............................................................. 9-1 
APPENDIX 10 NHS Ethics Approval, Stage 1 ....................................................... 10-1 
APPENDIX 11  University R&D Approval, Stage 1 ............................................... 11-1 
APPENDIX 12 Foundation Trust Approval Stage 1 .............................................. 11-1 
APPENDIX 13 Study Tool, Stage 1 ....................................................................... 13-1 
APPENDIX 14 Consent Form, Stage 1 ................................................................. 14-1 
APPENDIX 15 Interview results, Stage 1 ............................................................. 15-1 
APPENDIX 16 Protocol, Stage 2 .......................................................................... 16-1 
APPENDIX 17 Patient Information Sheet, Stage 2 .............................................. 17-1 
APPENDIX 18 Clinician Information Sheet, Stage 2 ............................................ 18-1 
APPENDIX 19 Trust Safeguarding Procedure ...................................................... 18-3 
APPENDIX 20 Consent Form, Stage 2 ................................................................. 20-1 
APPENDIX 21 NHS Ethics, Stage 2 ....................................................................... 21-1 
APPENDIX 22 Trust R&D Approval, Stage 2 ........................................................ 22-1 
APPENDIX 23 University Ethics Approval, Stage 2 .............................................. 23-1 
APPENDIX 24 CAPS .............................................................................................. 24-1 
APPENDIX 25 SIDES and TAQ .............................................................................. 25-1 
APPENDIX 26 Scoring Sheet ................................................................................ 26-1 
APPENDIX 27 Internal Validity, 10 Experts Assessment ..................................... 27-1 
APPENDIX 28 Detailed Results ............................................................................ 28-1 




 List of Tables  
 
Table 1-1  Thesis Structure ...................................................................................... 4 
Table 1-2 Diagnosis for different classifications ...................................................... 8 
Table 1-3 Short Definitions of Disorders ............................................................... 13 
Table 1-4  Research Objectives and Hypotheses ................................................... 21 
Table 2-1 Literature Review Sub Questions........................................................... 23 
Table 2-2 Search Methodology and Results .......................................................... 27 
Table 2-3 Empirical Studies .................................................................................... 30 
Table 2-4  Published Screens for PTSD .................................................................. 64 
Table 2-5 Literature Review Conclusions............................................................... 67 
Table 3-1 Sub-Questions ........................................................................................ 70 
Table 3-2 Mixed Method Design............................................................................ 75 
Table 3-3 Staged Hypotheses ................................................................................ 77 
Table 3-4 Threats, Bias and Mitigations ................................................................ 89 
Table 3-5   Validity of Instrument Development ................................................... 91 
Table 3-6  Design Conclusions ............................................................................. 102 
Table 4-1 Objectives of Quantitative Review ...................................................... 104 
Table 4-2 Comparison of Results with Empirical Studies .................................... 116 
Table 4-3 95% Confidence Intervals .................................................................... 116 
Table 4-4 Objectives of Clinician Discussions ...................................................... 120 
Table 4-5  Codes from First Interview .................................................................. 123 
Table 4-6  Categories from Interviews ................................................................. 124 
Table 4-7 Step 3 Results ....................................................................................... 126 
Table 4-8 Stage 1 Result Summary ...................................................................... 128 
Table 5-1 Stage 2 Objectives ................................................................................ 130 
  
x 
Table 5-2 Domain Set for 3 Disorders .................................................................. 133 
Table 5-3  Content Validity Index CVI .................................................................. 136 
Table 5-4 Questions that Discriminate between Disorders................................. 137 
Table 5-5 Pilot Accuracy ....................................................................................... 144 
Table 5-6  Patients Satisfying PTSD/CPTSD Symptoms ........................................ 150 
Table 5-7  Main Study Reliability of BTERS vs. CAPS/SIDES ................................. 151 
Table 5-8 Means, Standard Deviations and 95% Confidence Interval: PTSD and 
CPTSD ................................................................................................................... 151 
Table 5-9 Criteria-A Trauma Range based on 95% Confidence ........................... 151 
Table 5-10 ROC Values ......................................................................................... 152 
Table 5-11  Repeatability Results ......................................................................... 153 
Table 5-12 Limitations ......................................................................................... 154 
Table 5-13  Methodology Comparison Stages 1 & 2 ........................................... 161 
Table 5-14 Results Comparison ........................................................................... 161 




 List of Figures 
Figure 1-1 Overlapping Conditions ........................................................................ 16 
Figure 1-2 What happens today in our Hospitals .................................................. 19 
Figure 1-3 Research Concept ................................................................................. 19 
Figure 2-1 BPD Studies that have Reported Trauma ............................................. 34 
Figure 2-2 PTSD/CPTSD & Trauma in BPD ............................................................. 34 
Figure 2-3  Bio-Psychosocial Model (Modified Leichsenring et al., 2011) ............. 45 
Figure 3-1 Research Design Flow Diagram ............................................................ 69 
Figure 4-1 Stage 1 Methodology.......................................................................... 103 
Figure 4-2 Recruitment Process ........................................................................... 105 
Figure 4-3 Stage 1 Recruitment ........................................................................... 108 
Figure 4-4 Primary Clinical Diagnosis of Participants .......................................... 109 
Figure 4-5 Diagnoses as per DSM Criteria ........................................................... 111 
Figure 4-6 PTSD Criteria as per DSM .................................................................... 111 
Figure 4-7 CPTSD/DESNOS Criteria (in additional to PTSD) as per DSM ............. 112 
Figure 4-8 DMS Criteria for BPD .......................................................................... 113 
Figure 4-9 Percentage of DSM BPD Symptoms ................................................... 114 
Figure 4-10 Psychotherapy Documentations ...................................................... 115 
Figure 4-11 Validation of Stage 1 Findings .......................................................... 116 
Figure 4-12  Stage 1 interpretation Options ........................................................ 122 
Figure 5-1 Screen Development and Trial Roadmap ........................................... 131 
Figure 5-2 Recruitment Flowchart ....................................................................... 140 
Figure 5-3 Pilot outcome, BTERS vs. CAPS/SIDES ................................................ 144 




Figure 5-5 ROC PTSD and/or CPTSD ..................................................................... 153 
Figure 5-6  Results Comparison for Stages 1 and 2 ............................................. 160 
Figure 5-7 Comparison of Empirical Studies with Stages 1, 2 ............................. 162 






Chapter 1 Introduction 
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1 INTRODUCTION 
This chapter introduces the background to a very worrying mental healthcare 
problem of under-recognition of the history of traumatic experiences and the 
effects of trauma. Such an under-recognition can occur when patients with 
Borderline Personality Disorder (BPD) symptomatology are assessed and treated, 
which can lead to misdiagnosing/over-diagnosing BPD and or missing a comorbid 
diagnosis of Post Traumatic Stress Disorder (PTSD) or Complex PTSD (CPTSD).  This 
can result in a fragmented approach to treatment. To address this problem – and 
using an extensive empirical and theoretical literature review, which is set out in 
chapter 2 – the principal research question and aim is formulated. The thesis 
structure is then developed, and a detailed description of each chapter is 
presented. Brief descriptions of the relevant disorders then follow, along with a 
discussion of the links between trauma and BPD. A description of the diagnosing 
dilemma is then presented. From this background, detailed research sub 
questions, aims and hypothesis are formulated. The chapter concludes by 
examining how the research can contribute to improving academic and clinical 
knowledge. 
1.1 Background to the Problem, and why the Research is Important 
BPD is the most commonly diagnosed form of Personality Disorder (Shevin et al., 
2007). It has been recognised as a clinical condition that can be seriously disabling 
and often takes a huge toll on the individual (NICE, 2008). In the late twentieth 
century, interest in BPD seems to have exploded (Linehan, 1993). According to the 
UK National Institute for Clinical Excellence (NICE) there is currently a high 
prevalence of BPD, and Linehan asserts that over 30% of all psychiatry patients in 
the USA appear to meet the BPD criteria with treatment modalities appearing to 
be woefully inadequate (NICE, 2008; Linehan 1993). Suicide is a particular risk for 
BPD in the UK with up to 1 in 10 people with BPD committing suicide, 400 times 
higher than the national average suicide rate (NICE, 2008; Cailhol et al., 2008). 
Effective BPD treatment is therefore a high [UK] Department of Health (DoH) 
priority. In order to provide effective treatment NICE has suggested that a more 
reliable diagnosis should be made of BPD patients to ensure they receive 
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appropriate intervention with the aim of reducing repeated hospital admissions, 
suicidal rates, and cost to patients, their family members, social relations, 
clinicians and the NHS (NICE, 2008). 
Many highly respected organisations and authors have made sweeping but often 
unsubstantiated statements about this misdiagnosis. For example, the National 
Association for Mental Health has highlighted that 'there is a recognised and very 
worrying danger of misdiagnosing BPD’ (MIND, 2007). NICE (2008) also reported 
‘a high incidence of misdiagnosing BPD’. Authors such as Hodges have said that 
‘many women who have been exposed to chronic trauma are incorrectly 
misdiagnosed as having personality disorder, particularly BPD' (Hodges, 2003, 
p.413). Landecker noted that ‘frequently a patient presenting [PTSD] symptoms is 
diagnosed borderline….. leading to inappropriate treatment approaches and the 
placement of a burdensome label' (Landecker, 1992, p.235).  
That the diagnosis of BPD is problematic is a near universal view in the mental 
health community. A number of experts also believe that many cases of BPD 
should be re-conceptualised as PTSD associated with childhood abuse. This is 
related to a controversial link between BPD and both PTSD and CPTSD, with the 
possibility that PTSD/CPTSD may be under-recognised (or can be seen as a missed 
diagnosis) in patients with BPD presentations. CPTSD is also known as DESNOS 
(Disorders of Extreme Stress Not otherwise Specified), as identified in the 
Diagnostic and Statistical Manual of Mental Disorders Fourth Edition – Transcript 
Revised, DSM-IV-TR, 2000. Caution must be exercised, however, because, as will 
be shown in Chapter 2, there is limited empirical information currently available 
on the BPD misdiagnosis/over-diagnosing controversy. 
The current research project will thus investigate and attempt to substantiate the 
relationship between BPD and trauma experiences from both theoretical and 
clinical perspectives. It will make concrete proposals that should lead to improved 
diagnosis by developing and using a streamlined trauma-screening instrument for 
BPD presentation that should ultimately result in higher recovery rates through 
the proven techniques of trauma-focused therapy. The research will also consider 
how best to treat the non-life-threatening trauma that affects many BPD patients, 
Chapter 1 Introduction 
  Page 3 
traumatic experiences that are not symptomatic of PTSD/CPTSD. For these 
patients, treatment utilising techniques developed for Adjustment Disorder (AD) 
will be considered.  
1.2 Structure of the Thesis 
Two structural extremes can be considered in the design of a thesis, Focus Down, 
and Opening Out; with a Compromise Model balanced between the two 
(Dunleavy, 2003; Silverman, 2005). The Focus Down Method consists of an 
exhaustive literature review followed by a substantive methodology and research 
design. Fieldwork in this method is relatively short in depth and analysis, and 
discussions of the results can be even shorter. For example, in a Focus Down 
structure, there may be little opportunity for making changes based on input from 
practicing BPD clinicians who could be influenced by the initial parts of the 
investigation. 
The Opening Out Model is the reverse of Focus Down with a brief literature review 
and research design, for example confining the initial literature review to the 
empirical relationship between BPD and trauma, and thus potentially missing out 
on some important theoretical relationships. Similarly, the dilemma of BPD 
misdiagnosis could be downplayed in favour of greater attention to trauma 
diagnosis. This model focuses on what is seen to be the core of the research 
project, with a detailed commentary on the methodology, and the discussion 
includes an in-depth analysis. Literature references are initially close to the topic 
itself and then open out to wider literature based on research outcomes.  
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Table 1-1  Thesis Structure 
Structure 
Types 














































Risk of missing key 
relevant data and 
results  
Difficult to ensure 
that findings and 
proposals have not 
been previously 
considered   
 
In order to capture the advantages of both approaches as shown above, a 
Compromise Model – an amalgamation of Focus Down and Opening Out – will be 
adopted as a framework for the research design. This approach thus introduces 
the core proposals concerning trauma in BPD at an early stage while including as 
comprehensive a review as possible of this important subject, which has to date 
received limited attention in academic literature. This method should hopefully 
ensure that the extensive range of theoretical analysis is balanced with a 
measured analysis of clinical studies. It also allows for a considered and critical 
analysis and discussion of research findings to aim for a balanced judgement of 
the diagnosis controversy (the prevalence of trauma in BPD), and the benefits of 
screening BPD patients for trauma and PTSD/CPTSD. The individual chapters in this 
research are then balanced between a comprehensive literature review, a detailed 
research design, then a full analysis and discussion of methodology, ending with a 
critical discussions and recommendations. 
This thesis is divided into six chapters, each with its own opening and closing 
sections. The Introduction chapter first reviews the overlap between BPD and 
trauma, and then provides an introduction for the reader to the disorders. It moves 
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on by discussing the links between the disorders and how they are treated. This 
then provides the setting to develop a main research question divided into four 
detailed research sub questions with corresponding research objectives, from 
which four hypotheses are developed. The second Literature chapter starts by 
examining previous empirical studies of the relationship between trauma, 
PTSD/CPTSD and BPD, and the limited empirical information that is currently 
available to investigate the BPD misdiagnosis controversy. To complement the 
review of empirical evidence, the literature review also examines relevant 
publications that investigate the symptoms, causes or aetiology, and diagnosis of 
the disorders, BPD, and CPTSD, plus the effects and treatment options. Lastly, a 
review of available assessment and screening instruments for trauma in BPD is 
included. The Methodology begins with the third (Design) chapter, where an 
overall research design addresses ethical issues and how the hypotheses are 
effectively tested, resulting in two sequentially connected stages. The 
methodology continues with chapters four and five, which detail the data 
collection and analysis of the two stages as specified by the design, along with a 
review of threats to validity. Stage 1 is a quantitative review of BPD patients’ 
records, followed by qualitative interviews with BPD clinicians and hospital 
management personnel. Stage 2 then develops and tests a new trauma screening 
instrument ‘BPD Trauma Exposure and Reactions Screen’ (APPENDIX 1 , BTERS) 
against accepted clinical standards. Finally, the Discussion (sixth) chapter 
compares and discusses all of the results in the light of the latest clinical 
knowledge, and details progressive recommendations for clinical trials.  
This thesis has therefore been structured to focus down from the theoretical and 
the limited empirical studies, first by both quantifying and qualifying the presence 
of trauma and PTSD/CPTSD in BPD patients. It then opens out the controversy with 
a comprehensive design where the results are analysed and discussed prior to 
proposing and testing a trauma screening solution.  
1.3 The Dilemma of Diagnosing BPD: should it be CPTSD? 
A major dilemma for clinicians is making the correct diagnosis between BPD and 
PTSD or CPTSD. In this field, clinicians include specialist consultants, general 
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practitioners and all mental health professionals. This dilemma can perhaps best 
be illustrated by two examples from clinical cases. Both examples have been taken 
from Gunderson’s Clinical Guide (2008), which is a standard reference book for 
practitioners in BPD. The first example is of a patient who most likely would have 
received a diagnosis of BPD. 
In this case a forty four year old woman presented with flashback that 
disrupted her sleep and concentration, numerous admissions and suicidal 
attempts. Her childhood included eight hospitalizations, between ages 13–
14 for treatment of a congenital disease. Twenty-six years later, she could 
still access the feelings of being “helpless and alone”. In response, she would 
become agitated with bursts of accusatory, offensive anger towards her 
husband and children, which she would later deeply regret as unfair to her 
family. This remorse then prompted self-destruction or suicidal impulses for 
this woman (Gunderson et al., 2008, p.48).  
As Gunderson noted, Herman’s diagnosis of CPTSD is warranted when such 
patients have flashbacks or sustained dissociative experiences and an 
interpersonal style marked by weariness and fears of attachment, such that in 
adulthood, social isolation is usual, and only intermittently interrupted by brief, 
often alcohol-related social forays. He then goes on to say that if such a patient is 
very hungry for attention and protection, and expressive of intense angry feeling 
when hurt, the effect of the trauma is less likely to have been dominant, and the 
patient is better conceptualised as having BPD. Western (1990) pointed out that 
when patients are focused on their abuse experience (as in CPTSD), they are more 
likely to respond with paranoid accusations of malevolence within the context of 
ongoing relationships, whereas borderline patients are more likely to become 
accusatory when threatened by loss of their other relationships (Gunderson and 
Links, 2008). 
In the second example, a thirty-four year old married woman sought 
psychotherapy because she needed ‘support’. She then related this problem to a 
series of recent events. 
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Although she loved her job, after becoming convinced that she was 
underpaid, she demanded more money from her employer, consequently 
lost her job. She also had a fight with her landlord insisting on her rights. 
This too resulted in her being kicked out. In both instances, she righteously 
perceived injustice was done. However, she experienced the injustice too 
personally and her intense anger was disproportionate. Not only was she 
depressed about her job and her flat, but she also worried about the 
prospect of having no husband and no children, she then moved back to live 
with her mother and with her forty year old brother. To add insult to injury, 
her brother had sexually abused her when she was between 6 and 10. And 
although her mother knew about this, her mother coped by alternating 
between helplessness and denial. 
In this case, the patient presented as an over-sensitive individual, wary, and hyper 
vigilant to rejection and criticism, with a very defensive response about everything. 
While she acknowledged fears of intimacy and attachments, this defensiveness 
made exploratory therapy very difficult. Even when a supportive therapist 
attempted to work with her, she resisted getting attached. Gunderson noted that 
this patient might easily have been given a BPD diagnosis by virtue of her anger 
and need for support. However, in his opinion she would better be identified as 
having CTPSD (as proposed by Herman). Such bleakness in interpersonal life and 
resistance to any attachment makes the effect of trauma distinctly different from 
the affect (emotion) of trauma that is seen in BPD. 
1.4 Diagnostic Criteria 
The diagnostic criteria for BPD, trauma, PTSD, and CPTSD are defined fully in DSM-
IV-TR, produced by the American Psychiatric Association (APA, 2000), and DSM-5 
(2013). Definitions are also presented in the International Statistical Classification 
of Diseases-10 (ICD-10) produced by WHO (1992). These are the established 
systems for classification of mental disorders, which have achieved widespread 
acceptance in psychiatry. 
 
Chapter 1 Introduction 
  Page 8 
Table 1-2 Diagnosis for different classifications  
 
Both systems consider the disorders to be distinct, and in recent revisions the 
definitions in their respective manuals have converged to become broadly 
comparable, although some differences remain. A survey of over two hundred 
psychiatrists from different countries across all continents found that the current 
version of ICD (10) was the most frequently used system and most valued for 
clinical practice and training, whereas DSM was more valued for research. While 
DSM-5 is the current version approved in 2013, after this research commenced, 
the majority of available academic papers about BPD and trauma reference DSM-
IV (1994) or DSM-IV-TR (2000), and some go back to DSM-III (1980) or DSM-III-R 
(1987). ICD emphasises the role of causes such as experiences where symptoms 
are not definitive. DSM on the other hand is a descriptive sociological system 
where definitions are based on signs and symptoms, and although this makes it 
more subjective, it is conducive to research (American Psychological Association, 
2009). Consequently, this study will use DSM criteria. 
  
 DSM ICD 
CPTSD 
DSM-IV-TR: CPTSD is PTSD with the 
constellation of symptoms commonly seen in 
association with interpersonal stressors, e.g., 
childhood sexual or physical abuse, domestic 
battering  




experience  DSM-5:  PTSD in addition with either/or of the 
following depersonalisation and derealisation 
BPD 
DSM–IV-TR:  pervasive pattern of instability of 
interpersonal relationships, self-image and 
affects, and marked impulsivity beginning by 
early adulthood and present in a variety of 
contexts 





(Borderline Type)  DSM-5: No significant change from DSM-IV-TR 
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1.5 Brief Description of the Disorders and Traumatic Stressors 
NICE estimates that the prevalence of BPD in the general public could be as high 
as 2%, representing 20% of all psychiatric inpatients and 10-30% of outpatients 
(NICE, 2008). This is supported by epidemiological studies (Pinto et al., 2000; 
Torgenson, Kringler and Cramer, 2001; and Coid et al., 2006. BPD, which is 
described further in section 2.3.1.1, has a debilitating nature which makes it 
necessary for clinicians to address the disorder as early as possible to help assure 
positive outcomes. Effective assessment and the diagnostic process form an 
integral step towards determining appropriate intervention. 
1.5.1 Traumatic Stressors 
It would be remiss to discuss traumatic experiences that underpin the disorders of 
BPD, PTSD and CPTSD without a discussion of what constitutes a traumatic 
stressor. The traumatic stressor is the gatekeeper for the diagnosis of PTSD, and 
PTSD is the gateway for CPTSD. A life-threatening (or Criteria-A) traumatic stressor 
is a requirement for the diagnosis of PTSD (Cloitre et al., 2013). Measurement of 
stressor dose however can be complex and must in part be subjective. The 
definition of a traumatic stressor is itself controversial. Initially defined (DSM-III, 
p.238) as ‘a recognisable stressor that would evoke significant symptoms of 
distress in almost everyone’, the definition was criticised for its lack of specificity 
and as a result it was expanded to ‘an event that is outside the range of usual 
human experience that would be markedly distressing in almost anyone’ (DSM-III-
R, p.250). Subsequent research has demonstrated that traumas such as sexual and 
physical assault were not as rare as had been previously assumed and again 
challenged the definition (McNally, 2003). As a result the definition of a Criteria-A 
traumatic stressor was re-worded as ‘an event that involves actual or threatened 
death or serious injury or a threat to one’s personal integrity and includes learning 
about an unexpected or violent death, serious harm, or threat, or the unexpected 
death or injury to a family member or other close associates’ (DSM-IV, p.463). 
Some have argued that the definition of a traumatic stressor should be broadened 
even further to include non-life-threatening (non-Criteria-A) experiences that are 
distressing but not necessarily directly associated with physical threat, 
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experiences such as sexual harassment (Avina and O’Donohue, 2002), and 
homophobic discrimination taking into account the person’s subjective response 
to an event (Mascher, 2003).  
In contrast, others have been critical of a broad based approach, stating that the 
definition is too inclusive, failing to differentiate between normal distress and 
psychopathology. McNally (2003) said that loosening the definition could impede 
our ability to accurately identify the mechanisms underlying PTSD (Gold, 2004). 
There are specific symptoms that arise and persist after life-threatening traumatic 
experiences such as rape and military combat (Resick, 2001; Pelcovitz et al., 1997). 
Therefore, if the definition of a traumatic stressor is diluted, it may not be possible 
to identify causes and symptoms specific to PTSD/CPTSD, which requires life-
threatening experiences. These symptoms arise from such experiences and 
treatment must be tailored accordingly. DSM-5 recognises a general category of 
‘Trauma and Stressor related Disorders’, where the rationale is based upon clinical 
recognition of variable expressions of distress as a result of a traumatic experience 
(Canadian National Centre for PTSD, 2013). The diagnostic criteria for DSM-5 thus 
draw a clearer line detailing what constitutes a traumatic event, where (Criteria-
A) qualifying events are narrowed, excluding events such as unexpected death of 
a family member (DSM-5). This category includes both PTSD and Adjustment 
Disorder and also the symptoms of CPTSD, although not specifically mentioned. 
Thus, PTSD would not be diagnosed after many upsetting situations that are 
described as ‘traumatic’ in everyday language, e.g. divorce, loss of job, or failing 
an exam. In these cases, a diagnosis of Adjustment Disorder may be considered 
(NICE, 2005; Gelder et al., 2012). 
1.5.2 Adjustment Disorder 
The term Adjustment Disorder (described more fully in section 5.13.1) refers to 
the psychological reactions involved in adapting to new circumstances. DSM-5 
describes Adjustment Disorder as a heterogeneous array of stress response 
syndromes that occur after exposure to distressing (traumatic or non-traumatic) 
events. It is not merely an exacerbation of a pre-existing mental disorder, as in DSM-IV, 
but it also can include many PTSD and PTSD like symptoms, such as intrusions, avoidance 
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and sense of threat. Adjustment Disorders are commonly provoked by life changes, 
such as divorce and separation, a major change of work and abode.  Also events 
such as transition from school to university or immigration, bereavement, and 
sexual assault, but not rape, which involves special kinds of adjustment (Gelder et 
al., 2012).  
1.5.3 PTSD 
Epidemiological data shows that PTSD is a psychological condition with 
characteristic symptoms that may develop in response to life-threatening 
traumatic events or stressors such as a road traffic accident or an assault. The 
diagnostic criteria for PTSD from both DSM-5 and ICD-10 draw a clear line detailing 
what constitutes a traumatic event, where qualifying events are narrow, excluding 
events such as the unexpected death of a family member (DSM-5, ICD-10). 
Individuals suffering from PTSD continue to re-experience the traumatic event 
after it is over in the form of flashbacks or nightmares. These are intrusive 
thoughts causing emotional/ psychological distress in the face of reminders of the 
event. A PTSD sufferer seeks to avoid reminders such as conversations about the 
event, specific people, places, and activities associated with the event. They also 
have difficulties in recalling aspects or the totality of the event, and have 
diminished interest in formally pleasurable activities. Other characteristic 
symptoms include feelings of detachment, a sense of a foreshortened future, and 
exhibiting signs of persistent arousal such as sleep difficulties, increased 
irritability, concentration problems, constantly being startled, and scanning the 
environment for problems (DSM-5 appendix, p.663). PTSD is thus the presence of 
a circumscribed trauma and its related symptoms accompanied by low diagnostic 
comorbidity and normal range personality functioning. 
1.5.4 CPTSD  
CPTSD, which is described in further detail in section 2.3, has been defined as PTSD 
accompanied by marked personality dysfunction, with a broad array of symptoms 
including the domains of impaired emotional (affect) regulation, disturbed 
interpersonal relationships, identity disturbance and higher rates of psychiatric 
comorbidity (Miller and Resick, 2007). WHO refers to CPTSD as a lasting 
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personality change following catastrophic events that exceed the classic PTSD 
criteria, and typically comorbid with PTSD (World Health Organization, 1992). ICD-
10, referencing Roth et al., The DSM Field Trial (1997) defines CPTSD as a lasting 
personality change following catastrophic experience. Other experts see CPTSD as 
a complex condition encompassing a pervasive pattern of adjustment that may 
occur in response to trauma and across different settings and frequently involves 
numerous types of trauma, or trauma of long duration, which disrupts and alters 
developing and maturing biological and emotional systems (Luxemburg et al., 
2001). 
The above approaches complement each other and simply examine CPTSD from 
different perspectives. They are also consistent with the inception of CPTSD as 
some of the pioneering specialists such as Herman (1992) and van der Kolk, 
Hostetler and Herron (1994) initially identified CPTSD as a syndrome of 
psychological disturbances related to early, chronic interpersonal trauma 
frequently associated with PTSD. From the patient’s perspective, CPTSD sufferers 
have a negative view of themselves as helpless, permanently damaged and 
undesirable. This is the same theme observed in patients with psychological 
injuries that results from protracted exposure to social and interpersonal trauma 
with lack or loss of control, disempowerment in the context of either captivity or 
entrapment. 
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1.6 Comparisons between the Disorders 
Table 1-3 Short Definitions of Disorders 
BPD 
Self-harming, often suicidal and other emotional behavioural 
problems due to attachment gone awry, and a variety of traumatic 
experiences ranging from neglect to those that are life-threatening 
PTSD 
Re-experiencing and avoidance behaviour following a discrete 
traumatic event 
CPTSD 
Self-harming, often suicidal, a feeling of being permanently 
damaged with re-experiencing caused by prolonged and repeated 
complex trauma often beginning in childhood 
AD 
Maladaptive behaviour, intrusions and difficult personal 
relationships caused by bio-psycho-social factors and non-life-
threatening trauma 
1.6.1 Similarities and Differences between PTSD and CPTSD 
As CPTSD is often defined in relation to PTSD, it is worth highlighting the 
differences between the two conditions to show how CPTSD is distinct from, but 
similar to PTSD. The diagnosis of PTSD accurately describes the symptoms that 
result when a person experiences a short-lived trauma, such as a car accident, 
natural disaster and rape, all considered traumatic events of time-limited 
duration. However, following repeated and prolonged trauma for months or years 
at a time, clinicians and researchers have found that the current PTSD diagnosis 
often does not capture the severe psychological harm that occurs with such 
prolonged, repeated traumas (Herman, 1992; Whealin and Stone, 2008; Roth et 
al., 1997). 
 For CPTSD: 
a) Symptoms are more complicated, diffused and persistent than Simple PTSD (as 
defined by the recognised 17 symptoms listed in the DSM-IV-TR), including 
somatic complains, dissociation and dysregulation of affects; 
b) Marked personality disturbances including alterations in patterns of 
interpersonal relatedness and identity; 
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c) Heightened vulnerability to repeated self-harm. 
1.6.2 The Links between BPD and Trauma, CPTSD 
As numbers of patients diagnosed with BPD increased in the 1980s, psychologists 
looked at different constructs to support diagnosis. This period coincided with 
increasing awareness of PTSD and knowledge about childhood abuse that was 
emerging ‘from the closet’. It was within this clinical context that Judith Herman 
(1987), a pioneering research psychiatrist, posited the link between childhood 
trauma and BPD. Like so many scientific developments, there was no single eureka 
moment but a progressive coming together of interrelated theoretical and 
empirical knowledge. There are varieties of viewpoints regarding the connection 
between BPD and childhood trauma and this is demonstrated graphically in Figure 
1-1. Herman (1987 and 1992) suggested that BPD might be a complex variant of 
PTSD because many core BPD features such as affect instability, anger, dissociative 
symptoms and impulsivity are present in individuals with chronic PTSD. BPD was 
initially conceptualised as a mild form of schizophrenia, later as a variant of an 
affect disorder, and more recently as a variant of a traumatic stress disorder 
(Golier et al., 2003). Patients with BPD often present with so many symptoms of 
trauma that many American Psychiatrists were seeing it as a variant of CPTSD. This 
has been supported by Zimmerman (1999) and by Hodges (2003), who stated that 
BPD is actually a chronic form of PTSD that has become integrated into the 
personality framework. This theory maintains that prolonged and repeated stress 
can result in the development of behaviour patterns that are maladaptive and 
cannot readily be distinguished from personality traits. Thus, many people 
exposed to chronic trauma could be incorrectly misdiagnosed as having 
personality disorder, particularly BPD. 
The theoretical link between BPD and trauma and between BPD and CPTSD has 
remained controversial since Herman’s 1992 proposal to re-conceptualise BPD as 
PTSD associated with childhood abuse. This reconceptualization has not been 
universally accepted and van der Kolk has argued that while there is a large degree 
of overlap, and on the surface “these conditions appear to be quite similar, they 
only partially coincide and clear distinctions can be drawn between them as 
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separate diagnoses should be made” (van der Kolk, 1994; Haigh, 2003). Barnow et 
al., (2005) found that 80% of BPD patients that they assessed reported to have 
experienced at least one traumatic event in their life and 30% met the criteria for 
CPTSD in addition to BPD. Also up to 80% of these patients experience at least 
some post–traumatic symptoms (McLeer et al., 1992; Cuffe et al., 1998).  
This literature review has also confirmed the possibility that a very high 
percentage of cases of BPD can potentially be re-conceptualised as PTSD 
associated with childhood abuse and complex reactions (Herman, 1992). 
Potentially, the suggested re-conceptualisation could have very significant 
implications for the treatment and clinical management of these patients. 
Furthermore, a number of studies have shown that many who have been exposed 
to chronic childhood trauma are later diagnosed as having personality disorder, 
particularly BPD (Zimmerman and Mattia, 1999; Hodges, 2003; and Roth et al., 
1997). It has been argued that given effective treatment, patients with CPTSD may 
have a better prognosis than BPD patients (Harned et al., 2012; Cloitre et al., 2010; 
and Roth et al., 1997).  
Research has shown that if trauma is correctly diagnosed, then early intervention, 
especially trauma focused intervention, can be beneficial. Figure 1-1 graphically 
demonstrates the overlap between the three disorders. CPTSD is contained 
completely within PTSD, as it is not possible to have CPTSD without also having 
PTSD. PTSD is shown to exist independently, and has a comorbid relationship with 
both CPTSD and BPD shown as overlapping areas in the diagram. BPD is shown 
with a dotted outline in order to emphasise the uncertainty of its relation to PTSD 
and CPTSD, and in this particular diagram, BPD is shown to exist either 
independent of PTSD/CPTSD or in conjunction with PTSD and/or CPTSD.  
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Figure 1-1 Overlapping Conditions 
 
1.7 The Problem with BPD Assessment and Diagnosis 
Although the reliability of diagnostic assessments for BPD has been considerably 
improved by the introduction of ‘standardized interview schedules’, no single 
schedule has emerged as ‘the gold standard’, as each has its advantages and 
disadvantages, with excessive length of interview time being a problem common 
to many of the schedules (NICE, 2008). There is still a heavy reliance on the 
diagnosis of BPD following unstructured clinical assessment, and there are many 
potential pitfalls, such as obtaining agreement in judgement among clinicians 
(Melsop et al., 1982).  
Although NICE have recently recommended that patients should routinely be 
asked about early childhood traumatic experiences, which might reveal some 
causal factors such as abuse or neglect, this does not appear to be a diagnostic 
criterion for BPD in their recommended assessment instruments (NICE, 2008, 
pp.20,300-1). Hence there appears to be a problem, recognised by specialist 
trauma clinicians, that primary and secondary care clinicians are not assessing or 
recording a history of traumatic experiences in patients given the diagnosis of BPD, 
and are perhaps missing vital information that may enable recovery, and also, the 
BPD
PTSDCPTSD
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level of agreement between interview schedules remains at best moderate 
(Zimmerman, 1994). In addition, there are divergences in clinical and research 
methods for diagnosing personality disorders, particularly BPD. Westen has found 
that although current instruments for diagnosing BPD rely primarily on direct 
questions derived from DSM-IV, clinicians tend to find direct questions only 
marginally useful when assessing for the presence of personality disorders. 
Instead, clinicians are inclined to arrive at the diagnosis of personality disorder by 
listening to patients describe interpersonal interactions and observing their 
behaviour (Westen, 1997). 
To date, although research has investigated the link between traumatic childhood 
experiences and the development of BPD, and also the overlapping relationship 
between BPD and CPTSD, there does not appear to have been research into why 
there are so many BPD patients who are not considered for trauma treatment 
during the initial screening and diagnosis process. One reason could be that 
mental health professionals without in-depth and specialised training in trauma 
assessment and treatment may not recognise or diagnose the effects of trauma 
appropriately.  
According to Saakvitne et al., most diagnoses are descriptive and not exploratory, 
and seem to list behaviours and symptoms, but do not explain how or why a 
person may have developed their symptoms. For example, these symptoms could 
be as a response to traumatic stress, or a way of coping. Therefore, BPD diagnosis, 
like other diagnoses, fails to consider the role of abuse in people’s backgrounds. 
These static and incomplete diagnoses have thus not helped therapists to provide 
appropriate care for abuse survivors (Saakvitne et al., 2000).  
There therefore exists a potential to consider the effective use of a screening 
diagnostic instrument that includes childhood and other significant traumatic 
experiences and/or PTSD in the assessment of BPD, as existing BPD screening 
instruments do not allow the screening of traumatic experiences. Also, there 
needs to be an assessment of the practicality and value of in-depth assessment of 
circumscribed or specific traumatic events connecting to current disturbing 
symptoms. Many researchers have advocated the need to examine the link 
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between traumatic history and memories that give rise to disturbances of affect 
(Herman, Perry and van der Kolk, 1989; Ogata et al., 1990; van der Kolk, Hostetler 
and Herron, 1994; Landecker, 1992). 
1.8 Research Concept and Question  
As with any investigation, it was first necessary to understand what has already 
been achieved by examining the latest academic and clinical literature. From this, 
it can be seen that the connection between BPD and trauma has been 
controversial since the late 1980s, when CPTSD was proposed as a specific 
disorder by Judith Herman (1992). It was important therefore to establish firm 
objectives or criteria for a solution by commencing with a principal research 
question.  
An overall research question is thus presented below: 
Can trauma screening optimise the identification of traumatic 
experiences/PTSD/CPTSD in patients with BPD, and resolve the 
misdiagnosis of BPD controversy?   
The theoretical and clinical controversy, where some patients with a diagnosis of 
BPD are thought to be more suitable for trauma treatment, underpins the research 
concept. The research concept thus foresees the early screening of patients with 
BPD symptomology for trauma, aiming to divert appropriate patients from BPD 
units for specialist trauma care. The research concept is thus visualised by Figure 
1-2 and Figure 1-3, the first showing what happens today in our hospitals, and the 
second a vision of the future: 
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Figure 1-2 What happens today in our Hospitals 
 
 
Figure 1-3 Research Concept 
All BPD patients will be screened for trauma with a new trauma in BPD screening 
instrument during initial assessments, and then the proportion of patients with 
PTSD/CPTSD symptoms can receive prompt treatment in specialist trauma centres. 
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1.9 Secondary Research Questions, Objectives and Hypotheses  
To develop the research concept, it is necessary to examine in detail the BPD 
clinical environment, commencing with what can be expected according to 
currently accepted theory along with academic and clinical findings. The accepted 
theory can then be progressively investigated by critically analysing what actually 
happens, and by what should happen in clinical practice. Four secondary or 
research sub questions have therefore been formulated from the principal 
research question. To address the principal research question, it is necessary to 
first establish the facts relating to the BPD and the trauma underpinning the 
diagnosing dilemma. The first three sub questions therefore address the BPD 
diagnosing dilemma and the fourth aims for a solution.  
1 What is the proportion of BPD patients who have experienced traumatic 
stressors and what are the types of stressors?  
2 What is the proportion of BPD patients who also meet a PTSD/CPTSD 
diagnosis?  
3 What is the extent or otherwise of BPD over-diagnosis or misdiagnosis?  
4 Will a screening instrument reliably and sensitively discriminate BPD patients 
for trauma focused treatment? 
The research will therefore start by quantifying the trauma-BPD relationship as 
effectively as possible, and by measuring and challenging the comorbid 
relationship between BPD and PTSD/CPTSD from both theoretical and clinical 
perspectives. All findings will be quantified, comparing actual results with 
expectations and investigating any discrepancies from a comprehensive range of 
perspectives. Only then, with a strong quantitative and qualitative evidence base, 
will the controversial over-diagnosis or misdiagnosis of BPD be addressed from 
both academic and practical clinical perspectives. With a confident knowledge 
base of quantified findings and balanced clinical interpretation, a trauma 
screening solution to the BPD diagnosis dilemma will be developed, tested and 
refined for general clinical and academic acceptance. Four detailed objectives are 
mapped against the specific research sub questions, resulting in four 
corresponding hypotheses addressing the course of BPD, and these are listed 
below.  
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Table 1-4  Research Objectives and Hypotheses 
No Objective Hypothesis 
1 
Quantify and qualify the 
proportion of BPD patients who 
have experienced traumatic 
stressors 
A high proportion of BPD patients 
have had at least one highly 
distressing traumatic experience, 
either life-threatening or non-life-
threatening 
2 
Quantify and qualify the 
proportion of BPD patients who 
also meet a PTSD/CPTSD 
diagnosis 
A high proportion of patients 
diagnosed with BPD also meet a 
comorbid diagnosis of PTSD and or 
CPTSD/DESNOS 
3 
Establish the extent of BPD over-
diagnosis or misdiagnosis  
BPD is over-diagnosed (or 
misdiagnosed) in patients in mental 
health care 
4 
Using a screening instrument, 
quantify and qualify BPD patients 
for trauma focused therapy by 
validation against gold standards 
A short screening instrument can 
reliably, rapidly and sensitively 
discriminate which BPD patients are 
suitable for trauma focused 
treatment? 
 
Hypothesis 1 will investigate the underlying causes and symptoms of BPD, 
particularly examining the controversial impact and prevalence of trauma. Both 
life-threatening (Criteria-A) and non-life-threatening trauma are included in order 
to ensure that the effect of a wide range of causes and symptoms are considered 
Hypothesis 2 will attempt to quantify the clinical relationship between BPD and 
PTSD/CPTSD based on DSM diagnostic criteria, so that interpretations and 
recommendations are based as far as possible on unbiased facts 
Hypothesis 3 progresses to the heart of the over-diagnosing and misdiagnosing 
controversy, and will try to obtain a balanced interpretation of BPD diagnosis 
Finally, hypothesis 4 will address a potential solution to the BPD diagnosis 
dilemma by designing and clinically evaluating the reliability, validity and 
sensitivity of a trauma screening instrument which will enable patients to receive 
rapid proven treatment for debilitating trauma when presented. 
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1.10 Contribution to Academic and Clinical Knowledge 
This research project constitutes the first known systematic clinical attempt to 
quantify the presence of treatable traumatic events and post trauma reactions 
(PTSD/CPTSD) in a significant sample of BPD patients in a psychiatric population. 
To my knowledge, this research project constitutes the first known systematic 
clinical attempt to aid clinicians by utilising a simple screening technique prior to 
detailed diagnosis of BPD. This could hopefully lead to breaking the cycle of 
repetitive BPD hospital admissions. Ultimately, it could lead to a reduction in 
suicide rate in patients with BPD. 
1.11 Concluding Remarks  
The idea for this research project came from practical clinical experience of BPD 
patients with persistent trauma presentations. It received tremendous support 
from all the participants throughout as they were all strongly motivated by the 
goal of improving assessment and treatment for the many BPD patients who suffer 
from the reactions of traumatic experiences. With reinforcement and clarification 
from the views and findings of academic and clinical expertise, trauma focused 
therapy was identified as a potential solution for at least some of the BPD patients. 
However, as this potential solution did not seem to be adopted in clinical practice, 
a research question is posed. This thesis is then structured in order to 
systematically explore the problem (stage 1) and to test a potential solution (stage 
2). Three specific research sub questions and objectives were developed to try to 
establish the facts about trauma, PTSD and CPTSD in BPD patients, and to quantify 
and qualify the trauma history in BPD and the misdiagnosing dilemma. A fourth 
question and objective then draws on the initial results to develop and validate a 
screening instrument in order to identify which BPD patients are recommended 
for treatment for life-threatening trauma at specialist centres. 
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2 LITERATURE REVIEW 
2.1 Introduction   
The literature review chapter will now address the research question, first by 
examining key empirical evidence for the prevalence of trauma, PTSD/CPTSD in 
BPD patients, followed by an examination of complementary evidence from the 
theory of BPD and CPTSD in order to address the misdiagnosing/over-diagnosing 
controversy.   
Detailed sub questions for the literature review are aligned to the four research 
sub questions that were presented in the Introduction Chapter, section 1.9, and 
these literature review sub questions are thus shown in Table 2-1 below. Initially 
each relevant empirical study is individually assessed for its relevance to the 
research question including the trauma screening and assessment instruments 
used. Then each study’s relative theoretical and empirical merits and weaknesses 
are collated and compared.  
Table 2-1 Literature Review Sub Questions 
No 
Literature Review Sub Questions based on the Overall Research 
Question 
1 
From analysis of academic literature, what is the proportion of BPD 
patients who have experienced traumatic stressors, and what is the 
nature of the trauma they have experienced? 
2 
From analysis of academic literature, what proportion of BPD patients 
also meet a PTSD/CPTSD diagnosis? 
3 
From academic literature, to what extent is BPD over-diagnosed, or is 
a trauma diagnosis being missed? 
4 
What is the suitability of existing instruments for screening the types 
of trauma that are presented by BPD patients?  
 
An ideal literature review should examine all relevant published information, 
critically determining whether the research question has already been addressed 
in any form (Silverman, 2005). It is also important to examine other related work 
Chapter 2 Literature Review 
  Page 24 
to see what ideas can help to address the research sub questions. Search and 
update methodology is therefore organised in order to ensure the information 
gathered includes all relevant historical and ongoing studies as well as appropriate 
relevant theory. As knowledge was gained through the research process, 
supplementary searches were required in order to investigate the initial findings.  
The search therefore commences addressing sub questions 1 and 2 concerning the 
prevalence of trauma and PTSD/CPTSD in BPD, where particular attention is paid 
to the methodology used in selecting patients, the quality of the assessors and the 
instruments used. To complement the empirical study findings, academic 
literature was interrogated providing a review of the symptoms and aetiology 
(causes) of BPD and CPTSD, their diagnosis and comorbidity. This provides the 
theoretical context for the third literature search question regarding the 
controversial overlap between the disorders, which is supported by empirical 
evidence derived from a large study (Westen) of US diagnosing practices. A review 
of prognosis, physical and brain effects, and trauma treatment then follows, in 
order to guide the direction of recommendations from that research.   
Finally (for question 4),  building on initial findings from the search findings from 
the empirical studies, a dedicated search was conducted to examine existing 
trauma screening and assessment instruments that could be suitable for BPD 
patients. These are reviewed, so that a proposal for future screening can build on 
the best available information.  
2.2 Key Empirical Studies of Relationship between Trauma, BPD & CPTSD 
A number of authors have suggested a variety of causal mechanisms underlying 
the association between BPD and CPTSD, and there is an established resemblance 
and overlap between their presenting symptoms, e.g. McLean and Gallop (2003).  
While the association between general traumatic experiences and in particular 
childhood traumatic experiences and BPD appears well established (Yen and Shea, 
2001), more recently Charles has cautioned that it is important to know that the 
experience of traumatic events in childhood is not enough for the diagnosis of BPD 
(Charles, Davies and Harris, 2008). These authors suggest that such a diagnosis 
should signpost clinicians to provide appropriate, trauma-focused psychological 
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treatments such as treatments resulting from the diagnosis of PTSD, encouraging 
them to provide patients with specific NICE mandated therapies, namely trauma-
focused cognitive behaviour therapy (CBT) and/or EMDR (Eye Movement 
Desensitisation Reprocessing). One school of thought holds that BPD is best 
explained from a developmental theory perspective, maintaining that personality 
disorders manifest as the result of prolonged early experiences of childhood 
abuse, predisposing an individual to the development of BPD symptoms in 
reaction to stressors occurring in later life (Gunderson and Sabo, 1993). 
A seemingly opposing view is that direct causal connections between childhood 
trauma and BPD are inaccurate. This is based on the premise that not all people 
with BPD report histories of childhood abuse (Zanarini et al., 1997, p.203-4). There 
are also a number of relevant studies that do not report a causal link between 
childhood trauma and BPD (e.g., Vermetten and Spiegel, 2014). Perhaps typical of 
a researcher seeking ‘the best of both worlds’, Landecker (1992) advocates 
combining the diagnosis and treatment of dysfunction as in BPD with the trauma 
of PTSD. Researchers have also recognised that it is not enough simply to identify 
and diagnose abuse in BPD patients. Attention must be paid to the connection 
between abuse and behaviour, and which memories are related to which affect, 
etc. (van der Kolk, Hostetler and Herron, 1994; Linehan, Wagner and Cox, 1989). 
Any assessment of the association between childhood trauma and BPD must also 
consider Gunderson and Links (2008), who concluded that epidemiological data 
about BPD remains methodologically weak; pointing out that percentage on age 
of onset, history of traumatic abuse and prevalence should be considered best 
estimates. A descriptive but over-simplified explanation was given by Gunderson 
and Links (2008, p.48), who wrote that the interface between BPD and PTSD is 
‘complex’. 
The role of childhood trauma in the aetiology of BPD has been tested both in 
theory and in practice by a number of different methods and designs. In particular, 
experts have focused on cases where high rates of childhood sexual abuse are 
reported by patients with BPD diagnosis (Bryer, Nelson and Miller, 1987; Herman, 
Perry and van der Kolk, 1989; Zanarini et al., 2002; Briere and Zaidi, 1989; 
Goldman, Skodol and Lave, 1992). Furthermore, a degree of ‘borderline pathology’ 
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has been positively correlated with a degree of reported childhood trauma and 
with reports of more severe sexual abuse (Herman, Perry and van der Kolk, 1989; 
Landecker, 1992). The association with past trauma and the manifest similarities 
with PTSD have led some to suggest that BPD should be regarded as a form of 
delayed PTSD (Yen and Shea, 2001). Despite these concerns, BPD is a more 
uniform category than other personality disorders and is probably the most widely 
researched of the personality disorders.  
Since the late 1980s, and in particular following the initial proposal by Herman, 
Perry and van der Kolk (1989), a small but fairly significant number of studies have 
been conducted by psychology researchers, usually exploring patients’ history of 
sexual abuse. While none of these studies had exactly the same objective as the 
current research, all involved BPD patients where traumatic experiences were 
assessed. Therefore, data relevant to this review were extracted and presented in 
a consistent manner to address the main research question relating to the role of 
traumatic experiences in the development and diagnosis of BPD. 
2.2.1 Search Methodology for Empirical Studies 
Three standard computerised mental health related databases (MEDLINE, 
PsycINFO and EMBASE) were initially searched in February 2011 for publications 
mentioning BPD and CPTSD, using combination Boolean logic from the University's 
‘Library Services’ option.  The databases were chosen because of their strong 
relevance to psychology. The other two sources searched were the Healthcare 
Database at the National Health Library in Prospect Park Hospital and Oxford 
Radcliffe Science Library. Searches were conducted with the help of librarians 
from: 
1. Oxford Radcliff Science Library (Psychology specialist) 
2. Mental Health Library in Berkshire Foundation Health care Library (Mental 
health specialist) 
3. West London University (Psychology database specialist) 
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Table 2-2 Search Methodology and Results 
 Database Search Terms Hits 
1 MEDLINE BORDERLINE PERSONALITY DISORDER/  3982 
2 MEDLINE 
(complex ptsd" OR "complex post-traumatic 
stress disorder" OR "complex posttraumatic 
stress disorder"").ti,ab  
75 
3 MEDLINE 1 AND 2 [Limit to: English Language]  5 
4 MEDLINE trauma.ti,ab  121567 
5 MEDLINE 3 AND 4 [Limit to: English Language]  4 
6 MEDLINE 
BORDERLINE PERSONALITY DISORDER/et 
[et=Etiology]  
148 
7 MEDLINE 6 AND 2 [Limit to: English Language]  3 
8 PsycINFO BORDERLINE PERSONALITY DISORDER/  2670 
9 PsycINFO 
("complex ptsd" OR "complex post-traumatic 
stress disorder" OR "complex posttraumatic 
stress disorder"").ti,ab  
214 
10 PsycINFO 8 AND 9 [Limit to: English Language]  10 
11 PsycINFO 
("Disorders of Extreme Stress, Not Otherwise 
Specified" OR desnos).ti,ab  
38 
12 PsycINFO 8 AND 11 [Limit to: English Language]  2 
13 MEDLINE 
("Disorders of Extreme Stress, Not Otherwise 
Specified" OR desnos).ti,ab  
20 
14 MEDLINE 13 AND 1 [Limit to: English Language]  0 
15 EMBASE BORDERLINE STATE/  6774 
16 EMBASE 
("complex ptsd" OR "complex post-traumatic 
stress disorder" OR "complex posttraumatic 
stress disorder"").ti,ab  
98 
17 EMBASE 
("Disorders of Extreme Stress, Not Otherwise 
Specified" OR desnos).ti,ab  
25 
18 EMBASE 15 AND (16 or 17) [Limit to: English Language]  12 
 
Free-text was used because there was no subject heading that was entirely 
appropriate. In addition, only PTSD was searched for, rather than CPTSD, in order 
to increase the hit numbers. No date restriction was required as BPD entered the 
psychiatric nomenclature within the publication of DSM-III only in the 1980s, 
because this was when reliable criteria for BPD were introduced by the American 
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Psychiatric Association (Gunderson, Kolb, and Austin, 1981). Because of the 
importance of the subject matter in North America, it was possible to obtain 
sufficient data by restricting the search to the English language. In order to capture 
the maximum numbers for BPD, full article contents were searched, revealing 
several thousand articles from the three databases: Medline 3,982, Psycinfo 2,670 
and Embase 6,800.  
To refine these numbers, an abstract only search for either CPTSD or DESNOS was 
conducted, resulting in smaller, but still somewhat unwieldy numbers: 95, 252 and 
123, a total of 469. As PTSD and trauma will always be present in CPTSD, the 
refinement still adequately addresses both question 1 and 2. Combining the BPD 
and CPTSD searches using the AND logic function brought up three particularly 
useful articles. Once the major academic contributors were identified, additional 
searches then brought up further contributions from them. The reference lists 
from critical reviews were then manually scanned for additional references, in 
order to consolidate the range of investigation, and to ensure that key supporting 
investigations from leading experts were included. Due to the limited number of 
articles retrieved electronically (3), all abstracts were reviewed manually yielding 
167 articles that met the criteria for the research. All the abstracts of the refined 
search were examined by the researcher and supervisor yielding 10 more articles, 
a total of 13 plus 3 dissertations. The others were rejected because they were not 
controlled studies. The references of these were scanned, yielding a further 29 
making a total of 42 articles. These were divided into 5 categories: 
i. BPD and childhood trauma 
ii. BPD & CPTSD and childhood trauma 
iii. CPTSD, DESNOS and childhood trauma 
iv. Complexities and childhood trauma 
v. Related articles 
All categories address the first and third research sub questions (trauma in BPD, 
and the misdiagnosis controversy), and categories ii, iii and iv also address the 
second research question (PTSD/CPTSD and BPD). The forth research question 
(screen) is addressed by its own dedicated search (2.4). In each of the categories 
controlled studies were selected, and resulted in five initial articles. The rest were 
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added to the related article section. To support the investigation, Google searches 
for authors and titles proved a lively and efficient method of exploration. Many 
articles referred to three useful specialist books (Herman, 1992; Linehan, 1993; 
and Gunderson, 2008) and these books were often used to provide solid 
foundations. In one case, an online presentation by Herman from a trauma 
conference proved a useful adjunct to published articles and books. 
2.2.2 Search Results of the Empirical Studies  
The search resulted in a solid database of 37 articles for a detailed study of 
previous empirical studies. Five articles were initially selected by excluding the 
following categories: Non-controlled trials; Self-assessment studies; Case Studies; 
and Treatment analysis without assessment information. Subsequently, a further 
article by Famularo, Kinscherff and Fenton (1991) was added as a result of 
continuous literature searches. Table 2-3 lists the six most relevant empirical 
studies as identified in the search methodology. More recently, three additional 
studies were also included. All studies are described in detail below in 
chronological order. The Table 2-3 heading follow a modification of the Diagnostic 
Checklist from CASP (Critical Appraisal Skills Programme which is designed as a 
guidance (CASP UK, 2013). Some headings from official DSM assessment 
instruments such as ‘Are the benefits worth the harms and costs?’ were omitted, 
as they were not relevant to the overall current research question. Others were 
added such the assessment of independence and relevance to the current study. 
1. Author(s), Location and Date  
2. Study Objectives, which addressed the relevance to current project 
3. Sample Size and Type 
4. Selection Methodology, as input factors in order to assess questions of 
precision 
5. Trauma Assessment Techniques and Instruments used, to assess verification 
bias 
6. Questions Asked, to check if there is sufficient detail  
7. Assessment of Independence 
8. Results 
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Table 2-3 Empirical Studies 
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2.2.3 Chronology of Articles 
All of the earliest empirical studies of trauma and BPD came about due to the link 
between childhood sexual abuse and BPD. American psychiatric academics such 
as Herman, Perry and van der Kolk in 1989, followed by Ogata et al., and 
Famularo‘s team in 1991 all tested different types of abuse, and thus provided the 
first numerical evidence for the link between trauma and BPD. The Zanarini et al., 
study in 1997 then expanded the study population size to 356, and along with the 
subsequent studies confirmed 80% to 100% levels of trauma in BPD patients. In all 
of these studies, the requirements for satisfying a trauma condition were often 
quite loose such as the withdrawal of a caretaker. Famularo, Kinscherff and Fenton 
in the 1991 brief study were the first team to specifically test for PTSD with its 
requirement of a life threatening traumatic stressor. This was then confirmed by 
the major Golier et al. study in 2003, and by the later (2010) large studies by 
Harned et al., Pagura et al., and Grant et al. Although the quantification of 
comorbidity between CPTSD and BPD was first investigated by McLean and Gallop 
(2003), they did not fully report the assessment data that they conducted. The 
only usable investigation using DSM recommended assessment data into CPTSD 
was the 2010 German hospital study by Barnow et al.  
2.2.4 Location, Timing of Studies and Participant Selection 
All but one of the studies were conducted in North American medical health 
centres or hospitals, with both inpatients and outpatients. The studies spanned 
the period from 1989, when the link was first proposed, up to 2010. Subjects were 
generally selected from existing outpatients, though two studies (Zanarini et al. 
and Barnow et al.) were conducted only with inpatients. The overall sample 
numbers ranged from 19 (Famularo, Kinscherff and Fenton), to 1290 from the 
longitudinal study analysed by Pagura et al., and by Grant et al. In three studies 
(Golier et al., Herman, Perry and van der Kolk, and Harned et al.), numbers were 
supplemented by advertising and subjects were (at least on one occasion) paid for 
their interview time. For the first important review of the link between BPD and 
PTSD (Famularo, Kinscherff and Fenton), all the participants were children 
between the ages of 7 and 14. Written permission was invariably obtained, and 
consistent with the captive clinical environment, response rates were high. 
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Researchers usually tested for racial, social and sexual bias. Selection criteria for 
all studies were generally derived from DSM-III/DIB criteria, which is the closest 
thing to a widely accepted standard for mental health work. Strict inclusion and 
exclusion criteria appear to have been applied. 
2.2.5 Assessment Personnel for Traumatic Histories 
With the exception of the large US Alcohol study (Pagura et al.; Grant et al.), 
interviewers were fully trained psychology professionals. Studies strove to 
eliminate bias as much as possible, and on two occasions, interviewers were blind 
to the original diagnosis. Frequently, however, those who conducted the 
interviews were also the authors of the papers, which could lead to researchers 
assessing data to accord with expected outcomes. It should be noted, however, 
that all the diagnosis in the longitudinal alcohol study (Pagura et al.; Grant et al.) 
was independent of the research objectives.   
2.2.6 Assessment Techniques and Instruments in the Empirical Studies 
Because of their sensitive nature, all assessments are based on the patient’s own 
recollection of events. Also, the retrospective nature of patients’ recollections 
adds an additional element of uncertainty to the results (Torangeau, Rasinski and 
Rips, 2000). Memory involves reconstructive elements and can be influenced by 
present beliefs and expectations in the subject as well as in the researcher or 
clinician (Fossati, Madeddu and Maffei, 1999). Most of the studies employed their 
own specially designed or modified diagnostic instruments to acquire more 
information about traumatic histories; details of these are found in the summary 
table. Only Mclean reported exclusively using a structured interview with standard 
assessment criteria (Structured Interview for Disorders of Extreme Stress, SIDES), 
which is designed for a full-scale assessment of CPTSD symptoms by specially 
trained qualified trauma specialists. Golier et al. used the comprehensive self-
assessment ‘Trauma History Questionnaire’ (Greene, Caracelli and Graham, 1989). 
None of the articles used a BPD trauma screening instrument. There is however, a 
potential for bias due to the semi-structured interview approach, where so much 
depends on the interviewer. If the objective of the research is to confirm the 
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presence of trauma, then the use of a semi-structured questionnaire can be 
problematic.  
In several studies (e.g., Ogata et al.; Golier et al.; Zanarini et al.), it was not possible 
to merge all the results to come up with a single traumatic experience percentage. 
For this reason, the type of trauma recording the highest percentage has been 
noted (Figure 2-1). In addition, some of Golier et al.’s results included information 
from a close associate such as a relative. According to Fossati, Madeddu and 
Maffei (1999), this practice may reduce the number of recorded incidences.  
2.2.7 Findings from Empirical Studies  
The findings from the empirical studies address the first two literature review 
questions about the prevalence on Trauma, PTSD and CPTSD in BPD patients. In 
line with Herman’s proposed link, all studies, no matter which detection method 
was used, showed a high correlation between trauma and BPD. This correlation is 
significantly higher when compared with data from non BPD patients (Zanarini et 
al. and Golier et al.) No clear distinction could be detected in the results between 
paid and unpaid participants. It was notable that Barnow et al., who limited their 
analysis to inpatients, noted much higher rates of PTSD/CPTSD in BPD patients 
(68%/31%). In summary, therefore, there appears to be little controversy in 
identifying the presence of trauma amongst BPD patients in a general sense. 
However, none of these studies correlated the recorded trauma with the patients’ 
presenting symptoms, such as dissociation, self-harm, intrusive imagery, etc., as 
advocated by Landecker (1992) and DSM-IV recommendations. Also, from 
available data, it is not possible to establish an exact percentage of BPD patients 
with PTSD or CPTSD; however a number between 25% (Golier et al.) and 40% 
(Pagura et al., Grant et al.) seems representative of the BPD population as a whole. 
A high PTSD comorbidity in BPD is also consistent with the 30% to 50% noted by 
Harned et al. Some of the studies that report higher percentages, however, may 
have been biased in their selection process. A representative percentage of BPD 
patients with comorbid CPTSD is harder to establish as only one study (Barnow et 
al.) reported results (31%), and this was based on inpatients only.       
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The graph below summarises the percentages of trauma recorded for each of the 
studies.   
 
Figure 2-1 BPD Studies that have Reported Trauma 
In addition, as shown on the chart below, trauma percentages can be compared 
with the records of PTSD and CPTSD. 
 
Figure 2-2 PTSD/CPTSD & Trauma in BPD 
A limitation to the Herman et al., (1989) and Ogata et al., (1990) studies is that 
they relied on self-report data from the participants. Yet the remaining studies 
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argue that there is no reason to assume that patients with BPD would manufacture 
historical information at differing rates from those with other personality 
disorders or Axis 1 diagnoses. Nonetheless, inferences drawn from studies using 
self-report data without corroboration remain problematic. Another possible 
limitation was the use of advertising for paid participants (Herman and Golier et 
al.) This process can lead to compliant outcomes if not carefully managed. Possibly 
the most difficult aspect to assess is the potential for researcher bias. When the 
researcher is the prime interrogator and is applying a semi-structured interview 
technique, there is the potential for confirmation bias. If an author expects a high 
trauma outcome and then does the interviews him or herself, then the outcome 
might be too high. 
2.3 Theoretical Studies for the Mis/Over-Diagnosing Controversy 
Academic literature was then investigated to examine the current state of 
knowledge about the disorders themselves, and why the misdiagnosing/over-
diagnosing controversy exists. It is important first to understand the theories and 
recommendations of experts in order to assess and understand what happens 
within clinical practice, and why individual clinicians make their diagnosis. This 
part of the literature review starts by reviewing what is known about the 
symptoms and aetiology of BPD and CPTSD. This review therefore provides the 
theoretical context to address diagnosis and comorbidity (question 3), which is 
then supplemented by a key empirical study of US BPD practice (Westen). In order 
to give guidance for any recommendations that may result from this study, the 
discussion then moves to prognosis, both the physical effects, and the effect of 
the brain, and in particular to the types of treatment that are suitable for BPD 
patients with trauma, linking treatment and prognosis. 
2.3.1 Symptoms  
2.3.1.1 BPD Symptoms 
BPD portrays heterogeneous conditions with overlapping symptoms of 
depressive, schizophrenic, impulsive and dissociative identity disorder and 
problems with hostility and anger and bipolar features. There is a prolonged 
disturbance in personality. Disturbances in identity and relationships with others 
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is the hallmark of BPD, which arises from Attachment Disorder. BPD is 
characterised by rapid changes of mood with striking fluctuations from periods of 
confidence to times of absolute despair accompanied by fears of abandonment 
and rejection. BPD sufferers have strong tendency towards suicidal thinking and 
self-harm. In extreme cases, they experience transient psychotic and paranoid 
symptoms with strong fluctuations and variability. These are usually brief and 
linked to times of extreme emotional instability. In these cases, people can 
experience both visual and auditory hallucinations and clear delusions, but these 
can be distinguished from the core symptoms of schizophrenia and other related 
disorders (Links, Steiner and Mitton, 1989).    
2.3.1.1.1  CPTSD Symptoms 
DSM-IV-TR refers to CPTSD as a ‘constellation of symptoms’ more commonly seen 
in association with an interpersonal stressor (such as childhood sexual or physical 
abuse, domestic battering and torture). Its symptoms can be summarised as 
follows: impaired affection modulation, dissociation, feelings of ineffectiveness, 
feelings of permanent damage, shame, guilt, social withdrawal, impaired 
relationship with others or a change from previous personality characteristics. It 
is common in individuals exposed to extreme social and/or interpersonal trauma, 
especially childhood sexual abuse. These very much resemble the symptoms of 
BPD in terms of poor affect regulation, attachment problems and dissociative 
symptoms with a poor sense of self (de Zulueta, 2009). It is therefore possible to 
understand that making such a differentiation could be problematic for clinicians. 
2.3.2 Aetiology 
2.3.2.1 BPD Aetiology 
All Personality Disorders arise out of childhood /adolescent experiences, and it is 
not something that can occur de novo in adults. Therefore any consideration of its 
aetiology, including BPD, must consider childhood experiences and their 
interaction with childhood biological factors. While the validity of a BPD diagnosis 
is now generally accepted, the aetiology or cause of the disorder is still a 
controversial subject of hot debate (Zanarini et al., 1997), despite several decades 
of research. Establishing the etiological factors leading to its development is quite 
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significant given its prevalence, morbidity and mortality from suicide (one in ten, 
NICE, 2008), and NICE (2009) also acknowledges that the causes are complex and 
remain uncertain. They note that to date, although no model is able to integrate 
all the available evidence, many contributing factors have been advanced. The list 
of causes is long and includes genetic/epigenetic factors and constitutional 
vulnerabilities, neurophysiological, neurobiological and psychosocial factors. 
Other critical causes include a history of high incidence of childhood trauma, both 
sexual and physical abuse, maltreatment and abuse and neglect (Zanarini et al., 
1997).  
Patients with BPD report many negative events (e.g. trauma, and neglect) during 
childhood and substantially more adverse events than do patients with other 
personality disorders (Leichsenring et al., 2011, p.75). However, they go on to note 
that no close association between these experiences and the development of 
psychopathological changes in adulthood has been identified. For this reason, they 
expect that an interaction between biological (e.g. temperamental) and 
psychosocial factors (e.g. adverse childhood events in an invalidating 
environment) will probably provide the best explanation for how the condition 
develops. This is consistent with their results from recent studies of gene-
environment interaction for the disorder. While some people with BPD come from 
stable and caring families, deprivation and instability in relationships are likely to 
promote borderline personality development and should be the focus of 
preventive strategies. 
2.3.2.1.1 Genetic/Epigenetic and Neuro-transmitting Factors 
According to Zanarini, the biological factors that influence the development of BPD 
include genetics and epigenetics, harmful intra-uterine events and effects on the 
development of the brain and nervous system (Zanarini, 1997, p.206). 
Leichsenring notes that although current evidence suggests that genetic factors 
have an influence on the development of BPD, no specific genes have been clearly 
identified as causative (Leichsenring, 2011, pp.39-41). In studies of twins, 
hereditary factors for BPD were less than 1% (Torgensen, Kringler and Cramer, 
2001). This however contrasts with the 40-60% hereditary estimates for 
personality disorders in general (Leichsenring, 2001, pp.39-42). Current evidence 
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suggests that genetic influence on personality disorders generally, not specifically 
on BPD, acts both individually and in combination with environmental factors 
(White et al., 2003; Capsi et al., 2002. However, more recent studies on heredity 
suggest that the hereditary factor for Cluster C disorders (i.e., anxious and fearful 
factors such as avoidance, dependent and obsessive compulsive disorders) lies 
within the range of 27% to 35%. This would imply that genetic factors play a less 
important role than previously thought (Kendler, Torgensen, and Rechborn-
Kjennerud, 2008). 
Data from a candidate gene study shows an association between BPD and a 
haplotype containing a short allele in the serotonin transporter gene (the 
serotonin transporter-linked promoter region). Serotonin is thought to be a 
significant neurotransmitter in the aetiology of BPD (Leichsenring et al., 2011, 
p.45). Impulse aggression, which is common in BPD, is associated with reduced 
seretogenic responsiveness and some genes that might be linked to the 
psychopathological changes in the disorder are involved in the seretogenic system 
(Leichsenring et al., 2011, p.44). NICE (2009) noted that the regulation of 
emotional state is a core problem in BPD. Neurotransmitters have been implicated 
in the regulation of impulses, aggression and affects. Serotonin has been shown 
to have an inverse relationship with the level of aggression. Although the causal 
pathway remains unclear, reduced serotonergic activity may inhibit a person’s 
ability to modulate or control destructive urges. For dysregulation of affects, little 
evidence exists for the role of catechlolamines (norepinephrine and dopamine 
neurotransmitters). Compared with controls without BPD, people with BPD have 
lower plasma-free methoxyhydroxyphenylglycol, a metabolite of noreadrenaline. 
This regulates the body’s response to stress when amphetamine is administered 
to people with BPD. Coccaro, Lee, and McCloskey (2003) and also Schulz, Schulz, 
and Dommisse (1985) reported that they are uniquely sensitive and demonstrate 
greater behavioural sensitivity than control subjects. 
A number of studies have reported evidence of structural and functional deficit in 
brain areas central to affect regulation, attention and self-control and executive 
function in BPD. These include the amygdala, hippocampus and the orbitofrontal 
regions, (Rusch, van Elst and Ludaescher, 2003; Stein et al., 1997, cited in Judd and 
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McGlashan, 2003; De La Fuente et al., 1997). People with BPD also show increased 
activity in the dorsal-lateral prefrontal cortex and in the frontal part of the brain 
and a reduction in activity in the right anterior cingulate (Schmahl, Vermetten, and 
Elzinga, 2003). They also show greater activation of the amygdala while viewing 
emotionally aversive images (Herpertz, Dietrich and Wenning, 2001) or emotional 
faces (Donegan, Sanislow, and Blumberg, 2003). Epigenetic alterations are also 
reported as being hallmarks of altered gene expression and could be involved in 
the aetiology of BPD (Dammann et al., 2011). Epigenetics refers to the 
modification of gene expression, resulting in changes in the function of and/or 
regulation of genes, without alteration in the primary genetic sequences. In some 
cases, epigenetic changes may be stable and heritable, but in other instances, they 
are dynamic and change in response to environmental stimuli. In 2011, Dammann 
et al. analysed the DNA methylation patterns of 14 neuropsychiatric genes in the 
whole blood samples of patients diagnosed with BPD, and in controls. Aberrant 
methylation (the principal mechanism of epigenetic change) signatures on several 
promoter regions were established and significantly, increased average 
methylation (1.7%) occurred in the blood samples of the BPD patients. The authors 
surmised that their data suggested that aberrant epigenetic regulation of 
neuropsychiatric genes may contribute to the pathogenesis of BPD.  
2.3.2.1.2 Neurobiological Factors 
Studies investigating neurobiology testing on BPD patients suggest that individuals 
with BPD may have neurological deficits perhaps affecting the frontal lobe. 
O’Leary et al. found that individuals with BPD had deficits linked to brain 
dysfunction. This affects the frontal and limbic regions and implies that the 
dysfunction of the front limbic circuit could underlie core symptom clusters in 
patients with BPD, such as affect dysregulation self-injurious behaviours and 
dissociative symptoms (Wolf et al., 2011). Similarly, Judd and McGlashan 
themselves reported that outpatients with BPD had deficits in recalling complex 
information as well as visual-spatial tasks measuring discrimination, speed and 
fluency. It is important to note, however, that other research has failed to find 
neurobiological differences between individuals with BPD and patient populations 
in general (Zanarini et al., 1997, p.206). Most relevant is the well-established fact 
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that extreme environmental events and conditions can modify neural structures, 
most notably the effect of childhood trauma, abuse, and sexual abuse specifically 
on neurobiological development (Zanarini et al., 1997, pp. 206-207).  
A proposed information-processing model of the effects of sexual abuse asserted 
that the limbic system plays a key role in the perception of trauma and in the short 
and long-term effects of trauma (Wagner and Linehan, 1997). The authors argued 
that the limbic system is a primary neurological system for the integration of 
incoming information. When intensely activated or overwhelmed, which is 
assumed to happen in many cases of sexual abuse, numbing or dissociation occurs. 
Chronically, this can lead to alterations in the interaction between the limbic 
system and the prefrontal cortex, kindling it to respond intensely to stimuli. In 
turn, this can produce emotional dysregulation, which disrupts the development 
of the neocortical pathways that affect meaning systems and the integration of 
experiences. Sexual abuse can therefore lead to patterns of heightened emotional 
arousal, emotional dysregulation in response to events and conditions, which 
affects subsequent perceptions, interpretations and reaction to events or 
situations. This model can account for dissociative experiences, startle responses, 
avoidance, disrupted memories, difficulties in sexual relations, and other typical 
post-traumatic stress behaviours. In a sense then, childhood trauma, and sexual 
abuse specifically, may actually create biological emotional vulnerability by 
permanently altering the central nervous system of abused children (Wagner and 
Linehan, 1997). 
2.3.2.1.3 Social Factors 
Family studies for BPD were addressed by NICE in their clinical guidelines. They 
identified a number of social factors that may be important in the development of 
BPD, for example, a history of mood disorders and substance misuse in other 
family members. These studies point to recent evidence, which suggests that 
neglect, including supervision neglect, and emotional under-involvement by 
caregivers, are important. They point out that prospective studies in children have 
shown that parental emotional under-involvement contributes to a child’s 
difficulties in socialising and perhaps to a risk of suicide attempts (Johnson, Cohen 
and Gould, 2002). Also that some people with BPD, significantly more often than 
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people without the disorder, see their mother as distant or over-protective, and 
their relationship with her conflictual, while the father is perceived as less involved 
and more distant. They infer from this that problems with both parents are more 
likely to be the common pathogenic influence in this group rather than problems 
with either parent alone. Physical, sexual and emotional abuse can all occur in a 
family context and high rates are reported in people with BPD (Johnson et al., 
1999). Zanarini reported that 84% of people with BPD retrospectively described 
experience of bi-parental neglect and emotional abuse before the age of 18, with 
emotional denial of their experiences by their caregivers as a predictor of BPD 
(Zanarini et al., 2000). NICE suggests that these parents were unable to take the 
experience of the child into account in the context of family interactions. Thus 
abuse alone is neither necessary nor sufficient for the development of BPD and 
predisposing factors and contextual features of the parent-child relationship are 
likely to be mediating factors. The critical factor is therefore the family 
environment. 
Some studies suggest that people are made more vulnerable to highly stressful 
bio-psychosocial experiences by early inadequate mirroring and disorganised 
attachment. Mirroring is when someone does not learn their worth as a child 
before adulthood, and is always looking to others for self-validation (Kohut, 1971). 
NICE proposes that this is likely to be associated with a more general failure in 
families, such as neglect, rejection, excessive control, unsupportive relationships, 
incoherence and confusion. Attachment is the bond that develops with the 
mother/ caregiver, predominantly based on infants’ need for safety, security and 
protection. Attachment provides the context for growth and maintenance of many 
of developmental competencies, such as self-regulation, affect modulation, 
behaviour modulation, inter personal regulation, and cognitive aspects of the self 
and other. It thereby creates an infant who learns to control and modulate the 
exposures to environmental stimuli and develops internal homeostasis (a child’s 
ability to maintain internal equilibrium by adjusting its psychological processes). 
Research shows that people who develop BPD due to disruption of the attachment 
process tend to go off track, as the attachment process is disrupted and 
disorganised. Lack of attachment has a negative impact on neurobiology, i.e., the 
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functions, growth and structure of the brain, which leads to psychological factors 
such as negative changes in personality traits (Kohut, 1971). BPD is strongly 
associated with attachment and there are indications of disorganisation 
(unresolved attachment and inability to classify category of attachment) in 
interviews, and also fearful avoidant and preoccupied attachment in 
questionnaire studies (Levy, 2005). According to NICE (2009) in about 94% of BPD 
patients, early insecure attachment is a relatively stable characteristic, particularly 
in conjunction with negative life events. 
NICE (2009) also identifies evidence of the continuity of attachment from early 
childhood in adverse environments. The evidence fits with two longitudinal 
studies following children from infancy to early adulthood that reported 
associations between insecure attachment in early adulthood and BPD symptoms. 
This leads them to propose that disrupted childhood attachment may be an 
important factor in the development of BPD. Fonagy et al., (2003) suggest that 
adverse effects arises from insecure and/or disorganised attachment 
relationships. These may have been disrupted for many reasons, are mediated via 
a failure in the development of mentalising capacity – a social cognitive capacity 
to do with understanding and interpreting one’s own and others’ actions as 
meaningful on the basis of formulating what is going on in one’s own and other 
people’s minds. NICE then infers that this formulation overlaps with the 
importance of the invalidating family environment that was suggested by Linehan 
(1993) as a factor in the genesis of BPD. This is further developed by Fruzetti and 
Fruzetti (2003), and by Fruzzetti and Boulanger (2005). They also report that 
parental invalidation, in part defined as the undermining of self-perceptions of 
internal states and therefore anti-mentalising, is not only associated with the 
young person’s reports of family distress and their own distress and psychological 
problems, but also with aspects of social cognition, namely the ability to identify 
and label emotion in themselves and others.  
2.3.2.1.4 Bio-Psychosocial Factors   
Wagner and Linehan (1997) presented the theory according to which BPD arises 
from a combination of biologically based difficulties in the processing of emotions 
and specific environmental circumstances as well as their transaction. The 
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biological components in this model arise from a combination of genetic, intra-
uterine and developmental factors affecting physiological development. The 
environmental contributors can be any circumstance involving neglect, trauma or 
severe punishment. The outcome of combined biological vulnerability to 
emotions, an invalidating environment and adverse childhood events is thus seen 
as a fundamental disruption of the emotional regulation system. Linehan views 
emotional dysregulation as the core pathology of BPD and views all problematic 
behaviours in individuals with BPD as functionally related to regulating emotions 
or as natural outcomes of dysregulated emotions (Wagner and Linehan, 1997). 
According to this theory, emotional regulation in individuals with BPD consists of 
two factors. The first factor is called Emotional Vulnerability whose components 
are hypothesised to be high sensitivity to emotional stimuli, elevated emotional 
intensity and a slow return to an emotional baseline. In other words, in 
emotionally vulnerable individuals, it does not take much to provoke an emotional 
reaction. These individuals have the tendency to pick up emotional cues easily and 
to react quickly with intense and extreme reactions. The second factor identified 
by these authors is a deficit in the ability to regulate emotions. This trait in turn 
leads to attention towards mood incongruent aspects of the environment, biased 
memory and biased interpretation. All of which contribute to maintaining the 
original mood state and a heightened state of arousal.  
Linehan’s theory asserts that invalidating environments disrupt the normal 
learning of emotional meanings, discrimination and modulation. An Invalidating 
Environment is one that consistently communicates to the individual that his 
actions or reactions, both cognitive and emotional, are not appropriate or valid 
responses to events (Linehan, 1993). It is an environment in which the child’s 
communication of private experiences, i.e. thoughts and feelings, are responded 
to with erratic, inappropriate and extreme responses from caregivers. The 
expressions of private experiences, particularly emotional reactions, are not 
validated; instead, they are disregarded, trivialised or punished. Linehan then 
hypothesised specific consequences of invalidating environments: 
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a) When a child’s emotional expressions fail to be validated, the child does not 
learn how to label private experiences, and may actually come to experience 
emotions differently; 
b) When emotions are not acknowledged, the environment does not teach the 
child how to regulate them or to solve problems, therefore extreme emotional 
displays becomes necessary in order to evoke helpful environmental 
responses; 
c) When those around the child do not tolerate negative emotions, and 
oversimplify the child’s ability to solve problems, the child does not learn how 
to tolerate emotions or form realistic expectations; 
d) The invalidating environment does not teach the child to trust his or her own 
reactions as valid, and the child therefore distrusts or invalidates personal 
experiences and relies on the environment to provide information on how to 
feel, think or act. 
Bio-psychosocial Theory asserts that the effect of invalidation is not the sole cause 
of BPD. BPD arises from a combination of, and interaction with biological and 
environmental circumstances. Trauma is probably one of the primary influences 
on the biology of individuals with BPD (Wagner and Linehan, 1997, p.201). Bio-
psychosocial Theory can thus be seen as a transactional theory, in which the child 
and the environment are hypothesised to influence each other. The above 
explanation describes many ways in which the environment can influence the 
child, but there are also several ways in which the child may influence the 
environment. The biological predisposition to emotional vulnerability may 
manifest itself in ways that puts the child at risk of abuse. Compared with other 
children, the emotionally vulnerable child may initially cry more, may have more 
tantrums, may seek affection more, and in general may engage in behaviours that 
make him or her a more salient and likely target for abuse. As the invalidating 
environment teaches the child that his or her thoughts, feelings and emotions are 
irrelevant, the child may become less likely to complain or to disclose abuse. In 
turn this child is at a higher risk of continued abuse than other children (Wagner 
and Linehan, 1997). The interrelation between the bio-psychosocial factors is 
shown in Figure 2-3. Not all children who have been abused or born with 
emotional sensitivity or vulnerability develop BPD. Thus Bio-Psychosocial theory 
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asserts that the biological predisposition to emotional vulnerability becomes 
problematic in an environment that does not take the vulnerability into account. 
 Adverse Childhood Experience/ Trauma
 Invalidating Environment
 Disrupted /Disorganised attachment
Biological Factors
Psychological Pathology





 Inherited personality traits
 Predisposition Biological Vulnerability
Interact & impacts the development of:
Environmental Factors
Bio-Psychosocial Factors of BPD/PTSD/CPTSD
2. Neurobiology 
 Brain (Structure, Function, Growth)  Psychological
Leads to development of BPD Psychopathology
Treatment:              BPD - DBT, TC / Psychodynamics
PTSD/CPTSD – DBT, Exposure Therapy
1. Genetic, Epigenetic
Figure 2-3  Bio-Psychosocial Model (Modified Leichsenring et al., 2011)  
 
There are thus three important factors in this model. These are the biological 
component of constitutional vulnerability, an invalidating social environment, and 
the psychological development of the individual. All these undermine the 
development of the individual’s cognitive, emotional and social capacities. These 
factors, with or without further trauma, exemplified by severe neglect, abuse and 
other forms of maltreatment, may cause changes in the neural mechanisms of 
arousal and lead to structural and functional changes in the developing brain, and 
unless early adequate remedial measure are taken, BPD may develop (NICE, 2009). 
2.3.2.2 CPTSD Aetiology 
Simply speaking, the cause of CPTSD is complex trauma. Courtois refers to CPTSD 
as ‘Developmental Trauma’, a type of stressful event that occurs repeatedly and 
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cumulatively, usually over a period of time and within specific relationships and 
contexts (Courtois, 2004). Childhood abuse (sexual, emotional, physical and 
neglect) constitute typical forms of chronic traumatisation. Families with 
dysfunctions such as affect-dysregulation among family members can also be 
developmentally traumatising (Ozturk and Sar, 2005). Courtois also highlights 
traumatic stressors that are interpersonal, i.e. premeditated, planned and caused 
by other human beings, involving intrusion upon, violation or exploitation of the 
child (Courtois, 2011). Interpersonal violence can be a onetime event that occurs 
without warning, perpetrated by a stranger (i.e. robbery, rape, physical assault). 
When such violence occurs within the family, between family members or in other 
closed contexts that involve significant roles and relationships, it is usually 
repeated, prolonged and can become chronic over time. Child abuse within the 
family is the most common form of chronic interpersonal victimisation (Courtoise, 
2014). Such abuse is often founded on problematic and insecure attachment 
relationships between parent and child or others who have primary caretaking 
responsibilities (Courtois, 2011). Also, the cumulative adversities faced by many 
people, communities and ethno-cultural religious and political groups around the 
globe can constitute forms of complex trauma, some of which occurs throughout 
life from childhood onwards, and can have the same effects (Courtois, 2011).  Such 
complex stressors are often extreme, and due to their nature and timing may 
actually be life-threatening. Most threaten the individual’s emotional mental 
health and physical well-being (emotional and physical integrity) because of the 
degree of personal invalidation, disregard, deprivation and coercion, and meet the 
DSM-IV criterion A for PTSD (Courtois, 2011). 
2.3.3 Diagnosis 
In essence, BPD represents a disorder of attachment, while CPTSD can be better 
understood as a disorder of self-regulation (Luxenberg, Spinazzola and van der 
Kolk, 2001). This assertion supports other studies which suggest that many 
patients diagnosed with BPD should be assigned another more discriminating 
developmental diagnosis such as CPTSD (Vaillent, 1992; Herman, 1992). 
  
Chapter 2 Literature Review 
  Page 47 
2.3.3.1 BPD Diagnosis 
Although the prognosis of BPD can be relatively good, with most people not 
meeting the criteria for BPD diagnosis after 5 years, it is important to note that a 
minority of people have persistent symptoms into late in life. Recurrent self-harm 
possibly due to BPD may occasionally be a problem in the elderly. However, the 
condition is much less prevalent in the elderly than in the young and one of the 
encouraging features about remission from the condition is that it is less often 
followed by relapse than is the case with most other psychiatric disorders.  
The reliability and validity of the diagnostic criteria have however been criticised, 
and the utility of the construct itself has been called into question (Tyrer, 1999). 
Moreover, it is unclear how satisfactorily clinical or research diagnoses actually 
capture the experiences of people identified as personality disordered (Ramon, 
Castillo, and Morant, 2001). There is a large literature showing that BPD overlaps 
considerably with other categories of personality disorder, with ‘pure’ BPD only 
occurring in 3 to 10% of cases (Pfohl, Coryell and Zimmerman, 1986). The extent 
of overlap in research studies is particularly great with other so-called cluster B 
personality disorders (histrionic, narcissistic and antisocial). In addition, there is 
considerable overlap between borderline personality disorder and mood and 
anxiety disorders (Tyrer, Gunderson, and Lyons, 1997; Zanarini et al., 1998). 
2.3.3.1.1 Onset and Prognosis of BPD 
There is some controversy over the possible age of onset of BPD. Many believe 
that it cannot, or should not, be diagnosed in people under 18 years of age, while 
the personality is still forming (although diagnosis is possible in DSM-IV-TR based 
on the same criteria as adults, though with additional caveats). Nevertheless, 
borderline symptoms and characteristics are often identifiable at a much earlier 
age, and sometimes early in adolescence (Bradley, Jenei and Westen, 2005). More 
attention is now being paid to its early manifestations in adolescent groups (see 
Famularo, Kinscherff and Fenton). The course of BPD is very variable. Most people 
show symptoms in late adolescence or early adult life, although some may not 
come to the attention of psychiatric services until much later. The outcome in 
young people who have received treatment or formal psychiatric assessment is 
much better than was originally thought, with at least 50% of people improving 
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sufficiently not to meet the criteria for BPD 5 to 10 years after first diagnosis 
(Zanarini, 2003). This may be a consequence of treatment; however, evidence 
suggests that a significant proportion of improvement is spontaneous and is 
accompanied by greater maturity and self-reflection. 
2.3.3.1.2 BPD Diagnostic Criteria 
DSM-IV-TR sees BPD as a pervasive pattern of instability in interpersonal 
relationships, self-image and affects, and marked impulsivity beginning by early 
adulthood and present in a variety of contexts, as indicated by five (or more) of 
the following): 
1. Frantic efforts to avoid real or imagined abandonment, but not including 
suicidal or self-mutilating behaviour 
2. A pattern of unstable and intense interpersonal relationships characterised by 
alternating between extremes of idealisation and devaluation 
3. Identity disturbance: markedly and persistently unstable self-image or sense 
of self 
4. Impulsivity in at least two areas that are potentially self-damaging (for 
example, spending, sex, substance abuse, reckless driving, binge eating), but 
not including suicidal or self-mutilating behaviour 
5. Recurrent suicidal behaviour, gestures, or threats, or self-mutilating behaviour 
6. Affective instability due to a marked reactivity of mood (for example, intense 
episodic dysphoria, irritability, or anxiety usually lasting a few hours and only 
rarely more than a few days) 
7. Chronic feelings of emptiness 
8. Inappropriate, intense anger or difficulty controlling anger (for example, 
frequent displays of temper, constant anger, recurrent physical fights) 
9. Transient, stress-related paranoid ideation or severe dissociative symptoms. 
The key features are instability of interpersonal relationships, self-image and 
affect, combined with marked impulsivity beginning in early adulthood (Gelder et 
al., 2012). 
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2.3.3.1.3 BPD Diagnosis in Practice 
A major survey of American clinicians by Westen in 1997 found a low rate of 
compliance with DSM criteria for BPD diagnosis (Westen, 1997). He surveyed 52 
Harvard clinicians by email. The first finding was that of all the Axis II disorders, 
BPD represented the highest diagnosis at 85%, and that no mention was made of 
trauma related disorders such as PTSD/CPTSD. He then established that 44% of 
clinicians were satisfied with a single (BPD) diagnosis and did not wish to consider 
a second or comorbid Axis II diagnosis such as CPTSD. 14% did not consider their 
BPD diagnosis as a primary diagnosis. Another significant finding from the Westen 
study was the resistance by clinicians to the use of DSM recommended structured 
instruments. When surveyed, clinicians indicated that they preferred to observe 
patients’ behaviours and appearance and to listen to their narratives. Some of the 
responses indicated that semi-structured instruments were often too probing and 
excessively time consuming. Other complaints were that such instruments tended 
not to discern between differing presentations and thus tended to over predict 
comorbidity. Although Westen extended his survey from his original dataset of 52 
Boston practitioners to over 8,000 nationwide (25% response rate), the only 
applicable numerical results they present relate to their comorbidity rates, which 
confirmed previous findings. 
2.3.3.2 CPTSD Diagnosis 
The findings of the ‘DSM-IV Field Trial for PTSD’ suggested that trauma has its most 
profound impact when its onset occurs during early childhood or adolescence and 
becomes less pervasively damaging with later onset. The trial also reported that 
almost half of the traumatised sample in the research had experienced a Criterion-
A traumatic stressor before age 11. Also the high rates of current DESNOS in the 
individuals provided compelling evidence for the enduring impact of exposure to 
trauma during childhood (Luxenberg, Spinazzola and van der Kolk, 2001). Findings 
from the DSM-IV trial supported the CPTSD concept as a complex adaptation to 
chronic interpersonal violence, in both children and adults. One reason why DSM 
did not assign a separate diagnostic character is due to the comorbid nature 
between CPTSD and PTSD. DESNOS criteria were included among the associated 
features of PTSD. This reflects the view that DESNOS characteristics are not a 
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unique feature of survivors of childhood sexual abuse or other prolonged trauma, 
but instead apply to varying degrees to most PTSD sufferers. Brett (1996) 
commented that although it was suggested for inclusion as a separate DSM 
disorder by Herman in 1994, the debate surrounding the exclusion noted that the 
diagnosis of PTSD gave specific criteria for post-traumatic symptoms and fostered 
the appreciation of the generic features of a traumatic stress syndrome. However, 
CPTSD is included in DSM as DESNOS and ICD has a similar code ‘personality 
change due to classifications found elsewhere’ (31.1), and both parameters 
accommodate CPTSD (Herman, 1997).    
Many PTSD researchers and clinicians have proposed that most of the symptoms 
that DSM–IV lists as associated symptoms actually provide a description for 
CPTSD, and that this collection of symptoms clearly delineates the enduring 
developmental effects of trauma, and is helpful in conceptualising complex 
adaptations to trauma over a lifetime (van der Kolk and Courtois, 2005, p.386). 
Early research revealed that there were severe problem areas associated with 
interpersonal trauma at a young age (Herman, 1992). Although sometimes 
controversial, a growing number of empirical studies have supported the validity 
of CPTSD and its distinction from ‘simple PTSD’ (Roth et al., 1997; Zlotnick et al., 
1996; Ford, 1999; Yen and Shea, 2001; Miller and Resick, 2007). While constituting 
the main psychopathological dimensions of CPTSD, these diverse features led to 
elevated levels of general psychiatric comorbidity, from a point of view of the 
existing psychiatric nosology and classification both in cross-sectional evaluation 
and in longitudinal course.  
The comorbidity of CPTSD and PTSD reflect the view that CPTSD characteristics are 
not unique features of survivors of childhood sexual abuse or other prolonged 
trauma, but instead apply in varying degrees to most of PTSD sufferers (NICE, 
2004; 2007, p.35). There is also a high incidence of comorbidity with trauma in 
general, other Axis I (mood or bipolar) and Axis II (personality) disorders such as 
BPD (Luxenberg, Spinazzola and van der Kolk, 2001). 
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2.3.3.2.1 The DESNOS Criteria  
According to Roth et al., 1997: 
I. Alterations in Regulation of Affect & Impulses (A and one of B-F required) 
A. Affect Regulation (2)  D. Suicidal Preoccupation 
B. Modulation of Anger (2) E. Modulation of Sexual Involvement 
C. Self-Destructive   F. Excessive Risk Taking 
II. Alterations in Attention or Consciousness (A or B required) 
A. Amnesia 
B. Transient Dissociative Episodes & Depersonalization 
III. Alterations in Self-Perception 
A. Ineffectiveness   D. Shame 
B. Permanent Damage  E. Nobody Can Understand 
C. Guilt & Responsibility  F. Minimizing 
IV. Alterations in Perception of the Perpetrator (Not required) 
A. Adopting Distorted Beliefs 
B. Idealization of the Perpetrator 
C. Preoccupation with Hurting Perpetrator 
V. Alterations in Relationships with Others (One of A-C required) 
A. Inability to Trust 
B. Re-victimisation 
C. Victimizing Others 
VI. Somatization (Two of A-E required) 
A. Digestive System   D. Conversion Symptoms 
B. Chronic Pain   E. Sexual Symptoms 
C. Cardiopulmonary Symptoms 
VII. Alterations in Systems of Meaning (One of A-B required) 
A. Despair and Helplessness 
B. Loss of Previously Sustaining Beliefs 
The top DESNOS resembling criteria in DSM-IV–TR and still valid for DSM-5 are:  
1. Impaired affect modulation 
2. Self-destructive and impulsive behaviour 
3. Dissociative symptoms 
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4. Somatic complains 
5. Feelings of ineffectiveness 
6. Shame 
7. Despair and hopelessness 
8. Feeling of permanently damaged 
9. Loss of previous sustained beliefs 
10. Hostility, social withdrawal 
11. Feeling constantly threatened 
12. Impaired relationship with others or change from individuals’ previous 
personality character. 
2.3.4 BPD Comorbidity 
Either as a result of its position on the ‘border’ of other conditions, or as a result 
of conceptual confusion, BPD is often diagnostically comorbid with depression and 
anxiety, eating disorders such as bulimia, PTSD, substance misuse disorders and 
bipolar disorder (with which it is also sometimes clinically confused). The overlap 
with psychotic disorders can also be considerable. The level of comorbidity has 
been said to be so great that it is uncommon to see an individual with ‘pure’ BPD 
(Tyrer, 1999). Because of this overlap with other disorders, many have suggested 
that BPD should not be classified as a personality disorder, but should be classified 
as mood disorders or as disorders of identity. In clinical practice, it is sometimes 
difficult to determine if the presenting symptoms are those of BPD or a related 
comorbid condition. The main differences between the core symptoms of BPD and 
other conditions are that the symptoms of BPD undergo greater fluctuation and 
variability. These psychotic and paranoid symptoms are transient, depressive 
symptoms and change dramatically over a short period. Suicidal ideas may be 
intense and unbearable but only for a short time, doubts about identity may occur 
but are short-lived, and disturbances in the continuity of self-experiences are 
unstable. For each of the equivalent comorbid disorders there is much greater 
consistency of these symptoms. 
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2.3.5 Physical & Structural Effects of Trauma pre Treatment  
Trauma can have significant effects on the body (Luxenberg, Spinazzola and van 
der Kolk, 2001). There is also evidence that repeated traumatic experiences impact 
the body via numerous mediating models. The first is a Biological Model that 
includes neuro-anatomical factors and reduced hippocampal volume. Second is 
the Physiological or neurohormonal effect. This can affect the limbic system, 
causing excessive response in the nervous system and excessive activity in the 
sympathetic and parasympathetic system. Finally, there are somatic difficulties 
that also damage physical health and in extreme cases can lead to premature 
death (Luxenberg, Spinazzola and van der Kolk, 2001). 
2.3.6 Treatment of the Disorders 
What has been written about the treatment of the disorders is now presented. 
This starts with classical BPD treatment, explaining why this is not enough, and 
addresses how trauma treatment can benefit BPD. CPTSD treatment is then 
addressed in more detail as these techniques could be applied to BPD.  
2.3.6.1 BPD Treatment 
APA guidelines recommend psychotherapy as the main treatment for BPD, with 
pharmacotherapy as an adjunctive component of treatment that targets current 
symptoms during periods of de-compensation and trait vulnerabilities 
(Leichsenring et al., 2011; NICE, 2009). NICE also recommends that psychotherapy 
should be used as the cornerstone of treatment for BPD and identified several 
methods of psychotherapy. The outcome in young people who have received 
treatment or formal psychiatric assessment is much better than was originally 
thought, with at least 50% of people improving sufficiently not to meet the criteria 
for BPD 5 to 10 years after first diagnosis (Zanarini, 2003). This may be a 
consequence of treatment; however, evidence suggests that a significant 
proportion of improvement is spontaneous and is accompanied by greater 
maturity and self-reflection (NICE, 2009). DBT (Dialectical Behaviour Therapy) is a 
broad–based cognitive behavioural therapy (CBT) developed specifically for BPD 
(Linehan, 1993). It was the first type of psychotherapy shown via controlled clinical 
trials to be effective with BPD (Linehan et al., 1991). DBT including skills training, 
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is based on the Bio-psychosocial theory of the development of BPD, where neglect 
in early relationships leads to an impaired ability, both to represent and to 
moderate affect and control attentional capacity. These factors may cause 
changes in the neural mechanisms of arousal and lead to structural and functional 
changes in the developing brain.  
However, research on the treatment of BPD, such as that conducted by Marsha 
Linehan has largely ignored the traumatic origins of BPD and instead focused on 
symptom stabilisation (van der Kolk, 2001). As a comprehensive treatment for 
BPD, this is problematic, as it fails to intervene prior to the development of BPD 
psychopathology. The Bio-psychosocial model emphasises that we cannot change 
an individual’s genetics or some of the environment that they grow up in, nor can 
we even know what is happening in an individual’s environment. We can however 
intervene to reverse some of the adverse neural mechanisms of arousal, and thus 
lead to structural and functional changes in the developing brain. These changes 
happens in the environment due to adverse childhood traumatic experiences. The 
Bio-psychosocial model therefore informs the treatment of BPD in order to 
improve or sustain functional and affect long-term outcome. This model allow us 
to understand aetiology in terms that explain variations in long-term course, and 
it elucidates, or throws light on where to intervene for the most beneficial 
treatment. The model also shows that the etiological pathway is the same as for 
CPTSD, and therefore BPD can benefit from treatment that is designed for CPTSD 
as will be discussed in the next section (2.3.6.1.1). 
Shea et al., (2004) reported that treating PTSD due to the effects of traumatic 
experiences in BPD could, over time, lead to improvement in BPD because the 
latter shares some, but not all, the dimensions of PTSD. Leichsenring et al., (2011, 
p.79) reviewed 24 randomised controlled trials (RCTs) on psychotherapy alone for 
BPD using the gold standard ‘Cochrane’ criteria. For those studies that used CBT, 
the authors compared its effectiveness with treatment as usual and found that 
behaviour therapy was in general more effective in several outcome measures 
than ‘treatment as usual’, i.e. DBT and pharmacotherapy. Following treatment, 
however, a number of patients still met the diagnostic criteria for BPD. The authors 
also compared the effectiveness of various non-behaviour therapies with 
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behaviour therapy, and came to similar conclusions, noting that even brief CBT, 
which looks at the origins of dysfunctional behaviours, but does not focus 
specifically on possible underpinning traumatic histories can be beneficial. While 
these benefits are recognised, the authors noted that at present there is no clear 
evidence that one specific form of psychotherapy is superior to another and that 
the available forms of psychotherapy do not yet lead to remission of BPD for most 
patients.  
2.3.6.1.1 Trauma Treatment for BPD Patients 
In addressing the question of why most psychotherapy treatment does not yield 
remission for BPD, Landecker (1992) proposes that this could be due to the 
treatment being focused on borderline characteristics rather than the comorbid 
PTSD/CPTSD. Van der Kolk (1987) also suggests that it could be due to the fact 
that, in clinical settings, diagnosis has been made on presenting BPD symptoms, 
and treatment is consequently focused on behavioural skills training and 
development, and not on PTSD/CPTSD or underline traumatic histories. NICE has 
recommended several types of treatment for trauma. One is Exposure Therapy, 
and a subset of this – trauma focused exposure therapy – applied in conjunction 
with CBT (TF-CBT), an evidence-proven treatment for PTSD recommended by NICE 
(2005). This treatment focuses on how patients interpret aspects of their 
traumatic experiences that have become problematic for them. It also improves 
response techniques for coping with problems such as thought suppression, 
rumination or selective attention to threat (Ehlers et al., 2009). There are two main 
recommended types of exposure therapy: cognitive restructuring and prolonged 
exposure (PE), both of which incorporate cognitive behavioural structures, 
focusing on patients’ cognitions and attributions about both the traumatic event 
and themselves. They also allow both the extinction of conditioned fear and the 
regulation of emotions. This regulates the dysfunctional neural circuits involved 
with negative emotions and fear. PE was designed to be added to Dialectic 
Behaviour Therapy (DBT) to treat PTSD symptoms in suicidal and self-injuring 
individuals with BPD, and in the hands of therapists such as BPD clinicians with 
minimal CBT experience, it was found to be as efficacious as treatment by CBT 
experts (Foa, 2011).  
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The advantage of focusing BPD treatment on trauma and PTSD/CPTSD follows 
from studies that have found that treatment of PTSD leads to the integration of 
traumatic memories, (associated with PTSD) and reduces the symptoms of BPD 
(van der Kolk, 1987, pp.111-119). This is a precondition for the development of 
improved tolerance, impulse control, defensive organisation, and for the 
restoration of an integrated self-identity. Also in 1987, the same authors noted 
that clinical literature on the treatment of PTSD repeatedly cites the importance 
to recovery of the integration of traumatic memories with their associated affect, 
and the necessity for the patients’ traumatic experiences to be validated. This 
approach is consistent with the recommendation that there should be early, rapid 
and appropriate recognition of the connections between patients’ current 
symptomatology and their origin. 
Caution must always be employed, as intervening too early for PTSD/CPTSD could 
be problematic. Bryer, Nelson and Miller (1987) looked at sexual and physical 
abuse as factors in adult psychiatric illness and suggested that instituting 
psychological and pharmacological therapies without knowing about the original 
trauma would be like treating the varied and chaotic symptoms of Vietnam 
veterans without knowing about Vietnam or what happened there. In addition, it 
has been suggested that early intervention into PTSD symptoms by non trauma 
clinicians could lead to attrition and exacerbate symptoms (Grubagh et al., 2011). 
Bryer also found that many clinicians were uncomfortable about discussing abuse, 
because of suppressed or repressed trauma memories, but also because most 
clinicians have not had the appropriate training, especially when dealing with the 
difficult subjective reactions that can be evoked in themselves. 
Some researchers have concluded that a combination of early intervention with 
Trauma Focused CBT and treatment as usual will be beneficial (Deblinger et al., 
2006; Cloitter et al., 2010). In addition, Clarke, Rizvi and Resick (2008) 
demonstrated that PTSD focused CBT treatment may positively affect BPD 
symptomatology, although this tends to contradict the 2011 Lancet study, which 
concluded that the prevalent assumption is that individuals with BPD will not 
benefit from evidence-based treatment for PTSD (Leichsenring et al., 2011). 
However, it is inconsistent with Mueser et al., (2008) who demonstrated that with 
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16 weeks of CBT, severely ill BPD patients with PTSD could be treated successfully 
in conjunction with treatment as usual. One interesting point in this research was 
that they found that the burden of PTSD can be reduced in this population and 
that Exposure Therapy may not be necessary.  
Shea et al., (2004) conducted a prospective study, which included 223 BPD 
patients, 38% of whom had a comorbid PTSD diagnosis. They showed that patients 
with a high PTSD remission rate exhibited an even higher BPD remission rate over 
time. This could imply that when PTSD treatment is working well, it also has a 
beneficial effect on BPD symptoms. Remission from PTSD can also be associated 
with the increased probability of remission from BPD. Harned et al., (2012) treated 
PTSD in suicidal and self-injuring women with BPD. Their study focused on the 
development and pilot testing of a protocol based on Prolonged Exposure (PE) 
designed to be added to DBT to treat PTSD in suicidal and self-injuring individuals 
with BPD. Women with BPD, PTSD, and recent and/or imminent serious 
intentional self-injury (N=13) received one year of DBT compared with the DBT PE 
Protocol, plus three months of follow-up assessment. The treatment was 
associated with significant reductions in PTSD, with the majority of patients no 
longer meeting criteria for PTSD at post-treatment (71.4% of DBT PE Protocol 
completers, 60% of the intent-to-treat sample). Improvements were also found 
for suicidal ideation, dissociation, trauma-related guilt cognitions, shame, anxiety, 
depression, and social adjustment. Overall, the results indicate that successful 
integrated BPD and PTSD treatment can be achieved within one year of treatment 
starting. This is highly acceptable to both patients and therapists, safe to 
administer, and has showed promise as an effective intervention for PTSD in this 
complex and high-risk patient population. 
2.3.6.1.2 Consequences of not Screening and Treating for Trauma 
Failure to screen for trauma in BPD has the consequence of patients not being 
diagnosed with a trauma related syndrome, and therefore only receiving a 
diagnosis such as BPD, with the result that treatment is less effective (Tucker, 
2002). For BPD comorbid disorders, NICE recommends referral to a special plan 
addressing the core difficulty as well as the comorbid disorder. A failure to refer 
for trauma treatment denies effective and evidence validated treatment: e.g., 
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trauma focused CBT and/or EMDR (NICE, 2005; Mueser et al., 2008 and Cloittre et 
al., 2010). The failure to treat long-term disorders (PTSD/CPTSD) also perpetuates 
poor self-rated health and personality changes (Al-Saffer, Borgå and Hällström, 
2002; Canadian PTSD Association, 2004-2011). The greater the understanding of 
the developmental origins of psychological mechanisms underpinning disorders, 
the better the chance of at least partially effective psychological treatments which 
challenge traditional views of BPD as immutable (NICE, 2008, p.30). The phase 
based treatment approach that is recommended for CPTSD, combines a skills 
focused with an exposure-focused treatment, is discussed below.  
2.3.6.2 CPTSD Treatment 
The treatment of Simple PTSD and CPTSD (DESNOS) requires different approaches 
(van der Kolk, 2001). Effective treatment of complex post-traumatic problems 
needs amongst other things to address the imprint of trauma on the experience 
of the self as helpless and in danger. Trauma recovery needs to include dealing 
with defensive efforts that helped ensure survival, incorporate physical 
experiences that counter feelings and sensations associated with helplessness and 
disconnection, as well as an effective way of integrating fragmented memories of 
trauma. Experiencing physical mastery (as in yoga and specific body based 
techniques) is often necessary in order to initiate new ways of perceiving reality 
and to promote the types of behaviour patterns that are useful in dealing with 
trauma. Helping every aspect of the human organism to bring the traumatic 
experience to an end is the goal of treatment. The treatment recommended by 
the International Society for Traumatic Stress Studies (ISTSS) and many experts in 
the field is a Phased Oriented Treatment and advises a three-phase treatment 
model (ISTSS, Expert Consensus Guidelines for CPTSD, Cloitre et al., 2011):  
 Stabilisation and skills reinforcement;  
 Reappraisal of traumatic memory;  
 Greater engagement in community life.  
Cloitre et al., (2010) conducted a head-to-head comparison of this phase-based 
treatment with an exposure-focused treatment and a skills focused treatment. 
The results of this study indicated the superiority of the phase-based approached 
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as compared with exposure-focused treatment, while the skills-only approach fell 
in the middle (ISTSS). 
2.3.6.2.1 Phase One - Stabilisation and Skills Reinforcement 
This can be conceptualised as helping to maximise frontal lobe activity by learning 
to observe and attend to day-to-day activities, thereby diminishing the power of 
trauma-related physical sensations, emotions and perceptions. In this phase, DBT 
approaches are recommended as they can assist patients in developing skills to 
deal with affect regulation. DBT, which includes both skills training and individual 
work, can be extremely helpful as an adjunctive or sometimes preparatory 
treatment for individual trauma treatment (van der Kolk, 2001). 
2.3.6.2.2 Phase Two - Reappraisal of Trauma Memory/Trauma Processing 
Here, exposure-based treatments are applied, e.g. PE, Cognitive restructuring and 
Eye Movement Desensitization and Reprocessing (EMDR), all of which are 
cognitive behavioural in nature and focus on patients’ cognitions and attributions 
about both the traumatic event and themselves. EMDR is a technique that is 
thought to facilitate rapid adaptive associative information processing by 
integrating sensations, affects and self-attribution. In this way, it may share some 
qualities with REM sleep, which has been posited to help process day-to-day 
experiences (Stickgold, 1999, cited in van der Kolk, 2001). However, at this point 
there is no specific evidence of why EMDR works (van der Kolk, 2001). 
2.3.6.2.3 Phase Three - Greater Engagement in Community Life 
The purpose is to re-establish secure social connections and interpersonal efficacy, 
accumulating restorative emotional experiences (van der Hart et al., 1989; 
Herman 1992, cited in van der Kolk, 2001). Because so little systematic research 
has been done on both BPD and CPTSD patients, many questions remain about 
what constitutes optimal treatment. Some writers such as McCann and Pearlman 
(1992) and Herman (1992) emphasise the importance of a restorative therapeutic 
relationship with therapy and of building coping skills, with the formation of loose 
associations. Particular sensations then lose their power to evoke entire traumatic 
scenes and the patient learns to attach new meanings to old sensations and to 
process traumatic memories. What can be most important for these patients is to 
Chapter 2 Literature Review 
  Page 60 
learn to have a subjective sense of mastery and competence that will allow them 
to live in the present without constantly being pulled back into experiencing the 
present as a recurrence of the past (van der Kolk, 2001). 
2.3.6.3 Impact on the Brain following Treatment 
A meta-analysis, and a systematic review by Porto et al. of neuroimaging of 
emotional processing in PTSD and social anxiety disorder revealed that CBT was 
able to make quantifiable changes in functional brain response is empathetic and 
forgiving in judgement, and also shows that PTSD has been resolved (Porto et al., 
2009). The study also shows that CBT helps in the remission of PTSD symptoms as 
well as to promote activation of the brain areas related to social cognition of 
empathy and forgiveness. Neuroimaging also found structures that participated 
both in the brain circuits involved with fear extinction and in those involved with 
cognitive regulation of emotion. In addition, CBT regulated dysfunctional neural 
circuits involved with the regulation of negative emotions and fear extinction. This 
is because CBT treatments contain specific techniques of exposure, and cognitive 
re-structuring, which allows for both the extinction of conditioned fear, regulates 
behaviour, and the cognitive regulation of emotions (Porto et al., 2009). 
2.3.6.4 Treatment Conclusions 
Linking causes of BPD with trauma and proven treatment can improve or sustain 
functional day to day life and affect long-term outcome for BPD patients. Although 
trauma treatment has been proven for CPTSD patients, this can only happen if it 
is identified early by screening during assessment when patients initially present 
with BPD symptomatology. To manage these patients effectively, one first has to 
recognise the disorder (Paris, 2012). The principle disadvantage however of 
trauma treatment, is the requirement for trained clinicians competent in trauma 
screening and in the application of trauma focused therapies. 
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2.4 Question 4: Existing Screening and Assessment Instruments  
The fourth (trauma screening instrument) literature review question is addressed 
by a specific literature search, which addresses instruments that could be used to 
screen BPD patients by BPD clinicians for trauma prior to a detailed assessment by 
trauma specialists. BPD instruments are first examined.      
2.4.1 BPD Screening and Assessment Instruments 
Three principal instruments were identified. 
IPDE, International Personality Disorder Examination consists of a self-
administered questionnaire that contains 77 DSM-IV or 59 ICD-10 items (Loranger, 
Janca and Sartorius, 1997). It is recommended by NICE and contains questions that 
assess for any DSM-IV or ICD-10 personality disorder. IPDE is written so that a 9-
10 year old can complete it in 15 minutes or less. Qualified clinicians can then 
quickly score the questionnaire and identify those patients whose scores suggest 
a personality disorder. 9 questions of the 77 are relevant for the screening of BPD. 
IPDE has been developed as the most comprehensive instrument for the diagnosis 
of any personality disorders, and has been proved to have good inter-rater 
reliability when applying either the DSM or ICD diagnostic system (κ=0.8, Mann et 
al., 1999). It has also been proven to be user-friendly and to be a meaningful 
instrument for clinicians throughout the international psychiatric community. 
Although IPDE can be used as a valid screen to detect BPD symptoms, it can be 
lengthy, and more importantly does not identify the presence of traumatic 
experiences, or the reactions of trauma.  Most BPD patients seek help for trauma 
reactions but often go unrecognised in the initial screening and or assessment 
interviews. It is therefore important to discuss the patient’s background, but for 
this it is recommended to use other instruments that could enhance the 
questioning, probing and scoring process. IPDE is also not intended for subjects 
below the age of 18 years, although with slight modification it could be used with 
those as young as 15 years. As IPDE is self-reporting, it assumes that a person is 
capable of providing a valid description of their disturbances. Also IPDE is designed 
for experienced practitioners, including clinical psychiatrists and those with 
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comparative training capable of making independent psychiatric diagnosis; it is not 
intended for use by clinicians in the early phase of their training. 
SAPAS (Standardised Assessment of Personality – Abbreviated Scale, Moran et al., 
2003) is also a recognised screen for BPD, but currently it is not commonly utilised 
in the Trust.   
SCID (BPD module) is a commonly used assessment instrument. However the level 
of agreement between interview schedules is at best moderate (Zimmerman, 
1994). Nevertheless, the questions in SCID meet the criteria for both the DSM-IV 
and ICD-10 classification systems. 
2.4.2 Assessment Instruments for PTSD and CPTSD (DESNOS)  
The Structured Interview for Disorders of Extreme Stress or SIDES for DESNOS 
(Pelkovitz et al., 1997) is the only instrument that has been validated as a 
diagnostic assessment instrument for CPTSD (Luxenberg, Spinazzola and van der 
Kolk, 2001). The SIDES instrument consists of a 45 item structured interview 
comprising six sub-scales corresponding to the 12 symptom of DESNOS. It was 
developed by CAMH to measure current and lifetime presence of complex post-
traumatic stress and response severity. Instructions for SIDES recommend its use 
after recording a patient’s trauma history. It elicits information regarding the 
overall effects of trauma and is valuable in identifying the most critical areas of 
psychological impairment, which need to be addressed for effective treatment 
planning. SIDES measures the presence of the clinically most relevant issues 
associated with complex trauma. Zlotnick and Pearlstein (1997) supported SIDES 
as a valid measure of the associated features of PTSD in survivors of childhood 
sexual abuse. DSM field trials for PTSD found that SIDES prove a reliable and valid 
measure to assess the alterations in functioning that result from response to 
extreme stress (Roth et al., 1997; Perry and Herman, 1993). The SIDES instrument 
is also a valid measure for the associated features of PTSD in survivors of childhood 
sexual abuse (CSA). The principal limitation of SIDES is that it is long and very time-
consuming, so clinicians do not find it easy to use. In addition, the instrument does 
not itself elicit traumatic experiences but devolves this activity to another 
instrument, making the process very lengthy. 
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The Traumatic Antecedent Questionnaire (TAQ) is suggested to be used prior to 
SIDES. TAQ is a 78-item questionnaire to identify exposure to traumatic life events. 
A variation is TAQ–S (self-rated version) is recommended by (Herman, Perry and 
van der Kolk, 1989). The TAQ-S assessment instrument gathers information about 
lifetime experiences in 11 different domains: competence, safety, neglect, 
separation, emotional abuse, conflict resolution, physical trauma, sexual trauma, 
witnessing trauma relating to 4 different age periods, exposure to drugs and 
alcohol.  Although it discusses all of trauma it is very long, time consuming and 
very detailed, and hence daunting for clinicians not qualified to treat trauma. 
The CAPS (Clinical Administrated PTSD Scale by Blake, Weathers and Nagy, 1995) 
is considered to be the best measure for PTSD using DSM criteria (1994). Also the 
US Veterans National Centre for PTSD considers it the gold standard instrument 
for assessing PTSD (U.S. Department of Veterans Affairs). It consists of a 30 item 
structured interview that corresponds to the DSM criteria for PTSD by assessing 
the frequency and severity of the 17 DSM symptoms, and can be used to assess 
both lifetime and current PTSD. CAPS assessment is designed to be administered 
by clinicians and clinical researchers who have a working knowledge of PTSD, i.e., 
trauma trained Mental Health Professionals who have experience in conducting 
diagnostic interviews. It has been validated with good inter-rater and test-retest 
reliability (Brewin, 2005, p.153; Blake, Weathers and Nagy, 1995). One of the 
limitations of CAPS is that it is scored for symptoms rather than causes, one or 
more for frequency, and two or more for intensity. CAPS also evaluates trauma 
requesting three incidents. A full CAPS interview takes up to 45–60 minutes for a 
clinician competently trained to administer it; for untrained or inexperienced 
clinicians, it can take up to 90-120 minutes, and scoring is long and complicated. 
2.4.3 Trauma Screening Instruments 
To ensure a trauma screening technique did not already exist, a comprehensive 
search was made for existing screening instruments for trauma, and several 
existing screening instruments were identified. These instruments screen for the 
presence of PTSD but appear to focus only on traumatic stress symptoms, without 
asking about the trauma itself. They are also designed to be used following a 
known involvement in a major single-incident traumatic event called a ‘type 1 
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trauma’, ranging in type from 9/11 to a mugging, rape, car crash or heart attack 
(Terr, 1991). Terr divides childhood trauma into two basic types and defines the 
findings that can be used to characterize each of these types. Type 1 trauma 
includes full, detailed memories, “omens” and misperceptions. Type 2 trauma 
includes denial and numbing, self-hypnosis and dissociation, and rage. No single 
short screen was found that could be used for individuals with a history of complex 
traumatic experiences (type 2 trauma as described in section 1.5.1) and its 
complex reactions. Brewin (2005) had already completed a systematic review of 
PTSD screening instruments and found that several screening instruments aimed 
at identifying patients who have PTSD, prior to formal diagnosis by clinical 
interview, have been developed. The review identified 13 screening instruments 
(with mean diagnostic efficiency of 86%) that were used to identify the presence 
of PTSD following major traumatic events. The most relevant ones as presented in 
Brewin (2005) and in Walters, Bisson and Shepherd, (2007) are summarised below 
and are detailed in APPENDIX 2 . 
Table 2-4  Published Screens for PTSD 
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Brewin found that these ranged from simple four-item instruments to more 
complex scales (Foa et al., 1997). He only found a few of these scales that have 
been validated in large and diverse populations or tested independently. Given 
the relative uniform results obtained, he argued that the ideal instrument should 
have few items, simple response scales, and simple scoring methods, and thus 
gives better results than longer and more complex instruments. He suggested that 
such instruments are likely to be more accepted and provide less scope for errors 
or uncertainty in terms of answering specific questions.  Another consideration is 
that there is little information to date on acceptability for individuals who 
participate in the screening. 
The major limitation of SPAN is the limited information that can be obtained from 
only 4 questions, and therefore it can add little about the construct (disorder). 
SPAN also focuses on one particular PTSD symptom (numbing). The questionnaire 
also requires severity and frequency levels that are not easy for sensitive patients 
to handle, and the scoring system is quite complicated for busy clinicians (Brewin 
2005; Walters et al., 2007). The two instruments that appeared more suitable 
were TSQ (Brewin’s Trauma Screening Questionnaire) and IES (Horowitz’s Impact 
of Event Scale), but both only addressed PTSD and did not consider BPD or CPTSD 
(APPENDIX 2 ). TSQ comprises 10 items with important questions on re-
experiencing and arousing symptoms requiring straightforward yes/no answers, 
and it has the advantage of being validated. IES contains 15 questions about 
intrusion and avoidance relative to a specific event, which again are answered on 
a four-point scale. IES also has the advantage of having been validated on an 
independent sample. However, none of the existing screens proved suitable for 
non-specific traumas, such as those that typically experienced by patients with 
BPD/CPTSD often originating from childhood. 
2.5 Literature Review Conclusions 
A clear connection emerges from the nine most relevant published trials relating 
to BPD and the prevalence of trauma, showing high levels of trauma consistent 
with theoretical evidence. Also within these trials, there are some significant 
indications of both PTSD and CPTSD as proposed by Herman, van der Kolk and 
more recently by Harned and Barnow. From the extensive academic reviews and 
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clinical discussions of BPD, PTSD, CPTSD and their relation to trauma, the 
remaining areas of concern cover causes, diagnosis and proposed treatments. In 
particular, the link between BPD and CPTSD is still topical and controversial, and 
no definitive conclusions can be reached based on current published data. The 
theoretical concept behind the misdiagnosis of BPD originates from Herman 
(1992) and Vaillant (1992) who have consistently promoted the adoption of BPD 
as a complex variant of PTSD as an alternative diagnosis. While such experts have 
investigated the BPD-PTSD/CPTSD relationship empirically, scientifically 
acceptable studies remain few, and many of these could be said to be biased in 
selecting subjects from those with known traumatic experiences and symptoms.  
The empirical academic literature was also investigated to determine the reasons 
why BPD practitioners are not routinely diagnosing PTSD/CPTSD. In this case, 
answers were not so clear-cut, which therefore influenced the research design to 
investigate this area. Over-diagnosis of BPD was supported empirically by Westen 
(1997) in the examination of large-scale USA BPD practice when compared with 
the DSM requirements for at least five identified criteria. Westen found that the 
practice of diagnosing BPD with less than five DSM recorded symptoms was 
common throughout the US (section 2.3.3.1.3), and that clinicians supported BPD 
diagnosis based on a general observation of behaviour during interviews.  
Finally, a review of existing instruments for screening and assessment of trauma 
confirmed that while large-scale assessment instruments such as SCID, CAPS and 
SIDES are appropriate for full assessments by specialist trauma clinicians, there 
was no simple screen that is appropriate for BPD clinicians. The only trauma 
screens available were designed for PTSD. This finding thus provides support to 
the development of such a screen. 
  
Chapter 2 Literature Review 
  Page 67 





Empirical Findings from 
review 
1 
From analysis of 
published 
literature, what 




and what type of 
trauma have they 
experienced? 
While the link 
between trauma and 
BPD has been 
demonstrated, there 





More than 9 separate 
studies say that 70% - 100% 
of BPD patients experienced 
distressing trauma. 
Impact of trauma could have 
been exaggerated because 
sampling often encouraged 
inclusion of patients with 
existing trauma concerns. 
2 
From analysis of 
published 
literature, what 
proportion of BPD 





of BPD as PTSD 
associated with 
childhood abuse is not 
uniformly accepted, 
although overlap is 
generally agreed. 
PTSD-BPD comorbidity: 25% 




literature, to what 
extent is BPD over-
diagnosis or is a 
trauma diagnosis 
being missed? 
Herman and others 
have consistently 
promoted the 
adoption of BPD as a 
complex variant of 
PTSD as an alternative 
diagnosis. Hence, 
their view is 
consistent with the 
view of misdiagnosis. 
Over-diagnosis as per DSM 
was supported empirically 
by Westen (1997) in his 
examination of large scale 
USA BPD practice when 
compared against the 
requirements for at least 
five identified criteria, 
however misdiagnosis was 
not supported by this study. 
4 





types of trauma 
that are presented 
by BPD patients? 
N/A 
The only trauma screens 
that were found were those 
designed for patients with 
known trauma and PTSD 
assessment. Detailed 
assessment instruments 
were unsuitable for BPD 
clinicians. 

Chapter 3  Methodology - Design 
  Page 69 
3   METHODOLOGY: DESIGN 
3.1 Introduction 
The next step of the project is to select a suitable design in order to address the 
main research question, taking account of the knowledge gaps confirmed by 
academic and clinical literature. This chapter thus explains the design of chosen 
research methodology and the rationale for the choice. In practical terms, the 
nature of the research question being asked often determines the 
appropriateness of the methodology to be used in attempting to answer that 
question. Hence, a two-stage sequential mixed method design was selected and 
the rationale for its selection is presented in this chapter. The figure below 
illustrates the entire methodology. 
 
Figure 3-1 Research Design Flow Diagram 
 
The rationale for selection of the research methodology design must refer back to 
the main research question addressed via four sub-questions in order to explain 
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Table 3-1 Sub-Questions 
No Research Sub-Questions 
How the Design addresses the Sub 
Questions 
1 
What is the proportion of BPD 
patients who have 
experienced traumatic 
stressors and what are the 
types of stressors?  
Quantify proportions from stage 1 
survey. 
Qualify stressor types and diagnosis 
reasons from clinician interviews. 
 
Repeat and crosscheck in stage 2 using 
BTERS and gold standards. 
Compare stage 1 and 2 results with 
empirical studies. 
2 
What is the proportion of BPD 
patients who also meet a 
PTSD/CPTSD diagnosis? 
3 
What is the extent or 
otherwise of BPD over-
diagnosis or misdiagnosis?  
Quantify BPD DMS criteria from stage 1 
survey. 
Qualify using clinician interviews. 
Compare with empirical studies. 
4 
Will a screening instrument 
reliably and sensitively 
discriminate BPD patients for 
trauma focused treatment? 
In stage 2, a screen is designed from 
literature and clinician interviews about 
stage 1 results. 
Check reliability/validity/sensitivity by 
comparison with gold standards. 
Compare results with empirical studies. 
 
The chapter commences by explaining how and why this particular design was 
adopted, briefly highlighting the advantages and disadvantages of the selected 
quantitative and qualitative techniques. Then the required approach to data 
collection and analysis is discussed, including a full description of the mixed 
method methodology. Also to establish the most appropriate overall research 
design that will include feasibility, resources, time available, and ethical issues.  
Stage 1. To collect the necessary data, current BPD practice for addressing 
trauma in BPD is first determined using a survey technique. Then, based on the 
analysis of current practice using grounded theory and constant comparative 
approach, collate the requirements for a suitable ‘trauma in BPD’ instrument 
(BTERS).  
Stage 2. A second stage develops BTERS, then addresses the reliability and 
internal validity of BTERS, including enhancement by the use of a pilot study 
and a statistical analysis. The instrument will subsequently be validated by 
comparison with gold standards.  
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A dedicated section considers a range of threats to achieving validity in the 
research design in terms of types of bias, and discusses the mitigations adopted. 
Throughout the research, the process is guided and supported by a Project 
Steering Group (section 3.11.2), and a comprehensive quality control system is 
adopted. Finally, the different sections of the staged design are mapped against 
each of the research sub questions. 
3.2 Rationale for the Design 
A quantitative methodology therefore offers the opportunity to interrogate the 
documented evidence of trauma, PTSD, CPTSD and BPD diagnosis criteria in BPD 
patients’ medical records. Subsequently, these results are integrated with 
qualitative feedback from practising clinicians as to why trauma is not being 
diagnosed. Thus, the first three research sub questions are addressed along with 
their corresponding objectives, which require results to be qualified. Both these 
elements comprise stage 1, the first sequential mixed stage of the overall research 
design. The principal disadvantage of stage 1 is that patients’ traumatic 
experiences can only be accessed through the prism of clinicians who are 
dedicated to BPD treatments and are not trained in trauma assessment. Stage 1 
does however offer a window on the disorders with minimum chance of being 
influenced by views of the researcher.   
For the fourth research question, an additional research stage (stage 2) is required 
in order to develop and test a trauma screening instrument for patients with BPD 
symptomatology. The second stage will provide the opportunity to utilise the 
clinician interviews, building on the analysis of current practice using grounded 
theory and a constant comparative approach. Thus, a suitable ‘trauma in BPD’ 
instrument (BTERS) will be developed to both quantify and qualify BPD patients 
for trauma focused therapy by validation against gold standards. To achieve this 
final objective, a quantitative reliability study is selected in order to test BTERS 
against (DSM) standard assessment instruments. In addition, BTERS also provides 
the opportunity to reassess research sub questions 1 and 2 utilising primary data, 
whereas stage 1 provides secondary information. Stage 2 will also examine the 
comorbidity of BPD with PTSD/CPTSD and thus could provide further insight into 
the research question 3, the misdiagnosing/over-diagnosing controversy. 
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Although both stages represent separate sequential elements, the quantitative 
results from stages 1 and 2 will subsequently be discussed concurrently in order 
to develop overall conclusions. Thus, the overall design can be classified as a two 
stage sequential mixed method. The flow diagram above (Figure 3-1) summarises 
the different elements of the research introduced above, which will be described 
in some detail in section 3.5.  
3.2.1 Data Collection Rationale: Quantitative or Qualitative 
In quantitative research, results are deduced from observed data, but descriptive 
information can also be collected. This method is generally employed to test 
hypotheses such as relations between numerical variables that can be analysed 
statistically. Typical quantitative approaches used in health science are descriptive 
surveys, observational studies, case control studies, randomised controlled trials 
and time series designs (Creswell et al., 2011). Qualitative research focuses on the 
context and meaning of human experiences such as trauma in a BPD clinical 
environment, in order to induce interpretations from research data. It uses data 
collection methods such as in-depth interviews, ethnological observations and 
document review. Typical qualitative approaches used in health science are case 
studies, grounded theory, ethnological exploration and phenomenology (Creswell 
et al., 2011). While qualitative research does not give rise to mathematical 
abstractions, it should be systematic in its approach to data collection and analysis, 
and both approaches should be systematic and rigorous. Analysis of qualitative 
data can of course be subjective, so the design should include mechanisms to 
address this issue. The mixed method strategy of enquiry offers the opportunity 
to collect both quantitative and qualitative data to address all four research sub 
questions and hypotheses (Creswell et al., 2011). 
3.3 Types of Mixed Method Designs 
In order to select the optimum mixed method, the available options are first 
presented. Some types of questions can be answered only by using qualitative 
methods, whereas other types demand quantitative approaches. Some require 
mixed quantitative and qualitative methods, and there are other questions that 
are potentially open to either qualitative or quantitative approaches but which 
may be answered more efficiently, effectively or reliably by one approach than by 
Chapter 3  Methodology - Design 
  Page 73 
the other (Wellman, 2006). A simple definition of mixed methods in a research 
project is a combination of qualitative and quantitative components in the 
collection and/or analysis of research data (Bergman, 2008).  
Such an approach has been shown to provide a more comprehensive, persuasive 
and rigorous understanding than adopting a single approach (Creswell and Plano 
Clark, 2007, p.5). A mixed or multi-level method therefore starts with the 
philosophical assumptions (ontology and epistemology) that guide the direction 
of data collection and analysis, and employs a mixture of qualitative and 
quantitative methods, both rigorously applied, in order to enhance contextual 
understanding in the various phases of the research process. Given that all 
approaches have limitations, in this way the biases inherent in any one single 
method can potentially neutralise or cancel out the bias in the other methods. 
In the past, mixed methods were less common in research strategies compared 
with either exclusively qualitative or quantitative strategies (Creswell, 2003, p.15). 
Complex designs are now common place as they are driven by specific questions 
and aims in particular investigations (Creswell et al., 2011). Creswell and Plano 
Clark (2011) simplified what became a complex set of mixed method classifications 
into a few basic types. Mixes can be made either concurrently in order to converge 
on a solution by triangulation, or sequentially by having one method build on the 
other, in a way that gives priority to one or the other or both. Sequential designs 
can involve exploratory or explanatory phases of data collection such as 
quantitative data collection followed sequentially by qualitative data collection or 
vice versa.  
3.3.1 Triangulation Design 
Triangulation is a means of converging data across parallel qualitative and/or 
quantitative approaches (Jick, 1979). Triangulation Design can also be thought of 
as a concurrent mix which is considered central to qualitative analysis (Boeije, 
2002). This offers a means of converging data across parallel qualitative and/or 
quantitative approaches (Jick, 1979). Triangulation enhances confidence in the 
ensuing findings, and assures validity through the use of a variety of methods on 
the same topic, which can involve different types of samples, as well as data 
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collection. In addition, it can capture different dimensions of the same phenomena 
(Kulkerni, undated).  
For example, from a quantitative survey of patients’ records and a qualitative 
review of clinicians’ views, an overall view can be obtained by triangulating the 
results of these methodologies. 
3.3.2 Other Mixed Methods 
Multiple methods can thus be adapted to different phases of a study and should 
direct the research plan so that a researcher makes decisions during its 
implementation. A further significant feature of mixed methods is in helping the 
researcher to decide whether the sequential detailed methodology should be 
allowed to emerge during the research, on the basis of initial results, rather than 
being predetermined at the outset of the study (Creswell et al., 2011). Quality 
results can thus be achieved by intentionally integrating and combining separate 
methods to draw on the strengths of each, so that the investigation is framed 
within a philosophical and theoretical position (Creswell et al., 2011). In any 
design, the focus can be weighted to quantitative or qualitative data, and 
emphasis can be given to the timing of data collection (Morgan, 2007; Creswell 
and Plano Clark, 2007). 
Hall and Howard proposed a synergistic approach in which two or more options 
interact so that the combined effect is greater than the sum of individual parts. So 
instead of giving priority to one design over another, or weighting one approach 
within a mix of methods, they considered their value and representations as equal 
from an ideology of multiple points of view, balancing objectivity with subjectivity 
and collaboration, thus obtaining expertise in both qualitative and quantitative 
approaches (Hall and Howard, 2008). 
3.4 Selected Approach for the Design  
The selected approach as represented in Table 3-2 below has thus been identified 
as a mixed method sequential design, which also incorporates Hall’s synergistic 
approach. Stage 1 builds on the analysis of a database of BPD patients’ medical 
records and the sub-sequential results of clinician interviews, connecting them 
together to gain a broader perspective by using different methods (Creswell, 
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2003). Thus, qualitative BPD clinicians’ interviews about the results from the first 
part of stage 1 will be used to inform and describe aspects of the data that cannot 
be quantified.  The second part of stage 1 will utilise the emerging data analysis 
and interpretations to help to give a more in-depth picture of some of the 
underlying clinical mechanisms, such as how trauma is considered during BPD 
assessments (Creswell et al., 2011). In this way, the second quantitative data 
collection (stage 2) in the research is able to utilise the results of qualitative 
interviews to connect with the resulting stage 1 quantitative findings from the 
survey of patients’ medical records.  
Table 3-2 Mixed Method Design 











Type Quantitative Qualitative Quantitative 
Process 
Design    -> Collect Data    -> Analyse     -> Connect    -> 
Explanatory Exploratory 










Correlate Trauma in BPD 
Screen (BTERS) with DSM 



































Chapter 3  Methodology - Design 
  Page 76 
This approach will underpin the criteria applied in selecting items to identify types 
of trauma, in order to frame a trauma screening instrument for subsequent 
validity/reliability testing with BPD patients (stage 2). A trauma-screening 
instrument could alternatively have been developed using information from 
literature alone; however, in including a qualitative element from clinician 
interviews, the instrument can be made more useful. From a timing perspective, 
an emergent mixed design is more appropriate to this study, as from the outset it 
is important to obtain clinicians’ views of the controversies, and these interviews 
should be able to lead either to the development of a new instrument or to the 
modification of an existing instrument. In addition, in the final discussions of the 
research, when the results of all sections are available, a synergistic approach will 
be used to decide on the relative weighting to be given to each part when 
considering recommendations for the future. 
One of the strengths of the sequential design, beginning with a survey of patients’ 
medical records followed by clinician interviews, is that it is relatively 
straightforward in nature and easy to implement and report. It also allows the 
researcher to view the problem from multiple perspectives, and to enhance and 
enrich the meaning of a singular perspective (Creswell et al., 2011). The main 
weakness of this type of design however is the length of time it takes to collect 
data when working on sequential phases.  
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3.5 Design Concept 
In the table below, the four individual hypotheses can now be considered against 
the two sequential research stages.  
Table 3-3 Staged Hypotheses 
No Hypothesis Stage 1 Stage 2 
1 
A high proportion of BPD patients have had at least 
one highly distressing traumatic experience, either 
life threatening or non-life-threatening 
  
2 
A high proportion of patients diagnosed with BPD 




BPD is over- (or mis-) diagnosed in patients with 
symptoms of repeated self-harm, persistent risk-
taking behaviour and marked emotional instability 
 X 
4 
A short instrument (BTERS) can efficiently screen 
for PTSD/CPTSD referrals  during routine initial BPD 
assessment 
X  
3.5.1 Stage 1, Survey 
To satisfy the first research objective of establishing current practice, the first step 
is to choose the most appropriate method between an experiment (trial) with 
patient interactions, and a survey of pre-existing data. In general terms, a survey 
is a technique employed to identify the presence of patterns in a defined 
environment such as the criteria used to make the diagnosis of BPD or the 
presence of trauma in patients with BPD (Gosall and Gosall, 2009). As such, a 
survey is suitable for establishing the current status of trauma in the 
understanding of BPD. The rationale for starting with a survey of the medical 
records of BPD patients reflects the recognition of the subjective nature of our 
knowledge (of trauma in BPD), or of reality, where the views of practising BPD 
clinicians can be incorporated into the study (Bound, 2011). 
3.5.2 Clinicians Interviews (Grounded Theory and Const. Comp.) 
What a survey will not find out is what practising BPD clinicians and their 
departmental management personnel think about the world around them and in 
particular, what they think of the BPD/PTSD controversies as identified in the 
research objectives (Bound, 2011). In order to achieve this particular objective, 
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qualitative data collection and analysis is needed to understand and interpret 
behaviour, meanings, motives and other subjective reasoning. Therefore, the 
quantitative or objective approach inherent in the survey of patients’ medical 
records is supplemented by anonymous questionnaires and face-to-face semi-
structured clinician interviews. The intention of the interviews is to understand 
how trauma is being addressed in clinical settings by asking what clinicians do 
during BPD screening and assessment, and how they interpret their results, thus 
aiming for a more comprehensive and persuasive overall approach. 
3.5.2.1 Grounded Theory 
Methodological options for ascertaining and interpreting complex feedback 
include phenomenology and grounded theories. A variety of different qualitative 
approaches, including grounded theory, offers a comprehensive empirical 
methodology that can identify the most useful questions to ask for the final 
research question and hypothesis about the screening instrument. These two 
models are presented together, as one can be seen as an extension of the other, 
and they use very similar data collection and analysis methods (Sayre, 2001). The 
main difference is that phenomenological theory begins with a research question, 
whereas grounded theory is conducted to discover a research question for testing, 
which in this case is the content of the trauma screening instrument. 
Phenomenology thus describes the meanings or interpretation of experiences 
about a concept or phenomenon, which in this case is the clinician-patient 
interface. Phenomenology also develops understandings of social and 
psychological phenomena from the cumulative perspective of the people 
involved, by listening to their stories (Welman and Kruger, 1999, p.189). These 
strengths of the phenomenological approach were thus integrated into how 
grounded theory was adapted for the examination of the research hypotheses. 
Grounded theory contains an inductive loop where feedback from the clinician 
survey verifies the format of the final hypothesis concerning the design of the 
trauma screen for BPD. Questions that the researcher directly asks the clinicians 
in grounded theory are: “What is the effect of trauma?”, “Are there any 
preconceptions of BPD diagnosis?”, “What are the main challenges for 
participants”, “Do you ask patients about traumatic experiences“ and “How are 
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they trying to deal with trauma?” Grounded theory methodology does not aim for 
the absolute truth but conceptualises what is going on empirically, keeping an 
open mind as to the detailed formulation of hypotheses and thereby ensuring that 
they are grounded in real data. This technique results in information rich data, 
although any dataset can be subjective and value-laden, limiting the opportunity 
to make generalisations and compromising reliability estimates. Such an approach 
nonetheless encourages the freedom to interpret the behaviour of clinicians and 
presents the opportunity to generate explanations for that behaviour, an 
approach that is the essence of grounded theory (Glasser, 1988). As a cross 
validation, the analysis will also use techniques such as checking by an 
independent researcher, feeding back the findings to participants, and peer 
reviews such as a steering group to enhance the credibility of the overall 
interpretation of the data. 
Giving voice to clinician participants allows for a more holistic analysis of complex 
clinical problems, and advances the development of the knowledge of trauma in 
BPD to provide a richer understanding of both the patients and the clinicians who 
serve them. The survey of clinicians’ views thus becomes a shared focal point, and 
thereby binds the relevance of the BPD assessment process to the clinicians 
themselves, making the phenomena more clearly articulated. To obtain a 
comprehensive outcome from the shared interaction between the researcher and 
clinicians and to explain clinician behaviour, both structured (simple anonymous 
questionnaires) and semi-structured interview methods will be employed. To 
interface efficiently with the clinicians, a number of questions relating to the 
information required will be generated, i.e. what data is required to make an 
effective assessment, which specialists will collect the data and from whom, what 
processes will be used to collect the data, and what other considerations are 
required to support this process? Feedback will be sought from BPD frontline 
clinicians and consultant psychiatrists, who assess, diagnosis and work with BPD 
patients, and also from management. Strauss and Corbin (1998) suggest that in 
grounded theory, the number of participants is less important than the quality and 
depth of examination, hence a minimum number of patients is not incorporated 
into the design.  
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Grounded Theory needs to move fast as the researcher is often limited by 
fieldwork constraints such as the requirement for rapid note taking during 
interviews. Ideas or concepts that fit with data need to be generated quickly so 
that they are relevant and work in explaining what clinicians do and why. 
Interviews will also quickly follow after project presentations, so that the subject 
matter and preliminary results are fresh. In all interviews, efficient note taking is 
an essential part of quality control (Taylor and Robert, 1984). 
3.5.2.2 Constant Comparison Method 
A Constant Comparison Method is adopted which, together with theoretical 
sampling, constitutes the core of qualitative analysis within the grounded theory 
approach (Boeije, 2002). Theoretical Sampling is where the researcher decides 
what data will be gathered next. The objective of Constant Comparison is to find 
patterns within the words of the BPD practitioner’s narratives, and to present 
those patterns by simultaneously coding and analysing data while at the same 
time staying close to the clinical environment as the participant practitioners 
experienced this environment (Taylor and Bogdan, 1984). Framed by a focus of 
inquiry, through both interviews and questionnaires, open-ended questioning will 
be employed to allow clinicians and management personnel articulate their 
perceptions and experiences freely and spontaneously. Although access to the 
front line clinicians should be relatively straightforward, it will also be necessary 
to explore and discuss the outcomes with the consultant psychiatrist(s), as they 
are responsible for making the initial diagnoses. In this respect, the views of 
managerial personnel are also significant. In analysing interview results, responses 
should not be grouped according to predefined categories; instead, salient 
categories of meaning and relationships between categories can be derived from 
the interviews through a process of inductive reasoning.  
This should allow the perspectives of interviewees to be articulated and analysed, 
and thus integrated into the resultant BPD clinical model. Narratives of the 
interviews can thus be broken down into discrete items and then placed into 
categories (Glasser and Strauss, 1967; Lincoln and Guba, 2000). Categories take 
two forms: 
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A. Those that are derived from the interviewee’s customs and terminology; 
B. Those that the researcher identifies as significant to trauma within BPD. 
The goal of the former is to construct categories used by the clinicians to 
conceptualise their own experiences and worldview of BPD. The goal of the latter 
is to assist in developing insights into how BPD is perceived in the clinical 
environment. This process stimulates thinking that leads to both descriptive and 
explanatory categories (Lincoln and Guba, 1985, pp.334-341). Categories can 
undergo content and definition changes as various items are compared, and as 
understandings of category properties and the relationship between them are 
developed and refined over the course of the analytical process. Information from 
interviews will therefore be analysed simultaneously in order to establish 
empirical relationships by continually comparing and refining specific items, 
exploring relationships between them and integrating them into a coherent 
explanatory model (Taylor and Bogdan, 1984, p.126). 
An empirical approach can then be induced by comparing and connecting 
categories. Constant comparison goes hand in hand with Theoretical Sampling 
based on provisional empirical and theoretical ideas. This makes it possible to 
address questions that arise from the analysis of previous interviews. Such 
questions can include interpretations of findings as well as category boundaries, 
assigning segments of interviews or finding relations between categories. Data 
from practitioner interviews can then be analysed again and compared with 
subsequent interviews. Categories will be selected to ensure that both initial and 
supplementary interview questions were answered efficiently and effectively, 
thereby enhancing analysis and moving the comparative process forward. The 
cycle of comparison and reflection on previous and new interviews will be 
repeated several times, with each interview being conducted in the same manner. 
It is only when new interviews do not bring any significant new information to light 
that the categories would be considered to be saturated (Sayre, 2001). This means 
that subsequent new information will be easily assigned to one of the existing 
categories in the growing analysis.  
Three sets of comparisons (comparative steps or moments) will be made to 
incorporate the two separate groups of participants that were interviewed: day-
to-day clinicians and clinical managers. The process will start with a comparison 
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within a single interview and then compare that interview with the interviews with 
different clinicians. Interviews will consider the findings of the patient survey, how 
their views on trauma and BPD relate to one another, and the complexity of these 
relationships. The comparison between the clinicians and the management 
represents the third set. It is important to note that these steps do not constitute 
a strict linear process; instead, continual back-and-forth comparison maintains a 
cyclical process of reflection. 
3.5.2.2.1 Step 1:  Comparison within a Single Interview 
The initial aim of internal comparison is to develop distinct categories and to label 
them from the most appropriate codes (open coding). Comparisons will first be 
conducted from within the first interview. During the process, the interview will 
be studied to determine what exactly was said, and common codes elicited. 
Comparing different parts of the interview allows the consistency of the codes to 
be determined. Thus, fragments that relate to the same idea can be given a 
common code, and in this way core messages will be developed. 
3.5.2.2.2 Step 2:  Comparison between Interviews within the First Group 
There will then be a comparison between interviews within the first group – the 
BPD clinicians who conduct assessments – in order to assess the diversity of their 
views. All interviews will be conducted and handled in the same way, and as each 
interview is completed, outcomes will be compared. The first few interviews will 
therefore be selected with the aim of exploring the quantitative results and 
obtaining a meaningful variety of categories. Participants will be critically selected 
to answer any questions that are raised by the comparison process, and to ensure 
that the research hypotheses are being addressed. Items or segments from each 
interview will be compared so that themes that are common between the 
interviews are given the same coding (axial coding, Strauss and Corbin, 1998). 
Common themes will then be established by consolidating categories. 
3.5.2.2.3 Step 3: Comparison of Interviews from Different Groups 
The aim here is to compare the stage two interviews with a different group of 
people who hold the same knowledge and experience of trauma in a BPD clinical 
environment, that is, those responsible for the management of BPD patients, as 
opposed to those who assess and treat BPD patients, thus grouping participants 
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with same experiences. A data triangulation method will then be employed to 
gather interview segments through different types of sampling, or at different 
times and clinical situations. As these interviews will be conducted in the same 
way as the interviews with the clinicians, the process should therefore validate the 
information from clinicians, either confirming or challenging it. Responder 
validation is therefore adopted in preference to investigator triangulation in order 
to retain maximum engagement with raw data. This process representing an 
analysis of the clinician interviews concludes stage 1 of the research. The results 
from the clinician interviews will subsequently be used for the development of the 
screening instrument in stage 2.   
3.5.3 Stage 2: Reliability Study for Screening Instrument 
Having designed a research methodology for addressing the stage 1 objectives and 
hypotheses, the stage 2 design then builds on the results of stage 1. The stage 2 
design will thus test the efficacy and performance efficiency of a trauma screening 
instrument for patients diagnosed with BPD (hypothesis 4). It should also support 
and enhance the stage 1 design objectives of assessing trauma and PTSD/CPTSD 
in BPD (hypotheses 1 and 2). In so doing, the stage 2 design also refers back where 
knowledge (in this case, clinicians’ perspectives) is acquired from stage 1 utilising 
the grounding process (Welman and Kruger, 1999, p.189). The updated knowledge 
base will allow the quantification of trauma and PTSD/CPTSD by empirical 
evidence to be re-examined using an alternative to the survey used in stage 1. The 
proposed screening instrument will be tested in a study (stage 2) by a simple 
Reliability Study where the results from BPD patients screened with the new 
instrument are correlated with the results from the use of gold standard 
assessment instruments. 
3.6 Research Ethical Concerns  
Clinicians face many ethical dilemmas in their practice, so all research with human 
participants must consider the ethical concerns and rights of study participants. 
Studies should not expose people to harm and participants must be able to refuse 
participation (Polit, Beck and Hungler, 2001). Codes of ethics have thus been 
developed to guide the efforts of researchers and to help others evaluate their 
actions. “To do no harm” is embedded in the Helsinki Declaration adopted by the 
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World Medical Assembly (1964, revised 2013). Ethical responsibility is arguably 
even greater when dealing with a population which may be regarded as 
vulnerable, such as the mentally ill or those who are in some way victimised or 
abused, as is the case with any group of BPD patients. Because of the sensitive 
nature of this investigation, a staged approach to ethical approval will be adopted, 
allowing the approving authorities the opportunity to assess the effectiveness of 
researcher-patient interactions before granting approval for face-to-face 
interviews. In line with NICE guidelines, prior to all researcher-patient interactions, 
Patient and Clinician Information Sheets specifically designed for the research in 
question will be prepared, supported by a clear research protocol, patient consent 
forms and information posters. NHS approving authorities also require specific 
application forms and the option of a face-to-face ethics panel review. 
Relevant ethics approval authorities examine all research proposals and either 
grant permission, rejects the proposal or request further clarifications and 
modifications. In this research, both university and NHS ethical approval is 
required. When granting approval, a number of constraints are usually applied, 
often including informed consent, freedom of choice, anonymity of data, security 
of data, etc.  
3.6.1 Safeguarding of Vulnerable Patients 
For this research project, due to the nature of the patients’ conditions, additional 
safeguards are also considered, such as what should happen in the event of the 
disclosure of past or present abusive events and relationships. Appropriate clinical 
referrals can then be made for those who may require help, either at the time of 
the screening and assessment interview, and/or later should subsequent reactions 
occur. Prior to data collection, therefore, discussions will take place with as many 
clinicians who work with BPD patients as possible. This is because, should 
participants experience difficulties, it is important they should be able to speak to 
a clinician whom they already have a therapeutic relationship with and have built 
up trust and confidence. 
Patients must have effective contact information so that they can speak to their 
clinician or contact the clinic in an emergency. This is important, as it is possible 
that any discussions concerning trauma, particular for the first time, could trigger 
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traumatic memories that could cause great patient distress and even trigger 
flashbacks and/or nightmares. For this reason, complete familiarity with Trust 
Safeguarding Procedures (APPENDIX 19 ) is essential, through attendance at 
sufficient training courses and workshops. Access to safeguarding procedures 
must also be very clearly annotated as part of a Patient Information Sheet and this 
clause must be read to each patient prior to obtaining their written consent to be 
interviewed (APPENDIX 6), in order to ensure that patients are fully involved in any 
discussions of the action to be taken if abuse accusations are made. 
Patients’ clinicians will also be made aware of this clause and of the appropriate 
sections of the Trust procedures. To this end, the essential elements of the 
safeguarding procedures will be explicitly reproduced within the Patient 
Information Sheet and the (BTERS) screen itself. As an additional support for 
patients’ clinicians, the researcher will be also available to assist in dealing with 
any and all distress generated by the assessment as and when it arises, so as not 
to impinge on clinical services. At all stages the researcher is backed by the project 
Steering group (section 3.11.2) and clinical supervisor. The screening instrument 
will not ask participants to identify past abusers, only to record the broad nature 
of their relationship with an abuser (i.e., stranger, friend, relative, parent or 
sibling). This is because information on the relationship with the abuser is required 
to differentiate between different types of abusive events associated with BPD 
and CPTSD. Participants will also be informed (Patient Information Sheet) that any 
information provided will have to be shared with clinical staff if there are any 
safeguarding and protection issues. Any information that gives concern regarding 
the safety of the participant or other people in the community must be raised with 
the Trust Safeguard Lead, and then with the Local Authority Safeguarding Team, 
which will log all relevant information as reported by the clinician. This will be done 
with or without the participant’s permission, as there could be risk to other 
individuals. In addition, there is the possibility that participants could disclose 
information to someone else and claim that they had informed the clinician and 
that the authorities had failed to act on the information. 
3.6.2 Grounding Techniques for Intense Anxiety 
 Prior to starting potentially distressing discussions with patients (stage 2), it is 
important to obtain assurance as to the protection systems in place for 
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participants. These should include what are called ‘grounding strategies’, which 
are a set of simple strategies to help patients detach from emotional pain (such as 
anger, frustration, distress, cravings etc.) and to manage overwhelming feelings of 
intense anxiety (van der Kolk, 1996). These techniques will be discussed with 
patients at the beginning of (stage 2) screening. 
3.6.3 Impact on Interviewers (Vicarious Traumatisation)  
All research activity must also consider any adverse impact not only on the direct 
research participants (who can be considered as ‘subjects’ in the context of this 
research) but also on the research personnel themselves. This risk becomes 
particularly significant when interviewers are engaged in discussions about 
traumatic situations with vulnerable and potentially volatile patients. In this 
research, the greatest exposure to this risk will be the stage 2 screening process 
where interviewers have to assist volunteer patients to recall difficult traumatic 
experiences. The term applied to this situation is vicarious traumatisation. 
Vicarious trauma is the negative change in one’s thoughts, perception and 
interpretations as a result of repeated engagement with traumatic research-
related materials and experiences (Sexual Violence Research Initiative, SVI, 
internet reference, not dated). Vicarious trauma is often difficult to recognise; 
symptoms may include feelings of anger, anxiety, depression, sadness, exhaustion, 
difficulty in concentrating and making decisions, headaches, body aches, 
sleeplessness, increase in drug and alcohol use and social isolation. For services 
and professionals to remain effective and to get the best possible outcomes for 
patients it is essential to make sure that practitioners have access to the help and 
support that they need to protect themselves (NSPCC, 2013). It will therefore be 
important to address the possibility that both the researcher and the clinicians 
who have volunteered to administer trauma screening may experience vicarious 
trauma. This will include acknowledging how emotionally difficult and sensitive 
trauma research can be, and each interviewer must be made aware of how they 
could be affected by distress. Recognising the importance of self-care and learning 
how to self-identify vicarious symptoms early are key in the management of 
vicarious trauma (SVI). To this end, a discussion with the clinicians will be arranged 
to familiarise the clinicians with vicarious traumatisation and ways to recognise 
and prevent it.  
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The strategy to prevent and manage vicarious traumatisation will include the 
following: first, there will be adequate levels of managerial support or rigorous 
supervision and peer support (NSPCC, 2013). Then, for serious traumatic events, 
there would be a chance for the clinician involved to be fully debriefed. Finally, as 
exposure to trauma increases, there is an increasing likelihood that it could further 
negatively affect clinicians. Therefore, it is important to create the right working 
environment with strategies to improve clinicians’ resilience and help them stay 
emotionally healthy by preventing them from becoming isolated from their teams 
(NSPCC, 2013). 
3.7 Validity of the Research Design 
While no research design is perfect, all designs require a validation process to 
guide assessment of the design’s effectiveness and to strengthen the overall 
research design (Campbell and Stanley, 1963). Internal validity means that the 
resultant research data can be shown to support the research concept (Campbell 
and Stanley, 1963). In the case of the current project, internal validity will be 
established when the methodology can be shown to validate the four hypotheses, 
according to statistically acceptable standards. External validity refers to a study 
being generalisable outside the research parameter results, and in the context of 
this research, it is not necessary to distinguish external validity from what can also 
be called construct validity (Shadish, Cook and Campbell, 2002, p.467 and Table 
3.5. 
This is because Construct Validity is the degree to which the instrument performs 
consistently in measuring what it claims to measure (Hardesty and Bearden, 2004). 
There are various structural ways to achieve a strong design, principally by 
controlling any threats to validity. Although there are inevitable compromises, if 
validity threats are not addressed in the design process, there is a risk that the 
threats may be confounded (Campbell and Stanley, 1963). 
In any clinical trial, bias is one of the main threats to overall research validity. Bias 
may be defined as a systematic error or difference between the true value and 
that actually obtained due to all causes other than sampling variability (Friedman 
et al., 2010). Depending on the type of bias, it can apply to internal or external 
validity (3.7.2, 3.7.3). Bias describes errors at any stage of a study that are not due 
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to chance, from the initial design through to data analysis and interpretation 
(Friedman et al., 2010). Bias therefore cannot be effectively measured or 
controlled statistically, and can lead to a result in which there is a systematic 
deviation from the truth (Gosall and Gosall, 2009, p.34). It can be caused by 
conscious factors, subconscious factors or both (Gosall and Gosall, 2009). Types of 
bias range from the selection of participants, performance and observation, all the 
way through to the reporting of results (Campbell and Stanley, 1963; Bartlett, 
2005). In particular, the analysis of qualitative data can be subjective, so 
mechanisms are included in the design to address this issue. Campbell and Stanley 
(1963) identified a number of areas of possible threat to research design validity. 
These may have particular relevance for the stage 2 trial, which included an 
important test-retest element, and threats are listed below with relevant 
examples, where  a summary of the most important bias and proposed mitigations 
is tabulated followed by a more detailed review. These are arranged by the 
different stages of the research and are divided in internal validity threats and 
external validity threats. Table 3-4 below lists threats and mitigations for each of 
the major elements of the research design. 
The following three types of validity capture the full range of validity that are 
required for instrument development: Face Validity; Content Validity and 
Construct Validity (Gosall and Gosall, 2009). If any of the various forms of validity 
are low, the overall validity of the conclusion of will be suspect (Black, 2005). 
Content and Face validity have often been used interchangeably even though 
there is an important conceptual difference (Gosall and Gosall, 2009; Black, 2005). 
Face validity concerns the appearance and usability of the instrument, whereas 
Content validity ensures that the instrument measures what it is supposed to 
measure. Face validity is necessary because inferences are made on the basis of 
final items of a screen, and therefore they must be deemed to be (face) valid if we 
are to have confidence in any inferences made from the final screen form 
(Hardesty and Bearden, 2004). Nunnally and Bernstein (1994) described content 
validity as the degree to which an instrument measured items represent a proper 
sample of the theoretical content domain of a construct. 
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Table 3-4 Threats, Bias and Mitigations 
Stages 
Validity Threats/Bias: 









Accept all patients who consent from all Trust 
BPD hospitals. 
Create welcoming approach through ward 
presentations and group discussions. 
I: Attrition Bias due to 
stress 
 Analyse dropout causes and adjust recruitment. 
Consider impact of dropout during interpretation. 
E: Performance Bias, 
Expectancy Threat, 
Data Analysis Bias 
Include study tool for consistent interpretations 
(interpretation protocol). 
Critical reviews/ peer group presentations 
Supervisor support. 
E: Observation Bias 
(favouring expected 
outcomes) 
Compare results with empirical studies. 
Peer group presentations/ Steering Group 
reviews. 
E: Sample size 
Quantify accuracy/reliability/ confidence 
intervals. 








Invite all clinicians and managers to participate. 
E: Performance Bias, 
Expectancy Threat, 
Data Analysis Bias 
Playback results to participants. 
Rigorous' Grounding Study'. 







Check if BPD patients in selected hospital are 
representative of general population.  
I: Attrition Bias due to 
stress 
 Analyse dropout causes and adjust recruitment. 




Blinded inter-rater assessor. 
I: Data Analysis Bias Test-retest, blinded inter-rater. 
E: Performance Bias, 
Expectancy Threat, 
Data Analysis Bias 
Pilot reliability study. 
Face and content validity analysis. 
Scoring sheets. 
Test-retest, blinded inter-rater. 
E: Observation Bias 
(favouring expected 
outcomes) 
Compare results with stage 1 and empirical 
studies. 
Peer group presentations/ Steering Group 
reviews. 
E: Sample size 
Quantify accuracy/reliability/ confidence 
intervals. 
Compare with stage 1 and empirical studies.  
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3.7.1 Application of Validity to Screen Development 
Explanation of Face and Content validity:    
By way of example, a depression scale may lack content validity if it only assesses 
the affective dimensions of depression, but fails to take into account the 
behaviour dimensions (Black, 2005, p.193). One helpful way to distinguish 
between face and content validity is to picture the domains of a construct as a 
dartboard (Gosall and Gosall, 2009; Black, 2005). In order for the criterion of 
content validity to be established, darts must land all over the board to obtain a 
proper representation of the construct. If darts land on only the left hand side of 
the board (i.e. items measure only half of the domain of a construct), the 
measurement will not be content valid. Also if items are generated that are too 
similar and do not tap the full domain of the construct (i.e., cover the dartboard), 
content validity is not established. Using the dartboard analogy, an item has face 
validly if it actually hits the dartboard. 
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Table 3-5   Validity of Instrument Development 
Validity 
Types 





i. The degree to which clinicians and patients 
judge that the questions are appropriate to the 
target Construct and the screening objectives 
ii. Items must ‘hit the dartboard’ 
iii. Predominantly a form of usability: simple, safe, 
and precise questions 
iv. Appearance and usability of the questionnaire 
in terms of feasibility, consistency of style, 
layout, formatting, font design and size and 
clarity of language 
















Black,  2005 
Content 
Validity 
i. Refers to how well the set of questions 
represents what content (or subject matter) the 
instrument is supposed to be testing 
ii. The content of the instrument must contain 
appropriate and sufficient clinical detail to 
measure all the Domains of the construct 
iii. The degree to which measured items represent 
a proper sample of theoretical content domain 
of a construct 
iv. Details must be relevant to the purpose 
v. It should contain a complete range of all the 
attributes of the construct 
vi. Must annotate the various traumatic events 




i. The degree to which the instrument performs 
consistently in measuring what it claims to 
measure 
ii. Provide reliable and repeatable results and 
ensure quality control 
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3.7.2 Threats to Internal Validity 
Selection bias is the identification and recruitment of an unrepresentative sample 
from the population, which results from the way in which subjects were chosen 
(Gosall and Gosall 2009; Bartlett, 2005, p.75). Such bias can be introduced by the 
researcher’s selection of participants, or by third parties such as clinicians with 
vested interests in the research outcome. A particular version of selection bias can 
be labelled as Admission Bias, where a research programme can be limited to 
patients admitted to one particular institution without consideration of whether 
the sample is representative of the population; this is called a Berkson bias (Gosall 
and Gosall, 2009).  This can lead to a result in which there is a systematic deviation 
from the truth. In a more general sense, it could also be called a Convenience 
Sample where respondents were chosen because of convenience and availability 
(Creswell, 2003). The selected sample has to be representative of the population, 
in this case patients with BPD symptomatology. The sample also has to comply 
with the strict ethical requirements set by health authorities for vulnerable 
patients, and such requirements may have other implications in terms of time 
limitations. To mitigate selection bias for stage 2, clinicians, not the researcher, 
will identify the patients. However, as clinicians are aware of the research 
objectives, selection bias cannot be totally excluded. 
Threats to internal validity could occur if the content of a testing instrument is 
changed during the testing process, generating inconsistencies and misleading 
performance data. Similar inconsistencies can occur if changes are made to the 
calibration of measuring instruments. 
Other threats to internal validity include attrition threats and performance bias. 
Attrition is the loss of study participants in the course of the testing period can 
undermine the accuracy of the results, as participants will be allowed to exclude 
themselves at any stage because of the stresses involved in addressing historical 
traumatic experiences. 
Internal validity may suffer because of a poorly designed survey assessment 
protocol (study tool), or poorly designed questionnaires for clinicians or patients 
(screening instrument). To avoid this, the context created by written questions 
must be made clear and well defined. Also, the impact on how individual questions 
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are interpreted and answered will be enhanced by providing interesting questions 
to help reduce measurement error, and by encouraging respondents to answer 
questions carefully and to take the request for their participation seriously. In 
addition it is very important to ensure there are no leading or trigger questions 
(Schutt, 2011). Supervisors and Steering Group (section 3.11.2) support will be 
sought in devising all research documents. 
3.7.3 Threats to External Validity 
1. Expectancy Effect Threats: In stage 2 participants may answer questions in a 
way that they believe the researcher wants them to, rather than according to 
their true beliefs. In this project, ethical considerations will require that 
prospective participants are familiar with the research objectives and 
expectations, and consequently participants’ response may be unduly 
influenced by the research objectives. Similarly, if participants consider that 
certain responses could result in greater personal benefits such as extra 
attention, then outcomes may be invalid. 
2. Leakage between Participants Threat: When participants are co-located where 
the research takes place, there is a concern that, in order to increase solidarity 
and empathy, participants may discuss the research amongst themselves, and 
agree responses to research questions before a testing process. 
3. Sample Size: Reliability and accuracy are important for external validity, and 
can be compromised by an inadequate sample size. However, the selection of 
the samples must comply with practical and ethical considerations. For the 
quantitative analysis in both stage 1 and 2, the validity of a sample size can be 
tested by calculating confidence intervals for each of the results and then by 
comparing these results with the results of reliable clinical studies. If no 
comparison is available for qualitative methods, it is generally considered that 
the optimum sample size has been reached when no new themes arise in 
emerging data. That is, saturation occurs, a theme appears and no further 
insight can be gained from the data (Sayre, 2001). 
A number of different types of bias can also impact on external validity. For 
example, an observation bias in this research would be the failure to classify 
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outcomes correctly, whether in the assignment of disorders, or the correct 
representation of clinician views. Such a bias can be caused either by the 
investigator (stages 1 and 2), or the participant(s) as in stage 2. This is particularly 
important when there is a large interpretist or subjective element to the analysis 
of research data (Karanicolas, Farrokhyar and Bhandari, 2010). Therefore a 
specialist checklist for trials such as Consolidated Standards of Reporting Trials 
(CONSORT, Moher, Schulz and Altman, 2001; or Standards for the Reporting of 
Diagnostic accuracy studies (STARD, Bossuyt et al., 2000) can be used to maintain 
transparency. 
Researcher, interviewer or ascertainment bias arises when the investigator has a 
vested interest in a positive outcome and can alter the approach to the patient 
(stage 2) and the recording of results (stages 1 and 2). In any analysis there is 
always a risk of selective use and reporting of qualitative and statistical tests, 
which may be a subconscious response by investigators eager to see a positive 
result, but which can have profound consequences. Common method bias can 
occur if the same investigator provides all the interpretations for all stages of a 
research project (Curry, Nembhard and Bradley, 2009). Recall bias can arise for 
stage 2 if participants selectively remember past details (retrospective memory) if 
they have a particular interest in the outcome. Similarly, response bias can arise 
in any study in which participants are asked questions and they answer in the way 
that they believe the researcher wants them to rather than according to their true 
beliefs. This can occur when it is not possible to blind participants to the research 
objectives for ethical reasons. In the case of the clinician interviews, it may prove 
problematic to fully articulate the subtleties and sensitivities of the research scope 
to all participants. 
3.8 Mitigations for Threats to Validity 
In order to have confidence in the research results, how can threats to research 
design validity, both internal and external, be mitigated? Whereas it is not always 
possible to have full control of all threats, structured actions or mitigations must 
be put in place to minimise the impact of all threats on the validity of the research 
design. So what types of mitigation should be considered? For alternative methods 
such as reliability studies, other mitigations are required. In addition, as no 
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mitigations are ever completely effective, all weaknesses in the mitigations 
applied must be discussed and accounted for. The analysis will also be presented 
and discussed with the Steering Group (section 3.11.2), which includes members 
who are experienced in the topics that are being examined and in constant 
comparison methodology. 
3.8.1 Blinding 
In research design, blinding is one of the most effective methods of counteracting 
bias. Blinding is a technique that keeps participants and investigators involved in 
the research blinded or masked from the processes of the research, so that their 
actions are not unduly influenced by anticipated outcomes (Karanicolas, 
Farrokhyar and Bhanda, 2010). Blinding can be addressed at different levels. Single 
blinding is usually used in situations in which the patient is unaware of the 
investigation he or she will be participating in. Double blinding is where both 
patient and investigator are kept blind to the intervention (Karanicolas, Farrokhyar 
and Bhanda, 2010). Blinded investigators are much less likely to transfer their 
attitudes to participants than un-blinded investigators (Karanicolas, Farrokhyar 
and Bhandari, 2010). In this research, blinding will be considered in the second 
stage to reduce confirmation bias where a comparison will be made between 
different assessments. It is however important to ensure that the blinding process 
itself does not introduce additional problems by impairing the ability to evaluate 
research outcomes effectively, for example when critical feedback is required 
following pilot studies. Ensuring that all patient information is made anonymous 
may also assist the blinding process when analysing data (Karanicolas, Farrokhyar 
and Bhanda, 2010). Nevertheless for ethical reasons clinicians may object to 
blinding during data collection; for example to protect participants’ health, safety 
and security, it may become necessary to inform investigators about critical 
clinical diagnoses of particular patients, and thus either compromise the blinding 
process or cause particular tests to be excluded from the results (Freidman et al., 
2010, p.128).  
The effectiveness of blinding can be tested by asking outcome assessors which 
outcome (disorder in this case) they think was assigned.  Thus to check the 
effectiveness of blinding in the BTERS reliability study, a blinded screener will 
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make a statistical comparison of the screening results of the researcher, who 
should be unaware of the outcome of the full assessment.   
3.8.2  Attrition Mitigations 
If a limited sample size is anticipated, one of the threats to maintaining a large 
enough sample is that too many patient participants drop out due to anxieties 
(attrition). To mitigate this particular risk for both stage 1 and 2, participants will 
be given assurances regarding any anticipated negative effects. In addition, aiming 
to complete all assessments soon after screening can minimise anxiety. Other 
mitigations for reducing participant anxiety is to minimise the total period over 
which sensitive issues are discussed by completing the study quickly and dealing 
quickly with any concerns as they appear. Additional methods to reduce anxiety 
include joining treatment groups where participants can obtain reassurance and 
build some trust and confidence should they find the process stressful. Large 
sample sizes however do not reduce bias although they have other benefits for 
enhancing validity, such as improving precision (Friedman et al., 2010). 
3.8.3 Researcher Bias Mitigations 
In order to identify and isolate potential researcher bias and expectations 
bracketing can be applied where the researcher tries to remain open-minded and 
to consider the perspective of participants by reviewing progress with supervisors 
and groups (Bound, 2011). Another technique to address researcher bias is to 
reassess results using independent experts to try to assure objectivity. In addition, 
a comparison will be made between research results and relevant findings from 
literature.  
3.8.4 Other Mitigations 
The Constant Comparison method increases internal validity by describing and 
conceptualising the variety of views on trauma within BPD, comparing and looking 
for commonalities and differences in behaviour, reasons, attitudes, perspectives 
etc. In addition, assuming a reasonably homogeneous sample of practitioners, 
external validity is enhanced by providing a solid basis for generalising the results 
from patients’ medical records to other BPD units by using ideas developed during 
the clinician interviews.  
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Another method to increase external validity is to obtain high statistical reliability, 
which can be achieved by a number of techniques including a pilot study, and 
quantifying repeatability by retesting with independent assessors. Threats to 
external validity can also be partially offset by comparisons with similar studies 
from the literature. Inevitably, however, as with any research, some residual 
threats will always remain to the overall validity, and these must be addressed in 
the final discussions, conclusions and recommendations.  
3.9 Target Group and Recruitment 
As the ultimate aim of the research is to make an improvement to the diagnosis 
and treatment for all BPD patients worldwide, it would be ideal if there were no 
theoretical limit to the target group. However, in line with the design philosophy 
to verify findings by practical assessment, a target group must be limited to those 
patients and clinicians accessible by the researcher and supporting clinicians, 
which in turn restricts the pool of patients to specialist mental healthcare units. In 
addition, the practicalities of ethical approval could limit the opportunity to 
examine BPD patients’ medical records and interview practising clinicians (stage 
1) to a single NHS Trust. As the subsequent (stage 2) BTERS reliability study 
requires close collaboration between hospital clinicians and the researcher, 
restricting the trial to a single hospital ensures that the analysis of results benefits 
from consistency in clinical assessment policy. This also provides a sample size 
consistent with similar studies from literature. In both stage 1 and stage 2, the 
entire target group can be included in the study, thus providing what can be 
termed an open trial, although the grouping could alternatively be termed a 
convenience sample (Trochim, 2008). 
For the stage 1 survey of medical records, both outpatient and inpatients can be 
asked by their attending psychiatric consultants for permission to be contacted 
about the study. Prior to contacting participants individually, presentations will be 
given to relevant clinicians to explain the study and the ethical approval process. 
Outpatients will be given presentations in their group sessions and inpatients will 
be seen individually by their clinicians. Any patient who shows willingness to 
participate will require a discussion with their clinicians for the clinicians’ 
permission and to assess their eligibility to be recruited into the research. Willing 
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participants will then be seen by the researcher and informed consent obtained. 
For stage 1, a poster will be placed in all BPD outpatient clinics and wards, 
requesting people who are interested in participating in the research study to 
contact their clinicians and the researcher. 
3.10 Data Analysis 
Data will be analysed from every stage of the research. A study tool will first be 
designed to collect relevant psychological attributes from patients’ medical 
records according to DSM criteria. From this, interpretations of trauma, BPD, PTSD 
and CPTSD, can be made, and the frequencies of trauma and the disorders can 
then be calculated as well as comorbidity rates and treatments provided. From 
these results, frequency comparisons can be made with similar studies in the 
literature. Frequencies can then be compared graphically and in tabular form for 
presentation to clinicians. Questions for the qualitative semi-structured interviews 
with clinicians about different possible meanings concerning the recognition of 
trauma in BPD will be developed based on the findings of the survey of patients’ 
records. The results of subsequent open-ended questions for clinicians will then 
be collated by triangulation as patterns appear in the interviewing process, in 
keeping with the interpretist method (Polit, Beck and Hungler, 2001, p.381). A 
‘constant comparative analysis’ is thus applied by inducing individual 
interpretations from participants and comparing results of different interviews 
while editing, analysing and interpreting relevant information (Glaser and Strauss, 
1967). In order to give the interview results internal validity, additional peer 
reviews will be conducted with the Steering group (section 3.11.2).  
As part of the pilot study, the internal validity of the BTERS screen will be assessed 
by capturing the views of the participants (i.e. clinicians, subject matter experts 
and patients) on the appropriateness of the questions used to identify trauma and 
discern BPD, PTSD and CPTSD. From this, an internal consistency index can then 
be calculated using Cronbach’s alpha where α increases as the inter-correlations 
between the disorders increase. In addition, the pilot test results comparing the 
BTERS disorder assignment (PTSD or CPTSD) with gold standards can be analysed 
by calculating reliability and accuracy. A one-to-one comparison between the 
BTERS results and the gold standard assessments will be made with reliability and 
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accuracy rates calculated, including the use of area under the receiver operating 
characteristics curve (AUC, ROC, section 5.10). Reliability will be calculated with 
inter-rater and test-retest techniques by calculating Cohen’s kappa coefficients. 
3.10.1 Qualitative Software vs. Manual Analysis  
For the qualitative data analysis, software such as Computerised Assisted 
Qualitative Data Analysis (CAQDAS) can be utilised. This can provide discipline in 
logging data, coding patterns, and mapping categories. It can also render the 
various stages of a qualitative process more traceable and transparent, facilitating 
an audit trail. On the other hand, over-reliance on software can detract from the 
conceptual meaning, losing closeness to the data such as contexts, tones and 
emotions (Burton, 2000). For this reason, because of the risk of missing details of 
conceptual analysis, manual methodology will be utilised. 
3.11 Quality Control 
Integral with every aspect of this project, overall quality will be controlled and 
assurance confirmed by adopting systematic methodologies that have been 
shown to be suitable. The following are considered: 
3.11.1 QUADAS 
The development of the screening instrument will be adapted from the assurance 
system described in QUADAS (Quality Assessment of Diagnostic Accuracy Studies, 
Whiting et al., 2003). The QUADAS process was selected because it is used by 
recognised experts in analysing the reporting of diagnostic studies (Streiner and 
Norman, 2012; Jaded et al., 1996). It combines empirical evidence and expert 
opinion in a formal consensus method. The proposed stages (A-E) which were 
adapted from QUADAS will be applied directly to develop a trauma screening 
instrument as follows: 
A. Conceptual decision – screening instrument design and population selection 
for testing 
B. Generation of Items relating to both causes and symptoms of each of the 
disorders 
C. Assessment of Face validity and Content validity  
D. Pilot trial and refined instrument 
Chapter 3  Methodology - Design 
  Page 100 
E. Field trial to assess consistency and Construct validity 
3.11.2 Steering Group 
The Steering Group will be set up in order to provide advice on research aims, 
methodology and the impartial interpretation of data. It will consist of clinicians, 
researchers and supervisors with a full variety of clinical interests, which will 
provide regular critical reviews. 
This included the academic supervisor of this research, the clinical supervisor of 
the research who is also the former head of the Trust Trauma Centre, and the 
clinical director of the principal BPD Centre in Berkshire. Below is the list of the 
Steering Group members:  
DT Researcher 
Professor NW Supervisor, BPD and PTSD clinician and academic 
NP Clinician specialising in BPD 
Professor SR Academic and clinician CPTSD specialist, Clinical 
supervisor 
Dr SM Mental Health clinician. Nurse consultant 
Professor GB Mental health lecturer and clinician 
Dr RH Consultant psychiatrist, and psychotherapist (BPD 
specialist) 
Dr DL PTSD specialist Consultant clinical psychologist 
Full Terms of Reference are given in APPENDIX 4 , and enhancements to the scope 
of the Steering Group will be made whenever required to meet the full objectives 
of the Project.   
The group should form an important mitigation against many of the threats to 
research validity, as identified in section 3.7.2. 
3.11.3 STARD 
In this Project a 25 item quality checklist (STARD; Statement of Reporting Studies 
of Diagnostic Accuracy) will be applied (Bossuyt et al., 2000, and APPENDIX 29 ). 
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3.12 Research Design Conclusions 
The main research question is to be addressed via four research sub questions and 
hypotheses concerning the relation between trauma and BPD, a mixed method 
design approach was chosen with two sequentially connected stages. The 
rationale for this selection requires both post positivistic and interpretist 
paradigms, allowing BPD clinicians the freedom to feed back their own 
interpretations of a quantitative survey of patients’ records, where recorded 
trauma and BPD symptoms are correlated against DSM diagnostic criteria and the 
results of relevant empirical studies from literature. The results of qualitative 
questionnaires and interviews with clinicians will then be analysed using grounded 
theory, so that key information can emerge in order to inform and develop a new 
trauma-screening instrument (BTERS) for patients with BPD symptomatology. 
Stage 1 thus will consist of a survey of patients’ records plus a sequential analysis 
of clinician interviews. Stage 2 will thus build on the stage 1 findings in order to 
develop BTERS, validating BTERS by interviewing BPD patients who have not been 
previously screened for trauma, where correlations can be made between the 
results of BTERS screening against full assessments for PTSD/CPTSD using gold 
(DSM) standards. A pilot study will first address validity concerns, and BTERS will 
be refined before the main screening study. 
A number of threats to overall design validity have been recognised and have been 
analysed in terms of types of bias. Threats include restricted sample size, the 
potential for researcher bias, responder bias, as well performance and observation 
bias during the data collection and analysis process. As clinical practicalities limit 
the options to expand participant numbers, sample mitigations rely on a rigorous 
controlled selection process. Accuracy can then be carefully quantified and 
maximum use made of comparisons with similar studies. Blinding will be 
incorporated as much as possible to mitigate research bias; however ethical 
requirements reduce the opportunities to fully blind both patient and clinician 
participants to the research objectives and the consequences of the assessments. 
Also of importance to an effective design is the inclusion of a comprehensive range 
of critical statistical analysis. 
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Table 3-6  Design Conclusions 
No Research Sub Questions 
How the Design addresses the Sub 
Questions 
1 
What is the proportion of 
BPD patients who have 
experienced traumatic 
stressors and what are the 
types of stressors?  
Quantify proportions from stage 1 survey. 
Qualify stressor types and diagnosis reasons 
from clinician interviews. 
 
Repeat and crosscheck in stage 2 using 
BTERS and gold standards. 
Compare stage 1 and 2 results with 
empirical studies. 2 
What is the proportion of 
BPD patients who also 
meet a PTSD/CPTSD 
diagnosis 
3 
What is the extent or 
otherwise of BPD over-
diagnosis or misdiagnosis?  
Quantify BPD DMS criteria from stage 1 
survey. 
Qualify using clinician interviews. 
Compare with empirical studies. 
4 
Will a screening 
instrument reliably and 
sensitively discriminate 
BPD patients for trauma 
focused treatment? 
Design (stage 2) screen from literature and 
clinician interviews about stage 1 results. 
Check reliability/validity/sensitivity by 
comparison with gold standards. 
Compare results with empirical studies. 
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4 METHODOLOGY: STAGE 1, MEDICAL RECORDS & CLINICIAN INTERVIEWS 
4.1 Introduction 
This chapter develops the first stage of the research project in accordance with 
the research design, addressing the first three of the four sub questions and 
associated hypotheses. The principal feature is a survey of medical records of 
(N=68) BPD patients in a single NHS Trust over a period of one year for evidence 
of traumatic experiences and PTSD/CPTSD. This stage consists of two parts, a 
quantitative survey of BPD patients’ notes, followed by a qualitative analysis of 
BPD clinicians’ views of the results. 
 
Figure 4-1 Stage 1 Methodology 
 
As indicated above, the quantitative methodology chosen is first described, along 
with the mitigations against the identified threats to the design validity. Specific 
objectives for the survey are first established in accordance with three of the four 
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Table 4-1 Objectives of Quantitative Review 






proportion of BPD 




A high proportion of BPD 
patients have had at least 
one highly distressing 
traumatic experience, 
either life threatening or 
non-life threatening 
Identify any trauma 





proportion of BPD 




A high proportion of 
patients diagnosed with 
BPD also meet a 
comorbid diagnosis of 
PTSD and/or 
CPTSD/DESNOS 
% of BPD patients with 
comorbid PTDS/CPTSD 
and standard deviation 
3 
Establish the 
extent of BPD 
over-diagnosis or 
misdiagnosis 
BPD is over-diagnosed (or 
misdiagnosed) in patients 
in mental health care 
Identify information on 
which current diagnoses 
were based. 
Interrelation between 
variables (e.g., DSM 




This survey interrogated BPD patients’ records to map current practice for 
diagnosing BPD, and to obtain support information relevant to BPD, trauma, PTSD 
and CPTSD, and the assessment of trauma. The results of the survey were then 
analysed and compared with the relevant empirical studies obtained in the 
literature review. The detailed methodology for the qualitative part of the stage 1 
design is then presented, where BPD clinicians are asked for interactive feedback 
on the results of the survey and their comments are collated and compared in 
accordance with the research design. Finally, the validity of both quantitative and 
qualitative results is considered in terms of the identified threats and research 
bias. Relevant supplementary information was also obtained during the review. 
This included the frequency of the different assessment instruments used, the 
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variability of the results against demographics, clinical history, types of treatments 
received by the patients, and a comparison with hospital from previous years. 
4.2 Patients’ Medical Records Survey Methodology 
Figure 4-2 Recruitment Process shown the overall process flow followed to obtain 
participants. 
 
Figure 4-2 Recruitment Process 
 
In order to ensure a sound clinical and academic approach to a potentially 
sensitive subject, a series of professional discussions were held with academics 
and operational clinical professionals. Initially the results were reviewed with the 
Research Project Steering Committee (APPENDIX 4 ). During these discussions, 
questions that were considered included how and when to differentiate between 
BPD and CPTSD, and what is the optimum time to make this selection. Also of 
importance was to consider the effectiveness of PTSD and CPTSD treatment in the 
event that an increased number of referrals are made. To aid these discussions, a 
brief review of historical discharge records (APPENDIX 9 ) showed that 
approximately 14% of patients discharged had a BPD diagnosis, confirming the 
overall significance of the disorder in the NHS Trust. The next requirement was a 
review and approval of the research ethics by the university Ethics Committee. 
Before any discussions with hospital authorities, approval from NHS ethics was 
obtained (APPENDIX 10 ). The main outcome of the ethical approval process was 
the requirement to obtain prior informed consent of patients to have their records 
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included in the survey. The next step was to obtain R&D approval from the 
Healthcare Foundation Trust for all three principal hospitals containing units which 
treat BPD (APPENDIX 12 ). The approval process began in September 2009 and was 
completed in June 2010. At this stage, all Trust BPD consultants were contacted 
by e-mail, followed by face-to-face meetings with four consultants from the 
largest (Prospect Park) hospital, two from Heatherwood hospital and two from 
Wexham Park hospital. Each consultant was issued with a Clinician Information 
Sheet and a Project Protocol and the objectives of the project and agreed ethics 
were discussed (APPENDIX 7 , APPENDIX 5 ). Then, with consultant support, 
participant recruitment posters were placed in the three hospitals (APPENDIX 8 ). 
Depending on individual involvement in different cases, and often the personal 
preferences of particular consultants, follow-up meetings took place on several 
occasions.  
Discussions then commenced with hospital BPD clinicians. On several occasions, 
the researcher was invited to take part in ward meetings and group treatment 
sessions with patients, where the research process was discussed. Over the period 
from October 2010 to April 2011 a number of formal and informal presentations 
were made to both clinician-only and to joint clinician/patient groups in all three 
hospitals. These presentations covered the substance of the Protocol, the Clinician 
and Patient information sheets, and all presentations included active question and 
answer sessions that were well received by hospital authorities, clinicians and 
patients. In all, over 10 such presentations were delivered. Based on discussions 
with clinicians, the full range (both inpatient and outpatients) of BPD patients in 
all of the trust (3) hospitals – Prospect Park, Heatherwood and Wrexham Park – 
was established, giving a total of 77 patients. This number compares well with the 
total of BPD patients discharged from the same institutions in the period from June 
2008 to May 2009.  
Medical records of all admissions in the psychiatric departments were first 
screened against the inclusion criteria (listed below) by the relevant clinicians who 
agreed to participate. 
 
 
Chapter 4  Stage 1 
  Page 107 
Inclusion criteria 
• All potential participants must have the diagnosis of  BPD, and they must 
know and understand their diagnosis 
• Age between 18 and 65 years old 
• Able to give informed consent to participate in the study 
• Must have a good command and understanding of the English language 
Exclusion Criteria 
• Currently acutely disturbed / psychotic 
• Unable to give informed consent. 
Potential participants who met the criteria were then approached by the 
healthcare team. This was done by informal discussion about the research project 
and about how they could help. The method for obtaining patient agreement was 
in accordance with the Ethical Procedures specified within the agreed Research 
Protocol. Of this complete dataset of 77 patients, nobody needed to be excluded 
on grounds of age or understanding of English, and only two patients did not give 
permission for their medical records to be examined. However, it was not readily 
possible to obtain complete records for eight of the patients (due mainly to time 
constraints), resulting in a usable dataset of 68, or 88% of potential participants. 
Seven medical records were not available in the archives, further reducing the 
database to 60. A summary of the exclusions made is given in Figure 4-3 below. As 
no adult patient was excluded by the researcher, this eliminated the potential for 
selection bias. 
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Figure 4-3 Stage 1 Recruitment 
  
Overall, a substantial proportion (approximately 60%) of the medical records from 
all of the three relevant hospitals of all patients diagnosed with BPD was examined 
to extract relevant information. The medical records were investigated using a 
specially developed Study Tool designed by the researcher (APPENDIX 13 ). This 
tool records relevant medical and demographic information from BPD patient 
records. 
4.2.1 Sample Frame 
The 77 BPD patients’ records considered in this research represents almost the 
entire BPD population of one NHS Foundation Trust. As a crosscheck, the Trust 
Annual Report for 2014-2015 shown annual BPD new interventions of 109 
(Berkshire Healthcare NHS Foundation Trust, 2013-2014). The Berkshire NHS Trust 
is one out of 46 UK Mental Health Trusts, 1.7% of the English population. The 
English annual BPD (ICD-F60) admissions for 2008-2009 was 6,370, 1.7% of which 
(107) can be compared with the Trust mental health admission rate (HSCIC, 2007-
2008). Like many English NHS Trusts, Berkshire includes both rural and urban 
areas, and is not untypical for the UK.  
  
Presentation of Stage 1 Research Programme/ Objectives to:
 Mental Health Wards with BPD patients (all 3 Trust Hospitals)
 DBT group
 Open days
 ‘Getting Ready Group’ (DBT for intensive therapy)
 Intensive therapeutic group (Psychodynamic)
77 Identified




Records not in 
archives for 7 
60 records utilised
Records not available 
for 8 due to timing 
issues 
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4.3 Results of Patients’ Records Survey 
4.3.1 Demographics 
The average age of participants was 37, with a range from 19 to 67, and a standard 
deviation of 11. Additional tests were conducted to see if the there was any 
significant variation in age for any of the conditions and no significant variation 
was noted. 9% (N=6) were men which can be compared to 30% of national BPD 
admissions (HSCIC, 2007-2008). 91% were white with 5 patients of Indian origin 
and only one of Afro Caribbean origin. Whereas the samples are representative of 
the UK as whole (87% white), the percentage of white patients in the survey is 
higher that the white population in Berkshire (74%). Based on clinician diagnosis 
in the medical records, 4% (N=3) of patients were assigned a comorbid trauma 
related Axis II diagnosis (Figure 4-4 Primary Clinical Diagnosis of Participants).  
4.3.2 Clinician’s Diagnoses 
 (Percentages rounded to whole number) 
 










Chapter 4  Stage 1 
  Page 110 
It should be noted, however, that of the three1 patients assigned by their clinicians 
a comorbid PTSD or CPTSD diagnosis in their records, only one met DSM criteria. 
An additional observation was that once a diagnosis was recorded, it was rare that 
a reassessment was made for the diagnosis.  
4.3.3 Recorded Symptoms 
Using the Study Tool, recordings were made of the initial clinical primary diagnosis 
and then of the DSM criteria from the available medical records of each of the 
participants. The clear recording of the presence of DSM criteria within the 
patient’s notes allowed these records to be examined for specific characteristics 
identified by DSM for both PTSD and CPTSD. It should be noted that the criteria 
for trauma, PTSD and CPTSD did not change between DSM-IV-TR and DSM-5. 
According to DSM, any patient with Trauma and with Re-experiencing can be given 
a PTSD diagnosis (NICE, 2004). Similarly, patients with both Trauma, Re-
experiencing and Affect-Dysregulation can be assigned as CPTSD (van der Kolk et 
al., 2001; Brewin et al., 2013). References to the presence of trauma were 
recorded from the medical records (46%, N=28). On this basis, the records were 
then reassessed to identify comorbid PTSD and CPTSD using the data for trauma 
and the results presented in the figures below. This analysis therefore shows that 
17%2 (N=10) of all patients in this study could realistically be assigned either a 
comorbid PTSD or CPTSD diagnosis as per DSM (DESNOS), a situation that could 
be called a ‘missed diagnosis’. Figure 4-5 below is a summary chart which uses this 
data to highlight the diagnosis of PTSD and CPTSD based on the DSM criteria.  
 
                                                     
1 Two patients were assigned a CPTSD diagnoses (2.94% rounded to 3%), one PTSD (1.47% rounded 
to 1%). All summary results are given as integers, in order to be consistent with the small sample 
numbers which can only represent indicative results.    
2  The PTSD and CPTSD percentages do not add up to 17% due to rounding errors, 
13.333+3.333=16.666. Percentages are preserved as integers so as not to give the impression of 
high statistical accuracy. 
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Figure 4-5 Diagnoses as per DSM Criteria 
 
In most of these cases, the trauma was experienced in childhood as physical or 
sexual abuse and neglect. The records were then reassessed to identify underlying 
symptoms of comorbid PTSD and CPTSD (Figure 4-6 and Figure 4-7). It was also 
noted that only 2 patients had a record of an in-depth examination of their 
traumatic experiences.  
 













BPD: 46% trauma; 54% no trauma 
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Re-experiencing is the core characteristic of PTSD; so it is critical that the content 
of the re-experiencing is explored. The re-experiencing recorded could range from 
unwanted memories which could have a relatively mild impact, to disturbing 
flashbacks and nightmares. However, although 38% (N=23) of patients had records 
of re-experiencing in their medical records, on only one occasion was the content 
of this re-experiencing recorded. Similarly, on only 10 occasions was there a record 
of trauma with re-experiencing. This could therefore indicate that trauma is being 
under recorded. For CPTSD, affect dysregulation was selected as a critical 
parameter.  
 
Figure 4-7 CPTSD/DESNOS Criteria (in additional to PTSD) as per DSM 
 
4.3.4 DSM Criteria for BPD 
Although all patients were assigned a BPD diagnosis by their clinicians, Figure 4-8 
shows only 12% (N=7) satisfied the full DSM criteria for BPD which states that at 
least 5 symptoms must be present (DSM-IV and DSM-5).  
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Figure 4-8 DMS Criteria for BPD 
 
The distribution of the 5 symptoms in Figure 4-9 shows that suicidal ideas or self-
harm are the predominant symptoms identified, along with self-damaging 
behaviour. The dataset was then interrogated to see if the presence of trauma or 
PTSD/CPTSD influenced the proportions of DSM BPD criteria. One might speculate, 
for example, that patients with PTSD/CPTSD would exhibit higher percentages of 
BPD criteria. Although this dataset did permit percentages to be calculated, the 
small sample size on this occasion did not allow meaningful conclusions to be 
drawn. Another aspect of the comparison between BPD and PTSD/CPTSD is the 
severity of symptoms. Unfortunately, while the number of differing criteria was 
recorded, there was insufficient information in the recorded medical records to 
estimate severity. 
Number of DSM symptoms present
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Figure 4-9 Percentage of DSM BPD Symptoms 
 
4.3.5 Instruments used 
In the medical records there are records of two instruments being used, IPDE 
(International Personality Disorder Examination) in 22 cases (37%), SCID-II 
(Structured Clinical Interview for DSM Disorders) for only 2 patients (3%). For the 
other diagnoses there are no references to a specific assessment instrument.  
4.3.6 Psychotherapy Treatment 
The pie chart in Figure 4-10 below illustrates the percentages that were offered 
psychotherapy of different kinds. While high proportions were given 
psychotherapy (56%, N=38) of differing types, and CBT in particular (26%, N=18), 
only a small proportion (4%, N=3) was related to trauma focused therapy. The high 
percentage of CBT in particular was for comorbid Axis I presentations such as 
Anxiety, Depression, etc. 
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Figure 4-10 Psychotherapy Documentations 
 
It should be noted in addition that no evidence could be found in the medical 
records of the three trauma-focused CBT patients taking up the trauma treatment 
offered. This may explain why these patients are still being treated as BPD 
patients. 
4.3.7 Validation of the Stage 1 Survey Results 
To help check the external validity of the results, a comparison with previously 
published empirical data was completed, as recorded in the literature review. The 
reason that these particular studies were selected was because they represented 
the only trial-based information. These 9 reviews all recorded the percentage of 
trauma found in BPD datasets, while some of the studies also recorded the 
presence of PTSD and CPTSD. The results from this review were then plotted 
alongside the published data for comparison in Figure 4-11, and Table 4-2. Table 
4-3  lists the plus or minus error limits calculated from standard deviation at the 
routinely quoted confidence interval of 95% (Gosall and Gosall, p.76). This shows 
that the Trauma, PTSD and CPTSD results for the survey fall below the range of 
average results from the empirical studies. The reason for this is investigated 
during the clinician interviews. The reason for this is investigated during the 
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Table 4-2 Comparison of Results with Empirical Studies 
Study Trauma PTSD CPTSD BPD 
  Mean SD Mean SD Mean SD Mean SD 
Empirical 
Studies 





N/A 3.3% 18% 1.7% 13% 100% N/A 
Researcher 
Analysis 
47% 50% 17% 38% 13% 34% 12% 32% 
 
Table 4-3 95% Confidence Intervals 
Study Trauma PTSD CPTSD BPD 
Empirical Studies 8% 15% N/A N/A 
Diagnosis by clinicians N/A 5% 3% N/A 
Researcher Analysis 13% 10% 9% 8% 
 
 
Figure 4-11 Validation of Stage 1 Findings 
 
The 49% trauma presence in this survey can be compared to an average of 79% 
from the surveys in the literature. Although results initially appear lower than the 
previous selected studies, it should be noted that in all the previous studies the 
selection criteria were biased towards trauma. A situation that is especially true 
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expected outcomes. In addition, on all occasions (except possibly for Ogata) the 
authors themselves were either leading the assessment process or were taking a 
major part in it, and thus may have been inclined to find the results they were 
looking for. In several cases, traumatic experiences were a pre-requisite of 
participation. Direct mathematical comparisons between the various trauma 
percentages recorded are therefore problematic. One reason could be because 
the clinical significance of these traumatic experiences has not been consistently 
recorded in the literature, as it is possible that in some studies the type of trauma 
recorded may not represent the type of life-threatening experiences required for 
a diagnosis of a disorder such as CPTSD, whereas on other occasions, all types of 
trauma may be recorded.  CPTSD results for stage 1 (13%) do not compare 
particularly well with the 31% of inpatients with CPTSD reported by Barnow et al., 
(2005). There is an even greater contrast, however, with the less than 2% of the 
stage 1 patients (in fact, a single patient) assigned a CPTSD diagnosis by the 
clinicians in the BPD clinic. Similarly, the 17% figure for stage 1 patients with PTSD 
symptoms is significantly less than the average of 47% from empirical studies, 
although much higher than the 3% (2 patients) assigned a PTSD diagnosis by their 
clinician.   
4.3.8 Limitations 
The principal limitation is the potential for researcher bias. As only the researcher 
examined the patients’ records, it is feasible that interpretations of the data were 
biased towards the expectations of the Project. One potential mitigation could be 
to get an uninvolved party (blind examiner) to review a sample of the patients’ 
records and to compare the results with those of the researcher, and thus 
complete an independent validation of the results. Another potential limitation 
for generalising the numerical results is the small sample size. The numbers of 
some of the resultant categories were very low. For example, there were only 2 
patients assessed from the analysis of symptoms as having a ‘PTSD Only’ diagnosis, 
and only 7 patients with five or more BPD symptoms. The statistical significance 
of these data in terms of drawing general conclusions is therefore open to 
question. One possible way of improving statistical accuracy would be to repeat 
the exercise. This could be achieved by examining patient records at national scale. 
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However, before such a large undertaking, the results could be checked against 
stage 2 results. 
In the case of individual research projects investigating trauma, there is also the 
potential for bias in the sampling and assessment process. The lower PTSD results 
(17%) could again be explained by reluctance of BPD clinicians to address life-
threatening trauma. As one clinician suggested, clinicians tend not to discuss 
details of early childhood traumatic experiences, as they do not have the skills to 
manage this condition.  
4.3.9 Validation of Interpretations of Survey 
Although the criteria for assigning BPD, PTSD and CPTSD were obtained from the 
DSM-IV-TR, it is possible that working clinicians, academics and other relevant 
professionals could interpret DSM criteria in different ways. For example, some 
records that were written as re-experiences could perhaps be reinterpreted as 
unwanted memories rather than flashbacks and nightmares that are core to PTSD 
pathology and therefore PTSD results could be over-estimated. 
4.3.10 Discussion on Quantitative Survey Results 
Clinicians were recording adequate clinical information as per DSM-IV-TR and ICD-
10 requirements to undertake DSM diagnosis for any of the three disorders. That 
is, a comprehensive range of symptoms was found in the medical records for more 
than 82% of the BPD patients. Thus the DSM criteria for CPTSD/PTSD are being 
clearly recognised and annotated, but this information did not result in any 
significant comorbid trauma-related diagnosis, and therefore detailed assessment 
was not requested by the BPD clinicians. Moreover, from the analysis above, there 
was an apparent under-diagnosis of CPTSD (DESNOS) and PTSD in the sample 
examined. There could be several reasons for this. Detailed discussions and 
references for both the theoretical and empirical relationships can be found in the 
Literature Review Chapter (section 2). Although according to DSM (IV and 5), five 
or more criteria have to be present (for ICD, a minimum of 3 are required) in order 
to adequately diagnose BPD, on 88% of occasions clinicians in the Trust appear to 
be satisfied with fewer than 5 BPD criteria, and on 15% of occasions were willing 
to assign a BPD diagnosis with only a single (although not any particular) BPD 
criterion present. Another explanation for the high diagnostic rate of BPD could 
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relate to professional clinicians’ interpretations of DSM criteria. However, the 
DSM requirements were designed by committee to act as structural guidelines, 
making it easier for individual clinicians to make broad interpretations. Although 
the 1994 DSM-IV conditions were subject to constant interpretation, the recent 
DSM-5 BPD guidelines do not make any significant changes in this area.  
The BPD results are consistent with the major (Westen) survey of American 
clinicians discussed in detail in the Literature Review, where a similarly low rate of 
compliance with the strict DSM-IV criteria for BPD diagnosis was found. These 
clinicians tended to make their diagnosis not on DSM criteria, but on the basis of 
observation and patient narratives.  While it is logical to suggest that the patient 
narrative is led by thoughtful questioning by clinicians, a mapping of the clinician-
patient interface would be difficult to achieve without recording assessment 
sessions. Similarly, although DSM symptoms for CPTSD and PTSD are routinely 
recorded, less than 1% of these 60 BPD stage 1 patients had been assigned a PTSD 
or CPTSD comorbid diagnosis. This contrasts with the 17% of patients who satisfied 
the DSM criteria for either comorbid PTSD or CPTSD when the records were 
examined (Figure 4-4 and Figure 4-5). This concludes the first part of stage 1.  
4.4 Stage 1, second part, Clinician Discussions: Qualitative Review 
To fully understand the underlying reasons, the above stage 1 quantitative results 
were presented to a variety of clinicians and consultants. These events included a 
Hospital Research Club Presentation, Steering Group Presentation, ward 
meetings, and informal discussions. This constituted the initial step in allowing the 
professionals to validate the results. It also provided a forum for clinicians to 
discuss alternative views. The objectives for this part of the study refer back to the 
overall objectives as shown below. 
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Quantify and qualify 
the proportion of BPD 
patients who have 
experienced 
traumatic stressors 
Identify any trauma 
recorded and its 
frequencies 
BPD clinicians’ and 
management 
interpretation of 
trauma in patient 
presentations  
2 
Quantify and qualify 
the proportion of BPD 
patients who also 









Why identified trauma 
does not appear to be 
fully assessed and 
treated 
3 
Establish the extent 
of BPD over-diagnosis 
or misdiagnosis 
Identify information 





(e.g., DSM diagnostic 
criteria) and assigned 
clinical diagnosis 
What do clinicians 
consider the essential 
criteria to diagnose BPD 
 
4.4.1 Interview Methodology 
In order to build on group sessions and facilitate open discussions, a 
questionnaire was then prepared for a more comprehensive evaluation of 
clinician and management views. The questionnaire below was developed 
from the experience of the researcher, supervisors, peers, Steering Group and 
the literature on BPD, taking into account the link with trauma, PTSD/CPTSD:  
1. How do you diagnose BPD, and do you use an assessment instrument for this? 
2. What do you ask about childhood trauma and do you do a detailed examination 
of this? 
3. Are you aware of the concept of CPTSD? 
4. How do you differentiate between BPD and CPTSD? 
5. Would a screening instrument used during the assessment help, and what would 
you like to see in such a screening instrument? 
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6. What is your usual treatment for BPD, and do you do anything about trauma if it 
occurs? 
7. Do you find this treatment effective? 
8. How is it evaluated? 
9. Do you think referral to a Trauma clinic would be helpful to the patient? 
10. Which would be better (easier); Trauma clinician to come to the patient or 
patient to go to the clinician? 
The questionnaire attempts to balance the potential benefits of trauma 
treatments for BPD patients against the inherent stresses that could be involved 
in this study. It was then either discussed during the semi- structured interviews 
or distributed to participants who were not interviewed. In particular, it was 
important to find out if clinicians ask all their patients about abusive histories as 
per current Department of Health Policy, Refocusing the Care Programme: 
Approach and Practice Guidelines, Department of Health, 2008). To quote directly 
from this document:  
‘Childhood experience of sexual and other abuse is known to be more frequent in 
the histories of individuals with both mental illness and personality disorders 
(MNMSF, 1999). Research indicates that around 50% of women service users have 
been sexually victimised as children, notwithstanding further abuse in adulthood 
and a significant number of men service users have also experienced abuse. It is 
now DH policy that, following appropriate training for staff, exploration of 
violence and abuse is routinely undertaken in all mental health assessments. 
Questions should be asked by suitably trained staff at assessment about the 
experience of physical, sexual or emotional abuse at any time in the service user’s 
life. The response, with brief details, should be recorded in the case records/care 
plans. If the specific question is not asked, the reason (s) for not doing so should 
be recorded.’  
 
Based on these initial informal discussions, the steering group considered a 
number of potential explanations for the stage 1 quantitative results. Figure 4-12 
below illustrates these possibilities. 
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Figure 4-12  Stage 1 interpretation Options 
A selection of clinicians’ views on trauma, BPD, PTSD and CPTSD was then recorded 
based on the findings of the quantitative survey. The principal methodology for 
this review was the constant comparison method described fully in the design 
chapter (section 3.5.2.2). In line with the interpretist paradigm, this process 
considers the clinicians’ opinions of BPD patient presentations that informed their 
diagnosis, and the formulation of patients care plans which guide treatment.  
4.4.1.1 Constant Comparison  
This (qualitative) part of the study interviews two professional groups, practising 
clinicians (N=28) and medical directors/managerial personnel. The main focus 
area for the constant comparison technique was the second research objective: 
‘why identified trauma does not appear to be assessed and treated’. This was 
because there was most uncertainty about this particular issue. Clinicians’ views 
on trauma (Objective 1) and on BPD assessment (Objective 3) were also recorded, 
but as there was not a sufficient variety in views, the full constant comparison 
methodology was not required for these objectives. Comparisons were made by 
coding and categorising the narratives of both individual day-to-day BPD clinicians 
and BPD management according to the three constant comparison steps. 
1. Comparison within a single interview 
2. Comparison between interviews of different clinicians 
3. Comparison between the clinician and management interviews  
DSM Symptoms for 





Disagree with DSM 
Recommendations
Lack of confidence 
with CPTSD/PTSD 
Treatment
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4.4.1.1.1 Step 1 Aims and Methodology 
In order to make systematic comparisons, common codes from the initial 
interview narrative of one day-to-day clinician were developed, and the 
interviewee was asked about the survey findings and their views on trauma 
assessment and treatment in BPD.  
4.4.1.1.2 Step 1 Results 
Consistent codes and tentative categories emerged quite quickly. Four codes 
which were identified from the first interview are presented below.  
Table 4-5  Codes from First Interview 
1 Trauma resources  
 “We are very aware of trauma underpinnings - 
but we have no resources. Also we are stressed 
out with the lack of trauma specialists to see 
these patients.” 
2 Trauma training  
 “Trauma is not part of our BPD brief. We are not 
skilled enough to go into the past without the 
skills to deal with it.” 
3 Trauma screening 
 “ Agree with the need for trauma screening 
during assessments as our patients are usually 
not actively disturbed when they were referred to 
us” 
4 
Fear of  BPD patients’ 
reaction if pushed to 
explore past trauma 
 “Fear of trauma. We do not ask about trauma as 
we do not want to open up things that patients 
might not be able to deal with without help.” 
 
For example, fragments of an interview that were given the code “Fear” were then 
subjected to further comparison within the same interview to find out what they 
had in common, how they differed, in what context the interviewee made the 
remarks, and which dimensions or aspects of fear were highlighted. Some 
examples are as follows: 
”There is perhaps a fear of opening a can of worms”  
 “There is a fear of what to do with the information, and a worry about the 
possibly lack of services to deal with the information”  
Trauma does not appeared to be considered, perhaps it is due to not 
wanting to open a can of worms”. 
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4.4.1.1.3 Step 2 Aims and Methodology 
Then, in order to confirm a meaningful variety of categories, comparisons were 
made between the initial interview and individual clinician interviews (N=26) as 
shown in APPENDIX 15 . From these free ranging discussions, common 
occurrences of the above codes were recorded. The optimum number of 
interviews was realised as the emerging data became saturated and no further 
insight could be gained from the data. However a number of additional clinicians 
were added for confirmation. Restricting the number posed another challenge, 
because a high number of clinicians had expressed an interest in the outcome; 
there was therefore a risk of a sample snowballing effect, which had to be 
sensitively managed by using clinicians who were in daily contact with the 
patients. 
4.4.1.1.4 Step 2 Results 
A total of eight categories emerged as listed below.  
Table 4-6  Categories from Interviews 
1 Fear of opening Pandora’s Box 
2 Lack of resources for trauma treatment  
3 Lack of clinical competence to deal with distressing trauma 
4 Clinicians not aware of the need to assess for trauma 
5 
Instruments currently in use do not offer the opportunity explore 
trauma and its reactions 
6 
Not skilled enough to go into patients’ past without the skills to clinically 
manage any results, disclosures and distress 
7 
A simple trauma screening instrument would help to know which 
patients can be referred on to trauma specialist(s) thus reducing the fear 
of dealing with trauma 
8 Existing BPD screens do not help to identify trauma 
 
Clinicians were fearful about discussing trauma, and felt that they did not have the 
skills to manage the life-threatening trauma typical of PTSD that they anticipated 
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would be brought out during the assessment process. Consequently they either 
did not talk about it at all, or they skirted around the subject. Interviews generally 
confirmed that clinicians were in fact familiar with PTSD but not CPTSD. A common 
concern was the fear of ‘opening Pandora’s Box’, that is, if delicate and sensitive 
traumatic experiences such as child sexual abuse were to be explored, additional 
unknown problems might be exposed. One ward manager said “We do not ask 
about trauma as patients in the wards are in acute stress stage and are on the 
ward for a short time so we do not want to open things that cannot be dealt with.”  
This reaction has previously been noted by (Bryer, Nelson and Miller, 1987). The 
item most requested by clinicians however was brief and effective screening for 
the early identification of trauma, PTSD/CPTSD in BPD patients, so that they could 
obtain an in-depth assessment as early as possible for their patient. As expressed 
by one clinician: “Trauma must be explored in order to effect the treatment plan 
and to map a course through the mental health system with trauma screening the 
first step”. Some clinicians requested more specialist trauma support and more 
training for dealing with trauma and its consequences. “Clinicians are afraid to 
open trauma difficulties as they are not trained to deal with it. A screen would be 
good at the common point of entry, for referral for assessment of trauma 
component. Such a screen must be meaningful and clinicians must be trained in its 
use during formulation”. 
However, as the role of providing a full PTSD/CPTSD assessment is already being 
performed by specialist clinics, it could be more efficient for busy BPD clinicians to 
simply screen their patients for potential PTSD/CPTSD and to refer them 
appropriately for in-depth trauma exploration. In these circumstances, a simplified 
Screening Instrument should be considered for use by BPD clinicians. Screening 
instruments are commonly utilised prior to full clinical assessment.  
4.4.1.1.5 Step 3 Aims and Methodology 
Management participants (N=3) were independently asked to give their opinion 
on how they thought clinicians manage trauma and their reactions in BPD 
presentation, based only on the quantitative results, without access to results 
from the clinician interviews. This was done to obtain a comprehensive picture 
from a variety of perspectives. Categories identified were then presented to 
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management participants and to some of the clinicians in order to verify the 
results to make sure that the important issues that they had raised were not 
missed. 
4.4.1.1.6 Step 3 Results 
From all of the results, four themes emerged in the reasons given for not assessing 
and treating trauma. 
Table 4-7 Step 3 Results 
 Clinicians Management (with quotes) 
1 
Recognise and explain 
the presence of 
traumatic past histories 
Assume that clinicians were adequately 
managing trauma 
 “We must ask clinicians to pay more attention 
to trauma” 
2 
Trauma not explored by 
clinicians due to fear of 
‘Pandora’s Box’ 
Based on quantitative results, fear of 
addressing trauma was suspected as the root 
cause 
 “There appears to be a fear of dealing with 
trauma” 
3 
Not treating trauma 
underpinnings due to 
lack of resources and 
lack of competence for 
doing so 
Appropriate training should be provided 
“We have a lack of resources”  
“Clinicians must be trained to take away the 
fear of approaching trauma“ 
4 
Need a simple screening 
instrument that will help 
just to raise the issue 
and then refer on for an 
in-depth assessment by 
a trauma specialist, thus 
reducing the fear factor 
Recommend screening and referral to 
specialist clinic(s) 
”A meaningful and uncomplicated trauma 
screen should help clinicians feel confident in 
making a referral to trauma clinics” 
 
Management participants generally presented the same themes as the clinicians, 
but went further to suggest how they could help in terms of resources and 
training, as fear of ‘not wanting to open the Pandora’s Box’ could be due to lack of 
training and resources. They also felt that it was unethical not to screen and treat 
for trauma. 
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4.4.2 Additional Results from Clinician Interviews 
The relatively low reporting of trauma (47%) in patient medical records in 
comparison with empirical studies was explained by the BPD clinicians, who 
reported that discussing childhood trauma in particular with patients was a 
daunting experience. In general the criteria applied in making a BPD diagnosis in 
clinical practice were less strict than recommended by DSM and ICD, and typically 
patients were diagnosed and treated for BPD based on fewer symptoms. 
Avoidance of alternative diagnosis by BPD clinicians was also noted by Westen 
(1979) in his wide survey of US practitioners.  
A number of authors have reported on the reasons why clinicians do not ask 
patients about their abuse histories. Gallop et al., (1995) and Young et al., (2001) 
have concluded that uncertainty about how to respond to revelations of abuse 
was one of the main reasons why clinicians do not ask about this. Similarly Read, 
Hammersley and Rudefffeair, (2007) have reviewed this area. They then 
concluded that one of the reasons that clinicians do not enquire about abuse is 
because of ‘lack of training in how to ask and how to respond’.   
4.4.3 Follow-up of Stage 1 Patients 
A number of months after the completion of stage 1, an investigation was made 
into the treatment response of these patients. Of the (N=16) patients where 
information was available (N=3) 14% showed improvements resulting from their 
BPD as usual treatment. 
4.5 Stage 1 Conclusions 
The quantitative and qualitative parts of stage 1 are now brought together to 
address three of the four research sub questions. The findings from the survey of 
patients’ medical records formed the basis of the questions for the survey of BPD 
clinicians, views. The results were then assessed against the research objectives. 
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While the stage 1 results largely confirm NICE expectations, the urgent need now 
is to examine the value of the proposed changes in assessment techniques with 
systematic in-depth patient interviews. 
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5 METHODOLOGY: STAGE 2, TRAUMA, PTSD & CPTSD SCREENING TRIAL 
5.1 Introduction 
This chapter presents the objectives, methodology and results of the second or 
principal research stage of the project, and follows directly from the main 
recommendation arising from the findings from the stage 1 BPD patients’ medical 
records. When presented with the findings, BPD clinicians requested a streamlined 
but effective trauma screening instrument that would prove easy to use when new 
patients present with BPD psychopathology. Stage 2 develops and trials this 
screen.  
Specific objectives for the stage are first clarified, followed by a description of the 
stage 2 research methodology employed as sketched in the stage 2 Roadmap, 
Figure 5-1. Central to stage 2 is the development and trialling of a ‘BPD Traumatic 
Experiences and Reactions Screen’ (BTERS), a new trauma screening instrument 
for people who present with BPD-like symptoms. The process commenced with 
the development of the instrument, concentrating on how the instrument was 
validated, where validity was divided into a number of key elements. First, the 
conceptualisation of the instrument and the overall methodology are discussed. 
The next section then covers the creation of a pilot instrument, and the testing of 
the pilot version, leading to the trial of the final instrument. Finally, statistical 
analysis and results are presented in terms of validity and reliability, together with 
discussions on the limitations of the trial. 
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5.1.1 Stage 2 Objectives 
Table 5-1 Stage 2 Objectives 
No Research Objective Specific stage 2 objectives 
1 
Quantify and qualify the 
proportion of BPD patients who 
have experienced traumatic 
stressors 
Identify and specify the type of 
trauma experienced by BPD patients  
Establish the % of patients with the 
criteria for in-depth trauma 
assessment and treatment in BPD  
 
2 
Quantify and qualify the 
proportion of BPD patients who 
also meet a PTSD/CPTSD 
diagnosis 
Detect PTSD/CPTSD in BPD patients 
using gold-standard clinical 
instruments 
Compare % of Trauma, PTSD, CPTSD 
identified with stage 1 results and 
with literature 
3 
Establish the extent of BPD 
misdiagnosis or over-diagnosis  
(Misdiagnosis was addressed in 
stage1) 
Establish BPD over-diagnosis by 
calculating PTSD/CPTSD comorbidity  
4 
Using a screening instrument, 
quantify and qualify BPD 
patients using BTERS for 
trauma-focused therapy by 
validation against gold 
standards 
Develop and trial a trauma screening 
instrument for clinicians for early 
identification of trauma and 
PTSD/CPTSD 
5.2 Stage 2 Methodology 
Clinical diagnostic instruments such as BTERS are commonly used methods for 
screening and validation and are reported in the professional literature. The 
methodology summarised in the Roadmap was based on QUADAS, as described in 
section 3.11.1, and comprised the following steps: 
A. Conceptual decision – screening instrument design and population selection 
for testing 
B. Generation of Items relating to both causes and symptoms of each of the 3 
disorders 
C. Assessment of Face validity and Content validity  
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D. Pilot trial and refined instrument 
E. Field trial to assess consistency and Construct validity 
This development process also follows the approved Research Protocol and any 
deviations were noted and approved by the Supervisor and the Steering Group 
members whenever appropriate. First the overall methodology and 
conceptualisation of the instrument (A) is discussed. A list of items were then 
generated (B).The next sections then cover the creation of a pilot instrument (D) 
that deals primarily with Face and Content validity (C). Face validity concerns the 
appearance and usability of the instrument, whereas Content validity ensures that 
the instrument measures what it is supposed to measure. The data analysis used 
to calculate Construct validity (E) and the results are presented following the pilot 
study. Several statistical techniques were utilised throughout, and these are 
described in detail within the individual sections. In particular content validity 
index (CVI) and a discerning analysis using Cronbach’s alpha was used to fine tune 
the items on the screen (section 5.2.2), then sensitivity and specificity was used 
for the pilot (section 5.7). For the main study, again sensitivity and specificity was 
used, along with the evaluation of repeatability (Cohen’s kappa, 5.10).As in stage 
1, the statistical program SPSS (version 19) was utilised to manipulate and present 
the data.  
























*BTES subsequently changed to BTERS
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5.2.1 Screen Concept Decision (A) 
A new screening instrument was conceptualised in response to the results of stage 
1, medical records survey, the clinician survey, and feedback from the Steering 
group (section 3.11.2). Stage 1 thus highlighted the need for a streamlined but 
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use when new patients present with BPD symptomatology. Such an instrument 
would allow patients who could potentially benefit from PTSD/CPTSD treatment 
to be identified. It must, however, include sufficient clinical detail to annotate the 
various traumatic events including PTSD/CPTSD in order to provide repeatable 
results and ensure quality control. Thus BTERS (APPENDIX 1 ) was conceived as a 
single page form with a limited number of simple questions relating to traumatic 
experiences and patients’ reactions to the experiences, which could identify 
patients for subsequent detailed assessment of BPD or PTSD/CPTSD. To support 
the goal of simplicity, a structured interview was the preferred format; however, 
in recognition of the time pressures in the clinical environment and, in particular, 
the sensitive subject matter, the study also considered the effectiveness of self-
completion. The literature search confirmed that none of the existing screens 
were suitable for non-specific traumas, such as those typically experienced by 
patients with BPD/CPTSD often originating in childhood. 
5.2.1.1 Generating the Items for Screen Questions (B) 
To create relevant questions for the screen, a comprehensive list of items relating 
to the disorders was systematically developed, edited and refined. The list 
included traumatic experiences that have been repeatedly described in the 
literature on individuals exposed to both type 1 and type 2 trauma. 
Table 5-2 Domain Set for 3 Disorders 










The initial item list considered two Domains – Disorder Pre-Requisite and 
Symptom Set – for each of the disorders, which roughly correspond to the causes 
and symptoms of BPD, PTSD, and CPTSD as specified by DSM (Table 1-3). The first 
Domain deals with traumatic experiences, especially what is called ‘Criteria-A’ or 
Life-Threatening Trauma (see section 1.5.1 for further details) whereas the 
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Symptom set can be divided into Psychological, Behavioural and Physiological 
symptoms. Symptom sets were generated from a review of the literature on the 
sequelae of childhood sexual abuse, physical abuse, crime, rape, incarceration in 
concentration camps and torture. Other items derived from feedback from 
clinicians after the presentations of the results of stage 1, and from 
comprehensive assessment instruments for the disorders (Gold Standards). From 
this review, an initial ‘pool’ of 64 items was created. A series of meetings followed 
and presentations were made to both clinicians and experts on psychological 
reactions to extreme stress and BPD in order to choose which specific criteria 
should be included or deleted in the item list. The format and language of the 
question set was also modified to improve face validity, which is important 
because, for the criterion of content validity to be met by the initial pool items, 
these items must be face valid (Hardesty and Bearden, 2004). At the end of this 
process a refined list of 23 items remained.  
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5.2.2 Initial Content Validity of the BTERS Screen (C) 
The Zaichkowsky (1985) system was employed to produce an initial assessment of 
Content Validity. For this assessment, a panel of 3 judges specifically chosen for 
their expertise in the field of traumatised populations was asked to review the 23 
items. The judges consisted of the following: 
1. CPTSD: Former Head of Trust Trauma Unit – Professor and consultant 
psychological trauma therapist with expertise in CPTSD. As a clinician and 
academic, has published extensively and spoken worldwide. World renowned 
for her work on Trauma. Founder staff member of the traumatic stress services 
at the Institute of Psychiatry. A founder and a very long term lead of a national 
traumatic stress services. 
2. BPD: Head of the Trust BDP Unit - consultant psychiatrist specialist in the 
treatment and management of BPD. Member of BPD guideline development 
group for NICE clinical guideline 78 BPD: ‘Borderline Personality Disorder: 
treatment and Management’, NICE, 2009. 
3. PTSD:  Consultant clinical psychologist. Head of national trauma centre for 
PTSD, specialises in treating PTSD, and has wildly disseminated her clinical 
knowledge in Europe and North America. 
 
The most relevant items for the screen were chosen on the basis of the priorities 
assigned by each specialist in his or her field of expertise. Each specialist rated 
items as “completely representative”, “somewhat representative” or “not at all 
representative” of the construct for each of the 3 disorders, with scores from 1 to 
3. For each disorder, the designated expert was given double points because of 
their speciality. Therefore the lowest score for one disorder is 4 = 1 (non-expert) 
+1 (non-expert) + 1+1 (expert). The highest score is 12 = 3 (non-expert) + 3 (non-
expert) + 3+3 (expert). These numbers are presented below in two tables, Table 
5-3 below shows a Content Validity Index (CVI) where the numbers are 
represented by percentages (top score of 12 + 12 + 12 = 36 =100%). 
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 High CVIs are shaded CVI 
1 Did you experience or witness TE in your childhood 89% 
2 Was it before the age 13 86% 
3 Was is after age 13 89% 
4 Was it repeated 78% 
5 Was it life-threatening 81% 
6 Was it sexual abuse 100% 
7 Was it physical abuse 92% 
8 Was it non-life-threatening 61% 
9 Was the perpetrator always a family member or a care -giver 33% 
10 Was it inappropriate touching of your sexual parts 47% 
11 Did you feel rejected 67% 
12 Did you feel unloved 67% 
13 Did you think you were no good enough 69% 
14 Did you think you were permanently damaged 69% 
15 Abandonment 69% 
16 Did you lose trust in people 89% 
17 Intense distress 94% 
18 Flashbacks 94% 
19 Nightmares 94% 
20 Avoiding people and places that will cause you distress 89% 
21 Intense anger 72% 
22 Intense sense of fear 89% 
23 Irritable and jumpy when unexpectedly startled 94% 
 Mean 79% 
Table 5-3  Content Validity Index CVI 
 
It was also possible to identify items that discriminated between the disorders. In 
Table 5-4 below, colours highlight the differences in the scoring: dark green 
represents maximum value (12) for any particular disorder, and white represents 
minimum value (4), and the shade of green on all other cells is reduced 
proportionally using a built in Excel function. 
An ‘identifier’ can be defined where one item is scored notably higher by the 
experts in only one particular disorder, and an ‘excluder’ is defined where an item 
is scored notably lower in only one disorder. 
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Table 5-4 Questions that Discriminate between Disorders  
 
For example, non-life-threatening experiences (item 8) are indicative of BPD. Here 
we can see that BPD scores 12 points, PTSD scores 4 points and CPTSD scores 6 
points, so item 8 is a clear identifier for BPD. Similarly the presence of repeated 
traumatic experiences (item 4) excludes PTSD as it scores high (12 points) for 
CPTSD and BPD, but low (4 points) for PTSD. Also the thought of being 
permanently damaged (item 14) is a major CPTSD identifier. On the right hand side 
of the table, each item is then assigned a percentage. 100% (dark red) is where 
there is a maximum contrast between the low and high values (item 4); here there 
is a definite exclusion of PTSD.  On the other hand, 0% (white) represents the 
lowest contrast between the values (items 6 and 9), and so these questions do not 
help to discern any of the disorders. Where there is a moderate contrast such as 
item 18, (Flashbacks) the contract level is moderate and the percentage (25%) 
represents a lower ability of this particular question to definitely exclude BPD. 
Another example is items 13 to 15, where the percentage (69%) can be seen as a 
good identifier. If scores less than 25% were rejected, the lowest scoring 3 
questions could be excluded, and thus 25% could be used as a cut-off value. 
Nonetheless, the experts agreed with the selection of items with only a few 
exceptions (items 9/10). For simplicity, items were to be scored dichotomously, 
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i.e. each question to be answered by each patient with either “yes” or “no”. The 
number of questions was reduced from 23 to 16 to make screening quick enough 
to be used easily in a busy clinical environment, while maintaining sufficient detail 
to differentiate between the 3 disorders. Items were then refined and arranged 
into a structured interview format ready for the pilot study. The actual questions 
in the instrument were not selected solely on the basis of statistical parameters.  
A judgement was made of the suitability of the questions both in terms of Face 
and Content Validity for screening and their usefulness as a focus for discussing 
treatment options. For example, whereas item 6 (Was it sexual abuse?) scored 
low, it was retained because it was combined with item 4 (Was it repeated?) 
because repeated sexual abuse is a recognised indicator of CPTSD. From this 
review, a list of 16 questions for the pilot screen was finalised. Whenever 
compatible, items were combined to ensure that the high scoring items were 
presented in clear and simple questions. 
5.3 Stage 2 Ethical Approval 
NHS ethics placed a number of constraints, including informed consent, freedom 
of choice, anonymity of data, security of data, etc. As required by the NHS ethics 
committee and detailed in the Protocol and the Clinician Information Sheet 
(APPENDIX 16  and APPENDIX 18 ), prior to data collection, discussions took place 
with as many clinicians who work with BPD patients as possible. These included 
the Head of The Traumatic Stress Services Department responsible for possible 
referrals, key consultant psychiatrists, Medical Department Lead(s), the individual 
care coordinators for each patient participant, plus all clinicians in the crisis team. 
Prior to starting, assurance was obtained as to the protection systems in place for 
participants. These included what are called ‘grounding strategies’, and also the 
confirmation of efficient telephone contact numbers to be used in an emergency 
(Design Chapter, section 3.6.2). 
It was also necessary to consider the consequence to individual patients should 
they be diagnosed with PTSD/CPTSD. When the assessment process was 
completed, therefore, and with the patient’s permission, the patient’s 
consultant/responsible clinician was informed of any clinically relevant findings. 
Subsequently, recommendations could be made as to which participants it would 
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be appropriate to refer to the local traumatic stress services. In reality, as many of 
the patients were in BPD treatment, only a small number (N=7) of patients were 
referred to the Trauma Unit. BPD treatment continued unchanged for all patients, 
both those who were referred to the trauma services and those who were not, for 
as long as clinically necessary. 
5.4 Patient Selection and Recruitment 
In order to field-test BTERS, the sample area needed to be restricted to a 
manageable and controlled environment with sufficient suitable patients 
available. The project thus concentrated on one BPD specialist centre in a UK 
Health Trust (BPD unit), where patients were recruited mainly from a 
psychological treatment facility on the basis of their BPD diagnosis. Patients either 
in treatment for BPD or new referrals for assessment of BPD were included. At the 
time, all were outpatients, although some had previous psychiatric 
hospitalisations.  
Inclusion Criteria 
 Clinical diagnosis of Borderline Personality Disorder 
 Age 18 or over (no upper age limit) 
 Able to give informed consent 
 Currently receiving psychiatric care from the participating NHS Trust 
  Availability of professional support i.e. must have a key worker 
Exclusion Criteria 
 Age Less than 18 
 Unable to speak English 
 Acutely Distressed 
 Significant learning disability 
 Unable to give informed consent  
 Alcohol or drug impairment 
 Hospitalised  
 A recent crisis condition such as self-harming 
 Recent police involvement  
 Missing three appointments in a row without a valid explanation 
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A total number of (N=40) patients were targeted for the full study. This number 
was selected based primarily on practical clinical considerations for a single major 
treatment unit. For a single unit, a maximum of 60 prior to dropout can be 
expected based on annual discharge rates (APPENDIX 9 ). In addition, ethical 
considerations required a sensitive approach to recruitment, as many potential 
participants could not be included for clinical reasons.  
 
Figure 5-2 Recruitment Flowchart 
 
The treatment unit in question was for adults assigned a BPD diagnosis by their 
psychiatrist as per DSM (or ICD) criteria. The patients commonly had had different 
kinds of treatment for many years. Inclusion and exclusion criteria were based on 
both ethical and clinical factors. In this study therefore, no willing patient was 
excluded who satisfied the inclusion criteria. Previous published studies of trauma 
amongst BPD patients tended to suffer from bias, where participants were 
targeted from BPD patients who had experienced trauma. Therefore to reduce this 
bias during the recruitment process, patients were deliberately not asked if they 
had any traumatic experiences in their past.  
A presentation was given to the BPD unit team to remind all clinicians of the results 
of stage 1 and of their request for a screening instrument, and to present the initial 
(Pilot) BTERS. This also included a training discussion on how to use the screen. 
Presentation of Research Programme/ Objectives to:
 BPD clinics 
 DBT group
 Open days
 ‘Getting Ready Group’ (DBT for intensive therapy)
 Emotional intelligence group (DBT)
 Intensive therapeutic group (Psychodynamic)
63 Identified
11 not Screened
 Patients didn’t want to
 Clinician said patient not 
ready
 Clinician said doing well 






 Patients didn’t want to 
be assessed yet
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Positive feedback was received when clinicians were asked about their willingness 
to help with the study, as they felt it would be beneficial for their patients. The 
clinicians recommended that this presentation should also be made to the 
patients in their therapy group sessions. While the intention stated in the stage 2 
Research Protocol (APPENDIX 16 ) was to target the patients from stage 1, this did 
not prove to be practical as most of these patients were in the course of BPD 
treatment and introducing BTERS was seen as disruptive. Thus all other patients 
who attended the clinic during the study period (November 2012 - August 2013) 
were considered for enrolment into the study, which can therefore be considered 
a ‘convenience sample’. During the presentations, the possibility of trauma 
triggers and their immediate management was explained to both clinicians and 
patients, and the Trust approved support system was discussed (incorporated into 
the Patient Information Sheet). Support was provided for all patient interfaces. 
After the presentations, a number of patients showed willingness to participate, 
so with their clinicians’ permission they were recruited by the researcher who 
discussed the patient information documentation with them and obtained written 
consent. All other patients were recruited following recommendations by 
clinicians. In each case, formal written consent was obtained as per the process 
required for ethical approvals (the Patient Information Sheet and the Consent 
Form are shown in APPENDIX 17 and APPENDIX 14 ).  
5.5 Pilot Study Objectives 
As BTERS is a new instrument, piloting was required to confirm its clinical 
acceptability and to make any necessary refinements. The main purpose of the 
Pilot Study, therefore, is to carry out an initial assessment of Construct Validity, or 
reliability, prior to the main testing programme. In addition, an initial assessment 
of Content Validity was made to ascertain whether the questions selected for the 
pilot version of the screen were appropriate and relevant and adequately reflected 
the theoretical relationship between trauma and the different disorders. The Pilot 
thus required a representative selection of subjects (N=13) and, to assist with Face 
Validity, a number of the BTERS forms needed to be completed both by a clinician 
and by the patients themselves.   
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5.6 Pilot Study Methodology (D) 
Patients were administered a BTERS screening interview (some for self-
completion) followed by the reference assessment (Gold) standard. The SIDES 
instrument (Pelcovitz et al., 1997) was selected as the gold standard for CPTSD and 
CAPS (Blake, Weathers, and Nagy, 1995) for PTSD (APPENDIX 24 and APPENDIX 25 
). Although both instruments are discussed in detail in the Literature Chapter 
(section 2.4.2 and 2.2.6), it is worth reiterating some of the weaknesses of these 
assessment instruments that led to the request for a short screening device. Both 
are complex and time consuming, often taking up to 2 hours to complete, and 
requiring specialist trauma training. As CAPS is designed for PTSD it addresses only 
Criteria-A trauma and tends to focus on symptoms. Similarly the SIDES for 
CPTSD/DESNOS focus on trauma symptoms rather than their causes. 
The BTERS screening took about 10-15 minutes. To minimise the possibility of bias, 
the majority of screening was performed by clinicians or by the patients 
themselves. Thus an assignment of PTSD and/or CPTSD was made either by the 
patients’ clinician (N=10) or by the researcher (N=3). On occasions when the 
patients themselves completed BTERS, their clinician made the assignment. 
Although the stage 2 Research Protocol (APPENDIX 16 ) proposed that the 
participants should be assessed straight after screening using the gold standard 
instruments, most patients requested a pause following the screening process. 
The reason for the pause was because patients frequently found the screening 
distressing and a number reported that this was the first time that they had been 
asked to discuss such intimate and painful experiences. In all cases however, 
assessment was completed within 3 weeks of the screening. The researcher 
assessed each patient with both Gold standards whether or not they met the 
criteria for trauma and PTSD/CPTSD as defined in BTERS. Checking against a gold 
standard was completed in order to facilitate a determination of reliability or 
Construct validity. The researcher was blind to the outcome of 10 (5 clinician and 
5 patient) of the (N=13) pilot screens at the point at which she assessed these 
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5.6.1 Impact on Interviewers (Vicarious Traumatisation)  
Precautions adopted for managing vicarious traumatisation (section 3.6.3) 
included the following:  
 An initial presentation reminding clinicians about the risks and precautions 
 Weekly peer supervision, joining group treatment and supervision sessions 
 Making sure researcher is available during recruitment of clinicians 
 Researcher available almost every day for consultation 
 Researcher available for discussions and debriefing 
 Looking for signs of vicarious traumatisation 
 Clinical supervision also assisted the researcher who is a trauma clinician 
5.7 Accuracy of Pilot – Construct Validity (E) 
Construct Validity includes Diagnostic Accuracy which is an indication of how 
accurate BTERS (the Index Test) is at detecting traumatic experiences and the 
symptoms of PTSD/CPTSD when compared to the reference or gold standard 
(Reference Test).  The most relevant terms used for assessing accuracy are: 
sensitivity, specificity; positive and negative predictive values, positive and 
negative likelihood ratios, diagnostic odd ratios, and receiver operating 
characteristics (ROC) curve. 
 Sensitivity is the probability that someone who scores positive to CAPS, SIDES 
or to either CAPS or SIDES will have tested positive to BTERS, i.e., true positive 
 Specificity is the probability that someone who scores negative to CAPS, SIDES 
or either will also have tested negative to BTERS, i.e., true negative 
 The probability that someone with a positive BTERS will meet the criteria for 
PTSD/CPTSD, and that someone with a negative test will not receive the 
diagnosis of PTSD/CPTSD are respectively the positive and negative predictive 
power of BTERS (PPV/NPV) 
 False positives and false negatives are also calculated. 
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 Figure 5-3 Pilot outcome, BTERS vs. CAPS/SIDES 
 
 
Table 5-5 Pilot Accuracy 











PTSD 100% 22% 36% 100% 78% 0% 46% 
CPTSD 100% 55% 29% 100% 45% 0% 62% 
PTSD and/ 
or CPTSD 
100% 22% 36% 100% 78% 0% 46% 
The charts and table above show that when compared to either the gold 
standards, BTERS from the Pilot over-predicted both PTSD and CPTSD. Although 




























  Page 145 
high false positive (very low specificity of 22% to 55%) results give unacceptable 
accuracy figures (46% to 62%).  
5.8 Changes following Pilot – Face & Content Validity Enhancement 
To enhance face and content validity, both patients and clinicians provided 
feedback about their experience during the screening, including the instructions 
given before the test, the items, item structure, and response options. Patients 
responded well to the order of the questions. They reported that they understood 
the questions and did not find the screening to be too intrusive. However, they 
also reported that the initial BTERS instruction was too abrupt, and the distinction 
between BPD and CPTSD was not clearly laid out. Both patients and clinicians were 
satisfied with the ‘Yes’ or ‘No’ response format, as this gave them a sense of 
control that they appreciated, not requiring them to discuss their past if they felt 
unable to do so. Some of the forms completed by patients themselves (N=3) were 
incomplete, these patients did not answer the question on the nature of the 
relationships of their abuser and as to whether they were still around. This did not 
affect the objective of BTERS which is to identify trauma, PTSD and CPTSD, 
therefore all three were included in the analysis. On these occasions, there was 
sufficient information to be able to make a PTSD/CPTSD assignment appropriately. 
Nevertheless based on this finding, it was recommended that on future occasions, 
forms must be completed by a qualified clinician. 
Clinicians also reported that they appreciated the order of the questions which 
they found to be consistent with the clinical diagnosis. They requested more 
explanation of which experiences are defined as traumatic in DSM and ICD criteria 
and which are not. This was because they wanted the opportunity to record other 
traumatic experiences, since some of these were triggering the same responses as 
the (DSM and ICD) ‘Criteria-A’s. The clinicians requested an accompanying Scoring 
Sheet (APPENDIX 26 ) in order to align the replies from patients more closely with 
the elements of the disorders as defined in DSM-IV and ICD, and to reduce the 
subjective element in interpretations. Another finding was the need to ensure that 
a clinician should always conduct the screening interview, as some patients did 
not answer all the questions. There were also a few occasions when clinicians were 
reluctant to follow through with what they felt was intrusive questioning for 
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patients who were successfully handling their current BPD treatment. In addition, 
it was noted that questions relating specifically to each disorder were not placed 
clearly together, and BTERS would therefore benefit from more definite 
demarcation. The clinicians also identified aspects of the construct that were not 
adequately covered.  
Subsequently, with additional input from the Steering Group, while no items were 
eliminated, the following changes were made to BTERS in order to enhance face 
and content validity, while ensuring that the construct was not compromised: 
 Clearer examples of which type of abuse related to each condition  
 Examples of what was life-threatening trauma were given for clarity 
 More direct and short questions with wording and phrasing selected to 
minimise ambiguity  
 The order of the items was altered to introduce difficult questions gently and 
to keep items together as defined in the domain of the construct 
 Traumatic experiences were grouped in a hierarchical order according to 
severity 
 Items are scored dichotomously i.e. each question is answered with either 
‘yes’ or ‘no’ 
 The screen was divided into sections highlighting the screening of three 
separate disorders in a single instrument  
 The diagnosis was removed from the form, and an additional Scoring Sheet 
was added 
 A simple scoring sheet (APPENDIX 26 was required in order to foster 
consistency in the assignment of disorders.  
On the basis of the face, content and an initial construct validity enhancement, the 
full test version of the instrument was developed. A number (N=10) of experts 
were then requested to assess the relevance of the items in the revised screen. 
These experts included BPD clinicians, trauma clinicians, and the Project 
Supervisors. They were requested to assign a yes/no answer to the relevance of 
each of the items. Although various attempts to apply weightings were made, this 
particular test did not prove to be helpful and had to be abandoned. The data, 
including the scoring mechanism, are shown in APPENDIX 27 . The optimised 
instrument was then presented to some 50 clinicians who work with BPD, PTSD 
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and CPTSD patients. Their support for the revised instrument to be utilised for the 
main study was unanimous and they requested no further revisions. 
5.9 Main BTERS Reliability Trial Methodology 
The updated version of the instrument was then used to systematically screen the 
remaining (N=27) patients. In addition, all the patients from the pilot (N=13) were 
rescreened. And again all were then scored by an independent researcher (blind 
to the patients’ identity). As with the Pilot section, all patients were also given an 
in-depth PTSD/CPTSD assessment by the researcher. Following the request by the 
original pilot participants who felt that it was too stressful to follow BTERS 
immediately with CAPS/SIDES, the new patients were specifically offered the 
option for the CAPS/SIDES assessment to be done on another day (between one 
and three weeks later). To assist with reliability, (N=20) patients were re-tested. 
These patients were selected on the basis of clinical and logistical circumstances. 
These patients who were initially tested by a clinician where now retested by the 
researcher, and were scored by a separate researcher blind to the patients’ 
identity. All of the screening and scored data is presented in APPENDIX 28 . The 
diagram below illustrates the flow of the reliability study.  
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Figure 5-4 BTERS Reliability Flow Diagram  
 
The principal outcome of the main study is an assessment of Construct Validity, 
which is the degree to which BTERS measures what it claims to measure. Although 
results must be accurate, they must also be reliable (repeatable), and overall 
quality control must be ensured. Two aspects of reliability are commonly used and 
were employed in this study, external and internal; both were used to examine 
the reliability of BTERS. Nasrin (2009) describes reliability as the ability of an 
instrument to consistently measure an attribute and how well the items fit 
together conceptually. Good research techniques entail commenting on the 
reliability of these measurements, that is, the consistency of test results on repeat 
measurements. For external reliability, repeatability tests were employed. These 
consisted of test-retest and inter-rater examinations. 
Good reliability refers to the consistency of the results and conclusions drawn 
from the study (Gosall, p.61, 2009). Although reliability is necessary, it is not 
sufficient to validate an instrument, because an instrument may be reliable but 
not valid (Nasrin, 2009). Cronbach and Shavelson (2004) suggested that 
researchers should also consider the following issues when determining reliability: 
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 Independence of sampling 
 Heterogeneity of content 
 How the instrument is used (Nasrin, 2009) 
These issues are addressed in detail in the quality section (STARD, APPENDIX 29 ). 
Two techniques were then utilised for assessing the repeatability of BTERS. One 
was an inter-rater test, where two raters (clinician and researcher) separately 
scored the outcome of each BTERS screening. The second was a retest (Test Re-
test), where the initial screening by a practicing clinician was followed by 
researcher rescreening so that the so that the level of agreement between the 
initial results and the retest results can be assessed (Gosall and Gosall, 2009). For 
the test re-test exercise it was not possible to include any of the patients involved 
in the Pilot study as they had already participated in two screening interviews, and 
an additional interview could have created unnecessary stress. Similarly, several 
other patients were not available due to hospital logistics such as over running 
treatment sessions and hospital transport not being able to wait. Overall, N=20 
patients were re-tested. Both test-retest and inter-rater reliability can be 
quantified by a correlation coefficient (Cohen’s Kappa). Kappa (κ) coefficient is 
recommended for tests that measure categorical variables or nominal ordered 
data and it is weighted to allow for any near misses.  
Kappa is also known as the ‘chance correlated proportional agreement statistic’ 
that accounts for measurements that can be agreed by chance. It indicates 
whether this agreement is more than can be expected by chance. If the agreement 
is no more than can be expected by chance κ=0, with a perfect agreement κ=1 
(Gosall and Gosall, 2009, p.61). 
Internal consistency reliability or internal reliability is a test of the Validity of the 
Construct as previously discussed in section 3.7. It asks if the responses to the 
items are consistent across the construct (Creswell, 2003). Thus, while content 
validity was calculated before the pilot test by asking experts to judge the 23 items, 
the internal reliability of the items was re-evaluated using the actual responses of 
the (N=40) participants. This particular test was performed by analysing how each 
patient responded in the main study to each of the questions in BTERS. It 
determines how well the set of questions in BTERS represents the construct that 
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the instrument is supposed to be testing or how well the items fit together 
conceptually (Nasrin, 2009). Internal consistency was then evaluated numerically 
using the Chronbach’s Alpha coefficient, used because it is the most suitable when 
there are several variables in the measurement. In the case of dichotomous 
responses, this can also be called a Kuder Richardson test. If α > 0.5, there is a 
moderate agreement, and if > 0.8 there is a good agreement. 
5.10 Stage 2 Results 
Of the Stage 2 (N=40) patients, BTERS identified 15 (38%) with PTSD 
symptomatology and 8 (20%) with CPTSD. This compared with 40% and 23% 
respectively for CAPS and SIDES. The numbers of patients showing PTSD and 
CPTSD as identified by BTERS were compared with the gold standards and are 
displayed in the table below. Also shown are the BPD patients (52.5 %) who did 
not experience life-threatening trauma, but who reported that their particular 
traumatic experiences, mainly (45%) in childhood, were nonetheless highly 
distressing. 
Table 5-6  Patients Satisfying PTSD/CPTSD Symptoms 
N=40  Screen (BTERS) Assessment (CAPS, SIDES) 
PTSD 15 38% 16 40% 
CPTSD 8 20% 9 23% 
PTSD and/or CPTSD 18 45% 16 40% 
Life-threatening trauma 19 47.5% 16 40% 
Non-life-threatening 
Trauma (only) 
21 52.5%   
 
Accuracy and efficiency calculated by the test performance indicators of 
sensitivity, specificity, positive and negative predictive values, as well as false 
positives and negatives, are shown below (format from Gosall and Gosall, 2009, 
p.133; Brewin et al., 2002). 
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PTSD 81% 92% 87% 88% 8% 19% 88% 
CPTSD 89% 100% 100% 97% 0% 11% 98% 
PTSD and 
or CPTSD 
100% 96% 94% 100% 4% 0% 98% 
. 
Table 5-8 Means, Standard Deviations and 95% Confidence Interval: PTSD and 
CPTSD 
Study PTSD CPTSD 
  Mean SD 95% CI Mean SD 95% CI 
Stage 2 BTERS Screen 38% 49% 15% 20% 41% 13% 
Stage 2 DSM 
Standards 
40% 50% 15% 23% 42% 13% 
 
Accuracy (see section 5.7) was thus calculated as 88% for PTSD and 98% both for 
CPTSD on its own and for when a patient has either of both of the disorders. This 
also shows the trade-off between sensitivity and specificity (any increase in 
sensitivity will be accompanied by a decrease in specificity). 
Table 5-9 Criteria-A Trauma Range based on 95% Confidence 
Criteria-A Trauma Gold Standards BTERS 
95% Confidence Interval Range Numbers Range Numbers 
Minimum expected 25% 10 32% 13 
Expected value (mean) 40% 16 45% 18 
Maximum expected 55% 22 58% 23 
 
The above table thus shows the statistical analysis of the stage 2 data. Here there 
is a 95% probability between 25% and 55% of BPD patients in any future 
experiment will satisfy a diagnosis of PTSD or CPTSD based on CAPS and SIDES. At 
the same time we are also 95% confident that BTERS will screen between 32% and 
58% the same BPD patients as suitable for PTSD or CPTSD assessment. Thus, we 
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are 95% confident that BTERS will identify a range of Criteria-A Trauma amongst 
BPD patients similar to the gold standards. Of greater significance perhaps, is that 
the range for BTERS falls within the overall 95% confidence range of the published 
empirical studies.  
Sensitivity and specificity values were then supplemented by estimating the value 
under the ROC curve (AUC) where a value close to 1.0 confirms a high level of 
accuracy, which is a quality cross-check that was established using the standard 
parameters as recommended in SPSS (version 19). 
ROC identifies the points of maximum sensitivity and specificity with respect to 
predisposing traumatic experiences and its accompanying post trauma reactions 
(AUDIT, Barbor et al., 2001). ROC was originally developed from signal detection 
theory and has only recently been applied in psychiatric research (Slade et al., 
1998 p.85). In this case, it plots the proportion of individuals classified by BTERS 
and this plot thus represents the ability of the test to discriminate between those 
with and those without PTSD/CPTSD. The resulting curve which in this case is a line 
based on three points is called the Receiver Operating Curve (ROC). The area under 
the ROC curve (AUC) summarises the ability of the test instrument to discriminate. 
The computer program SPSS was used to calculate the (AUC) and the confidence 
intervals around this value to ensure that they were acceptable. 





PTSD .865 .734 .995 
CPTSD .984 .948 1.000 
PTSD AND OR CPTSD .984 .948 1.000 
 
These figures calculated by SPSS compare well with a value greater than 0.5, which 
can be considered a poor match, and 1.0 for a perfect match. AUC values were 
also plotted below, and the values are equivalent to the calculations in the above 
Table. 
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Figure 5-5 ROC PTSD and/or CPTSD  
 
Internal Consistency estimated by Cronbach Alpha as calculated for both PTSD and 
CPTSD was 0.80. Alpha increased to 0.91 and 0.89 respectively when only 4 of the 
23 items were considered. These 4 were: life-threatening trauma, sexual abuse, 
flashbacks and nightmares.  
The repeatability results of the test-retest and the inter-rater reliability analysis 
are shown below, where a Cohen’s kappa of 0.8 or higher defines an acceptable 
match (Gosall and Gosall, 2009, p.61). 
Table 5-11  Repeatability Results 
Cohen’s κ PTSD CPTSD PTSD and/or CPTSD 
Test-retest .80 .86 1.00 
Inter-rater .95 1.00 .95 
 
The performance of BTERS was also evaluated against the 25 STARD criteria for 
appraising the validity, effectiveness and appropriateness of a screening 
programme, and the results are shown in APPENDIX 29 . 
5.11 Stage 2 Limitations 















PTSD CPTSD PTSD and/or CPTSD
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Table 5-12 Limitations 
Bias Limitation Impact 
Admission; 
Recruitment 
Due to the limited numbers of 
available BPD patients, all (N=63) 
current patients were invited to 
participate 
Thus admission bias was not 
an issue for this project as 




The BPD sample from the hospital 
may not meet the DSM BPD 
criteria 
The BPD group was 
determined by hospital 
processes, not recruited by 
the project, and therefore was 
not influenced by the research 
objectives  
Attrition  It is possible that some patients 
may have excluded themselves 
because they fear the stresses 
involved in addressing historical 
traumas 
Again this possible exclusion 
would tend to lead to an 
underestimation of potential 
trauma patients 
Sample size N=40 may be too small to prove 
that BTERS will consistently 
identify CPTSD/PTSD 
95% confidence interval 
calculations (Fig 5.8) shows 
sample is within range of 
empirical studies for either/or 
PTSD/CPTSD, but range is too 
wide to confirm exact 
percentages for individual 
disorders with confidence  
Interviewer 
bias 
The researcher scored both the 
retest (N=20) and the assessment, 
therefore these results may be 
influenced by previous knowledge 
This potential bias may cause 
accuracy figures to be lower 
than those calculated 
Response bias Some patients may be over keen 
to present additional clinical 
conditions in order to seek 
attention 
Such a risk is equally likely for 
any assessment, and thus 




Optimum information may not 
have been obtained from 
participating experts 
BTERS may not be fully 
optimised 
The overall research limitations are again considered in the Conclusions section 
where a comparison is made with stage 1 results and with findings from published 
academic and clinical literature.  
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5.12 Unanticipated Clinical Finding 
The majority of BPD patients (52.5%, N=21) did not experience life-threatening 
trauma, yet all BPD patients reported that their particular (life-threatening or non-
life-threatening) traumatic experiences, particularly in childhood (45%, N=18), 
were nonetheless highly distressing.   
 
Non-life-threatening trauma symptoms include intrusions, avoidance and arousal, 
and are PTSD-like symptoms. A number of patients with such non-Criteria-A 
trauma (N=13) reported many of the CPTSD (PTSD) cluster symptoms required as 
per DSM (IV and 5):  
 Intrusions in the form of highly distressing unwanted memories, images and 
nightmares all associated with the stressful events (5% experienced 
flashbacks) 
 Avoidance  
 Alterations in arousal and reactivity  
 Negative alterations in cognition and mood. 
Although this particular finding was not initially anticipated, it is supported by an 
assessment of psychopathology and exposure to traumatic events where 
individuals who were exposed to non-Criteria-A trauma reported the same 
amount of overall distress as those exposed to Criteria-A trauma (Gold et al., 
p.263, 2005). The traumas listed by these authors included threats to personal 
integrity, learning about an unexpected or violent death, or the unexpected death 
or injury of a family member or other close associates. Although both Criteria-A 
and non-Criteria-A experiences can elicit symptoms of PTSD and PTSD-like 
symptoms, the two groups differ to some degree with respect to re-experiencing 
symptomatology. Stage 2 patient interviews indicated experiences reported as 
non-Criteria-A, such as bullying, inappropriate touching of sexual parts, family and 
relationship problems. These appeared to be linked with thought processes such 
as intense and chronic rumination, reflection, selective attention, irritable and 
startled; and these are similar to re-experiencing symptoms such as intrusive 
thoughts, and hyper-arousal. 
Whereas such a category may be seen as somewhat new in a BPD environment, it 
is clinically equivalent to Adjustment Disorder (discussed in section 1.5.2), which 
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is a well-established psychological condition, although not common in a clinical 
environment. Allowing for two separate trauma categories can, however, avoid 
the controversy of either widening or restricting the definition of a traumatic 
stressor. And while Adjustment Disorder places strong emphasis on symptoms, it 
also considers how patients perceive the impact of trauma. When these results 
were presented to BPD Management and clinicians, the initial feedback about 
incorporating such findings into treatment was positive. 
5.13 Reliability Study Discussions  
While showing encouraging true positives and negatives for PTSD and CPTSD in 
comparison with the gold standards (accuracy 88% - 98%, sensitivity - 81% and 
89%, and specificity - 92% and 100%), the false negative results (19% and 11%) 
mean that if the screen is utilised as an alternative to a full gold standard 
assessment, up to one case in five may be missed. BTERS of course was never 
designed as an alternative to CAPS or SIDES for diagnosing PTSD or CPTSD, and 
these results confirm that it is not suitable for this purpose. The effectiveness of 
correctly identifying either PTSD and/or CPTSD is therefore also assessed and 
presented, which shows a greater level of agreement with the gold standards. 
Thus if BTERS is used to determine if a patient has either PTSD, CPTSD or both, true 
positives and negatives are over 95% with no false negatives. To support this, 
reliability results as calculated by Cohen’s Kappa (Table 5-9) are considered 
acceptable by statistical standards. The Cronbach Alpha test (α=0.8) confirmed 
that the optimised 16 questions in BTERS provides an acceptable level of internal 
consistency for the detection of PTSD/CPTSD. The analysis also indicated that 
reducing the number of questions from 16 to just 4 questions covering life-
threatening trauma and sexual abuse, plus flashbacks and nightmares, would 
actually increase the internal consistency (α=0.9) for PTSD/CPTSD detection. 
However, in order to optimise the screen for non-Criteria-A trauma, items must 
be specifically identified that single out non-life-threatening trauma. So in order 
to identify items that satisfy tests for internal consistency of non-threatening 
trauma, additional internal consistency testing could be undertaken. Therefore, 
the full range of 16 questions in BTERS was appropriate for the requirement, i.e. 
to identify all trauma, BPD, PTSD and CPTSD. 
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Out of the (N=40) BPD patients, there are 3 patients where BTERS identified 
CPTSD, but in each of these 3 patients, BTERS did not support a PTSD referral. For 
each of these three patients, CAPS assigned PTSD whenever CPTSD is diagnosed, 
because according to the DSM definition, CPTSD can only occur if PTSD is present. 
As CAPS/SIDES are considered the gold standards, all 3 BTERS cases were assigned 
as ‘false’ results, which is consistent with accepted DSM theory. Nevertheless, 
DSM theory could be challenged, possibly allowing CPTSD to be assigned without 
the strict criteria-A trauma requirement. In each of these cases, the possibility of 
a CPTSD diagnosis without PTSD is currently being considered by the relevant 
clinical specialists. It should be made clear however that this research does not 
seek to make such a proposal.  
5.13.1 Adjustment Disorder 
Many of the problems facing those who suffer from non-Criteria-A trauma are 
quite similar to those associated with Criteria-A trauma, including substance 
dependence and suicidal behaviour. It is therefore possible that individuals who 
have been subjected to non-Criteria-A trauma (or can be identified as having 
Adjustment Disorder), should also be able to benefit from an exposure therapy 
such as Prolonged Exposure (PE) Psychotherapy, which currently appears to be 
available only to PTSD patients. 
However, in order to make this proposal clinically effective, the PTSD patients who 
require specialist attention first need to be separated or identified. Using a simple 
trauma screening instrument such as BTERS, BPD clinicians can thus confidently 
identify non-Criteria-A trauma and its symptoms, and they could categorise such 
individuals as also suffering from Adjustment Disorder. Early screening also allows 
clinicians to progress all relevant treatment without having to wait for specialist 
trauma assessment for all patients with the symptoms of post trauma reactions. 
An additional concern noted during the trauma-focused screening was that 
patients who were not assigned a PTSD/CPTSD result felt somewhat undervalued 
when their particular distressing trauma was not assigned a prominent 
categorisation, a situation that often made them feel abandoned, as with the 
‘early abandonment’ criteria. Assigning a valid clinical label such as Adjustment 
Disorder, with its specific and recognised treatment options, can help vulnerable 
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and sensitive BPD patients to feel more included, enhancing therapeutic 
relationships. This helps them personally recognise and address all the difficult 
psychological conditions as an integral part of their personalised BPD treatment.  
The symptoms of an adjustment disorder included anxiety, worry, poor 
concentration, irritability, automatic arousal such as palpitations and depression. 
There may also be outbursts of dramatic or aggressive behaviour, single or 
repeated episodes of deliberate self-harm, or the abuse of alcohol or drugs. 
Usually, social functioning is impaired. The onset is gradual and the course 
becomes prolonged. Stressful life events may precipitate anxiety, depression, and 
other psychiatric disorders.  
5.13.1.1 Adjustment Disorder Criteria 
According to both DSM and ICD the symptoms generally start within three months 
of the stressing event. 
The development of emotional or behavioural symptoms in response to identifiable 
stress(es) occurring within 3 months of the onset of the stressor; 
These symptoms or behaviours are clinically significant, as evidenced by one or 
both of the following: 
A. Marked distress that is out of proportion with the severity or intensity of the 
stressor, taking into account the external context and the cultural factors that 
might influence symptom severity and presentation; 
B. Significant impairment in social, occupational or other important areas of 
functioning. 
The stress-related disturbance does not meet the criteria for another mental 
disorder and is not merely an exacerbation of a pre-existing mental disorder; 
The symptoms do not correspond to normal bereavement; 
Once the stressor or its consequence have terminated, the symptoms do not persist 
for more than a further 6 months. 
5.13.1.2 Aetiology  
Stressful circumstances are a necessary cause of an adjustment disorder, but 
individual vulnerability must be an important cause because not all people 
exposed to the same stressful circumstances develop an adjustment disorder. 
Although no systematic studies on prognosis have been carried out, Gelder et al., 
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(2012) suggests that most adjustment disorders last several months and a few 
persist for years. Adjustment disorder is thus classified as either acute or chronic, 
depending on whether it lasts more or less than six months.  According to DSM-
IV-TR and DMS-5, if the disorder lasts less than six months then it can be acute, 
but if it lasts more than six months then it must be considered chronic (Casey, 
2001). The presence of a causal stressor is essential before a diagnosis of 
adjustment disorder can be made, and those exposed to repeated trauma are at 
greater risk, even if that trauma is in the distant past (Bisson and Sakhuja, 2006). 
5.13.1.3 Differential Diagnosis 
The distinction between an adjustment disorder response and a normal stress 
response is based on the severity of symptoms and their duration, where the 
impact on everyday functioning is related to the nature of the stressor and how it 
is perceived. PTSD, with its very specific constellation of symptoms, requires the 
presence of a high magnitude stressor that would be traumatic for almost 
everybody. Not everybody exposed to such a traumatic event, however, responds 
by developing PTSD, and the possibility that other disorders can follow instead 
needs to be considered. For those not meeting the diagnostic criteria for PTSD, 
but with significant symptoms and/or functional impairment, Rosen suggests that 
Adjustment Disorder should be considered as a practical alternative (Rosen et al., 
2008, cited in Gelder et al., 2012). 
5.13.1.4 Treatment 
Adjustment Disorder treatment is designed to help with the resolution of the 
causal stressor problems if at all possible, but also to aid the natural process of 
adjustment by reducing avoidance of the stressful events, reducing maladaptive 
coping responses and encouraging problem solving. Counselling in problem-
solving can encourage patients to seek solutions and to consider the advantages 
and disadvantages of various kinds of actions (Gelder et al., 2012). The evidence 
base for the treatment of Adjustment Disorders is limited due to paucity of 
studies. A further problem is that the disorder is to a large extent a self–remitting 
condition, so that it may be hard to distinguish between the results of intervention 
and spontaneous resolution. However both this current study and Gold et al. have 
shown that effects can be long-lasting and debilitating. Three specific 
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psychological therapies, spanning the range of supportive, psycho-educational, 
cognitive and psychodynamic approaches, have been found to ameliorate 
Adjustment Disorder symptoms.  
 Dialectic Behaviour Therapy (DBT) for example has been found to be beneficial 
to patients who engage in deliberate self-harm. The effectiveness of DBT was 
confirmed following two years of randomised controlled trials, which 
compared DBT with therapy by experts specialising in suicidal behaviour 
(Linehan, 2006) 
 Cognitive Behaviour Therapy (CBT) was also shown to be helpful when 
administered to patients with adjustment disorder who experience work 
related stress (National Child Traumatic Stress Network, 2003) 
 Prolonged Exposure (PE) Psychotherapy is designed to reduce psychological 
fear where patients intentionally address fear in otherwise safe objects, 
situations, thoughts sensations and memories. The goal is to reduce fear and 
other negative reactions to similar stimuli in the future (Foa, 2011). 
5.14 Comparison of Stage 2 with Stage 1 Results 
The stage 2 PTSD/BPD comorbidity rate of 40% is considerable higher than the 
16% interpreted from patients’ medical records in stage 1.  
 
Figure 5-6  Results Comparison for Stages 1 and 2 
In order to validate a comparison of the results between stages 1 and 2, a 
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Table 5-13  Methodology Comparison Stages 1 & 2 
 Stage 1 (N=60) Stage 2 (N=40) 
Location 3 hospitals 1 hospital  
Sample 
Selection 
Existing BPD Patients 
Medical Records  
Current and new BPD patients 
(not same as stage 1) 
Assessment 
Technique 




Interviews utilising new 1 page 
(BTERS) structured screen then 
followed by CAPS/SIDES  
Assessors BPD Clinicians’ records 
analysed by Researcher  
BTERS by Clinicians, CAPS/SIDES by 
Researcher 
 
5.15 Comparison of Stage 1 and 2 with other Empirical Studies 
As shown below, stage 2 with its combination of life-threatening and non-life-
threatening trauma, compares more closely than stage 1 with the overall trauma 
records. Levels of PTSD and CPTSD are higher than stage 1 and are in line with the 
mean and standard deviations of the other studies.  
Table 5-14 Results Comparison 
Study Trauma PTSD CPTSD 
  Mean SD Mean SD Mean SD 
Empirical Studies 89% 12% 45% 17% 31% N/A 
Stage 1 Diagnosis N/A N/A 3.3% 18% 1.7% 13% 
Stage 1 Analysis 47% 50% 17% 38% 13% 34% 
Stage 2 BTERS Screen 100% N/A 38% 49% 20% 41% 
Stage 2 DSM Standards N/A N/A 40% 50% 23% 42% 
 
95% confidence intervals were estimated and results plotted below. This 
calculation utilises the standard deviations and the sample size so that a range of 
results from stages 1 and 2 can be compared with previously published empirical 
results. 
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Figure 5-7 Comparison of Empirical Studies with Stages 1, 2 
 
The error calculations show that the stage 2 results for both BTERS and CAPS/SIDES 
are consistent with the mean results from empirical studies, although stage 1 
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5.16 Stage 2 Conclusions 
Referring back to the specific stage 2 objectives identified in the chapter 
introduction, the table below summarises the quantitative results. 
Table 5-15 Stage 2 Conclusions 
No Specific Stage 2 Objectives Conclusions 
1 
Establish the % of patients with 
criteria for in-depth trauma 
assessment and treatment in BPD.  
 
Identify and specify the type of 
trauma experienced by BPD 
patients. 
100% (N=40) of the BPD patients 
interviewed identified significant 
traumatic experiences, 92.5% 
(N=37) in childhood. 
47.5% (N=19) were life-
threatening. 
52.5% (N=21) non-life-threatening. 
2 
Detect PTSD/CPTSD in BPD patients 
using gold-standard clinical 
instruments. 
 
Compare % of Trauma, PTSD, 
CPTSD identified with stage 1 
results and with literature 
40% of BPD patients satisfied 
PTSD/CPTSD requirements based 
on CAPS/SIDES. 
PTSD-BPD comorbidity: 25% 
(Golier) to 39% to 50% (Harned), 
and 16% had PTSD and/or CPTSD 
symptoms based on an 
interpretation of patients’ notes. 
3 
Establish the extent of BPD over-
diagnosis.  
High comorbidity PTSD/CPTSD is 
consistent with over-diagnosis of 
BPD 
4 
Develop and trial a trauma 
screening instrument for clinicians 
to discriminate BPD with possible 
PTSD/CPTSD. 
BTERS field testing confirmed 
PTSD/CPTSD in agreement with 
gold standards CAPS/SIDES (98% 
accuracy). 
 
Stage 2 did not address the misdiagnosis of BPD as this was adequately discussed 
in stage 1; however, stage 2 results confirm that the opportunity to treat comorbid 
PTSD/CPTSD in almost half of the BPD patients is being missed.  
The numerical results of the stage 2 tests have identified that BTERS could be a 
useful instrument for identifying trauma in BPD patient presentations, and in 





  Page 165 
6 DISCUSSION  
6.1 Introduction 
The overall project research question was: 
Can trauma screening optimise the identification of traumatic 
experiences/PTSD/CPTSD in patients with BPD, and resolve the 
misdiagnosis of BPD controversy?   
The research question was addressed by four sub questions. These sub questions 
were derived by breaking down the overall question.  They were designed not only 
to establish the facts in a systematic manner, but also to find and test a 
contribution to the solution to the misdiagnosis controversy. Findings are 
synthesised by discussing the results from literature together with the results from 
stage 1 (BPD Patient Medical Records Review, N=60 and clinician interviews), and 
also from stage 2 where BPD patients from one hospital (N=40) were screened for 
trauma/PTSD/CPTSD using a newly developed ‘BPD Traumatic Experiences and 
Reactions Screen’ (BTERS), plus a full PTSD/CPTSD assessment according to DSM 
standards (CAPS and SIDES). The additional (5th) finding relating to the application 
of Adjustment Disorder for non-life-threatening trauma is also discussed. The 
principal findings are first listed below, and are then discussed in detail, before 
being presented in a summary which forms a conclusion to the research. 
• Consistent with previous empirical studies, a high proportion of BPD patients 
in this study were found to suffer from at least one highly distressing traumatic 
experience 
• A significant proportion of these patients also meet a comorbid diagnosis of 
PTSD and or CPTSD/DESNOS which is in line with generally, though not 
universally accepted, academic knowledge. For these patients therapies are 
available which improve outcome 
• BPD is over-diagnosed, rather than misdiagnosed as interviewed BPD clinicians 
are reluctant to ask about trauma due to fear of triggering reactions for which 
they are not trained. Diagnosing BPD with less than the recommended number 
of criteria from the DSM/ICD diagnostic manuals was found to be an accepted 
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practice, not only in this study, but also in a wide-ranging US survey of BPD 
clinicians 
• The BTERS short screening instrument, although based on the results using a 
small sample, has reliably identified trauma and rapidly discriminated which 
BPD patients are suitable for specialised PTSD/CPTSD trauma focused 
treatment 
• Almost half of interviewed patients suffer from only non-life-threatening 
traumatic experiences, a condition consistent with Adjustment Disorder, and 
treatable by simple trauma treatment techniques by BPD clinicians without 
PTSD/CPTSD specialist trauma training  
 A dedicated section then draws together the overall limitations to the project 
along with advantages and strengths. These were confirmed by both patient and 
clinician feedback as well as academic and clinical peer reviews, and the section 
also includes a review of the effectiveness of the Research Structure and Design. 
Implications and recommendations are then drawn together and discussed in 
terms of clinical, research recommendations and recommendations for the screen 
itself. Finally, the implications of the findings and recommendations for 
enhancements to clinical practice and for further research are discussed. This is 
followed by highlighting the unique contributions to academic knowledge. 
6.2 Discussing the Research Findings  
This study has demonstrated that from the BPD patients whose records were 
reviewed in stage 1, and from those screened and interviewed in stage 2, a high 
proportion have had at least one highly distressing traumatic experience, either 
life-threatening or non-life-threatening. Trauma was recorded on 47% of BPD 
patients’ records, and 100% (N=40) of stage 2 patients screened and interviewed 
had some traumatic experience. While the link between trauma and BPD has been 
previously demonstrated (section 1.6.2), there are also a number of equally 
relevant biological and environmental causes of BPD. Marsha Linehan (1997) 
presented the Bio-Psychosocial Model of BPD, and according to this theory, BPD 
arises from a combination of biologically based difficulties in the processing of 
emotions and specific environmental circumstances as well as their transaction. 
The biological components in this model arise from a combination of genetic 
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vulnerability, intra-uterine and developmental factors affecting physiological 
development. The environmental (which she terms invalidating) contributors can 
be any circumstance involving neglect, such as emotional withdrawal by a carer,  
psychological trauma such as sexual abuse,  or severe punishment. The outcome 
of combined biological vulnerability to emotions, an invalidating environment and 
adverse childhood events is thus seen as a fundamental disruption of the 
emotional regulation system and the development of BPD. More than 9 separate 
empirical studies (section 2.2.2) reported that between 70% and 100% of BPD 
patients have experienced distressing trauma, supporting evidence for the high 
percentage of trauma in BPD. These studies range from a limited inpatient study 
by Famularo, Kinscherff, and Fenton (1991) to a recent large-scale US longitudinal 
national study of BPD in the community by Pagura et al. (2010), and Grant et al. 
(2008). It is worth noting however that the impact of trauma could have been 
exaggerated in these studies because sampling often encouraged the inclusion of 
patients with existing trauma. In stage 2 of the current study where 100% (N=40) 
experienced trauma, of which 92.5% (N=37) identified specific distressing 
traumatic experiences in their life before the age of 13. While such a level of 
trauma may appear to be high, it was confirmed that the type of trauma 
encountered consisted of a combination of life-threatening (47.5%) and non-life-
threatening (45%) childhood trauma.  
On the other hand, the relatively low recording of all references to both life-
threatening and non-life-threatening trauma (47%) in patient records by BPD 
clinicians in stage 1 was explained by the BPD clinicians themselves, who reported 
that discussing trauma, particularly childhood trauma, with patients was a 
daunting experience, as they felt that they did not have the skills to manage the 
life-threatening trauma typical of PTSD that they anticipated would emerge during 
the assessment process. Avoidance of alternative diagnosis by BPD clinicians was 
also noted by Whealin and Stone (2009), and by Westen (1997) in his wide survey 
of BPD practitioners in the US.  
However, direct mathematical comparisons between the various trauma 
percentages recorded can be problematic, not only because the clinical 
significance of these traumatic experiences has not been consistently recorded in 
the literature, but also because, if individual research projects were investigating 
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trauma, this has the potential to bias the sampling and assessment process. This 
is especially true when findings have to rely on memory, which can be influenced 
by expected outcomes.  
Nonetheless, the evidence found both in literature and in the current investigation 
strongly supports the hypothesis that a high proportion of BPD patients have had 
distressing traumatic experiences. Although BPD was originally defined in terms of 
presenting symptoms, trauma has been identified by many authors (such as 
Herman, Perry, and van der Kolk, 1989; Gunderson and Sabo, 1993 and DSM-5) as 
one of many equally relevant biological and other environmental causes such as 
attachment processes gone awry. This finding is valuable because addressing 
trauma during treatment has proven to be beneficial in promoting long term 
remission and improvement in prognosis of BPD (Shea et al., 1997). This study has, 
however, demonstrated in addition that, from a treatment perspective, non-life-
threatening trauma, as well as life-threatening trauma as defined by DSM, can be 
highly distressing and have a significant long-term impact.  
The second finding from the study supports the notion that a high proportion of 
patients presently clinically diagnosed with BPD also meet a comorbid diagnosis 
of PTSD and or CPTSD (DESNOS). The low rates in patients’ records are explained 
by the clinician themselves, who revealed that trauma is rarely discussed for fear 
of ‘opening Pandora’s Box’ and disturbing existing treatment with volatile 
reactions to complex traumatic memories. The theoretical link between BPD and 
PTSD/CPTSD (DESNOS) has remained controversial since Herman’s (1992) 
proposal to re-conceptualise BPD as PTSD associated with childhood abuse. This 
re-conceptualisation has not been universally accepted, and Roth et al., (1997) 
have argued that that while there is a large degree of overlap, and on the surface 
these conditions appear to be quite similar, they only partially coincide. It was also 
recommended that clear distinctions be drawn between the disorders, requiring 
separate diagnosis (Haigh, 2003). This distinction was accepted by many Trust 
clinicians during clinical discussions. It is thus left to empirical studies to establish 
the level of comorbidity between BPD and PTSD/CPTSD.  
The comorbid hypothesis is supported by this research, as 40% of the BPD patients 
in stage 2 were confirmed with a PTSD diagnosis by the DSM gold standard (CAPS) 
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whereas a comorbid diagnosis was not previously identified. This percentage is 
consistent with comorbid PTSD in BPD as reported in comparable studies in the 
academic literature (section 2.2.2). These percentages range from 25% reported 
by Golier et al. (2003), to 39% reported in the major US longitudinal study analysed 
by Pagura et al. (2010) and also by Grant et al. (2008). High comorbidity rates of 
PTSD in BPD, ranging from 30% to 50%, are also noted by Harned et al., (2012). 
The lower stage 1 PTSD results (16%) could again be explained by the reluctance 
of BPD clinicians to address life-threatening trauma. While according to Roth et 
al., (1997), there is no direct theoretical link between CPTSD (as opposed to 
classical PTSD) and BPD, CPTSD in stages 1 and 2 (13% and 23%) could be seen as 
comparable with the 31% of inpatients with CPTSD reported by Barnow et al., 
(2005). There is a marked contrast, however, with the less than 4.41% (N=3) of the 
stage 1 patients who were assigned a PTSD or CPTSD diagnosis by the clinicians in 
the BPD clinic. Both stage 1 and 2 results therefore confirm that a significant 
proportion of BPD patients could benefit from PTSD/CPTSD treatment. In practical 
terms, clinical leaders would first need to find a way to systematically introduce 
early trauma screening by practising BPD clinicians. Given the comorbid PTSD 
diagnosis and the reluctance to address potentially difficult memories, a dedicated 
treatment trial with associated trauma screening and assessment may prove 
beneficial in order to fully confirm and promote the benefits of PTSD/CPTSD 
treatment for BPD patients. 
Although the evidence from this study was insufficient to support the hypothesis 
that BPD is misdiagnosis as noted by NICE (2008) and MIND (2007), the high 
comorbid PTSD/CPTSD rates confirmed by CAPS/SIDES in stage 2 identifies under-
diagnosis of BPD-PTSD/CPTSD comorbidity as a significant finding, and arguably an 
over-diagnosis of BPD. The theoretical concept behind the misdiagnosis of BPD 
originates from Herman (1992) and, other trauma specialists such as Vaillant 
(1992). These pioneers have been consistently promoting the adoption of BPD as 
a complex variant of PTSD as an alternative diagnosis. A contrasting explanation is 
that trauma might not be a significant underpinning cause, supporting findings 
from literature that whereas trauma can cause BPD, other causes  such as 
genetic/epigenetic factors and constitutional vulnerabilities, neurophysiological, 
neurobiological and psychosocial can be just as significant (e.g., Zanarini et al., 
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1997). Although approached from a completely different perspective, over-
diagnosis of BPD was explained empirically by Westen (1997) in his examination 
of large scale USA BPD practice. These results were compared against the DSM 
requirements that specify the presence of at least five criteria for BPD. Westen 
found that the practice of diagnosing BPD with less than five DSM recorded 
symptoms was common throughout the US (section 2.3.3.1.3), and that clinicians 
supported BPD diagnosis based on general behaviour and observation during 
interviews. This is supported by the stage 1 BPD patients’ medical records where 
only 12% of patients satisfied this strict DSM criterion for BPD. For ICD-10, a 
minimum of three criteria are recommended, so the BPD percentage would rise 
to 32%. Subsequent discussions with clinicians showed that the required criteria 
in clinical practice were less strict than recommended by DSM, and typically 
patients have been diagnosed and treated for BPD based on fewer symptoms, the 
most common indicators being suicidal and self-damaging behaviour.  
While 12% compliance with strict DSM criteria would tend to support the 
misdiagnosis of BPD, such a definitive conclusion cannot be confirmed, as 
diagnosing BPD based on fewer DSM criteria is a well-established and accepted 
clinical practice. The ‘high prevalence of BPD’ noted by NICE could well be related 
to the willingness by clinicians to assign a BPD diagnosis when fewer symptoms 
than the DSM recommended criteria are presented. Of greater significance 
however, is that the opportunity to treat comorbid PTSD/CPTSD (16% in stage 1, 
and 47% in stage 2) in almost half of the BPD patients is being missed, as clinicians 
feel unqualified to deal with the consequences of disclosing life-threatening 
trauma. If, on initial presentation, patients receive the opportunity for 
PTSD/CPTSD treatment, then a higher recovery rate than with BPD treatment is 
likely to result, (Harned, 2012).  
Currently the only RCT on treating BPD patients for trauma was conducted by 
Harned et al., (2012) as a pilot, treating (N=7) BPD patients with PTSD with DBT 
and Trauma Focused CBT, and this indicated that the treatment was efficacious 
and effective in minimising PTSD. The majority of patients no longer met criteria 
for PTSD at post-treatment (71.4% of DBT PE Protocol completers, 60% of the 
intent-to-treat sample). Although a very small sample, it also indicated a large 
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amount of reduction in suicidal ideation and intentional self-harm, with global 
social and emotional adjustments improving significantly, and the resolution of 
the trauma symptoms making these patients more able to manage and deal with 
their day to day life. Another limitation, which Harned also identified, was that 
patients may have reported a reduction in suicide tendencies because they 
received more attention from the trial clinicians. Nevertheless the treatment of 
BPD patients for trauma is recommended by a number of authors (Shea et al., 
2004; Foa et al., 1997). Thus, while in many cases a BPD diagnosis may be valid, 
almost half of these patients may be better served by receiving immediate 
treatment for PTSD/CPTSD. A sole (BPD) diagnosis means the potential benefits of 
trauma treatment are being missed, either life-threatening (PTSD/CPTSD), or non-
life-threatening (Adjustment Disorder), both of which can be addressed if 
identified on first contact with the system. 
The stage 2 field trial (reliability study) supported the notion that a short trauma 
screening instrument can reliably, rapidly and sensitively discriminate which BPD 
patients are suitable for trauma focused treatment, although limitations such as 
the small sample size will have to be addressed in future trials. Although a number 
of PTSD screens are already available, screens such as SPAN, TSQ, IES and others 
(reviewed in  
Table 2-4) focus on the psychological sequalae of discrete life-threatening 
traumas. These screens generally did not prove suitable for detecting the complex 
often repeated and frequently non-life-threatening types of (generally childhood) 
trauma typically experienced by patients with BPD/CPTSD. 
 When presented with evidence of significant percentages (47%) of trauma and 
comorbid PTSD/CPTSD from the stage 1 analysis of patients’ medical records, 
practising BPD clinicians requested an effective trauma screening methodology – 
BTERS. A subsequent trial with (N=40) BPD patients confirmed the accuracy of 
BTERS in identifying trauma, PTSD and/or CPTSD when compared with DSM 
standards (CAPS/SIDES - 98% accuracy), and thus satisfies the objective as an 
efficient screening instrument for both Criteria-A and non-Criteria-A trauma. 
While the specificity of BTERS for predicting PTSD or CPTSD alone was acceptably 
high (92% and 100%), unacceptably relatively low sensitivities (high false negatives 
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of 19% and 11%) in comparison the sensitivities experienced for predicting 
either/or PTSD/CPTSD (100%), confirms that BTERS, as currently designed, is not a 
suitable substitute for CAPS/SIDES assessments.  
BTERS therefore should not be used for the diagnosis of PTSD/CPTSD as it was not 
developed as a diagnostic instrument. Nevertheless, the form and usability of this 
one page screen has been welcomed as efficient by practising BPD clinicians. In 
discussions however, clinicians confirmed that, once BPD treatment commences, 
they did not recommend diverting patients for alternative trauma assessment and 
treatment even if PTSD/CPTSD is identified during screening. The most effective 
opportunity for trauma/PTSD/CPTSD screening, therefore, would be to 
incorporate BTERS screening as an integral part of initial BPD assessment, at first 
contact with health professionals.  
Early discussion at initial contact about trauma was discussed by Bryer, Nelson and 
Miller, where they advocate caution because of the potential danger of re-
traumatising patients (see section 2.3.6.1.1). However this hasn’t been borne out 
by Gaubaugh et al. (2011). While recognising these concerns, they concluded that 
mental illness will almost certainly be exacerbated, and care hindered if trauma 
related treatment is not offered at an early stage. Mueser and Rosenberg 
conducted an extensive literature search from the past 31 years on PTSD 
treatment of people with severe mental illness (Mueser et al., 2001). They were 
unable to locate a single published report that provided evidence that addressing 
the sequalae of trauma amongst severely mentally ill including PTSD was unsafe 
or clinically harmful. In addition, more than 150 clinicians suggested that 
inpatients receiving acute care as well as outpatients with severe mental illness 
can respond to assessment of trauma and PTSD without psychotic distortions that 
would invalidate their responses (Rosenberg et al., 2011). Mueser et al. also 
demonstrated that with 16 weeks of CBT trauma focused therapy, severely ill BPD 
patients with PTSD could be treated successfully in conjunction with treatment as 
usual (Mueser et al., 2008). Under these circumstances, the clinicians and 
managers interviewed expressed a willingness to adopt this form of trauma, 
PTSD/CPTSD screening.  
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This study identified that the majority of BPD patients (52.5%, N=21) had not 
experienced life-threatening trauma, yet 45% (N=18) of all BPD patients reported 
that their particular non-life-threatening traumatic experiences such as being used 
as a sexual object, sexual organs inappropriately touched, or subjected to severe 
bullying particularly in childhood, were nonetheless highly distressing. The stage 2 
results confirm the presence of non-life-threatening trauma (non-Criteria-A) in 
addition to life-threatening trauma in BPD patient presentations. Some patients 
presented with PTSD-like symptoms including intrusions, avoidance and arousal. 
Others (N=5) reported many of the CPTSD (PTSD) symptoms required as per DSM 
(IV and 5), including intrusions in the form of re-experiencing highly distressing 
memories, images and nightmares all associated with the stressful events (5% 
experienced flashbacks). This unanticipated finding is supported by a reported 
assessment of psychopathology and exposure to traumatic events where 
individuals who were exposed to non-Criteria-A trauma reported the same 
amount of overall distress as those exposed to Criteria-A trauma (Gold et al., 2005, 
p.263). It has already been shown (section 1.5.2) that Adjustment Disorder can be 
considered as the clinical consequence of suffering from non-Criteria-A traumatic 
stressors. Although a well-established psychological condition, Adjustment 
Disorder is not currently a common diagnosis in a BPD clinical environment. 
However, allowing for two separate trauma categories can avoid the controversy 
of either widening or restricting the definition of a traumatic stressor. While 
Adjustment Disorder places strong emphasis on symptoms, it also considers how 
patients perceive the impact of trauma.  
However, in order to make this proposal clinically effective, the PTSD cases that 
will require specialist attention first need to be identified and separated. Once the 
more challenging Criteria-A patients are screened and sent for specialist trauma 
care, BPD clinicians can confidently identify non-Criteria-A trauma and its 
symptoms, categorising such individuals as also suffering from Adjustment 
Disorder. As a result, with minimal additional training, all BPD clinicians could 
apply simple trauma-focused treatment such as PE (Prolonged Exposure Therapy) 
to their patients (currently only available for PTSD), without having to cope with 
the types of problematic life-threatening trauma that needs specialist care and 
that can be anxiety provoking for clinicians not specialised in trauma.  
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PE develops a restorative therapeutic relationship, building coping skills, where 
patients learn to attach new meanings to old sensations and thus process 
traumatic memories (McCann and Pearlman, 1992). This process therefore 
complements established BPD treatment processes of building cognitive and 
behavioural skills and then re-establishing secure social connections. In this way, 
BPD clinicians, who welcomed the format and usability of BTERS for improving and 
optimising the identification of traumatic experiences, should not be required to 
cope with the types of problematic life-threatening trauma that need specialist 
care and that can cause anxiety for non trauma trained clinicians.  
Early screening also allows clinicians to progress all relevant treatment without 
having to wait for specialist trauma assessment for all patients with the symptoms 
of post trauma reactions. Applying a valid clinical label such as Adjustment 
Disorder with its specific and recognised treatment options can also help 
vulnerable and sensitive BPD patients to feel more included, less abandoned, 
enhancing therapeutic relationships. This helps them personally recognise and 
address all of the difficult psychological conditions as an integral part of their 
personalised BPD treatment. 
6.3 Conclusions 
In conclusion, the literature review and both stages of the study demonstrated 
that traumatic experiences, PTSD, and CPTSD are probably under-recognised in 
patients with the diagnosis of BPD. In stage 2, all patients who reported life-
threatening trauma met the criteria for a diagnosis of PTSD/CPTSD as well as BPD. 
The high rates of trauma make a sharp contrast with low rates of comorbid 
BPD/PTSD or CPTSD diagnosis in the patients’ records survey. These low rates 
were explained by BPD clinicians who revealed that trauma is rarely discussed for 
fear of ‘opening Pandora’s Box’ and disturbing ongoing treatment with volatile 
reactions to complex traumatic memories. Although this apparent contradiction is 
problematic, low rates of PTSD and/or CPTSD diagnosis are consistent with 
internationally accepted practice for clinicians to diagnose and effectively treat 
BPD on less than the recommended criteria. Nevertheless, the high PTSD/CPTSD 
comorbidity in stage 2 emphasises an under-diagnosis of, or under-recognition of 
comorbid BPD-PTSD/CPTSD. A single (BPD) diagnosis means the potential benefits 
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of trauma treatment are being missed, either life-threatening (PTSD/CPTSD), or 
non-life-threatening (Adjustment Disorder), both of which can be addressed if 
identified on first contact with the system. 
The stage 2 reliability study showed that the newly developed screen (BTERS) can 
improve and optimise the identification of traumatic experience in this client 
group which may help to resolve the misdiagnosis controversy. The importance of 
non-life-threatening trauma then came to light as some interviewed patients 
reported no life-threatening experiences, but had non-life-threatening 
experiences that were nonetheless highly distressing. BPD clinicians considered 
Adjustment Disorder as a promising treatable option for such patients who do not 
require specialist trauma treatment. 
6.4 Advantages and Limitations of the Research  
The advantages and limitations of the research design can be assessed in terms of 
the effectiveness of the thesis structure and the research design. 
6.4.1 Effectiveness of Thesis Structure 
The effectiveness of the selected Compromise Thesis Model combining Focus 
Down and Opening Out (section 1.2) can now be evaluated. From the beginning of 
the study, the research benefited from a comprehensive literature review focusing 
down on the relationship between trauma and BPD. This was complemented by a 
theoretical analysis of the disorders inherent in the Focus Down technique, 
without being overly diverted by the many findings about BPD and trauma that 
are so important to analysis. The Opening Out element then permitted the whole 
research programme to devote considerable efforts to the individual 
methodologies within the two stages, while remaining close to the initial research 
concept and question. The Opening Out approach also proved beneficial in 
developing the findings relating to non-life-threatening trauma. Finally, in order to 
complement the strong focus on the practical results, and not to risk missing any 
relevant academic findings, regular updates to the literature search were included 
and well as frequent reviews with subject matter experts. 
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6.4.2 Evaluation of the Effectiveness of Research Design  
The effectiveness of the selected methodology (chapter 3) which was designed in 
order to address the research sub questions can now be assessed by referring back 
and critically assessing the mixed method sequential design (section 3.3). In doing 
so, BPD practitioners were facilitated to make critical contributions to the detailed 
design of the instrument development. This may not have been possible without 
the mixed method approach involving the discipline of the patients’ records survey 
and the screen pilot study. In this respect, the numerical results both from the 
survey of medical records and the comparison between BTERS and CAPS/SIDES 
provided the backbone for drawing the principal conclusions. Central to the 
success of the interviews with BPD clinicians and management was the grounded 
theory/ constant comparison. While this method proved to be useful, the constant 
comparison method of analysis did not reveal any new findings from what could 
have been deduced from a simple summary of the results of the individual 
interviews. 
6.5 Overall Limitations 
The limitations of each component of the research are discussed in detail within 
the individual chapters, with attention given to the various types of validity, 
threats to validity and bias; so that mitigations could be systematically applied. For 
an overarching perspective, threats to the validity of the conclusions and 
recommendations are now discussed. Two primary limitations appear to stand 
out: the relatively small number of available patients and the potential for a single 
researcher to unduly influence the results to fit with expectations. In each case, 
mitigations were put in place.  
As numbers of patients involved were limited (N=60 in stage 1, and N=40 in stage 
2) this meant that a precise percentage for trauma and for potential PTSD and 
CPTSD diagnosis cannot be predicted. As the sample was small, there is a larger 
error range (also called a 95% Confidence Interval). From stage 2, the Criteria-A 
trauma as identified by the Gold Standards was 40%, with an error range of ±15% 
(Table 5-8). Similarly, Criteria-A trauma for BTERS was 45% ±13%, (Table 5-9). 
Whereas utilising a larger sample would tend to reduce the error range, and result 
in more precise trauma, PTSD and CPTSD percentages, this would not alter the 
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research conclusion that there is 95% confidence that a significant proportion of 
BPD patients would benefit from specialised (Criteria-A) trauma treatment.  In 
order to establish a narrower error range it would be necessary to repeat the 
BTERS reliability study with a larger sample size. 
An additional consequence of this range is that a future treatment trial (RCT) may 
have to plan for a consequently wider range of BPD patients that may require 
detailed assessment for Criteria-A trauma. For a successful treatment trial, higher 
sample numbers are likely to be required, and in this case the required sample 
numbers should be statistically confirmed during a treatment trial feasibility study. 
For budget control, such a programme may require a more precise prediction of 
the number of BPD patients expected to be treated at trauma centres. 
Nevertheless, the use of literature comparisons also provided significant 
robustness to the overall interpretation of the results. In addition, Steering Group 
reviews and regular discussions with clinical personnel at all levels confirm their 
support for a screening, assessment and treatment RCT based on their confidence 
in the suitability of BTERS. Similarly the risks due to undue researcher bias were 
mitigated by the use of blind scorers and analysts, and again by challenging group 
and individual feedback sessions. 
6.5.1 Advantages and Disadvantages of the Research  
The advantages and disadvantages of the research design can be assessed in terms 
of the effectiveness of the thesis structure and the research design.   
6.5.2 Evaluation of the Effectiveness of Research Design  
The effectiveness of the selected methodology (chapter 3) which was designed in 
order to address the research sub questions can now be assessed by referring back 
and critically assessing the mixed method sequential design (section 3.4). In doing 
so, BPD practitioners were facilitated to make critical contributions to the detailed 
design of the instrument development. This may not have been possible without 
the mixed method approach involving the discipline of the patients’ records survey 
and the screen pilot study. In this respect, the numerical results both from the 
survey of medical records and the comparison between BTERS and CAPS/SIDES 
provided the backbone for drawing the principal conclusions. Central to the 
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success of the interviews with BPD clinicians and management was the constant 
comparison/ grounded theory. While this method proved to be useful, the 
constant comparison method of analysis did not reveal any new findings from 
what could have been deduced from a simple summary of the results of the 
individual interviews. 
6.6 Recommendations 
The implications of the findings are now discussed for the clinical environment, 
which include specific recommendations. Recommendations are then presented 
for research and for BTERS. 
6.6.1 Clinical Implications and Recommendations 
The underlying childhood trauma that has been demonstrated to cause significant 
distress should be routinely screened for each new BPD patient as represented in 
the revised clinical concept below, and reconsidered for existing BPD patients.  
Suspected BPD 
Symptoms: Repeated suicide attempts; 
Self Harm; Paranoia; etc.


























Figure 6-1 Revised Clinical Concept 
 
Clinical policy should therefore be adjusted to require the BTERS simple trauma 
screening device to be formally incorporated into standard assessment 
procedures in BPD units (“Tier 3 Personality Disorder Services”). The implications 
are that this will permit BPD clinicians to both isolate comorbid PTSD/CPTSD and 
to identify distressing non-life-threatening trauma. Thus, at the common point of 
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entry to the mental health system, as soon as potential PTSD/CPTSD comorbidity 
is identified, a referral programme should be developed with specialist trauma 
units for appropriate assessment.  
NICE has highlighted that in the circumstances of any BPD comorbid disorder, it is 
necessary to refer the patient to a special treatment plan that addresses his or her 
core difficulty as well as the comorbid disorder (NICE, 2009). Not making these 
referrals could thus be denying patients effective and evidentially validated 
treatment such as trauma focused CBT and EMDR (Eye Movement Desensitization 
and Reprocessing; NICE, 2005; Mueser et al., 2008; Cloitre et al., 2010). In addition, 
not treating long term disorders such as PTSD/CPTSD can perpetuate poor self-
rated health and personality changes, and PTSD symptoms can become worse. 
Indeed, this had been confirmed in recent studies (Grubagh et al., 2011; Al-Saffer 
et al., 2002). Some documented cases include addiction to drugs or alcohol; 
chronic pain; hypertension or physical maladies; self-injury; overwhelming fear of 
death; compulsiveness; personality changes and self-destructive incidents, to 
name a few (Canadian PTSD Association, 2004-2011). Also, as a number of studies 
have reported high health costs associated with BPD, overall costs could be 
reduced (Greenberg et al., 1999; Solomon and Davidson, 1997).  
To support the screening process, all BPD clinicians should receive sufficient basic 
training to become confident in addressing patients’ non-life-threatening 
traumatic history. As a comorbid Adjustment Disorder diagnosis can legitimately 
be assigned to such BPD patients who are troubled by non-Criteria-A traumatic 
events. Adjustment Disorder Treatment consisting of clinically proven active 
psychotherapy treatment processes such as CBT/DBT, psychoanalysis and in 
particular PE, could become a more readily identifiable label. These techniques 
focus on the causal links in BPD and could be immediately integrated into 
individual treatment programmes without the requirement for dedicated trials. 
The results of this study can therefore be utilised to promote and highlight the 
adoption of Adjustment Disorder for all BPD assessments as a separate comorbid 
category. This is derived from the non-Criteria-A traumatic stressors that include 
experiences such as those identified by the patients in stage 2. 
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No specific recommendation can be supported by the current study to re-diagnose 
or to declassify BPD patients either according to Herman’s CPTSD proposal or by 
strict (DSM-IV and 5, or ICD) criteria guidelines. These patients were usually 
assessed by the clinically approved SCID assessment technique (section 2.4.1). 
However, this research has identified a significant weakness, in that clinicians are 
stopping with a single (BPD) diagnosis and not considering comorbid PTSD/CPTSD. 
And as recovery rates with treatment for these disorders is generally higher, in this 
sense BPD can be considered to be over-diagnosed. 
Nevertheless, clinical evidence from professional practitioners from both stage 1 
and stage 2 also supports the practical benefits of a BPD diagnosis, and patient 
improvement rates were confirmed using classical BPD treatment. However, the 
continuing high rate of readmission for BPD provides a constant incentive to seek 
out and adopt enhanced treatment methods such as PE with DBT, in addition to 
specialist treatment for comorbid PTSD/CPTSD. Ongoing academic and clinical 
debate about BPD diagnosis must, however, never lose sight of the priority of 
providing vulnerable patients with an effective range of treatment methods, 
commencing with therapeutic relationships. 
6.6.2  Research Recommendations 
The initial requirement for future research is to replicate the BTERS screening with 
a larger sample. This should confirm the prevalence of trauma and reinforce the 
effectiveness of trauma focused treatment for BPD patients both with the DSM 
specified PTSD criteria, and without (but nonetheless with post trauma 
symptoms). An efficient approach to this objective could be to perform a two part 
trauma focused trial. The first part would repeat and consolidate the performance 
of BTERS utilising a larger number of participants by comparing BTERS results 
performed by practicing BPD clinicians, with trauma assessments using 
CAPS/SIDES performed by independent trauma clinicians. The second part then 
offers tangible benefits to Criteria-A participants by repeating the controlled 
treatment comparison trial (section 2.2.2) of BPD patients conducted by Harned 
et al., (2012).  This 2012 trial examined comorbid BPD/PTSD patients (N=13) with 
a history of suicide attempts, and over 50% of the patients showed a reduction in 
PTSD symptoms. Concurrently, a trial should be undertaken for patients who have 
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been identified by BTERS as not been affected by life-threatening trauma (i.e., 
patients with non-Criteria-A trauma). A comparison should therefore be made 
between trauma-focused PE with DBT, against DBT on its own, both undertaken 
by a single team of BPD Clinicians.  
In order to ensure that the benefits of all forms of treatment continue to be 
maintained, such a test would require critical clinical oversight from both BPD and 
trauma practitioners. For such a major controlled trial to be successful, it would 
require the participation of several specialist hospitals and significant professional 
clinical engagement by both specialist BPD and Trauma units as well as the 
patients themselves, and might take a number of years to reach its full 
conclusions. Once relevant findings and recommendations from this current 
research are published in topical clinical and academic literature, the publicity and 
exposure could assist in promoting such a treatment trial.  
Further research should also be considered to distinguish between flashbacks (the 
intrusive symptoms and thought processes that are the hallmarks of PTSD), and 
distressing intrusive thoughts that may arise from non-life-threatening traumatic 
memories. This research should seek to better characterise and create a typology 
of these experiences and memories.  The implication of such a programme is that 
clinicians could feel more confident about discussing signs and symptoms and 
differentiating between memories associated with life-threatening and those that 
are not, without having to discuss the causative traumatic events in detail. 
6.6.3 BTERS Screen Recommendations 
BTERS should be used as a starting point to allow BPD clinicians to deal with non-
life-threatening traumatic experiences. During this research, the BTERS screen has 
already been used in practice by a number of clinicians in initial BPD assessments, 
and its introduction in its current state as a practical day-to-day instrument has 
now been requested by a representative selection of clinicians who work with BPD 
patients. More importantly, its adoption has been strongly endorsed by BPD 
clinical managers working with BPD patients in the participating hospital. 
Moreover, it already has a significant track record among both patients and 
clinicians who found it useful. It must always be remembered however, that the 
proposed application of the screen is not to replace the full PTSD/CPTSD 
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assessments (CAPS & SIDES) but to identify whether a patient should be referred 
to a specialist clinic where they will receive a full assessment of both disorders, or 
if they should receive trauma focused treatment such as PE for non-life-
threatening trauma from their regular clinicians. In addition, as BTERS makes it 
possible to screen separately for Complex PTSD as well as (classical) PTSD, such an 
early indication is likely to be of assistance when referrals are made to trauma 
specialists. BTERS should also be tested in different clinical settings where BPD 
symptoms may be presented, e.g., primary care settings such as GP clinics, 
school’s nurses, and common point of entry to hospitals. Discussions with BPD 
professionals concluded that using BTERS at an early stage, i.e., the common point 
of entry into hospital(s) can steer patients to the appropriate department for full 
and appropriate assessment without delays, so that they can receive the early 
treatment required. BTERS is a new instrument that has to date only been field 
tested in a single study, although it has been successfully used by several clinicians. 
Like any new screening instrument, BTERS has the potential for further 
improvement. No clinical screening device can be successful without the effective 
participation of both clinicians and patients. To achieve this, any enhancements 
should therefore be carefully aligned to changes in each specific clinical 
environment. In particular, as this project has clearly demonstrated, all new 
screening applications must be supported by comprehensive patient and clinician 
interaction and feedback.  
6.7 Original Contribution to Clinical and Academic Knowledge  
This research project constitutes the first known systematic clinical attempt to 
quantify the presence of treatable PTSD and CPTSD in a significant sample of BPD 
patients utilising a simple screening instrument. It may therefore prove to be a 
significant contribution to psychiatric knowledge in aiding clinicians by means of a 
simple screening technique prior to detailed diagnosis. This could potentially 
break the cycle of repetitive BPD hospital admissions for BPD patients with 
CPTSD/PTSD comorbidity. In addition, it could be the first occasion where life-
threatening and non-life-threatening trauma has been differentiated in a BPD 
population. Such a differentiation is a critical parameter in the potential for 
subsequent successful treatment of the trauma component in BPD.  
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6.8 The Future Outlook 
If replication studies support the value of the BTERS instrument, its routine use 
could offer hope of the provision of more effective treatment and thus a better 
quality of life for the many thousands of individuals who suffer from BPD and 
comorbid CPTSD/PTSD. To translate such aspirations into reality, the starting point 
following the proposed retesting and treatment trial, is for NHS Trusts to embrace 
the clinical recommendation for the introduction of the BTERS screen at common 
point of entry to the mental health system. The application of BTERS will then 
encourage high quality trauma focused treatment for BPD patients for both life-
threatening traumatic experiences and non-life-threatening experiences (in 
parallel with existing BPD treatments) to become the norm. Treatments for 
PTSD/CPTSD (life-threatening trauma) and Adjustment Disorder (non-life-
threatening trauma) already exist within the NHS. The distinctions between the 
different trauma types for patients with BPD symptomatology cannot be 
recognised and the correct treatment implemented without the dedication and 
collaboration of our excellent clinical and academic personnel, who work tirelessly 
with one of the most challenging and debilitating illnesses in modern society. 
Similarly, there can be no success story without the future contribution of a well-
designed, well-funded and well-led treatment trial of the screening, assessment 
and treatment of BPD for underlying trauma. Such a research programme will 
make a vital contribution to credible and effective new ways of caring for some of 
our most vulnerable citizens.    
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 Abbreviations 
 
AD Adjustment Disorder 
APA American Psychiatric Association 
AUC Area under the ROC curve (statistical accuracy) 
AUDADIS Alcohol instrument 
AUDIT Alcohol Use Disorders Identification Test 
BPD Borderline Personality Disorder 
BTERS BPD Trauma Exposure and Reactions Screen 
CA Criteria-A (for trauma) 
CAMH Canadian Centre for Mental Health 
CAPS Clinical Administrated PTSD Scale 
CASP (group, 2013) Critical Appraisal Skills Programme 
CAQDAS Computerised Assisted Qualitative Data Analysis 
CBT Cognitive Behaviour Therapy 
CONSORT Consolidated Standards of Reporting Trials 
CPTSD Complex PTSD 
CSA Childhood sexual abuse 
CVI Content Validity Index 
DBT Dialectical Behaviour Therapy 
DES Disorders of Extreme Stress 
DESNOS Disorders of Extreme Stress Not otherwise 
Specified 
DIB Diagnostic Instrument for Borderline 
DICA 
Diagnostic Interview for Children and 
Adolescents, Revised 
DoH UK Department of Health 
DSM 
Diagnostic and Statistical Manual of Mental 
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EMBASE Biological document database 
EMDR  Eye Movement Desensitization and Reprocessing 
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PsycINFO  Psychology Information 
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QUADAS Quality Assessment of Diagnostic Accuracy Studies 
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SCID Structured Clinical Interview for DSM Disorders 
SIDES  Structured Interview for Disorders of Extreme Stress 
SPAN Startle Physiological arousal Anger and Numbness 
SPSS   Statistical Package for the Social Sciences 
STARD Statement of Reporting Studies of Diagnostic 
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SVI Sexual Violence Research Initiative 
TA Traumatic Antecedent 
TAQ Traumatic Antecedent Questionnaire 
TF-CBT  Trauma focused Cognitive Behaviour Therapy 
TSQ Trauma Screening Questionnaire 
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A. Did you experience or witness any events that were repeated and particularly highly upsetting, e.g.  Physical 
abuse, domestic violence, bullying, emotional neglect etc.?            YES □, NO □           
B. Indicate the most upsetting event ________________________________________   and at what age? 
C. Did any of these events make you feel not important, rejected unsure of yourself or abandoned? YES □, NO □ 
D. Did anyone repeatedly inappropriately touch your private parts, or made you touch theirs?           YES □, NO □  
E. Did anyone ever made you have any form of repeated sex against your will?   i.e., rape                    YES □, NO □ 
F. Did you feel as if you were permanently damaged?              YES □, NO □ 
G. Indicate your relationship with the abuser(s), e.g. stranger, family member.  And is he/she still around? 
____________________       ______________________________                     ______________                               
Before age 13 Box 1 
Advise Patient that: 
a. Talking about upsetting events can bring back distressing memories and or nightmares 
b.  Teach grounding techniques to be used at home if required 
c.  If that does not work, to contact their care coordinator for further advice 
Patient Number:   
I am going to ask you some questions about some stressful things that sometimes happen to 
people. You may find it upsetting, as it may bring back uncomfortable feelings or memories. 
People sometimes find that talking about them can be helpful.  
If anything gets upsetting, we can slow down and talk about it. 
BPD Traumatic Experiences and Reactions Screen (BTERS) 
D 
A. Did you experience or witness traumatic event/s that was life threatening or a serious injury (e.g. stabbing, car 
accident, rape, torture, a sudden death of someone close), (not bullying, divorce, redundancy, etc.)  YES □NO □        
B. Any other experiences?    ____________________________________________________________________ 
Which events above distressed you most at the time?   
A. Box 1     YES □, NO □      Which letter in Box 1___  
B. Box 2     YES □, NO □      Which letter in Box 2___ 
Box 3 
        
A. When unexpectedly reminded of the worse event, is it very distressing for you?                YES □, NO □     
B. Worst than that, do you re-experience the event in the present, (like it is happening now) accompanied with the 
fear or horror that you felt at the time of the event?                     YES □, NO □ 
C. Do you get nightmares associated with the event/s?                    YES □, NO □ 
D. Are you startled, irritable, jumpy at something unexpected?                  YES □, NO □ 
E. Do you sometimes try to push the memory of the trauma and the feeling of fear away?  YES □, NO □ 
Box 4 
                      At the time, what aspect of the traumatic event did you find most upsetting?  
A.   Was it the event itself that upset you?        YES □, NO □ 
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SPAN (four-item Startle, Physiological arousal, Anger, and Numbness instrument) 
To use the PC-PTSD instrument ask the patient:  
In your life have you ever had any experience that was so frightening, horrible, or upsetting 
that in the past month you: 
1. Have had nightmares about it or thought about it when you did not want to? 
2. Tried hard not to think about it or went out of your way to avoid situations 
that reminded you of it? 
3. Were constantly on guard, watchful, or easily startled? 
4. Felt numb or detached from others, activities, or your surroundings? 
Three or more "yes" answers to these questions represent a positive result for PTSD. 
 
Finally, another four-item screening instrument was validated in a group of veterans with 
symptoms of depression. The instrument consists of an initial question (“Have you witnessed 
or experienced an event that involved threatened or actual serious injury or death”?”), 
followed by three additional questions about symptoms (i.e., troubling memories, feeling 
distant or cut off, and feeling “super alert” or on guard). The overall likelihood of PTSD for 
patients experiencing trauma was 37 percent. The likelihood was 11 percent for those with 
none of the three symptoms, 27 percent for those with one symptom, 45 percent for those 
with two symptoms, and 71 percent for those with all three symptoms.8 
 
Among the four instruments discussed above, Breslau's short screening scale and the PC-PTSD 
instrument have been validated in representative populations and can be recommended for 
use in the primary care setting. 
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Trauma Screening Questionnaire (TSQ) 
Your own reactions now to the traumatic event 
Please consider the following reactions which sometimes occur after a traumatic event. This 
questionnaire is concerned with your personal reactions to the traumatic event which 
happened to you. Please indicate (Yes/No) whether or not you have experienced any of the 
following at least twice in the past week. 
1. Upsetting thoughts or memories about the event that have come into your mind against 
your will 
2. Upsetting dreams about the event 
3. Acting or feeling as though the event were happening again 
4. Feeling upset by reminders of the event 
5. Bodily reactions (such as fast heartbeat, stomach churning, sweatiness, dizziness) when 
reminded of the event 
6. Difficulty falling or staying asleep 
7. Irritability or outbursts of anger 
8. Difficulty concentrating 
9. Heightened awareness of potential dangers to yourself and others 
10. Being jumpy or being startled at something unexpected 
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APPENDIX 4  Steering Group Terms of Reference 
Group Objective  
Provide informal advice on research aims, methodology and interpretation of data. 
Commitments 
Reading a reasonable selection of provided information 
Critically questioning interpretations and conclusions whenever practicable  
Proactively suggesting improvements to methodology 
Attendance at occasional meetings is not a requirement but could be considered 
Members can resign from the Group due to conflicting commitments  
Provision for anonymous participation will be provided 
Group will comply with the Project agreed ethical procedures, (e.g., confidentiality 
will be respected). 
Membership of the Group does not imply endorsement of the findings or conclusions 
of the research. However, if desired, acknowledgements will be made in the final 
report.   
Methodology 
Primarily an e-mail sharing group  
A shared web area can be included 
I will act as group moderator 
Moderator will provide regular summary updates 
Participants  
I am looking for a small group of clinicians, researchers, supervisors, who could give 
a varied and intelligent view on the different aspects of this study.  
Participants should not necessarily feel as passionately as I do about the study, nor 
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APPENDIX 5  Protocol, Stage 1 
A study of Life Experiences and the Diagnosis 
of Mental Health Problems 
Protocol for:  A study of Life Experiences and the Diagnosis of Mental Health Problems 
REC No: 10/H0605/23 
Background 
Borderline Personality Disorder (BPD) is the most commonly diagnosed form of 
Personality Disorder (Shevin et al., 2007) and has been recognised as a clinical 
condition that can be seriously disabling and often takes a huge toll on the individual 
(NICE, 2008).   
The key diagnostic criteria of BPD (as presented in the Diagnostic and Statistical 
Manual of Mental Health disorders, DSM-IV) is an instability in interpersonal 
relationships, self–image and affect, combined with marked impulsivity beginning in 
early childhood and present in a variety of contexts. BPD patients also portray 
transient, stress related paranoid ideation, with recurrent suicidal behaviours, 
gestures, threats and self-mutilation. 
 NICE estimates that 0.7-2% of the general public could be suffering from BPD, with 
20% of all psychiatric inpatients and 10-30% of outpatients (NICE, 2008). This is 
supported by epidemiological studies (Pinto, 2000; Torgenson, 2002; and Coid, 2006). 
Suicide is a particular risk in BPD with up to 1 in 10 people with BPD committing 
suicide, 400 times higher than the national average suicide rate (NICE 2008; Jeffrey 
et al., 2009; Cailhol et al., 2008).  The UK Department of Health (DoH) and the National 
Association for Mental Health (MIND) have highlighted a worrying ‘danger of 
misdiagnosing BPD’. Many experts also believe that most if not all cases of BPD 
should be re-conceptualized as Post Traumatic Stress Disorder (PTSD) associated 
with childhood abuse, (e.g., Lineham, 1993).   
An initial literature review has confirmed the possibility that a very high percentage of 
cases of BPD can potentially be re-conceptualized as Post Traumatic Stress Disorder 
(PTSD) associated with childhood abuse (Lineham, 1993; Herman, 1992), usually 
called Complex Post Traumatic Stress Disorder (CPTSD). Potentially this may have 
very significant implications for the treatment and clinical management of these 
patients. 
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Furthermore, a number of studies have shown that many who have been exposed to 
chronic childhood trauma are diagnosed as having personality disorder, particularly 
BPD (Zimmerman et al., 1999; Hodges, 2003; and van der Kolk et al., 1994). Some 
studies have linked this to a causal effect (e.g., McLean, 2003), thus there is an 
established resemblance and overlap between the presenting symptoms of BPD and 
CPTSD. However according to van der Kolk, while there is a large degree of overlap 
and on the surface both conditions appear to be quite similar, these disorders only 
partially coincide and there is a clear distinction between them (van der Kolk et al., 
1994). It has also been suggested that many of patients diagnosed with BPD can be 
assigned more discriminating diagnosis such as CPTSD (Valliant, 1992; Herman, 
1997), which would signpost clinicians to provide appropriate psychological 
treatments. 
NICE (2009) has suggested that failure to make the diagnosis sufficiently early may 
prevent appropriate early intervention to ameliorate the difficulties. Therefore reliable 
identification and assessment of BPD is required.  
Assessment Instruments 
The reliability of diagnostic assessments for BPD has been considerably improved by 
introduction of ‘standardized interview schedules’. However, no single schedule has 
emerged as ‘the gold standard', as each has its advantages and disadvantages’ 
(NICE, 2008). There is still a heavy reliance on the diagnosis of BPD being made 
following unstructured clinical assessments, and there are more potential pitfalls, such 
as obtaining agreement among clinicians, (i.e. inter-rater reliability) (Melsop, 1982).  
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Recognised Area for Further Investigation 
Objectives 
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The current project is the first stage of a planned doctoral program of research. The 
aim of this first stage is to map current practice in Berkshire Healthcare Foundation 
NHS Trust (BHFT) for diagnosing BPD/CPTSD. This mapping exercise will inform the 
later development of a new, trauma sensitive diagnostic instrument for assessing 
patients presenting in ways suggestive of BPD/CPTSD. To this end, the researcher 
will examine a selection of medical records of patients diagnosed with BPD to extract 
information on which life experiences clinicians have discussed with patients, and how 




The medical records of all patients admitted to acute psychiatric inpatient wards in 
Berkshire over a 12 month period will be screened against the inclusion criteria by 
clinical staff. Potential participants who meet the criteria will be approached by the 
health-care-team. This will be done by informal discussion about the research project 
and how they could help. Written information about the voluntary nature of their 
participation will be given to those who express an interest in participation. All patients 
will be given the opportunity to discuss the study with the researcher if they wish and 
ask questions before making a decision. Patients will be given a minimum of 24 hours 
to consider if they wish to take part and to allow their medical records to be examined. 
Investigation of medical records using the Study Tool designed by the researcher of 




1. To identify information on which current diagnoses are based 
2. To calculate the frequency of different assessment instruments used 
3. To identify the nature of any trauma recorded and their frequencies. Establish the 
number and types of different treatments received to date 
4. To determine, through a structured format, the percentage of patients with CPTSD, 
and also the index of variability, or standard deviation 
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5. To establish interrelationship patterns between variables such as demographics, 
clinical history and treatments received. This will be presented in frequency tables 
The data analysis is essentially descriptive but statistical computer packages such as 
SPSS will be employed whenever required to calculate frequencies and percentages 
etc. 
Inclusion criteria 
All acute in-patients diagnosed with BPD in a one-year period in Berkshire will be 
approached. (Based on 2008/2009 discharge statistics, this should be about, n=120). 
 All potential participants must know and understand their diagnosis 
 Age between 18 and 65 years old 
 Able to give informed consent to participate in the study 
Exclusion Criteria 
 Currently acutely disturbed / psychotic. 
 Unable to give informed consent. 
Risks to Participants 
The study of the medical records of patients in the sample group in Berkshire should 
not generate any significant risks to these patients. 
Data Management and Storage  
The master-file which links names linked to unique code numbers will be kept in a 
secure location on an NHS computer according to NHS data security practices. All 
other data will be stored under anonymised code numbers in encrypted forms on 
password-protected computer (personal laptop and university computer). No hard 
copy will be created where a participant who could potentially be identified. 
Proposed Security Procedures 
No data with names of patients or clinicians will be removed from its source location. 
However, a list of patient’s names and hospital number etc. will be securely maintained 
at the source location. This is to aid good coverage, minimise the possibility of 
duplication, and the clearing of anomalies for external quality control. 
Photocopying or scanning of information will be restricted to ensure any copies are 
stripped of all identifiers. Thus when collating records, a coded number will replace all 
names, where the index relating names to codes will reside only at the source location. 
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All (coded) records from the source will be kept in a secured electronic folder (i.e. kept 
on a password protected computer). Where separate patients records are kept in 
different hospital locations in Berkshire (BFT maintains acute psychiatric admission 
wards on three hospital sites – Prospect park Hospital in Reading, Wexham Park 
Hospital near Slough and Heatherwood Hospital in Ascot), then separate secure 
records will be maintained in each hospital. 
The clinical team will have full access to all participants’ personal data that will also be 
accessed by the researcher and the supervisor (who also has an honorary contract 
with the Trust) according to agreed ethical procedures. 
Project Management    
This project will be overseen by my research supervisor Professor Nigel Wellman of 
Thames Valley University. 
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APPENDIX 6  Patient Information Sheet, Stage 1 
Life Experiences and the Diagnosis of  
Mental Health Problems 
Patient Information Sheet for:    Life Experiences and the Diagnosis of Mental Health 
Problems  
 REC No: 10/H0605/23 
You are invited to take part in a research study undertaken as part of a Doctorial study at 
Thames Valley University. 
Before you decide, it is important for you to understand why the research is being done 
and what it will involve.  
Please take time to read this information carefully and discuss with others if you wish. If 
there is anything that is not clear, or if you would like more information, please feel free 
to contact the researcher using the contact number below. Please take time to decide 
whether or not you wish to take part. 
Alternatively you may wish to speak to a representative for the Patients Advise and Liaison 
Services (PALS) who may also be able to answer questions and discuss with you about 
participating in NHS research.   
The Purpose of the Study: 
The primary purpose of this study is to look at how mental health clinicians evaluate 
patients’ life experiences, and the effects of these experiences on how patients cope with 
life.  
We are also interested in how this information is used to guide the mental health services 
that patients are offered. We are doing this because we hope to use this information to 
develop new assessment tools such as questionnaires to help clinicians assess patients. 
To this end I would like to ask your permission to look at your medical records and extract 
information on which life experiences doctors have discussed with you, and how that has 
informed your diagnosis  and the care plan which guides your treatment. 
Why have I been invited? 
You have been invited because you have received care for mental health issues from 
the Berkshire Healthcare NHS Foundation Trust. Many patients with similar mental 
health issues over a period of the next twelve months will also be invited to take part.
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Do I have to take part? 
No, your participation is entirely voluntary. If you decide not to take part, this will in no 
way affect your treatment or entitlement to services. Furthermore, you can withdraw 
your consent at any time, without having to give a reason and this will not affect your 
treatment. 
What will happen to me if I decide to take part? 
If you decide to take part, you will be given this information sheet to keep, and you will 
be asked to sign a consent form giving permission for the examination of your medical 
records.   
What do I have to do? 
If you decide to take part, please sign the attached consent form giving permission for the 
examination of your medical records. 
What are the possible Risks or Disadvantages of taking part? 
You will be giving up a few minutes of your time to read the information sheet and decide 
if you wish to let the researchers review your medical records. 
What are the benefits of taking part? 
There may be no direct benefit for you in taking part in this study, but we hope that the 
development of improved assessment tools may help to improve the care of people who 
have similar mental health issues to you in the future. 
What happens when the research study is finished? 
When the research study is finished and the information has been analysed, we will 
inform you of the results of the study if you wish. 
What if there is a problem? 
If you experience any problems as a result of the study you should discuss this with the 
researcher, but the normal university and NHS clinical support as well as the NHS 
complaints mechanisms remain open to you. 
What if something goes wrong? 
It is unlikely that anyone will be harmed by taking part in this study; however this study is 
covered by Thames Valley University’s insurance policy. If you are harmed due to 
someone’s negligence, then you may have grounds for legal action, but you may have to 
pay for it.  
Regardless of this, if you have any concerns, you can speak to your clinical staff or the 
researcher.  Or if wish to complain about the way that you have been approached for this 
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study, the normal Thames Valley University and NHS complaints mechanism will be fully 
available to you.  
Will my taking part in this study be kept confidential? 
If you decide to take part in the study I will inform the mental health clinicians involved 
with you about your participation. All information collected about you during the course 
of the research will be kept entirely confidential.  Any information about you that leaves 
the NHS site will have your name removed so that you cannot be recognized from it. 
What will happen to the results of the study? 
When the study is finished, we hope to use the information to develop new assessment 
tools. We also hope to publish the results in academic journals, in various mental health 
publications, and to present the findings of the study at conferences and research 
meetings, but will ensure that no individual participant in the study can be identified. 
Who is organizing and funding this research? 
The researcher is not being paid; neither will there be any payment for your participation. 
However the study will form part of the researcher’s thesis as part of a Doctorial study at 
The Thames Valley University. 
Who has reviewed this study? 
All research in the NHS is looked at by an independent group of people called the Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity.  
Before obtaining permission to distribute this Information Sheet, this study has been 
given a favorable ethical opinion for conduct by the Oxfordshire Research Ethics 
Committee B, and the Faculty of Health and Human Science Research Committee at 
Thames Valley University. 
Contact for further information 
For further information about the study, please contact: 
1. Researcher: Doris Tallon, doris.tallon@berkshire.nhs.uk 07977984758 
2. Dr Gwen Bonner,  01344 874340, gwen.bonner@berkshire.nhs.uk  
Thank you very much for taking the time to read this information sheet, which is now 
yours to keep.  
If you agree to take part in the study, you will be asked to sign the consent form and you 
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APPENDIX 7  Clinician Information Sheet, Stage 1 
 
 
 Life Experiences and the Diagnosis of Mental Health 
Problems 
 
My name is Doris Tallon; I worked for many years with Complex PTSD patients in 
the Berkshire Traumatic Stress Clinic and I am currently undertaking research for 
a PhD at Thames Valley University.  
 
The first stage of my research is a project entitled “Life Experiences and the 
Diagnosis of Mental Health Problems””, and it aims to map how clinicians in 
Berkshire make the diagnosis of Borderline Personality Disorder (BPD), including 
any questionnaires or clinical tools they use and what life experiences they 
consider in making this diagnosis  
NICE estimates that 0.7-2% of the general public could be suffering from BPD, with 
20% of all psychiatric inpatients and 10-30% of outpatients (NICE, 2008) and these 
figures are supported by epidemiological studies. Suicide is a particular risk in BPD 
with up to 1 in 10 people with BPD committing suicide, 400 times higher than the 
national average suicide rate (NICE 2008).  
Assessment 
The literature suggests the diagnosis of BPD is generally made following 
unstructured clinical assessment, and that there are often pitfalls, such as difficulty 
in obtaining agreement on diagnosis among clinicians (Melsop, 1982) and overlap 
with a range of other conditions.  NICE have suggested that more reliable methods 
of diagnosis need to be developed for BPD and related conditions in order to 
enable patients to obtain speedy access to the most appropriate interventions and 
services. The current project aims to understand current practice in Berkshire with 
a view to building on this work to develop and test new diagnostic instruments and 
procedures.
Researcher:  Doris Tallon tallondoris@googlemail.com         Phone 07779728985 
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Data Collection  
Medical records of all admissions in the acute inpatient wards will be screened 
against the inclusion criteria by clinical staff. 
Potential participants will be approached by the health-care-team. This will be done 
by informal discussion about the research project and how they could help; written 
information about the voluntary nature of their participation will be given to those 
who express an interest in participation. 
All patients will be given the opportunity to discuss the study with the researcher if 
they wish and ask questions before making a decision. Patients will be given a 
minimum of 24 hours to consider if they still wish to take part to allow their medical 
records to be examined. Investigation of medical records of the BPD patients, 




1. To identify information on which current diagnoses are based. 
2. To calculate the frequency of, and  different assessment instruments used 
3. To identify the nature of life events recorded in the medical records and their 
frequencies. Establish the number and types of different treatments received to 
date 
4. To determine, through a structured format, the percentage of patients with 
CPTSD, and also the index of variability, or standard deviation 
Inclusion Criteria 
All acute in-patients diagnosed with BPD in a one-year period in Berkshire will be 
approached. (Based on 2008/2009 discharge statistics, this should be about, 
n=120). 
 All potential participants must know and understand their diagnosis 
 Age between 18 and 65 years old 
 Able to give informed consent to participate in the study
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Exclusion Criteria 
 Currently acutely disturbed / psychotic 
 Unable to give informed consent 
Risks to Participants 
The study of the medical records of patients in the sample group in Berkshire 
should not generate any significant risks to these patients. This project has been 
given a favourable ethical opinion for conduct by the Oxford B NHS Research 
Ethics Committee and the Faculty of Health & Human Sciences Research Ethics 
Committee at Thames Valley University. 
If you require further information then please do not hesitate to contact me by e-
mail tallondoris@googlemail.com or phone 07779728985. 
I will truly be grateful for your co-operation in this matter. Your time and the 
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APPENDIX 11   University R&D Approval, Stage 1 
    
 
                                                                                            
Ms Doris Tallon 
3 Chazey Road 
Caversham Heights 
Reading RG4 7DS 
13 April 2010 
Dear Doris 
Re: Application for Ethical Approval No FREC24/March10  
Thank you for sending in your application for approval by the Faculty Ethics Committee. This 
is to confirm that the Committee has considered your application and approved the research 
without major amendment. 
If you make any changes to your research proposal or methodology can you please inform 
the Committee in writing, as this may entail the need for additional review.  A report on the 
progress/completion of the research is required in 12 months from the date of this letter, or 
on completion of the research, whichever is the sooner. 
The Committee wish you well with the research and look forward to your report. 
Yours sincerely 
Heather Loveday 
Principal Lecturer (Research)  
Chair of the Faculty Research Ethics Committee 
 
 
THAMES VALLEY UNIVERSITY 
Faculty of Health and Human Sciences 
Faculty Research Ethics Committee 
Paragon House 
Boston Manor Road 
Brentford TW8 9GA 
Tel: +44 (0)20 8209 4110/4145 
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APPENDIX 13  Study Tool, Stage 1 
 
Study Tool for:  A Study of Life Experiences and the Diagnosis of Mental Health Problems 
REC No: 10/H0605/23 
Study Tool (for medical records) 
Objectives 
 To obtain information regarding diagnosis of co-morbid psychiatry disorders and the 
severity of these disorders, i.e. duration, course treatment and use of acute services over 
a period of one year of the patients admitted to the acute wards 
 To establish relationships between sets of data and to look for etiology and symptoms of 
BPD and CPTSD 
Statistical measurements (e.g. percentages) will be made. 
Procedure 
The data required includes: 









b) Patient data (a code must be assigned):  
a. General; Age, Sex, Nationality, Social Class 
b. Marital Status, accommodation, occupation, ethnicity 
c. Trauma History, and type including childhood trauma 
d. Initial referral date 
e. Age at first trauma symptoms 
f. Previous number of referrals  
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g. Previous diagnosis, location, by whom, including PTSD records 
h. Previous kinds of treatment (e.g., psychotherapy and type) 
i. Treatments offered 
j. Effectiveness of treatment 
k. Medications used 
l. Admission history 
m. Number of subsequent assessments 
c) Ward data 
a. Number of overall admissions throughout the acute wards within the Trust 
b. Number of BPD admissions 
c. Where they are discharged to 
A draft is shown below: 
Formulation:  
Presenting symptoms: 
Symptoms to look for when assessing for BPD are: 
 Repeated self-harm: 
 Persistent risk taking 
 Marked emotional instability: 
 Risk of self-harm or to other 
1. Assessment process used: Structured or semi-structured interview, self-assessment 
questionnaire, etc. 
2. Was there a Standard Assessment Instrument used? 
3. If so, which one or ones: 
4. If not, why not? Is the reason given? 
5. Was a family member present? 
6. Is there a recording of traumatic history? 
7. If no, was it asked and none was given? 
8. What exactly was the diagnosis recorded 
9. When was the diagnosis made? 
10. How many assessment sessions before diagnosis was made? 
11. Reasons for the diagnosis 
12. Treatment offered: 
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13. Prognosis: 
o How long was, or has the patient been in hospital 
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APPENDIX 14  Consent Form, Stage 1 
REC No:  10/H0605/23 
Patient Identification Number for this trial:                                      Please initial the box below 
Name of Researcher: Doris Tallon. 
______________ 






Name of Person taking consent  











 When complete, 1 copy for patient: 1 copy for researcher site file: 1 (original) to be kept in 
medical notes 
 I confirm that I have read and understand the information sheet 
dated ......................... for the above study.  
 
 I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily.  
 
 I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care 
or legal rights being affected.  
 
 I understand that relevant sections of any of my medical notes and data 
collected during the study may be looked at by responsible individuals from 
the NHS Trust, where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my records.  
 
 I wish to be sent a summary of the results of this study once completed    
 I agree to take part in the above research study 
 
 I give permission for the researcher to assess my medical records for the 
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Fear of  BPD patients 
reaction if encouraged 












  x 
Asks about trauma but 




BPD specialist  
  x To ask about trauma 





















x   Yes 
10 Psychologist x x   
11 Psychologist x x   
12 Ward manager x x  Yes 




x   
Aware of trauma 
underpinnings 
15 Doctor   x  
16 Ward manager    






  x 
Worry about trauma 
not recorded in all the 





 x   
  









  x 
Trauma must be 
explained 












x  x  
25 Doctor   x 
Patient need trauma 
pathway 




  x 
Trauma must be 





   
Yes, fear of what to do 
with the information 
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APPENDIX 16  Protocol, Stage 2 
Protocol: Trauma in Borderline 
Personality Disorder 
“Is Complex Post Traumatic Stress Disorder (CPTSD) 
under recognised in Diagnosing Borderline Personality 
Disorder (BPD)?” 
REC No: 12/SC/0382 
Background 
Borderline Personality Disorder (BPD) is the most commonly diagnosed form of 
Personality Disorder (Shevin et al., 2007) and has been recognised as a clinical 
condition that can be seriously disabling and take a large toll on the individual 
(NICE, 2008).  The key diagnostic criteria of BPD (as presented in the Diagnostic 
and Statistical Manual of Mental Health disorders, DSM-IV) is instability in 
interpersonal relationships, self–image and affect, combined with marked 
impulsivity beginning in early childhood and present in a variety of contexts. BPD 
patients may also experience transient, stress-related paranoid ideation, with 
recurrent suicidal behaviours, gestures, threats and self-mutilation. 
NICE have estimated that 0.7-2% of the general public could be suffering from 
BPD, with 20% of all psychiatric inpatients and 10-30% of outpatients meeting 
diagnostic criteria (NICE, 2008). This is supported by epidemiological studies 
(Pinto, 2000; Torgenson, 2002; and Coid, 2006). Suicide is a particular risk in 
BPD with up to 1 in 10 people with BPD committing suicide, a rate 400 times 
higher than the national average (NICE 2008; Jeffrey et al., 1985).  The National 
Association for Mental Health (MIND, 2009) have highlighted a worrying ‘danger 
of misdiagnosing BPD’. A number of experts also believe that many cases of BPD 
should be re-conceptualised as Post Traumatic Stress Disorder (PTSD) 
associated with childhood abuse, (e.g., Lineham, 1993).  
A literature review has confirmed the possibility that a very high percentage of 
cases of BPD can potentially be re-conceptualised as PTSD associated with 
childhood abuse (Lineham, 1993; Herman, 1992), which is usually called 
Complex Post Traumatic Stress Disorder (CPTSD).  The proposed diagnosis of 
CPTSD is currently covered by the current DSM-IV diagnostic category of 
‘Disorders of Extreme Stress Not Otherwise Specified (DESNOS).  Potentially, 
re-diagnosis could have very significant implications for the treatment and clinical 
management of these patients. Furthermore, a number of studies have shown 
that many who have been exposed to chronic childhood trauma are diagnosed 
as having personality disorders, particularly BPD (Zimmerman et al., 1999; 
Hodges, 2003; and van der Kolk et al., 1994) and some studies have linked this 
to a causal effect (e.g., McLean, 2003).
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Definitions of Disorders 














Follows a sudden, unexpected event of a life threatening or catastrophic nature, “outside the range 
of usual human experiences” which engenders feelings of helplessness, fear or horror.  
Recent research shows events qualifying for PTSD are quite common, (childbirth, car crashes, heart 
attacks, assaults, rapes, combat) and some traumas so powerful that the exposure typically leads 
to PTSD. 
Symptoms: 
 Patients continue to intermittently re-experience aspects of the traumatic event after it was all 
over (e.g. flashbacks, nightmares, intrusive thoughts with emotional and physical distress in the 
face of reminders of the event). They seek to avoid reminders of the event, show diminished 
interest in formerly pleasurable activities, and display feelings of detachment and a sense of a 
foreshortened future.   
In addition, patients typically can exhibit signs of persistent arousal, (e.g. difficulty with sleep, 
increased irritability, concentration problems, scanning the environment for danger and a 
heightened startled response. Impacts on relationships and ability to work are common, as are 
secondary problems such as major depression, other anxiety disorders, alcohol and drug abuse, 





Cause: Follows catastrophic changes 
beyond classic PTSD criteria. It is 
common in individuals exposed to 
extreme social and/or interpersonal 
trauma (especially childhood sexual 
abuse). 
Symptoms:  PTSD, shame and guilt, 
anxiety and depression. 
Lasting personality changes, with 
chronic mood dysregulation being the 
classic hallmark of CPTSD, 
characterised by difficulties in 
regulating impulses, affects, attention, 
consciousness, self–perception and 
relationships with others. They report 
significant dissociation 
symptomatology, ranging from 
episodic experiences of derealisation 
to lasting amnesia for all or portions of 
the traumatic experiences 
 CPTSD individuals have negative view 
of themselves as being helpless, 
damaged and undesirable with strong 
feelings of shame and guilt. 
Cause: As with other mental disorders, the causes are 
complex and controversial. Childhood abuse and 
neglect have been found to be strongly associated.  
Researchers have suggested diverse possible causes 
such as genetic predisposition, neurobiological 
factors, environmental factors and or brain 
abnormalities. 
Symptoms: Heterogeneous condition with symptoms 
overlapping depressive, bipolar disorder, 
schizophrenic, impulsive, dissociative, and identity 
disorders with problems with hostility, anger and 
anger expression.  
Prolonged disturbance in personality with disturbance 
in identity and relationships with others being the 
hallmark of BPD, (seen in Attachment Disorder), 
characterised by rapid changes of mood with striking 
fluctuations from periods of confidence to times of 
absolute despair with fears of abandonment and 
rejection.  
BPD individuals have strong tendency towards suicidal 
thinking and self-harm. In extreme cases they 
experience transient psychotic and paranoid 
symptoms with greater fluctuations and variability 
with brief clear delusions and hallucinations, both 
visual and auditory. These are usually brief and linked 
to times of extreme emotional instability. 
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Assessment Instruments 
The reliability of diagnostic assessments for BPD has been considerably 
improved by introduction of ‘standardised interview schedules’. However, no 
single schedule has emerged as ‘the gold standard', as each has its advantages 
and disadvantages’ (NICE, 2008). There is still a heavy reliance on the diagnosis 
of BPD being made following unstructured clinical assessments, with consequent 
pitfalls, in obtaining agreement among clinicians, (i.e. poor inter-rater reliability) 
(Mellsop, 1982).  
Although NICE and the Department of Health have both recently recommended 
that clinicians should routinely ask patients about early childhood traumatic 
experiences, which might reveal abuse or neglect (NICE, 2008; DH, 2008), there 
still appears to be a problem that clinicians are not adequately assessing and 
efficiently recording histories of traumatic experiences and PTSD in patients 
given the diagnosis of BPD and hence may be missing vital information that 
potentially could help to facilitate recovery.  To date, although research has 
investigated both the link between childhood traumatic experiences and the 
development of BPD, and also the relationship between BPD and CPTSD, there 
is a clear need for an instrument to efficiently map childhood traumatic 
experiences and PTSD in the assessment of BPD. 
Recognised Area for Further Investigation 
NICE has suggested that a more reliable diagnosis should be made of BPD 
patients to enable the most appropriate interventions to be adopted, with the aim 
of reducing repeated hospital admissions, suicide, and costs to patients, their 
family members social relations, clinicians and the NHS (NICE, 2008). 
Stage 1 and Stage 1 Results 
The current project is part of a staged doctoral program of research, which will be 
completed in two stages. The aim of the first (completed) stage was to map 
current practice in Berkshire Healthcare Foundation NHS Trust (BHFT) for 
diagnosing BPD/CPTSD. That exercise was designed to inform the later 
development of a new, trauma sensitive screening instrument for assessing 
patients presenting in ways suggestive of BPD/CPTSD. To this end, a selection 
of medical records of patients diagnosed with BPD was examined to extract 
information on which life experiences clinicians have discussed with patients, and 
how that information has informed diagnosis and the formulation of the care plans 
which guide their treatment. This was supplemented by recording a selection of 
clinicians’ views on BPD/CPTSD and how that information had informed 
diagnosis and the formulation of the care plans guiding treatment. 
Records from BPD patients in psychiatric units operated by the Berkshire 
Healthcare NHS Foundation Trust were examined, and less than 3% of the 
patients did not give their permission for their notes to be examined, (Figure 2). 
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Figure 2: Clinicians’ Diagnosis from Medical Records 
CPTSD & BPD: -
2; 3%; 3%
PTSD & BPD: - 1; 
1%; 1%
BPD; 96%; 96% CPTSD & BPD: - 2
PTSD & BPD: - 1
BPD
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Figure 3: Trauma Recording, and Diagnosis as per DSM-IV Criteria  
 








PTSD & CPTSD; 
8; 13%
PTSD; 2; 3%
BPD: 46% trauma; 54% no truma 
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It appears that clinicians are recording adequate clinical information as per 
requirements to undertake DSM-IV diagnosis. That is, a full set of symptoms was 
located within the medical records for more than 82% of the BPD patients. 
However, from the analysis above, there was an apparent under-diagnosis of 
CPTSD and PTSD in the sample examined, and an apparent over-diagnosis of 
BPD. 
Although DMS-IV requires that 5 or more criteria to be present in order to assign 
a diagnosis of BPD, clinicians in Berkshire on 88% of occasions appear to be 
satisfied with less than 5 BPD criteria, and on 15% of occasions were willing to 
assign a BPD diagnosis with only a single BPD criterion present. This particular 
result is consistent with a recent large-scale survey of American clinicians 
(Westen, 1997)(Westen et al., 1997), and was not of undue concern to the 
Steering Group (p.11 below). The initial results largely confirmed expectations 
from literature that a significant proportion of cases of BPD can potentially be re-
conceptualised as PTSD associated with childhood abuse (Lineham, 1993; 
Herman, 1992). There is a need now to examine the value of the proposed 
changes in assessment to include screening for trauma, PTSD and CPTSD. 
Second Stage: Trauma Screening followed by Assessment 
Stage 2 Objectives 
At present there is no specific trauma screening instrument in regular use in 
patients with BPD in Berkshire. 
The aims of this second (PhD) stage are: 
 To develop a brief trauma screening instrument for clinicians to facilitate the 
discrimination of BPD patients with possible CPTSD/ PTSD diagnosis. 
 To test the new brief trauma screening instrument against the gold-standard 
clinical instruments for the identification of PTSD and CPTSD/DESNOS  
 To compare the percentages of Trauma, PTSD, CPTSD and BPD identified 
in this screening trial with the results of Stage 1  
 To compare all results with the latest information from academic literature 
 
Stage 2 Data Collection Method 
The Second Stage methodology builds on the results of Stage One.  
This Stage is described in Roadmap in Figure 5 (with elements marked A-H in 
line with the bullet points below).  
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A. Has anyone ever made you have any form of sex against your will?   
Indicate nature of relationship with person _______________  
e.g. stranger, friend, relative, parent, and sibling  
B. Has anyone, including family members or friends, ever attacked 
you with a gun, knife or some other weapon?  
C. Has anyone ever touched private parts of your body, or made you 
touch theirs, under force or threat?  
D. Has anyone in your family ever beaten, spanked or pushed you 
hard enough to cause injury?  
E. Have you experienced any other extraordinarily stressful situation 
or event that is not covered above? ____________________ 
Is it is another aspect such 
as parents/guardians not 
stopping it?   What aspect?  
_______________________ 
Advise patients that talking about 
upsetting events can trigger more 
flashbacks  
Remind patients to use grounding 
techniques at home when upset 
If that does not work, patient should be 




Patient Number: XXXXXX  
Is the abuse itself the 
most upsetting aspect of 
the event for you? 
 
Do you sometimes remember this so vividly that you feel 
that you are reliving the event?  
Which one event is most upsetting and troublesome for you?   
_________________________________________________ 





No PTSD or CPTSD referral: 
Continue BPD assessment  
Outcome 2 
CPTSD presentation 




Refer for PTSD assessment 
Before age 13 are there any events 
that stand out that cause you 
nightmares or flashbacks? 
Yes to any 
Question 
If nothing volunteered, ask the following 
supplementary questions: 
These are some questions about possible traumatic experiences in your past that may have upset you, but not 
everyone will have such experiences.   If necessary we will refer you for further assessment. 
 
YES YES 
If Patient gets upset:  show how to use simple grounding strategies 
Outcome 1 
No PTSD or CPTSD referral: 
Continue BPD assessment  
Trauma Screening Questionnaire, Pilot Version, v00-3
OR 
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assessment will take place immediately following the screening. After this the 
results will be compared 
E. Based subsequently on the clinical evidence that will be collected, and 
feedback from the clinical community and the Steering Group, the screening 
instrument will be refined if necessary 
F. Following the Pilot study, all remaining participants will then be systematically 
screened for trauma and PTSD/CPTSD, using the finalised screening 
instrument. And as with the Pilot section, all patients will also be given an in-
depth PTSD/CPTSD assessment 
G. Following completion of the assessment process, with the patient’s 
permission, the researcher will inform the patient’s consultant/responsible 
clinician of any clinically relevant findings together with recommendations as 
to which participants it would be appropriate to refer to the Berkshire 
Traumatic Stress Service, which is headed by a member of the Project 
Steering Group 
H. BPD treatment will continue unchanged for all patients, both those who are 
referred to the trauma services and those who are not, for as long as clinically 
necessary 
 
For all of Stage 2, an independent clinician will undertake the screening and the 
researcher will undertake the assessment of the participants. 
Inclusion Criteria 
 Clinical diagnosis of Borderline Personality disorder 
 Age 18 or over (no upper age limit) 
 Able to give informed consent 
 Currently receiving psychiatric care from the participating NHS Trust 
Exclusion Criteria 
 Age Less than 18 
 Unable to speak English 
 Acutely Distressed 
 Significant learning disability 
 Unable to give informed consent 
  
Participants: 
All participants in the previous study were consented in person by the applicant. 
The original consent was just to allow the researcher to access participants’ 
medical records but participants were told that this review of medical records 
would form the first part of a two-part study. Participants were asked whether 
they would be willing to be contacted about possibly participating in the second 
part of the study which would be likely to involve a more in-depth assessment. 
All participants without exception expressed an interest in being contacted about 
taking part in the second part of the study. 
 
For the participants who expressed an interest in being contacted about the 
taking part in the second part of the study, The researcher will liaise with relevant 
clinicians to determine that these patients still meet the inclusion criteria and are 
  
Stage 2 Protocol  A16-10 
not currently acutely distressed before re-contacting them and ascertaining if 
they would still be interested in participating.  
 
Contacting these patients will be in two forms. 
 
1. At the start of stage 1 of this project, the clinical staff requested presentations 
to be given to potential participants in their BPD groups at their therapeutic 
treatment units. This was found to be very helpful to explain the project to 
the patients. This will be done again to explain the aims of the project and 
the nature of participation will also be explained. The PIS will be made 
available. As for stage 1, any patients who express interest in the study will 
then be given a copy of the PIS and will have at least 24 hours to consider 
whether or not they wish to take part. Once they agree verbally, the 
researcher will be available to provide a further verbal explanation of the 
study, answer patients’ questions if requested and obtain consent. Once 
consent has been obtained the researcher will liaise with the patient and with 
relevant clinicians to arrange a date and time for the administration of the 
screening tool and the in-depth interview 
 
2. For patients who still meet the criteria and are interested in participating but 
are either unavailable for presentations or did not want to join the 
presentation, the researcher will seek permission from their clinicians to re-
contact them. Once re-contacted, the same procedure as above will be 
followed: 
 
 Explain the nature of their participation 
 Ascertain whether they are still interested in participating in the research 
 Give a copy of the PIS 
 As usual give 24 hrs. for patient to consider taking part 
 After that the researcher will be available to provide further explanation, 
answer any questions and obtain written consent 
 Once consent has been obtained the researcher will liaise with the patient 
and with relevant clinicians to arrange a date and time for the administration 
of the screening tool and the in-depth interview 
 
If necessary, any new participants would be recruited using the methods 
approved by the Faculty Research Ethics Committee at Thames Valley 
University and by the Oxford B NHS Research Ethics Committee for recruitment 
of participants to stage 1 of this study (Application number 10/H0605/23). That 
is: if new participants are required, patients diagnosed with BPD who meet the 
inclusion criteria will be approached by a member of their own health-care team 
and given a verbal explanation of the study. Any patients who express interest 
in the study will then be given a copy of the PIS and will have at least 24 hours 
to consider whether or not they might wish to take part. Once they agree 
verbally, the researcher will be introduced to them and will provide a further 
verbal explanation of the study, answer patients questions and obtain consent. 
Once consent has been obtained the researcher will liaise with the patient and 
with relevant clinicians to arrange a date and time for the administration of the 
screening tool and the in-depth interview. For new patients it will also be 
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necessary, as in stage 1, to anonymously record key medical information from 
their notes. The Consent form accounts for this possibility. 
Stage 2 Data Analysis 
The CAPS, SIDES and BTES will generate predominantly quantitative data. This 
will be supplemented by the use of descriptive analysis. 
 
The predominant presentation of the results of the screening/interview process 
will be descriptive but we will also use linear discriminant and principal 
components techniques. The statistical analysis will be undertaken by the 
applicant aided by her supervisors. Any uncertainties about diagnostic or other 
issues relating to specific participants will be discussed first with the applicant’s 
clinical supervisor Professor Suzanna Rose and then with other member of the 
Steering Group as required. 
Risks to Participants 
All participants will be under current specialist psychiatric care and will have 
access to support from trained mental health clinicians. Discussing traumatic 
events which occurred in an individual’s past may be temporarily distressing for 
some participants but some participants will undoubtedly receive benefit by being 
referred for appropriate psychological therapies and future patients may benefit 
from increased diagnostic precision. Other participants may receive benefit from 
feeling that they have been listened to and taken seriously and from knowing that 
they have contributed to a scientific research project.  
 
It is also current Department of Health Policy as articulated in the ‘Refocusing the 
Care Programme: Approach and Practice Guidelines’ (DH, 2008), that mental 
health clinicians should ask all mental health service users about their abuse 
history. To quote directly from the above document: ‘Childhood experience of 
sexual and other abuse is known to be more frequent in the histories of individuals 
with both mental illness and personality disorders (MHNFS, 1999). Research 
indicates that around 50% of women service users have been sexually victimised 
as children, notwithstanding further abuse in adulthood and a significant number 
of men service users have also experienced abuse. It is now DH policy that, 
following appropriate training for staff, exploration of violence and abuse is 
routinely undertaken in all mental health assessments. Questions should be 
asked by suitably trained staff at assessment about the experience of physical, 
sexual or emotional abuse at any time in the service user’s life. The response, 
with brief details, should be recorded in the case records/care plans. If the specific 
question is not asked, the reason(s) for not doing so should be recorded.’  
 
In general, well-conducted research interviews are likely to be interesting, 
engaging and reassuring rather than distressing. In support of this, Griffin et al. 
(2003) have reported on the outcomes of 430 individuals including n=260 victims 
of domestic violence, n=108 rape victims and n=62 victims of physical assault 
who were subject to research trauma assessments including the CAPS interview 
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(Blake et al., 1995) which is to be used in this project. Griffin et al. (2003) 
concluded that ‘Results indicated that participation was very well tolerated by the 
vast majority of trauma survivors. Participants generally found that the 
assessment experience was not distressing and was, in fact, viewed as an 
interesting and valuable experience. The findings suggest that trauma survivors 
are not too fragile to participate in trauma research even in the acute aftermath 
of a traumatic experience’. Similarly, Jorm et al., (2007) conducted a systematic 
review of participant distress in  psychiatric research including a number of 
studies relating to a range of traumatic and other distressing experiences and 
concluded that ‘a minority of participants become distressed but there is no 
evidence of longer term harm’.  
The Screening Instrument starts by explaining to the patient that he or she might 
experience an increase in unwanted distressing memories and this is normal 
when one discusses adverse life experiences. If this occurs, the patient is advised 
to use what are called ‘grounding techniques’. This is a common practice in any 
patient/clinician interface with this client group and these simple techniques will 
be discussed with patients at the beginning of the screening. If any memories 
become significantly distressing, participants will be advised to contact their 
keyworker who will offer support and advice.  From the Information sheet and 
verbal explanation of the study, participants will know that they can stop the 
assessment and/or withdraw from the study at any time, without prejudice and 
without affecting their treatment in any way.  
For every patient who discloses childhood sexual abuse or other forms of child 
abuse there must have been at least one abuser and it is possible that that person 
may still be alive and have access to children. The screening instrument does not 
ask participants to identify past abusers; only to record the broad nature of their 
relationship with the abuser (i.e. stranger, friend, relative, parent, and sibling). 
This is because the relationship with the abuser is required to differentiate 
between different types of abusive events associated with BPD and CPTSD 
respectively. This sensitive issue will be tackled according to normal trust policy 
and procedures, specifically, the Berkshire Healthcare NHS Foundation Trust’s 
Safeguarding of Adults Policy and Procedures (2008). This policy stipulates that 
any information that gives concern regarding the safety of the participant or other 
people in the community must be raised with the Trust Safeguarding Lead, and 
then with the Local Authority Safeguarding Team who will log all relevant 
information as reported by the clinician. This will be done regardless of the 
participant’s permission, as there could be risk to other individuals. This will be 
made clear to the patient at the beginning of the interview session. This has to be 
done because there is the possibility that the participant could disclose the 
information to someone else and claim that they have told the clinician about it 
and that the authorities did nothing about it. 
If there is a disclosure of an abuse and or an abuser, Trust Policy is as follows: 
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a. Clinicians are advised not ask probing questions, but must explain that any 
reported abuse will be recorded in their notes and to record information as it 
is given to them using patients own words  
 
b. Any disclosure of abuse must be entered as an incident via the official data 
recording system (Datix), which will be seen by the safeguarding lead. This 
requires the safeguarding lead to complete the safeguarding section of this 
form as well as updating the patient’s notes. 
 
c. Concerns about abuse or actual abuse must also be raised formally with the 
Safeguarding team to the local Authority Safeguarding Team who will 
determine the next stage, as they do not get automatic notification. 
 
d. Where there is suspicion of a criminal offence the patient should be asked if 
they wish to report to the police. 
 
e. If they wish to report the alleged crime (to the police), they must be advised 
that this could lead to prosecution, although they do not have to prosecute if 
they do not wish to. However it is still the responsibility of the clinician 
(researcher) to report all concerns about abuse to the Safeguarding Adults 
team. 
 
f. This will then be reported to the Police who will deal with it as per Police 
procedures, such as any criminal investigation 
 
g. If the perpetrator could be a risk to others, then the police must always be 
made aware. Iif the perpetrator is not currently a risk to others (e.g. if they 
have passed away) and the patient does not wish to make a report, then it is 
acceptable not to inform the police 
 
h. Patients will be advised that they do not have to identify the abuser if they do 
not wish to. Patients should also be advised that once a report is made, it is 
likely that either the police or the local authority will request that the patient 
disclose the abusers’ identity 
 
i. Patients must be asked if the perpetrator is still around and whether or not 
he/she is in a position to further abuse the participant or any other children 
or adults 
 
j. If the abuser is around, identified, and is in apposition to abuse again, this 
will be reported to the police whether or not the patient wishes to prosecute 
 
k. Patients will be advised that, where there is abuse or neglect, action will be 
taken, and they will be involved as sensitively as possible. This process 
must be explained to ensure their full understanding. However, it is not 
possible to explain every consequence as these are dependent on the 
outcome of any subsequent investigation and/or criminal proceedings) 
 
l. Once informed, the local authority are obliged to put safeguarding measures 
in place with the agreement of the patient 
 
Proposed Ethical Procedures 
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No data with names of patients or clinicians will be removed from its source 
location. However, a list of patient’s names and hospital number etc. will be 
securely maintained at the source location. This is to aid good coverage, minimise 
the possibility of duplication, and the clearing of anomalies for external quality 
control. 
When collating records, a coded number will replace all names where the index 
relating names to codes will reside only at the source location. 
All (coded) records from the source will be kept in a secure electronic folder (i.e. 
kept in a file on a password protected computer). No paper records with 
participants’ names will leave the Hospital. 
 
No identifiable data will be stored any laptop computer. All data stored on laptop 
and university computers will be stored under research code-numbers. The file 
linking the research code number to patient identifiers will be stored only on a 
secure NHS computer.  The data files will also be stored in encrypted form. Only 
one laptop will ever be taken to the source location and all files will be made 
available for inspection at any time. 
No findings will be shared outside the Steering Group, and no publication will be 
attempted without Steering Group approval. 
No professionals will be contacted unless the approach has been approved by 
the project supervisor(s). All professionals to be contacted will receive an e-mail 
describing the study, with all required details listed in an information sheet agreed 
by the Steering Group. No interviews will be conducted unless consent has been 
received in discussions with Departmental Heads and consultants. 
Steering Group  
The Steering Group is an informal arrangement. It consists of a number of 
secondary care clinicians, specialist research development professionals, subject 
specialists as well as the course supervisor(s).  The consent of the Berkshire 
Medical Director was obtained for Stage 1 and will be re-sought for Stage 2. As 
before, the Steering Group participants have received a full briefing concerning 
the aims, objectives and methodology proposed. 
Patient Consent 
 Every patient who is to be screened and assessed will give full informed consent. 
Consent will be sought after patients have had time to study the Patient 
Information Sheet and have also received a verbal explanation of the study from 
researchers. Consent will be taken in writing and participants will be free to 
withdraw at anytime. 
Data Management and Storage 
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The master-file which links names linked to unique code numbers will be kept in 
a secure location on an NHS computer according to NHS data security practices. 
All other data will be stored under anonymised code numbers on password-
protected computer (personal laptop and university computer). No hard copy will 
be created where a participant could potentially be identified. 
Proposed Security Procedures 
All (coded) records from the source will be kept in a secured electronic folder (i.e. 
kept on a password protected computer). All records will be maintained on the 
secure NHS Master Global Intranet. The participant’s clinical team will have full 
access to all participants’ personal data. 
Project Management    







Stage 2 Patient Information Sheet A17-1 
APPENDIX 17  Patient Information Sheet, Stage 2 
Trauma in Borderline Personality Disorder 
Is Complex Post Traumatic Stress Disorder (CPTSD) under recognised in 
Borderline Personality Disorder (BPD)?' 
1. You are invited to take part in the second stage of a Study about trauma in borderline 
personality disorder (BPD). This study is principally concerned with negative childhood 
experiences that may have caused you stress.  
 
2. Before you agree to take part, it is important for you to understand why the research is 
being done and what it will involve. Please take time to read this information carefully and 
discuss it with others if you wish. If there is anything that is not clear, or if you would like 
more information, please feel free to contact the researcher Doris Tallon using the contact 
number given at the end of this information sheet. 
 
3. Alternatively you may wish to speak to a representative from the Patients Advice and 
Liaison Services (PALS), Trevor Lyalle, 0118 960 5027 who should also be able to answer 
questions and discuss participation in research with you. This study will form part of Doris 
Tallon's PhD research at Oxford Brookes University. 
 
4. Purpose of the study 
The overall aim of this study is to test a new brief screening tool (questionnaire) designed 
to try and identify patients diagnosed with BPD who have experienced significant traumas 
and other distressing events in their lives. This information should help clinicians offer the 
most appropriate care and treatment to their patients.  The screening tool is new and we do 
not know whether it will be useful or not, so we need to compare the results it gives with 
results obtained from assessing patients using well-established but longer questionnaires. 
 
5. Why have I been invited?  (For the patients that participated in stage 1) 
You have been invited because you have received care for BPD from the Berkshire 
Healthcare NHS Foundation Trust, and when you were approached about our previous 
study - Life Experiences & the Diagnosis of Mental Health Problems you expressed 
interest in hearing about the second stage of our research. 
 
Why have I been invited?   (For potential new Participants)  
You have been invited because you are receiving care for Borderline Personality Disorder, 
and your healthcare team has identified you because you meet the inclusion criteria for this 
research.
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6. Do I have to take part? 
No, your participation is entirely voluntary. You do not have to take part if you do not 
want to. If you decide not to take part, this will not affect your treatment or entitlement 
to services. Furthermore, you can withdraw your consent at any time, without having to 
give a reason and this will not affect your treatment in any way. 
 
7. What will happen to me? 
You will be giving up about two hours of your time to attend the screening and 
assessment interview about your past experiences. This will be in two parts in the same 
session including a short break if required. This will take place at the hospital during 
your regular attendance. 
 
8. Payment   
There will not be any payment for your participation. 
 
9. What do I have to do?  
If you decide to take part, you will be asked to sign a consent form and we will then 
arrange a screening and assessment interview with you. The first part (screening) will be 
with an independent clinician using a new instrument for screening trauma in BPD 
patients. The second part will be an assessment with the researcher using standard 
assessment forms: CAPS (Clinician-Administrated PTSD Scale) and SIDES (Structured 
Interview for Disorders of Extreme Stress Not Otherwise Specified). 
 
10. What are the possible risks or disadvantages to me for taking part? 
When you are asked about your past experiences, some of these experiences may be 
difficult to talk about because stressful and very upsetting things may have happened to 
you. Discussing these experiences may temporarily bring back uncomfortable and 
distressing memories or feelings. However, quite often people find that talking about 
past experiences can actually be helpful. It will be up to you to decide how much you 
want to tell the interviewer. As we go along, if you find yourself getting upset, or you 
don’t understand anything, let the interviewer know and we can slow down and talk 
about it.  
 
If you have experienced sexual or physical abuse in the past, you may also be concerned 
about the possibilities of disclosure of this abuse. As discussed in the confidentiality 
paragraph, our sessions will remain confidential. However we have a duty to report or 
share information with the Trust Safeguarding Team if we have concerns about your 
safety or that of others. The diagram below shows the disclosure process that has been 
put in place by the Trust to protect you and others who may be at risk.  
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It will be up to you to decide how much you want to tell the interviewer.  Your 
participation in the research can be suspended or stopped altogether, at any time with no 
disadvantage to you. 
 
16. What if something goes wrong? (What if there is a problem?) 
It is unlikely that taking part in this study will harm anyone; however this study is 
covered by Oxford Brookes University’s insurance policy. If you are harmed due to 
someone’s negligence, then you may have grounds for legal action, but you may have to 
pay for it. Regardless of this, if you have any concerns, you can speak to your clinical 
staff or the researcher.  
 
If you wish to complain about the way that you have been treated in this study, the 
normal NHS and Oxford Brookes University complaints mechanism will be fully 
available to you. If you have any concerns about the conduct of the study, please contact 
Hazel Abbott, the Chair of the Faculty Research Ethics Committee – 
heabbott@brookes.ac.uk. 
 
17. What will happen to the results of the study? 
When the study is finished, we hope to use the information to continue the development 
of the new screening tool for patients with problems similar to yours. We also hope to 
publish the results in academic journals, in various mental health publications, and to 
present the findings of the study at conferences and research meetings, but will ensure 
that no individual participant in the study can be identified. You may also request a copy 
of the findings. 
 
18. Who is organising this research? 
The study will form part of the researcher’s thesis as part of her doctoral studies at 
Oxford Brookes University.  
 
19. Who has reviewed this study? 
All research in the NHS has to be looked at by an independent group of people called 
the Research Ethics Committee to protect your safety, rights, wellbeing and dignity.  
This study has been given a favourable ethical opinion by the National Research Ethics 
Service - Portsmouth Research Ethics Committee, and the Faculty of Health and Life 
Science Research Ethics Committee at Oxford Brookes University. 
 
20. Contact for further information 
For further information about the study, please contact: Researcher: Doris Tallon, 
11117615@brookes.ac.uk 07779728985 or Dr. Sue McLaughlin, Consultant Nurse 
Sue.Mclaughlin@berkshire.nhs.uk 0118 9605000 who is familiar with the Research. 
Thank you very much for taking the time to read this information sheet, which is now 
yours to keep.  
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APPENDIX 18  Clinician Information Sheet, Stage 2 
Participant Information Sheet for Clinicians 
Trauma in Borderline Personality Disorder: 'Is Complex Post Traumatic Stress 
Disorder (CPTSD) under recognised in Borderline Personality Disorder (BPD)?’ 
Dear Colleague 
My name is Doris Tallon; having worked for several years as a clinical trauma specialist 
in the Erleigh Road Trauma Services Centre, I am currently undertaking research at 
Oxford Brookes University. The research project is entitled “A Study of Trauma in 
Borderline Personality Disorder (BPD); is Complex PTSD (CPTSD) under recognised in 
diagnosing BPD?” This is the beginning of the second part of a doctoral programme of 
research aimed at assessing a reported weakness in BPD diagnosis.  You may already be 
familiar with this project, as it has already been presented to a number of clinicians in 
February at Prospect Park.  
The first stage of this research is complete. Using patients’ medical records, and with full 
support and cooperation of clinical staff, I measured current practices in the diagnosis 
of PTSD/CPTSD for borderline patients in Berkshire. In particular, I measured the use of 
assessment instrument(s), the documentation of trauma history, and symptoms against 
the DSM-IV diagnostic criteria for BPD, PTSD and CPTSD (listed in the DSM as Disorders 
of Extreme Stress Not Otherwise Specified - DESNOS). I then recorded how this informed 
their care plan, and treatment(s). Preliminary findings support the research hypothesis 
that PTSD/CPTSD is under recognised in this patient group. Building on this work I have 
developed a screening instrument to facilitate delineating BPD from PTSD/CPTSD, using 
a subset of the same patients.  
This second stage will now test the Screening Instrument for its reliability and sensitivity, 
and also its validity against gold standard PTSD & CPTSD/DESNOS assessment 
instruments. Patients from Stage 1 have already verbally agreed to participate in a 
subsequent assessment.  All participants in Stage 1 will now be informed about the 
second stage of the study and invited to take part in it. Depending on the actual number 
of Stage 1 patients that grant their approval, a few new patients may be needed. 
Following consent, an independent clinician will use the new instrument to screen 
participants, and they will then be assessed by me in an interview which will use the 
CAPS for PTSD and SIDES for DESNOS tools and the results of the interview will be 
compared to the results from the screening instrument.  
Ethical approval has been granted by the National Research Ethics Service and by Oxford 
Brookes University and Berkshire Healthcare NHS Foundation Trust has agreed to the 
project going ahead. 
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What do you have to do? 
You are requested to give your agreement for the researcher to approach Stage 1 
participants who have already given verbal consent.   
 
If sufficient Stage 1 patients do not provide consent, I may revert to you to approach 
new patients that meet the criteria below for inclusion.  As with Stage 1, any new 
potential participants will initially be approached by a member of their direct 
healthcare team who should informally discuss the research project with them and 
explain how they could help. All patients (Stage 1 or new) who express an interest in 
the study will be then be given a copy of the Patient Information Sheet which 
emphasises the voluntary nature of their participation, and they will have at least 24 
hours to consider whether or not they might wish to take part. Once they agree 
verbally then the researcher will be (re) introduced to them to answer any further 
questions they may have and take consent. Once consent has been obtained I will 
liaise with the patient and with you to arrange a date and time for the administration 
of the screening tool and the in-depth interview. 
 
Inclusion criteria for all participants (already satisfied for Stage 1 participant) 
 
 Must know and understand their diagnosis 
 Age 18 or over (no upper age limit), diagnosed with BPD 
 Must be able to give informed consent to participate in the study 
 Be an in or out patient of the participating Trust 
 Able to speak English 
Principal exclusion criteria  
 
 Acutely distressed 
 Significant learning disability 
 Not aware of their diagnosis of BPD 
 
Administrating of Screening Tool 
An important part of this research is to have an independent clinician administer the 
new screening instrument. I would like to discuss with you if you are willing to 
participate in this activity  
Further Information 
If you require further information then please do not hesitate to contact me by e-mail 
or phone (below). I am truly grateful for your co-operation in this matter both in the 
past and the future. Your time and the participation in this study will be greatly 
appreciated. 
Thank you,  
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APPENDIX 19  Trust Safeguarding Procedure 
Trust Policy Safeguarding of Adults Policy and Procedures (2008) 
 
 Clinicians are advised not ask probing questions, but must explain that any reported abuse 
will be recorded in their notes and to record information as it is given to them using patients own 
words  
 
 Any disclosure of abuse must be entered as an incident via the official data recording system 
(datix), which will be seen by the safeguarding lead. This requires the safeguarding lead to complete 
the safeguarding section of this form as well as updating the patient’s notes. 
 
 Concerns about abuse or actual abuse must also be raised formally with the Safeguarding 
team to the local Authority Safeguarding Team who will determine the next stage, as they do not get 
automatic notification. 
 
 Where there is suspicion of a criminal offence the patient should be asked if they wish to 
report to the police. 
 
 If they wish to report the alleged crime (to the police), they must be advised that this could 
lead to prosecution, although they do not have to prosecute if they do not wish to. However it is still 
the responsibility of the clinician (researcher) to report all concerns about abuse to the Safeguarding 
Adults team. 
 
 This will then be reported to the Police who will deal with it as per Police procedures, such as 
any criminal investigation 
 
 If the perpetrator could be a risk to others, then the police must always be made aware. If the 
perpetrator is not currently a risk to others (e.g. if they have passed away) and the patient does not 
wish to make a report, then it is acceptable not to inform the police 
 
 Patients will be advised that they do not have to identify the abuser if they did not wish to. 
Patients should also be advised that once a report is made, it is likely that either the police or the 
local authority will request that the patient must disclose the abusers’ identity 
 
 Patients must be asked if the perpetrator is still around and whether or not he/she is in a 
position to further abuse the participant or any other children or adults 
 
 If the abuser is around, identified, and is in apposition to abuse again, this will be reported 
to the police whether or not the patient wishes to prosecute 
 
 Patients will be advised that, where there is abuse or neglect, action will be taken, and they 
will be involved as sensitively as possible. This process must be explained to ensure their full 
understanding. However, it is not possible to explain every consequence as these are dependent 
on the outcome of any subsequent investigation and/or criminal proceedings) 
 
 Once informed, the local authority are obliged to put safeguarding measures in place with 
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APPENDIX 20  Consent Form, Stage 2 
CONSENT FORM 
Patient Identification Number:_______  Research Project: Stage 2, Trauma in Borderline 
Personality Disorder 'Is Complex Post Traumatic Stress Disorder (CPTSD) under recognised in 
Borderline Personality Disorder (BPD)? 
                                                                                                                       Please 
Initial box  
 I confirm that I have read and understand the information sheet 
dated .........................version….. for the above study  
 I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily  
 I understand that my participation is voluntary and that I am free to 
withdraw at any time, including during any assessment, without giving 
any reason, without my medical care or legal rights being affected  
 I understand that sections of my medical notes may be looked at by 
responsible individuals from the NHS Trust where it is relevant to my 
taking part in this research. I give permission for these individuals to 
have access to my records. 
 
 I agree to take part in the study ‘Trauma in Borderline Personality 
Disorder 'Is Complex Post Traumatic Stress Disorder (CPTSD) under 
recognised in Borderline Personality Disorder (BPD)?’  
 I agree to my consultant being informed of my participation in the 
study, and to be kept informed of all results  
 I agree to have the session(s) audio-recorded   














Name of Person taking consent  
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APPENDIX 21  NHS Ethics, Stage 2 
  
Stage 2, NHS Ethics  A21-2  
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…
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APPENDIX 23  University Ethics Approval, Stage 2 
 
Oxford Brookes University 
Faculty of Health and Life Sciences 
Research Ethics Committee 
 
Scientific Peer Review Form 
The Research Ethics Committee (REC) of the Faculty of Health and Life Sciences have 
undertaken an independent scientific peer review of the following research proposal:   
 
Project Title: Trauma and diagnosis of BPD: is CPTSD under-recognised in diagnosing BPD? 
Name of Researcher: Doris Tallon   
Name of Research Supervisor: Professor Nigel Wellman 
Faculty REC Application Number: 2011/15 
 
Following review on 09/02/12 and 18/05/12, the above research is considered to ethically and 
scientifically sound (see attached letters). 
 
Signed: …………………………………………..Hazel Abbott………………………………………………………………… 
Designation: Departmental Research Ethics Officer 
(Signed on behalf of the Faculty of Health and Life Sciences Research Ethics Committee) 
 
Date: …11/06/2012 ………………………..………………………………………………… 
Independent scientific peer review and ethics review undertaken by the following members 
of the Faculty REC: 
Mrs Hazel Abbott (Chair) Ms Gail Lansdown 
Professor David Foxcroft Dr Mandy Plumb 
Ms Morag Maclean Dr Sally Richards 
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APPENDIX 24  CAPS 
National Center for PTSD   
CLINICIAN-ADMINISTERED PTSD SCALE FOR DSM-IV  
  
Name: ___________________________ID # :_________________  
Date: _________________  
 
Interviewer: ___________________________  
Study: ___________________________  
Dudley D. Blake, Frank W. Weathers, Linda M. Nagy,   
Danny G. Kaloupek, Dennis S. Charney, & Terence M. Keane   
National Center for Posttraumatic Stress Disorder   
Behavioral Science Division -- Boston VA Medical Center   
Neurosciences Division -- West Haven VA Medical Center   
Revised July 1998 
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Criterion A.  The person has been exposed to a traumatic event in which both of the 
following were present:  
(1) the person experienced, witnessed, or was confronted with an event or events that 
involved actual or threatened death or serious injury, or a threat to the physical integrity 
of self or others  
(2) the person’s response involved intense fear, helplessness, or horror. Note: In children, 
this may be  expressed instead by disorganized or agitated behavior  
I 
’m going to be asking you about some difficult or stressful things that sometimes happen to 
people. Some examples of this are being in some type of serious accident; being in a fire, a 
hurricane, or an earthquake; being mugged or beaten up or attacked with a weapon; or being 
forced to have sex when you didn’t want to. I’ll start by asking you to look over a list of 
experiences like this and check any that apply to you. Then, if any of them do apply to you, I’ll 
ask you to briefly describe what happened and how you felt at the time.  
Some of these experiences may be hard to remember or may bring back uncomfortable 
memories or feelings. People often find that talking about them can be helpful, but it’s up to 
you to decide how much you want to tell me. As we go along, if you find yourself becoming 
upset, let me know and we can slow down and talk about it. Also, if you have any questions or 
you don’t understand something, please let me know. Do you have any questions before we 
start?  
ADMINISTER CHECKLIST, THEN REVIEW AND INQUIRE UP TO THREE EVENTS. IF MORE THAN 
THREE EVENTS ENDORSED, DETERMINE WHICH THREE EVENTS TO INQUIRE (E.G., FIRST, 
WORST, AND MOST RECENT EVENTS; THREE WORST EVENTS; TRAUMA OF INTEREST PLUS 
TWO OTHER WORST EVENTS, ETC.)  
IF NO EVENTS ENDORSED ON CHECKLIST:  (Has there ever been a time when your life was in 
danger or you were seriously injured or harmed?)  
IF NO:  (What about a time when you were threatened with death or serious injury, even if you 
weren’t actually injured or harmed?)  
IF NO:  (What about witnessing something like this happen to someone else or finding out that 
it happened to someone close to you?)  
IF NO: (What would you say are some of the most stressful experiences you have had over 
your life?)  
EVENT #1  
What happened?  (How old were you? Who 
else was involved? How many times did this 
happen? Life threat? Serious injury?) 
 
 
How did you respond emotionally?  (Were 
you very anxious or frightened? Horrified? 
Helpless? How so? Were you stunned or in 
shock so that you didn’t feel anything at all? 
What was that like? What did other people 
notice about your emotional response? What 
about after the event - how did you respond 
emotionally?)  
Describe (e.g., event type, victim, perpetrator, 
age, frequency): 
A. (1)  
Life threat?    NO YES      [self ___ other ___]  
Serious injury?    NO YES      [self ___ other ___]  
Threat to physical integrity?   NO YES   [self ___ 
other  
A. (2)  
Intense fear/help/horror?   NO YES   [during ___ 
after  
Criterion A met?    NO   PROBABLE   YES  
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EVENT #2  
What happened?  (How old were you? Who 
else was involved? How many times did this 
happen?  
Life threat? Serious injury?)  
How did you respond emotionally?  (Were 
you very anxious or frightened? Horrified? 
Helpless? How so? Were you stunned or in 
shock so that you didn’t feel anything at all? 
What was that like? What did other people 
notice about your emotional response? What 
about after the event - how did you respond 
emotionally?)  
Describe (e.g., event type, victim, perpetrator, 
age, frequency):  
A. (1)  
Life threat?    NO YES      [self ___ other ___]  
Serious injury?    NO YES      [self ___ other ___]  
Threat to physical integrity?   NO YES     [self ___ 
other  
A. (2)  
Intense fear/help/horror?   NO YES   [during ___ 
after ___]  
Criterion A met?    NO   PROBABLE   YES  
EVENT #3   
What happened?  (How old were you? Who 
else was involved? How many times did this 
happen?  
Life threat? Serious injury?)  
How did you respond emotionally?  (Were 
you very anxious or frightened? Horrified? 
Helpless? How so? Were you stunned or in 
shock so that you didn’t feel anything at all? 
What was that like? What did other people 
notice about your emotional response? What 
about after the event - how did you respond 
emotionally?)  
Describe (e.g., event type, victim, perpetrator, age, 
frequency):  
A. (1)  
Life threat?    NO YES      [self ___ other ___]  
Serious injury?    NO YES      [self ___ other ___]  
Threat to physical integrity?    NO YES      [self ___ 
other ___]  
A. (2)  
Intense fear/help/horror?    NO YES      [during 
___ after ___]  
Criterion A met?    NO   PROBABLE   YES  
 
For the rest of the interview, I want you to keep (EVENTS) in mind as I ask you some questions 
about how they may have affected you.  
I’m going to ask you about twenty-five questions altogether. Most of them have two parts. First, 
I’ll ask if you’ve ever had a particular problem, and if so, about how often in the past month 
(week). Then I’ll ask you how much distress or discomfort that problem may have caused you. 
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Criterion B.  The traumatic event is persistently reexperienced in one (or more) of the 
following ways:  
1. (B-1) recurrent and intrusive distressing recollections of the event, including images, thoughts, or 
perceptions.  
Note:  In young children, repetitive play may occur in which themes or aspects of the trauma are 
expressed.  
Frequency  
Have you ever had unwanted memories 
of (EVENT)? What were they like? 
(What did you remember?)  [IF NOT 
CLEAR:] (Did they ever occur while you 
were awake, or only in dreams?)  
[EXCLUDE IF MEMORIES 
OCCURRED ONLY DURING 
DREAMS] How often have you had 
these memories in the past month 
(week)?  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples   
Intensity  
How much distress or discomfort did 
these memories cause you? Were you 
able to put them out of your mind and 
think about something else?  (How hard 
did you have to try?) How much did they 
interfere with your life?  
0 None  
1 Mild, minimal distress or disruption of 
activities  
2 Moderate, distress clearly present but 
still manageable, some disruption of 
activities  
3 Severe, considerable distress, difficulty 
dismissing memories, marked 
disruption of activities  
4 Extreme, incapacitating distress, 
cannot dismiss memories, unable to 
continue activities  
QV (specify)  
______________________________  
Past week  
F _____  
I  _____  
Past month  
F _____  
I  _____  
Sx: Y N   
Lifetime F 
_____  
I  _____  
Sx: Y N   
2. (B-2) recurrent distressing dreams of the event. Note:  In children, there may be frightening dreams 
without recognizable content.  
Frequency  
Have you ever had unpleasant 
dreams about (EVENT)? Describe a 
typical dream.  (What happens in 
them?)  How often have you had 
these dreams in the past month 
(week)?  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples  
Intensity  
How much distress or discomfort did 
these dreams cause you? Did they ever 
wake you up?  [IF YES:] (What happened 
when you woke up? How long did it take you 
to get back to sleep?)  [LISTEN FOR 
REPORT OF ANXIOUS AROUSAL, 
YELLING, ACTING OUT THE  
NIGHTMARE] (Did your dreams ever affect 
anyone else? How so?)  
0 None  
1 M ild, minimal distress, may not have 
awoken  
2 Moderate, awoke in distress but readily 
returned to sleep  
3 Severe, considerable distress, difficulty 
returning to sleep  
4 Extreme, incapacitating distress, did not 
return to sleep  
QV (specify)  
______________________________  
Past week  
F _____  
I  _____  
Past month  
F _____  
I  _____  
Sx: Y N   
Lifetime F 
_____  
I  _____  
Sx: Y N   
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3.  (B-3)  acting or feeling as if the traumatic event were recurring (includes a sense of reliving 
the experience, illusions, hallucinations, and dissociative flashback episodes, including those that 
occur on awakening or when intoxicated).  Note:  In young children, trauma-specific reenactment 
may occur.  
Frequency  
Have you ever suddenly acted or felt as 
if (EVENT) were happening again?  (Have 
you ever had flashbacks about [EVENT]?)  
[IF NOT CLEAR:] (Did this ever occur while 
you were awake, or only in dreams?)  
[EXCLUDE IF  
OCCURRED ONLY DURING DREAMS] 
Tell me more about that. How often has 
that happened in the past month (week)?  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples  
Intensity  
How much did it seem as if (EVENT) 
were happening again?  (Were you 
confused about where you actually were 
or what you were doing at the time?)  
How long did it last? What did you do 
while this was happening?  (Did other 
people notice your behavior? What did 
they say?)  
0 No reliving  
1 Mild, somewhat more realistic than 
just thinking about event  
2 Moderate, definite but transient 
dissociative quality, still very aware 
of surroundings,  
daydreaming quality  
3 Severe, strongly dissociative 
(reports images, sounds, or smells) 
but retained some awareness of 
surroundings  
4 Extreme, complete dissociation 
(flashback), no awareness of 
surroundings, may be 
unresponsive, possible amnesia for 
the episode (blackout)  
QV (specify)  
_______________________________  
Past week  
F _____  
I  _____  
Past month  
F _____  
I  _____  
Sx: Y N   
Lifetime F 
_____  
I  _____  
Sx: Y N   
4. (B-4) intense psychological distress at exposure to internal or external cues that symbolize or 
resemble an aspect of the traumatic event  
Frequency  
Have you ever gotten emotionally 
upset when something reminded you 
of (EVENT)?  (Has anything ever 
triggered bad feelings related to  
[EVENT]?)  What kinds of reminders made 
you upset? How often in the past month 
(week)?  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples   
Intensity  
How much distress or discomfort did  
(REMINDERS) cause you? How long 
did it last? How much did it interfere 
with your life?  
0 None  
1 Mild, minimal distress or disruption 
of activities  
2 Moderate, distress clearly present 
but still manageable, some 
disruption of activities  
3 Severe, considerable distress, 
marked  
disruption of activities  
4 Extreme, incapacitating distress, 
unable to continue activities  
QV (specify)  
_______________________________  
Past week  
F _____  
I  _____  
Past month  
F _____  
I  _____  
Sx: Y N   
Lifetime F 
_____  
I  _____  
Sx: Y N   
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5.  (B-5)  physiological reactivity on exposure to internal or external cues that symbolize or 
resemble an aspect of the traumatic event  
Frequency  
Have you ever had any physical 
reactions when something reminded you 
of (EVENT)? (Did your body ever react in 
some way when something reminded you of 
[EVENT]?)  Can you give me some 
examples?  (Did your heart race or did your 
breathing change? What about sweating or 
feeling really tense or shaky?)   What kinds 
of reminders triggered these reactions? 
How often in the past month (week)?  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples   
Intensity  
How strong were (PHYSICAL 
REACTIONS)?  
How long did they last?  (Did they last 
even after you were out of the situation?)  
0 No physical reactivity  
1 Mild, minimal reactivity  
2 Moderate, physical reactivity clearly 
present, may be sustained if 
exposure continues  
3 Severe, marked physical reactivity, 
sustained throughout exposure  
4 Extreme, dramatic physical reactivity, 
sustained arousal even after 
exposure has ended  




F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
Criterion C. Persistent avoidance of stimuli associated with the trauma and numbing of 
general responsiveness (not present before the trauma), as indicated by three 
(or more) of the following:  
6. (C-1) efforts to avoid thoughts, feelings, or conversations associated with the trauma   
Frequency  
Have you ever tried to avoid 
thoughts or feelings about 
(EVENT)?  (What kinds of thoughts 
or feelings did you try to avoid?)  
What about trying to avoid talking 
with other people about it?  (Why 
is that?)  How often in the past 
month (week)?  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples   
Intensity  
How much effort did you make to avoid  
(THOUGHTS/FEELINGS/CONVERSATIONS)?  
(What kinds of things did you do? What about 
drinking or using medication or street drugs?)  
[CONSIDER ALL ATTEMPTS AT 
AVOIDANCE,  
INCLUDING DISTRACTION, SUPPRESSION, 
AND USE OF ALCOHOL/DRUGS] How much 
did that interfere with your life?  
0 None  
1 M ild, minimal effort, little or no disruption 
of activities  
2 Moderate, some effort, avoidance 
definitely present, some disruption of 
activities  
3 Severe, considerable effort, marked 
avoidance, marked disruption of activities, 
or involvement in certain activities as 
avoidant strategy  
4 Extreme, drastic attempts at avoidance, 
unable to continue activities, or excessive 
involvement in certain activities as 
avoidant strategy  




F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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7. (C-2) efforts to avoid activities, places, or people that arouse recollections of the trauma   
Frequency  
Have you ever tried to avoid certain 
activities, places, or people that 
reminded you of (EVENT)?  (What 
kinds of things did you avoid? Why is 
that?)  How often in the past month 
(week)?  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples  
Intensity  
How much effort did you make to avoid  
(ACTIVITIES/PLACES/PEOPLE)?  (What did 
you do instead?)  How much did that 
interfere with your life?  
0 None  
1 M ild, minimal effort, little or no disruption 
of activities  
2 Moderate, some effort, avoidance 
definitely present, some disruption of 
activities  
3 Severe, considerable effort, marked 
avoidance, marked disruption of 
activities or involvement in certain 
activities as avoidant strategy  
4 Extreme, drastic attempts at avoidance, 
unable to continue activities, or 
excessive involvement in certain 
activities as avoidant strategy  
QV (specify)  
_______________________________  
Past week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
8. (C-3) inability to recall an important aspect of the trauma   
Frequency  
Have you had difficulty remembering 
some important parts of (EVENT)? 
Tell me more about that.  (Do you feel 
you should be able to remember these 
things? Why do you think you can’t?)  In 
the past month (week), how much of 
the important parts of (EVENT) have 
you had difficulty remembering?  
(What parts do you still remember?)  
0 None, clear memory  
1 Few aspects not remembered (less 
than 10%)  
2 Some aspects not remembered 
(approx 20- 
30%)  
3 Many aspects not remembered 
(approx 50- 
60%)  
4 Most or all aspects not remembered 
(more than 80%)  
Description/Examples  
Intensity  
How much difficulty did you have recalling 
important parts of (EVENT)?  (Were you 
able to recall more if you tried?)  
0 None  
1 M ild, minimal difficulty  
2 Moderate, some difficulty, could recall 
with effort  
3 Severe, considerable difficulty, even with  
effort  
4 Extreme, completely unable to recall 
important aspects of event  
QV (specify)  
_______________________________  
Past week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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9.  (C-4) markedly diminished interest or participation in significant activities   
Frequency  
Have you been less interested in 
activities that you used to enjoy?  (What 
kinds of things have you lost interest in? 
Are there some things you don’t do at all 
anymore? Why is that?)  
[EXCLUDE IF NO OPPORTUNITY, IF  
PHYSICALLY UNABLE, OR IF  
DEVELOPMENTALLY APPROPRIATE 
CHANGE  
IN PREFERRED ACTIVITIES] In the past 
month (week), how many activities have 
you been less interested in?  (What kinds 
of things do you still enjoy doing?) When 
did you first start to feel that way?  (After 
the [EVENT]?)  
0 None  
1 Few activities (less than 10%)  
2 Some activities (approx 20-30%)  
3 Many activities (approx 50-60%)  
4 Most or all activities (more than 80%)  
Description/Examples   
Intensity  
How strong was your loss of interest?  
(Would you enjoy [ACTIVITIES] once you 
got started?)  
0 No loss of interest  
1 M ild, slight loss of interest, probably 
would  enjoy after starting activities  
2 Moderate, definite loss of interest, but 
still has some enjoyment of activities  
3 Severe, marked loss of interest in 
activities  
4 Extreme, complete loss of interest, no 
longer participates in any activities  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past 
week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
10. (C-5) feeling of detachment or estrangement from others   
Frequency  
Have you felt distant or cut off from 
other people? What was that like? How 
much of the time in the past month 
(week) have you felt that way? When 
did you first start to feel that way? (After 
the [EVENT]?)  
0 None of the time  
1 Very little of the time (less than 10%)  
2 Some of the time (approx 20-30%)  
3 Much of the time (approx 50-60%)  
4 Most or all of the time (more than 
80%)  
Description/Examples   
Intensity  
How strong were your feelings of being 
distant or cut off from others?  (Who do 
you feel closest to? How many people do 
you feel comfortable talking with about 
personal things?)  
0 No feelings of detachment or 
estrangement  
1 M ild, may feel “out of synch” with 
others  
2 Moderate, feelings of detachment 
clearly present, but still feels some 
interpersonal connection  
3 Severe, marked feelings of 
detachment or estrangement from 
most people, may feel close to only 
one or two people  
4 Extreme, feels completely detached or 
estranged from others, not close with 
anyone  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past 
week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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11.  (C-6)  restricted range of affect (e.g., unable to have loving feelings)   
Frequency  
Have there been times when you 
felt emotionally numb or had 
trouble experiencing feelings like 
love or happiness? What was that 
like?  (What feelings did you have 
trouble experiencing?)  How much 
of the time in the past month 
(week) have you felt that way? 
When did you first start having 
trouble experiencing 
(EMOTIONS)?  (After the [EVENT]?)  
0 None of the time  
1 Very little of the time (less than 
10%)  
2 Some of the time (approx 20-
30%)  
3 Much of the time (approx 50-
60%)  
4 Most or all of the time (more 
than 80%)  
Description/Examples   
Intensity  
How much trouble did you have experiencing 
(EMOTIONS)?  (What kinds of feelings were you  
still able to experience?)  [INCLUDE  
OBSERVATIONS OF RANGE OF AFFECT 
DURING INTERVIEW]  
0 No reduction of emotional experience  
1 M ild, slight reduction of emotional 
experience  
2 Moderate, definite reduction of emotional 
experience, but still able to experience most 
emotions  
3 Severe, marked reduction of experience of 
at least two primary emotions (e.g., love, 
happiness)  
4 Extreme, completely lacking emotional 
experience  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 unlikely     
 Current  _____  Lifetime _____  
Past week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
12. (C-7)  sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, 
or a normal life span)  
Frequency  
Have there been times when you felt 
there is no need to plan for the future, 
that somehow your  
future will be cut short? Why is that?  
[RULE  
OUT REALISTIC RISKS SUCH AS LIFE- 
THREATENING MEDICAL CONDITIONS] 
How  
much of the time in the past month 
(week) have you felt that way? When 
did you first start to feel that way?  
(After the [EVENT]?)  
0 None of the time  
1 Very little of the time (less than 10%)  
2 Some of the time (approx 20-30%)  
3 Much of the time (approx 50-60%)  
4 Most or all of the time (more than 
80%)  
Description/Examples   
Intensity  
How strong was this feeling that 
your future will be cut short?  (How 
long do you think you will live? How 
convinced are you that you will die 
prematurely?)  
0 No sense of a foreshortened future  
1 M ild, slight sense of a 
foreshortened future  
2 Moderate, sense of a foreshortened 
future definitely present, but no 
specific prediction about longevity  
3 Severe, marked sense of a 
foreshortened future, may make 
specific prediction about longevity  
4 Extreme, overwhelming sense of a 
foreshortened future, completely 
convinced of premature death  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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Criterion D. Persistent symptoms of increased arousal (not present before the trauma), as 
indicated by two (or more) of the following:  
13. (D-1) difficulty falling or staying asleep   
Frequency  
Have you had any problems 
falling or staying asleep? How 
often in the past month (week)? 
When did you first start having 
problems sleeping?  (After the 
[EVENT]?)  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Sleep onset problems?  Y  N  
Mid-sleep awakening?           Y     N  
Early a.m. awakening?  Y  N  
Total # hrs sleep/night  _____  
Desired # hrs sleep/night  _____  
Intensity  
How much of a problem did you have with 
your sleep?  (How long did it take you to fall 
asleep? How often did you wake up in the 
night? Did you often wake up earlier than you 
wanted to? How many total hours did you 
sleep each night?)  
0 No sleep problems  
1 M ild, slightly longer latency, or minimal  
difficulty staying asleep (up to 30 
minutes loss of sleep)  
2 Moderate, definite sleep disturbance, 
clearly longer latency, or clear difficulty 
staying asleep (30-90 minutes loss of 
sleep)  
3 Severe, much longer latency, or marked 
difficulty staying asleep (90 min to 3 hrs 
loss of sleep)  
4 Extreme, very long latency, or profound 
difficulty staying asleep (> 3 hrs loss of 
sleep)  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
14. (D-2) irritability or outbursts of anger   
Frequency  
Have there been times when you 
felt especially irritable or showed 
strong feelings of anger? Can 
you give me some examples? 
How often in the past month 
(week)? When did you first start 
feeling that way?  (After the 
[EVENT]?)  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples   
Intensity  
How strong was your anger?  (How did you 
show it?)  [IF REPORTS SUPPRESSION:] (How 
hard was it for you to keep from showing your 
anger?) How long did it take you to calm 
down? Did your anger cause you any 
problems?  
0 No irritability or anger  
1 M ild, minimal irritability, may raise voice 
when  angry  
2 Moderate, definite irritability or attempts to 
suppress anger, but can recover quickly  
3 Severe, marked irritability or marked 
attempts to suppress anger, may become 
verbally or physically aggressive when 
angry  
4 Extreme, pervasive anger or drastic 
attempts to suppress anger, may have 
episodes of physical violence  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 unlikely     
 Current  _____  Lifetime _____  
Past week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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15.  (D-3)  difficulty concentrating   
Frequency  
Have you found it difficult to 
concentrate on what you were 
doing or on things going on 
around you? What was that like? 
How much of the time in the past 
month (week)? When did you first 
start having trouble 
concentrating? (After the 
[EVENT]?)  
0 None of the time  
1 Very little of the time (less than 
10%)  
2 Some of the time (approx 20-
30%)  
3 Much of the time (approx 50-
60%)  
4 Most or all of the time (more 
than 80%)  
Description/Examples   
Intensity  
How difficult was it for you to concentrate?  
[INCLUDE OBSERVATIONS OF  
CONCENTRATION AND ATTENTION IN  
INTERVIEW] How much did that interfere 
with your life?  
0 No difficulty with concentration  
1 M ild, only slight effort needed to 
concentrate, little or no disruption of 
activities  
2 Moderate, definite loss of concentration 
but could concentrate with effort, some 
disruption of activities  
3 Severe, marked loss of concentration 
even with effort, marked disruption of 
activities  
4 Extreme, complete inability to 
concentrate, unable to engage in activities  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past 
week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
16. (D-4)  hypervigilance   
Frequency  
Have you been especially alert or 
watchful, even when there was no 
real need to be?  (Have you felt as if 
you were constantly on guard?)  Why 
is that? How much of the time in 
the past month (week)? When did 
you first start acting that way?  
(After the [EVENT]?)  
0 None of the time  
1 Very little of the time (less than 
10%)  
2 Some of the time (approx 20-
30%)  
3 Much of the time (approx 50-
60%)  
4 Most or all of the time (more 
than 80%)  
Description/Examples   
Intensity  
How hard did you try to be watchful of 
things going on around you?  [INCLUDE  
OBSERVATIONS OF HYPERVIGILANCE IN 
INTERVIEW] Did your (HYPERVIGILANCE) 
cause you any problems?  
0 No hypervigilance  
1 M ild, minimal hypervigilance, slight 
heightening of awareness  
2 Moderate, hypervigilance clearly present, 
watchful in public (e.g., chooses safe place 
to sit in a restaurant or movie theater)  
3 Severe, marked hypervigilance, very alert, 
scans environment for danger, exaggerated 
concern for safety of self/family/home  
4 Extreme, excessive hypervigilance, efforts 
to ensure safety consume significant time 
and energy and may involve extensive 
safety/checking behaviors, marked 
watchfulness during interview  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 unlikely  
   
 Current  _____  Lifetime _____  
Past 
week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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17.  (D-5) exaggerated startle response  
Frequency  Intensity  Past 
week  
Have you had any strong startle 
reactions? When did that happen?  
(What kinds of things made you 
startle?)  How often in the past 
month (week)? When did you first 
have these  
How strong were these startle reactions?  
(How strong were they compared to how most 
people would respond?)  How long did they 
last?  
F _____  
I  _____  
reactions?  (After the [EVENT]?)  0 No startle reaction  
1 M ild, minimal reaction  
 
0 Never  
1 Once or twice  
2 Once or twice a week  
2 Moderate, definite startle reaction, feels 
“jumpy”  
3 Severe, marked startle reaction, sustained  
Past 
month  
F _____  
3  Several times a week  arousal following initial reaction  I  _____  
4  Daily or almost every day  4 Extreme, excessive startle reaction, overt 
coping behavior (e.g., combat veteran who  Sx: Y N   
Description/Examples  “hits the dirt”)  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 unlikely     
 Current  _____  Lifetime _____  
Lifetime 
F _____  
I  _____  
Sx: Y N   
Criterion E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 1 
month.   
18. onset of symptoms   
[IF NOT ALREADY CLEAR:] When did you first 
start having (PTSD SYMPTOMS) you’ve told me 
about?  (How long after the trauma did they start? 
More than six months?)  
________ total # months delay in onset  
With delayed onset (> 6 months)?      NO  
YES  
19. duration of symptoms   
 [CURRENT] How long have 
these (PTSD SYMPTOMS) 
lasted altogether?  
Duration more than 1 
month?  
Current 
NO    
YES  
Lifetime 
NO    YES  
[LIFETIME] How long did these  
(PTSD SYMPTOMS) last 
altogether?  
Total # months duration  
Acute (< 3 months) or 
chronic (> 3 months)?  
________  
acute   chronic  
________  
acute   chronic  
Criterion F. The disturbance causes clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.  
20. subjective distress   
[CURRENT] Overall, how much have you 
been bothered by these (PTSD SYMPTOMS 
0  None  Past week  
you’ve told me about?  [CONSIDER 




Mild, minimal distress  
Moderate, distress clearly present but 
still manageable  
_____ 
Past month  
[LIFETIME] Overall, how much were you  
3  
4  
Severe, considerable distress 
Extreme, incapacitating distress  _____  
bothered by these (PTSD SYMPTOMS) 
you’ve told me about? [CONSIDER 
DISTRESS  
REPORTED ON EARLIER ITEMS]  
  Lifetime  
CAPS Page 13   
 
21. impairment in social functioning  
[CURRENT] Have these (PTSD 
SYMPTOMS)  
0  No adverse impact  Past week  
affected your relationships with other 
people? How so?  [CONSIDER 
IMPAIRMENT IN SOCIAL  




Mild impact, minimal impairment in 
social functioning  
Moderate impact, definite impairment, 
but  
_____  
[LIFETIME] Did these (PTSD SYMPTOMS) 
affect  3  
many aspects of social functioning still 
intact Severe impact, marked 
impairment, few  
Past 
month  
your social life? How so? [CONSIDER 
IMPAIRMENT IN SOCIAL FUNCTIONING  
REPORTED ON EARLIER ITEMS]  
4  aspects of social functioning still intact 





22. impairment in occupational or other important area of functioning   
[CURRENT -- IF NOT ALREADY CLEAR] Are you 
working now?  
IF YES: Have these (PTSD SYMPTOMS) affected 
your work or your ability to work?  
How so?  [CONSIDER REPORTED WORK  
HISTORY, INCLUDING NUMBER AND  
DURATION OF JOBS, AS WELL AS THE  
QUALITY OF WORK RELATIONSHIPS. IF  
PREMORBID FUNCTIONING IS UNCLEAR,  
INQUIRE ABOUT WORK EXPERIENCES  
BEFORE THE TRAUMA. FOR  
CHILD/ADOLESCENT TRAUMAS, ASSESS  
PRE-TRAUMA SCHOOL PERFORMANCE AND  
POSSIBLE PRESENCE OF BEHAVIOR 
PROBLEMS]  
IF NO:  Have these (PTSD SYMPTOMS) 
affected any other important part of your 
life? [AS APPROPRIATE, SUGGEST  
EXAMPLES SUCH AS PARENTING, 
HOUSEWORK, SCHOOLWORK, VOLUNTEER 
WORK, ETC.]  How so?  
[LIFETIME -- IF NOT ALREADY CLEAR] Were you 
working then?  
IF YES: Did these (PTSD SYMPTOMS) affect 
your work or your ability to work? How so?  
[CONSIDER REPORTED WORK HISTORY,  
INCLUDING NUMBER AND DURATION OF  
JOBS, AS WELL AS THE QUALITY OF WORK  
RELATIONSHIPS. IF PREMORBID  
FUNCTIONING IS UNCLEAR, INQUIRE ABOUT  
WORK EXPERIENCES BEFORE THE  
TRAUMA. FOR CHILD/ADOLESCENT  
TRAUMAS, ASSESS PRE-TRAUMA SCHOOL  
PERFORMANCE AND POSSIBLE PRESENCE OF 
BEHAVIOR PROBLEMS]  
IF NO:  Did these (PTSD SYMPTOMS) affect any 
other important part of your life? [AS  
APPROPRIATE, SUGGEST EXAMPLES SUCH  
AS PARENTING, HOUSEWORK,  







No adverse impact  




Moderate impact, definite 
impairment, but  
many aspects of 
occupational/other 
important functioning still 
intact  
Severe impact, marked 
impairment, few aspects of 
occupational/other 
important  
functioning still intact  
Extreme impact, little or no 
occupational/other 
important functioning  
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Global Ratings  
23. global validity   
ESTIMATE THE OVERALL VALIDITY OF 
RESPONSES. CONSIDER FACTORS SUCH AS 
COMPLIANCE WITH THE  
0  Excellent, no reason to suspect invalid 
responses  
INTERVIEW, MENTAL STATUS (E.G., PROBLEMS 
WITH  
1  Good, factors present that may 
adversely  
CONCENTRATION, COMPREHENSION OF ITEMS, 
DISSOCIATION), AND EVIDENCE OF EFFORTS TO  
2  
affect validity  
Fair, factors present that definitely 
reduce  
EXAGGERATE OR MINIMIZE SYMPTOMS.   validity  
 3  
4  
Poor, substantially reduced validity  
Invalid responses, severely impaired 
mental status or possible deliberate 
“faking bad” or “faking good”  
24. global severity  
ESTIMATE THE OVERALL SEVERITY 
OF PTSD  
SYMPTOMS. CONSIDER DEGREE OF 
SUBJECTIVE DISTRESS, DEGREE OF  
FUNCTIONAL IMPAIRMENT, 
OBSERVATIONS OF BEHAVIORS IN 
INTERVIEW, AND JUDGMENT 






No clinically significant symptoms, no 
distress and no functional impairment  
Mild, minimal distress or functional 
impairment Moderate, definite distress 
or functional impairment but functions 
satisfactorily with effort  
Severe, considerable distress or 
functional impairment, limited 
functioning even with effort  
Extreme, marked distress or marked 
impairment in two or more major areas 
of functioning  
Past week  
_____  




25. global improvement   
RATE TOTAL OVERALL IMPROVEMENT PRESENT 
SINCE  
0  Asymptomatic  
THE INITIAL RATING.  IF NO EARLIER RATING, ASK 
HOW  
1  Considerable improvement  
THE SYMPTOMS ENDORSED HAVE CHANGED 
OVER THE  
2  Moderate improvement  
PAST 6 MONTHS.  RATE THE DEGREE OF 
CHANGE,   
3  Slight improvement  
WHETHER OR NOT, IN YOUR JUDGMENT, IT IS 
DUE TO  
4  No improvement  
TREATMENT.  5  Insufficient information  
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Current PTSD Symptoms  
Criterion A met (traumatic event)?  NO  YES  
_____ # Criterion B sx (> 1)?  NO  YES  
_____ # Criterion C sx (> 3)?  NO  YES  
_____ # Criterion D sx (> 2)?  NO  YES  
Criterion E met (duration > 1 month)? NO 
YES Criterion F met (distress/impairment)? 
NO YES  
___________________________________________  
CURRENT PTSD (Criteria A-F met)?  NO  YES  
IF CURRENT PTSD CRITERIA ARE MET, SKIP TO ASSOCIATED FEATURES 
 
IF CURRENT CRITERIA ARE NOT MET, ASSESS FOR LIFETIME PTSD. IDENTIFY A PERIOD OF 
AT LEAST A MONTH SINCE THE TRAUMATIC EVENT IN WHICH SYMPTOMS WERE WORSE.  
Since the (EVENT), has there been a time when 
these (PTSD SYMPTOMS) were a lot worse than they 
have been in the past month? When was that? How 
long did it last?  (At least a month?)  
IF MULTIPLE PERIODS IN THE PAST: When were you 
bothered the most by these (PTSD SYMPTOMS)?  
IF AT LEAST ONE PERIOD, INQUIRE ITEMS 1-17, CHANGING FREQUENCY PROMPTS TO REFER 
TO WORST PERIOD: During that time, did you (EXPERIENCE SYMPTOM)? How often?  
 
Criterion A met (traumatic event)?  NO  YES  
_____ # Criterion B sx (> 1)?  NO  YES  
_____ # Criterion C sx (> 3)?  NO  YES  
_____ # Criterion D sx (> 2)?  NO  YES  
Criterion E met (duration > 1 month)? NO 
YES Criterion F met (distress/impairment)? 
NO YES  
___________________________________________  




  Lifetime PTSD Symptoms  
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Associated Features  
26. guilt over acts of commission or omission  
Frequency  
Have you felt guilty about anything you 
did or didn’t do during (EVENT)? Tell 
me more about that.  (What do you feel 
guilty about?)  How much of the time 
have you felt that way in the past month 
(week)?  
0 None of the time  
1 Very little of the time (less than 10%)  
2 Some of the time (approx 20-30%)  
3 Much of the time (approx 50-60%)  
4 Most or all of the time (more than 
80%)  
Description/Examples   
Intensity  
How strong were these feelings of 
guilt? How much distress or 
discomfort did they cause?  
0 No feelings of guilt  
1 Mild, slight feelings of guilt  
2 Moderate, guilt feelings definitely 
present, some distress but still 
manageable  
3 Severe, marked feelings of guilt, 
considerable distress  
4 Extreme, pervasive feelings of guilt, 
selfcondemnation regarding 
behavior, incapacitating distress  




F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
27. survivor guilt [APPLICABLE ONLY IF MULTIPLE VICTIMS]   
Frequency  
Have you felt guilty about surviving 
(EVENT) when others did not? Tell me 
more about that. (What do you feel guilty 
about?)  How much of the time have 
you felt that way in the past month 
(week)?  
0 None of the time  
1 Very little of the time (less than 10%)  
2 Some of the time (approx 20-30%)  
3 Much of the time (approx 50-60%)  
4 Most or all of the time (more than 
80%)  
8  N/A   
Description/Examples   
Intensity  
How strong were these feelings of guilt? 
How much distress or discomfort did 
they cause?  
0 No feelings of guilt  
1 Mild, slight feelings of guilt  
2 Moderate, guilt feelings definitely 
present, some distress but still 
manageable  
3 Severe, marked feelings of guilt, 
considerable distress  
4 Extreme, pervasive feelings of guilt, 
selfcondemnation regarding survival, 
incapacitating distress  




F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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28. a reduction in awareness of his or her surroundings (e.g., “being in a daze”)   
Frequency  
Have there been times when you felt out 
of touch with things going on around 
you, like you were in a daze? What was 
that like?  
[DISTINGUISH FROM FLASHBACK 
EPISODES]  
How often has that happened in the past 
month (week)?  [IF NOT CLEAR:] (Was it 
due to an illness or the effects of drugs or 
alcohol?)  When did you first start feeling 
that way?  (After the [EVENT]?)  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples   
Intensity  
How strong was this feeling of being 
out of touch or in a daze?  (Were you 
confused about where you actually were 
or what you were doing at the time?)  How 
long did it last? What did you do while 
this was happening?  (Did other people 
notice your behavior? What did they say?)  
0 No reduction in awareness  
1 M ild, slight reduction in awareness  
2 Moderate, definite but transient 
reduction in awareness, may report 
feeling “spacy”  
3 Severe, marked reduction in 
awareness, may persist for several 
hours  
4 Extreme, complete loss of 
awareness of surroundings, may be 
unresponsive, possible amnesia for 
the episode (blackout)  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past 
week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
29. derealization  
Frequency  
Have there been times when you felt as if 
you were outside of your body, watching 
yourself as if you were another person?  
[IF NO:]  (What about times when your body 
felt strange or unfamiliar to you, as if it had 
changed in some way?)   What was that 
like? How often has that happened in the 
past month (week)? [IF NOT CLEAR:]  
(Was it due to an illness or the effects of 
drugs or alcohol?)  When did you first start 
feeling that way?  (After the [EVENT]?)  
0 Never  
1 Once or twice  
2 Once or twice a week  
3 Several times a week  
4 Daily or almost every day  
Description/Examples   
Intensity  
How strong was (DEREALALIZATION)? 
How lond did it last? What did you do  
while this was happening?  (Did other 
people notice your behavior? What did they 
say?)  
0 No derealalization  
1 Mild, slight derealalization  
2 Moderate, definite but transient 
derealalization  
3 Severe, considerable derealalization, 
marked confusion about what is real, 
may persist for several hours  
4 Extreme, profound derealalization, 
dramatic loss of sense of reality or 
familiarity  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past 
week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
 





Have there been times when you felt as if 
you were outside of your body, watching 
yourself as if you were another person?  
[IF NO:]  (What about times when your body 
felt strange or unfamiliar to you, as if it had 
changed in some way?)   What was that 
like? How often has that happened in the 
past month (week)? [IF NOT CLEAR:]  
(Was it due to an illness or the effects of 
drugs or alcohol?)  When did you first start 
feeling that way?  (After the [EVENT]?)  
5 Never  
6 Once or twice  
7 Once or twice a week  
8 Several times a week  
9 Daily or almost every day  
Description/Examples   
Intensity  
How strong was 
(DEPERSONALIZATION)? How  
long did it last? What did you do while 
this was happening?  (Did other people 
notice your behavior? What did they say?)  
5 No depersonalization  
6 M ild, slight depersonalization  
7 Moderate, definite but transient 
depersonalization  
8 Severe, considerable 
depersonalization, marked sense of 
detachment from self, may  
persist for several hours  
9 Extreme, profound depersonalization, 
dramatic sense of detachment from 
self  
QV (specify)  
_______________________________  
Trauma-related?    1 definite 2 probable 3 
unlikely     
 Current  _____  Lifetime _____  
Past 
week  
F _____  
I  _____  
Past 
month  
F _____  
I  _____  
Sx: Y N   
Lifetime 
F _____  
I  _____  
Sx: Y N   
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CAPS SUMMARY SHEET  
Name:________ ID#:________ Interviewer:________ Study:_______ Date:____  
A. Traumatic event:   
B. Reexperiencing symptoms  PAST WEEK  PAST MONTH  LIFETIME   
 Freq  Int  F+I  Freq  Int  F+I  Freq  Int  F+I  
(1) intrusive recollections           
(2) distressing dreams           
(3) acting or feeling as if event were recurring           
(4) psychological distress at exposure to cues           
(5) physiological reactivity on exposure to 
cues  
         
B subtotals           
Number of Criterion B symptoms (need 1)           
C. Avoidance and numbing symptoms  PAST WEEK  PAST MONTH  LIFETIME   
 Freq  Int  F+I  Freq  Int  F+I  Freq  Int  F+I  
(6) avoidance of thoughts or feelings           
(7) avoidance of activities, places, or people           
(8) inability to recall important aspect of 
trauma  
         
(9) diminished interest in activities           
(10) detachment or estrangement           
(11) restricted range of affect           
(12) sense of a foreshortened future           
C subtotals           
Number of Criterion C symptoms (need 3)           
D. Hyperarousal symptoms  PAST WEEK  PAST MONTH  LIFETIME   
 Freq  Int  F+I  Freq  Int  F+I  Freq  Int  F+I  
(13) difficulty falling or staying asleep           
(14) irritability or outbursts of anger           
(15) difficulty concentrating           
(16) hypervigilance           
(17) exaggerated startle response           
D subtotals           
Number of Criterion D symptoms (need 2)           
 
Total Freq, Int, and Severity (F+I)  PAST WEEK  PAST MONTH  LIFETIME   
 Freq  Int  F+I  Fre
q  
Int  F+I  Freq  Int  F+I  
Sum of subtotals (B+C+D)           
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E. Duration of disturbance  CURRENT  LIFETIME  
(19) duration of disturbance at least one month  NO    YES  NO    YES  
PTSD diagnosis  CURRENT  LIFETIME  
PTSD PRESENT -- ALL CRITERIA (A-F) MET?  NO     YES  NO     YES  
Specify:  
(18) with delayed onset (> 6 months delay)  NO    YES  NO    YES  
(19) acute (< 3 months) or chronic (> 3 months)  acute    chronic  acute    chronic  
F. Significant distress or impairment in functioning  PAST WEEK  PAST MONTH  LIFETIME  
    
(20) subjective distress     
(21) impairment in social functioning     
(22) impairment in occupational functioning    
 AT LEAST ONE > 2?  NO    YES  NO    YES  NO    YES  
Global ratings  PAST WEEK  PAST MONTH  LIFETIME  
(23) global validity     
(24) global severity     
(25) global improvement     
Associated features  PAST WEEK  PAST MONTH   LIFETIME   
 Freq  Int  F+I  Freq  Int  F+I  Freq  Int  F+I  
(26) guilt over acts of commission or 
omission  
         
(27) survivor guilt           
(28) reduction in awareness of surroundings           
(29) derealization           
(30) depersonalization           
  
SIDES and TAQ  A25-1 
APPENDIX 25  SIDES and TAQ 









SIDES and TAQ  A25-3 
The Traumatic Antecedent Questionnaire (TAQ) is suggested to be used prior 
to SIDES. 
TAQ Revised 3.2010, Bessel A. van der Kolk,  
  
1. I generally felt safe and cared for 
2. Someone made sure I got up in the morning and went to school.  
3. I was really good at something (like sports, a hobby, school, work or some 
creative activity).  
4. I had good friends.  
5. I felt close to at least one of my brothers and sisters. 
6. Somebody in my family had so many problems that there was little left for 
me 
7. I felt that nobody cared whether I lived or died. 
8. I had someone to talk with outside my family when something was bugging 
me  
9. My parents confided things in me that made me feel uncomfortable.  
10. My parents were divorced or separated 
11. I lived with different people at different times (like different relatives, or 
foster families).  
12. I had a serious illness and/or had to be hospitalized for a medical problem. 
13. Someone I was close to was very sick, or in an accident for which they 
needed to be hospitalized. 
14. I received news that someone close to me had been seriously injured or 
violently killed during an accident, a fight, or a crime. 
15. In my parents’ eyes, nothing I did was ever good enough.  
16. People in my family called me insulting names.  
17. The rules in my family were unclear and inconsistent. 
18. The punishments I received were unfair.  
19. My parents hurt each other physically when they argued and fought.  
20. I spent time out of the house and no one knew where I was.  
21. People in my family were out of control. 
22. I witnessed physical violence in my family.  
23. Someone in my family got medical attention because of violence. 
24. Someone in my family had a problem with alcohol and/or drugs 
25. I abused alcohol and/or drugs. 
  
SIDES and TAQ  A25-4 
26. My caregivers were so into alcohol or drugs that they couldn't take care of 
me 
27. I was beaten, kicked or punched by someone close to me.  
28. I was in a situation in which I was convinced that I would be physically 
injured or lose my life. 
29. Someone outside my family attacked me. 
30. I saw dead bodies 
31. I was involved in a serious accident.  
32. I was in a natural disaster.  
33. I saw sexual things that scared me.  
34. Someone (older) touched me sexually, against my wishes or tried to make 
me touch them 
35. Someone forced me to have sex against my will.  
36. Someone threatened me with physical harm unless I did something sexual.  
37. I believe that one of my brothers or sisters was sexually molested. 
38. I have had another very frightening or traumatic experience where I felt 
intense fear, helpless, or horrified.  
39. Something terrible happened to me that still remain a mystery to me.  
40. How upsetting was it to answer these questions? 
  
Scoring Sheet  A26-1 




Internal Validity Expert Assessment  A27-1 
APPENDIX 27  Internal Validity, 10 Experts Assessment 
 
This appendix outlines one of the 2 exercises to improve the internal validity of BTERS. 
Here, a number of different specialists scored the selected sub items (Section 5.7) as to 
whether or not they considered the particular item to be important. Different weightings 
were then assigned to the various experts as shown below and the overall summary 
examined in order to see if a pattern emerged. Unfortunately, no discernible pattern 
emerged and this particular method was abandoned in favour of the 3 expert review 
described in (Section 5.7). In the tables below, Green represents a high score, red 




1 Did you experience or witness TE in your childhood 11 18 24 10
2 Was it before the age 13 11 16 18 8
3 Was it after age 13 11 18 24 10
4 Was it repeated 11 18 24 10
5 Was it life threatening 11 16 18 8
6 Was it sexual abuse 11 16 18 8
7 Was it physical abuse 11 18 24 10
8 Was it non life threatening 3 9 20 7
9 Always a familly member, or carer 0 0 0 0
10 Was it inappropriate touching of your sexual parts 9 13 17 7
11 Did you feel rejected 9 15 23 9
12 Did you feel unloved 9 15 23 9
13 Did you think you were no good enough 9 15 23 9
14 Did you think you were permanently damaged 9 13 17 7
15 Abandonment 5 12 21 8
16 Did you loose trust in people 9 13 17 7
17 Intense distress 11 18 24 10
18 Flashbacks 11 18 24 10
19 Nightmares 11 18 24 10
20 Avoiding people and places that will cause you distress 11 18 24 10
21 Intense anger 4 10 19 7
22 Intense sense of fear 11 18 24 10




Internal Validity Expert Assessment  A27-2 
Disipline PTSD CPTSD CPTSD BPD BPD BPD All BPD BPD BPD
CPTSD 2 3 3 0 1 1 1 0 0 0
PTSD 3 3 3 1 2 1 2 1 1 1
BPD 1 1 2 3 3 3 2 3 3 3
Sub items Expert 1 Expert 2 Expert 3 Expert 4 Expert 5 Expert 6 Expert 7 Expert 8 Expert 9 Expert 10
Did you experience or witness 
TE in your childhood
1 1 1 1 1 1 1 1 1 1
Was it before the age 13 1 1 1 1 1 1 1 1 0 0
Was it after age 13 1 1 1 1 1 1 1 1 1 1
Was it repeated 1 1 1 1 1 1 1 1 1 1
Was it life threatening 1 1 1 1 1 1 1 1 0 0
Was it sexual abuse 1 1 1 1 1 1 1 1 0 0
Was it physical abuse 1 1 1 1 1 1 1 1 1 1
Was it non life threatening 0 0 0 1 1 1 1 1 1 1
Always a familly member, or 
carer
0 0 0 0 0 0 0 0 0 0
Was it inappropriate touching 
of your sexual parts
0 1 1 1 1 1 1 0 0 1
Did you feel rejected 0 1 1 1 1 1 1 1 1 1
Did you feel unloved 0 1 1 1 1 1 1 1 1 1
Did you think you were no 
good enough
0 1 1 1 1 1 1 1 1 1
Did you think you were 
permanently damaged
0 1 1 1 1 1 1 0 0 1
Abandonment 1 0 0 1 1 1 1 1 1 1
Did you loose trust in people 0 1 1 1 1 1 1 0 0 1
Intense distress 1 1 1 1 1 1 1 1 1 1
Flashbacks 1 1 1 1 1 1 1 1 1 1
Nightmares 1 1 1 1 1 1 1 1 1 1
Avoiding people and places 
that will cause you distress
1 1 1 1 1 1 1 1 1 1
Intense anger 1 0 0 1 1 1 0 1 1 1
Intense sense of fear 1 1 1 1 1 1 1 1 1 1
Irritable and jumpy when 
unexpectedly startled
1 1 1 1 1 1 1 1 1 1
15 19 19 22 22 22 21 19 16 19
 
Results, Stage 2 A28-1 





PTSD CPTSD PTSD CPTSD CAPS SIDES 
Researcher Independent PTSD CPTSD 
1 1 1 0 1 0 1 1 1 
2 0 1 0 0 0 0 0 0 
3 1 1 0 0 0 0 0 0 
4 1 1 0 0 0 0 0 0 
5 1 1 0 0 0 0 0 0 
6 1 1 0 0 0 0 0 0 
7 1 1 0 0 0 0 0 0 
8 1 1 0 0 0 0 0 0 
9 1 1 0 0 0 0 0 0 
10 1 1 0 1 0 1 1 1 
11 1 1 1 0 1 0 1 0 
12 1 1 0 0 0 0 0 0 
13 1 1 0 1 0 1 1 1 
14 1 1 1 1 1 1 1 1 
15 0 1 1 0 1 0 1 0 
16 1 1 1 0 1 0 1 0 
17 1 1 1 0 1 0 1 1 
18 1 1 0 0 0 0 0 0 
19 1 1 0 0 0 0 0 0 
20 1 1 0 0 0 0 0 0 
21 1 1 1 1 1 1 1 1 
22 1 1 0 0 0 0 0 0 
23 1 1 0 0 0 0 0 0 
24 1 1 0 0 0 0 0 0 
25 1 1 0 0 0 0 0 0 
26 1 1 0 0 0 0 0 0 
27 1 1 0 0 0 0 0 0 
28 1 1 1 1 1 1 1 1 
29 1 1 1 0 1 0 1 0 
30 1 1 1 0 1 0 1 0 
31 1 1 1 0 1 0 0 0 
32 1 1 1 0 0 0 0 0 
33 1 1 0 0 0 0 0 0 
34 1 1 1 1 1 1 1 1 
35 1 1 1 0 1 0 0 0 
36 1 1 0 0 0 0 0 0 
37 0 1 1 0 1 0 1 0 
38 1 1 1 1 1 1 1 1 
39 1 1 1 0 1 0 1 0 





Quality Assurance  A29-1 
APPENDIX 29  Quality Assurance Results 
STARD 
1 Title (Screen) Screen not in title as only one of the 4 objectives 
2 Objectives Yes, objective number 4 
3 Population description Those already identified with BPD presentations 
4 Recruitment description Detailed in text and checked with Steering Group 
5 Sampling description Not sampled due to limited resource  
6 Data collection Methodology described 
7 
Reference standard and 
rationale 




BTERS validated with expert groups 
9 Categorisation Scoring sheet utilised 
10 
Qualification, training of 
interviewers 
Qualified clinicians were all briefed on objectives 
11 Blindness Scorer was blind to patient’s diagnosis 
12 Diagnostics Identified by CAPS/SIDES 
13 Reproducibility Test-retest performed 
14 Reporting timing 
Written reports were all completed and reported to 
clinicians and patients 
15 Applicable population One large psychiatric hospital 
16 Results  Percentage identifies and compared with literature 
17 
Time between screen 
and standard 
Break introduced to allow recovery 
18 Severity Patient suitability confirmed with clinicians, 
19 Cross tabulation Comparison with stage 1 
20 Adverse events Safeguarding procedure explained  
21 Accuracy 
Calculated by SPSS and discussed with Steering 
Group 
22 
What happened to those 
who dropped out 
Well understood at group sessions 
23 Subgroup Variability  No subgroups 
24 Reproducibility estimates Addressed in validity and limitations discussions 
25 Clinical Applicability 
For ‘common-point-of-entry’ and initial assessment 
in BPD clinics 
 
